Query 022617
Match_columns 294
No_of_seqs 178 out of 1542
Neff 10.5
Searched_HMMs 46136
Date Fri Mar 29 04:54:24 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/022617.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/022617hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0575 Polo-like serine/threo 100.0 7.1E-59 1.5E-63 397.6 25.5 264 17-281 18-283 (592)
2 KOG0615 Serine/threonine prote 100.0 1.5E-59 3.3E-64 384.3 16.9 264 10-273 165-442 (475)
3 KOG0581 Mitogen-activated prot 100.0 4.1E-57 8.8E-62 366.7 23.3 261 14-278 76-345 (364)
4 KOG0598 Ribosomal protein S6 k 100.0 1.5E-56 3.2E-61 363.3 21.5 260 14-274 22-287 (357)
5 KOG0592 3-phosphoinositide-dep 100.0 5E-55 1.1E-59 368.8 21.4 260 14-274 70-344 (604)
6 KOG0595 Serine/threonine-prote 100.0 5.5E-54 1.2E-58 351.7 24.4 265 12-278 5-278 (429)
7 KOG0583 Serine/threonine prote 100.0 2.4E-53 5.1E-58 362.9 28.0 262 12-273 12-280 (370)
8 KOG0616 cAMP-dependent protein 100.0 2E-53 4.4E-58 334.8 21.3 267 14-283 41-317 (355)
9 KOG0588 Serine/threonine prote 100.0 1.3E-53 2.8E-58 367.6 21.4 261 14-274 9-269 (786)
10 KOG0593 Predicted protein kina 100.0 2.7E-54 5.9E-59 340.9 13.5 271 16-288 1-304 (396)
11 KOG0591 NIMA (never in mitosis 100.0 2.8E-54 6.1E-59 337.6 9.7 248 13-262 15-275 (375)
12 KOG0661 MAPK related serine/th 100.0 3.8E-53 8.3E-58 352.3 15.3 261 12-275 5-298 (538)
13 KOG0198 MEKK and related serin 100.0 5.1E-52 1.1E-56 341.7 20.1 258 16-276 16-284 (313)
14 KOG0597 Serine-threonine prote 100.0 1.7E-52 3.7E-57 354.9 17.0 257 16-275 1-258 (808)
15 cd05612 STKc_PRKX_like Catalyt 100.0 1.9E-51 4.1E-56 345.6 23.3 254 17-273 1-259 (291)
16 PTZ00263 protein kinase A cata 100.0 3.2E-51 7E-56 349.8 25.0 255 16-273 17-276 (329)
17 KOG0582 Ste20-like serine/thre 100.0 8.7E-51 1.9E-55 336.0 25.0 272 7-280 16-305 (516)
18 KOG0605 NDR and related serine 100.0 3.9E-51 8.4E-56 345.2 22.8 259 14-274 138-451 (550)
19 cd05571 STKc_PKB Catalytic dom 100.0 9.2E-51 2E-55 346.2 24.3 251 23-274 1-257 (323)
20 KOG0610 Putative serine/threon 100.0 1.8E-50 4E-55 331.3 23.7 265 9-274 69-398 (459)
21 PTZ00426 cAMP-dependent protei 100.0 3.5E-50 7.6E-55 344.3 25.0 260 12-274 25-290 (340)
22 KOG0578 p21-activated serine/t 100.0 3.3E-51 7.2E-56 347.9 17.3 261 13-278 269-533 (550)
23 KOG0659 Cdk activating kinase 100.0 2.3E-50 5E-55 313.1 20.4 255 17-273 2-286 (318)
24 cd05631 STKc_GRK4 Catalytic do 100.0 1.3E-49 2.8E-54 333.5 25.4 256 18-274 1-267 (285)
25 cd05585 STKc_YPK1_like Catalyt 100.0 1.2E-49 2.5E-54 338.0 25.0 249 25-274 1-253 (312)
26 cd05595 STKc_PKB_beta Catalyti 100.0 1.6E-49 3.4E-54 338.6 25.3 250 23-273 1-256 (323)
27 KOG0033 Ca2+/calmodulin-depend 100.0 7.3E-52 1.6E-56 318.4 9.1 276 13-290 7-289 (355)
28 cd05593 STKc_PKB_gamma Catalyt 100.0 1.9E-49 4.2E-54 338.6 25.1 250 23-273 1-256 (328)
29 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 2.3E-49 4.9E-54 339.2 24.4 255 17-274 1-263 (333)
30 KOG0694 Serine/threonine prote 100.0 7.7E-50 1.7E-54 346.1 21.4 260 13-274 364-630 (694)
31 KOG0580 Serine/threonine prote 100.0 1.5E-50 3.3E-55 309.7 14.8 263 10-274 15-279 (281)
32 KOG0600 Cdc2-related protein k 100.0 1E-49 2.2E-54 334.1 20.6 260 10-271 110-403 (560)
33 KOG0201 Serine/threonine prote 100.0 7.7E-52 1.7E-56 341.7 7.3 276 14-292 10-287 (467)
34 cd05590 STKc_nPKC_eta Catalyti 100.0 4.4E-49 9.5E-54 335.4 24.5 251 23-274 1-259 (320)
35 cd05587 STKc_cPKC Catalytic do 100.0 9.7E-49 2.1E-53 334.0 26.4 256 18-274 1-263 (324)
36 KOG0611 Predicted serine/threo 100.0 7.1E-50 1.5E-54 327.5 18.0 259 13-272 49-307 (668)
37 cd05573 STKc_ROCK_NDR_like Cat 100.0 1.7E-49 3.6E-54 342.4 21.4 256 17-274 1-291 (350)
38 KOG0660 Mitogen-activated prot 100.0 1.6E-49 3.4E-54 321.3 19.1 260 13-274 18-316 (359)
39 KOG0192 Tyrosine kinase specif 100.0 1.9E-48 4.2E-53 329.8 26.3 251 13-267 37-298 (362)
40 cd05628 STKc_NDR1 Catalytic do 100.0 1.8E-48 3.8E-53 337.3 26.5 256 17-274 1-299 (363)
41 cd05594 STKc_PKB_alpha Catalyt 100.0 4.4E-49 9.5E-54 336.2 22.1 251 23-274 1-258 (325)
42 cd05591 STKc_nPKC_epsilon Cata 100.0 1.4E-48 3E-53 332.6 24.5 251 23-274 1-260 (321)
43 KOG0585 Ca2+/calmodulin-depend 100.0 2.7E-49 5.8E-54 329.3 19.5 264 14-278 94-382 (576)
44 cd05589 STKc_PKN Catalytic dom 100.0 1.7E-48 3.6E-53 332.5 25.0 254 19-274 1-263 (324)
45 KOG0589 Serine/threonine prote 100.0 1.6E-49 3.4E-54 335.2 17.9 259 15-275 2-265 (426)
46 cd05599 STKc_NDR_like Catalyti 100.0 1.3E-48 2.9E-53 338.4 23.9 256 17-274 1-302 (364)
47 cd05588 STKc_aPKC Catalytic do 100.0 2.5E-48 5.4E-53 332.0 24.7 250 23-273 1-267 (329)
48 cd05570 STKc_PKC Catalytic dom 100.0 3E-48 6.6E-53 330.0 24.9 251 23-274 1-258 (318)
49 cd05620 STKc_nPKC_delta Cataly 100.0 3.3E-48 7.2E-53 329.4 25.0 251 23-274 1-254 (316)
50 cd07848 STKc_CDKL5 Catalytic d 100.0 2.4E-48 5.2E-53 326.2 23.8 253 17-271 1-287 (287)
51 cd05575 STKc_SGK Catalytic dom 100.0 2.1E-48 4.6E-53 331.8 23.7 250 23-273 1-256 (323)
52 KOG0032 Ca2+/calmodulin-depend 100.0 7.4E-48 1.6E-52 328.9 26.7 261 12-274 30-299 (382)
53 cd05616 STKc_cPKC_beta Catalyt 100.0 4.6E-48 1E-52 329.7 25.4 255 18-273 1-262 (323)
54 cd07871 STKc_PCTAIRE3 Catalyti 100.0 5.1E-48 1.1E-52 324.4 25.0 253 16-271 4-288 (288)
55 cd05584 STKc_p70S6K Catalytic 100.0 4.9E-48 1.1E-52 329.5 25.2 252 22-274 1-262 (323)
56 cd05592 STKc_nPKC_theta_delta 100.0 5.9E-48 1.3E-52 327.9 25.1 251 23-274 1-254 (316)
57 cd05629 STKc_NDR_like_fungal C 100.0 3.3E-48 7.1E-53 337.3 23.7 256 17-274 1-311 (377)
58 cd05626 STKc_LATS2 Catalytic d 100.0 7.6E-48 1.6E-52 335.3 25.9 257 17-274 1-311 (381)
59 KOG0197 Tyrosine kinases [Sign 100.0 1.8E-48 4E-53 329.9 21.3 248 14-267 203-456 (468)
60 cd07869 STKc_PFTAIRE1 Catalyti 100.0 6.4E-48 1.4E-52 326.1 24.4 258 16-276 4-296 (303)
61 cd05618 STKc_aPKC_iota Catalyt 100.0 6.3E-48 1.4E-52 329.4 24.5 251 23-274 1-268 (329)
62 cd05605 STKc_GRK4_like Catalyt 100.0 9.9E-48 2.1E-52 322.1 25.1 255 18-273 1-266 (285)
63 cd06649 PKc_MEK2 Catalytic dom 100.0 3E-47 6.4E-52 325.7 28.5 257 15-275 3-308 (331)
64 cd05614 STKc_MSK2_N N-terminal 100.0 1E-47 2.2E-52 328.8 24.8 257 18-274 1-273 (332)
65 cd05625 STKc_LATS1 Catalytic d 100.0 8.3E-48 1.8E-52 335.4 24.3 256 17-274 1-311 (382)
66 cd05601 STKc_CRIK Catalytic do 100.0 3.5E-48 7.6E-53 331.5 21.5 257 17-274 1-269 (330)
67 cd05619 STKc_nPKC_theta Cataly 100.0 1.6E-47 3.6E-52 325.1 25.3 251 23-274 1-254 (316)
68 cd05598 STKc_LATS Catalytic do 100.0 5.7E-48 1.2E-52 335.8 22.7 256 17-274 1-307 (376)
69 cd05596 STKc_ROCK Catalytic do 100.0 1.3E-47 2.7E-52 332.3 24.3 259 14-273 40-309 (370)
70 cd05580 STKc_PKA Catalytic dom 100.0 4.4E-47 9.5E-52 319.0 26.8 255 17-274 1-260 (290)
71 cd05615 STKc_cPKC_alpha Cataly 100.0 2.5E-47 5.4E-52 325.0 25.4 256 18-274 1-263 (323)
72 cd05582 STKc_RSK_N N-terminal 100.0 5E-48 1.1E-52 328.8 20.9 251 22-274 1-260 (318)
73 cd07876 STKc_JNK2 Catalytic do 100.0 3.7E-47 8.1E-52 328.7 26.5 266 14-284 18-331 (359)
74 cd05627 STKc_NDR2 Catalytic do 100.0 1.1E-47 2.5E-52 331.9 22.7 256 17-274 1-299 (360)
75 cd05604 STKc_SGK3 Catalytic do 100.0 1.3E-47 2.9E-52 327.1 22.8 251 23-274 1-257 (325)
76 PLN00034 mitogen-activated pro 100.0 6E-47 1.3E-51 326.6 27.1 259 13-277 70-337 (353)
77 cd05603 STKc_SGK2 Catalytic do 100.0 2.3E-47 4.9E-52 325.2 23.8 250 23-273 1-256 (321)
78 cd07859 STKc_TDY_MAPK_plant Ca 100.0 3E-47 6.4E-52 326.8 24.6 256 18-276 1-298 (338)
79 cd05608 STKc_GRK1 Catalytic do 100.0 5.3E-47 1.1E-51 316.9 24.9 249 25-274 1-263 (280)
80 cd05617 STKc_aPKC_zeta Catalyt 100.0 4.8E-47 1E-51 323.8 25.1 251 23-274 1-266 (327)
81 KOG0599 Phosphorylase kinase g 100.0 1.8E-48 4E-53 304.1 14.1 266 12-277 12-292 (411)
82 cd05602 STKc_SGK1 Catalytic do 100.0 3.4E-47 7.4E-52 324.6 23.4 250 23-273 1-256 (325)
83 cd05621 STKc_ROCK2 Catalytic d 100.0 3.9E-47 8.4E-52 329.0 24.0 261 13-274 39-310 (370)
84 cd06625 STKc_MEKK3_like Cataly 100.0 2.4E-46 5.3E-51 310.0 27.8 254 17-271 2-263 (263)
85 cd05607 STKc_GRK7 Catalytic do 100.0 1.7E-46 3.6E-51 313.5 25.7 249 25-274 1-260 (277)
86 cd05586 STKc_Sck1_like Catalyt 100.0 2.3E-47 5.1E-52 326.3 20.9 250 25-274 1-259 (330)
87 cd05630 STKc_GRK6 Catalytic do 100.0 1.5E-46 3.3E-51 314.9 25.1 256 18-274 1-267 (285)
88 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.1E-46 2.4E-51 319.3 24.4 269 16-287 5-305 (309)
89 cd07862 STKc_CDK6 Catalytic do 100.0 1.3E-46 2.9E-51 316.1 24.4 252 17-271 1-290 (290)
90 cd05622 STKc_ROCK1 Catalytic d 100.0 1.4E-46 3E-51 325.8 25.0 262 12-274 38-310 (371)
91 cd06650 PKc_MEK1 Catalytic dom 100.0 3.9E-46 8.4E-51 318.9 27.3 258 15-276 3-307 (333)
92 PF00069 Pkinase: Protein kina 100.0 3.4E-47 7.3E-52 314.5 19.8 251 19-271 1-260 (260)
93 KOG0667 Dual-specificity tyros 100.0 3.8E-47 8.3E-52 328.7 20.8 254 13-274 182-508 (586)
94 PTZ00036 glycogen synthase kin 100.0 1.3E-46 2.7E-51 332.4 24.3 253 15-275 64-358 (440)
95 KOG0663 Protein kinase PITSLRE 100.0 4.5E-47 9.7E-52 303.6 19.1 255 17-273 76-366 (419)
96 PHA03212 serine/threonine kina 100.0 2.5E-46 5.4E-51 325.7 25.3 249 15-274 90-382 (391)
97 cd07874 STKc_JNK3 Catalytic do 100.0 2.6E-46 5.6E-51 323.0 25.0 259 14-277 14-320 (355)
98 cd05574 STKc_phototropin_like 100.0 6.5E-46 1.4E-50 315.7 26.7 257 17-274 1-295 (316)
99 cd07875 STKc_JNK1 Catalytic do 100.0 2.6E-46 5.6E-51 324.0 24.6 260 14-278 21-328 (364)
100 cd05632 STKc_GRK5 Catalytic do 100.0 6.4E-46 1.4E-50 311.2 26.2 256 18-274 1-267 (285)
101 cd05597 STKc_DMPK_like Catalyt 100.0 4.5E-46 9.8E-51 318.3 25.7 257 17-273 1-271 (331)
102 KOG0594 Protein kinase PCTAIRE 100.0 2E-46 4.4E-51 303.9 22.0 257 16-274 10-308 (323)
103 cd07853 STKc_NLK Catalytic dom 100.0 2.2E-46 4.7E-51 325.4 23.9 255 18-274 1-294 (372)
104 cd05578 STKc_Yank1 Catalytic d 100.0 1.3E-46 2.8E-51 310.9 21.4 253 18-271 1-258 (258)
105 KOG4717 Serine/threonine prote 100.0 5E-47 1.1E-51 318.9 18.9 263 13-276 14-278 (864)
106 PTZ00284 protein kinase; Provi 100.0 3.1E-46 6.7E-51 333.1 25.2 262 13-282 125-452 (467)
107 cd05572 STKc_cGK_PKG Catalytic 100.0 8.5E-46 1.8E-50 306.7 25.7 249 25-274 1-258 (262)
108 KOG0658 Glycogen synthase kina 100.0 2.5E-47 5.4E-52 309.1 15.5 255 15-277 22-315 (364)
109 PTZ00267 NIMA-related protein 100.0 9.9E-46 2.2E-50 330.1 26.9 256 15-274 65-329 (478)
110 PTZ00283 serine/threonine prot 100.0 1.1E-45 2.4E-50 330.1 27.1 265 10-276 25-305 (496)
111 cd07863 STKc_CDK4 Catalytic do 100.0 6.8E-46 1.5E-50 311.5 23.8 251 18-271 1-288 (288)
112 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.2E-45 2.6E-50 311.9 25.4 264 16-282 5-300 (301)
113 cd06609 STKc_MST3_like Catalyt 100.0 7.9E-46 1.7E-50 308.9 23.8 256 17-276 1-259 (274)
114 cd06628 STKc_MAPKKK_Byr2_like 100.0 3.1E-45 6.6E-50 304.2 26.7 253 18-271 1-267 (267)
115 cd05623 STKc_MRCK_alpha Cataly 100.0 1.5E-45 3.3E-50 315.3 25.1 258 17-274 1-272 (332)
116 cd08223 STKc_Nek4 Catalytic do 100.0 6.2E-45 1.3E-49 300.6 27.7 252 18-271 1-257 (257)
117 cd08529 STKc_FA2-like Catalyti 100.0 5.7E-45 1.2E-49 300.6 27.4 252 18-271 1-256 (256)
118 cd05624 STKc_MRCK_beta Catalyt 100.0 1.4E-45 3.1E-50 315.3 24.0 257 17-273 1-271 (331)
119 cd05609 STKc_MAST Catalytic do 100.0 6.7E-45 1.4E-49 307.9 27.7 256 17-273 1-278 (305)
120 cd06611 STKc_SLK_like Catalyti 100.0 3.9E-45 8.5E-50 305.7 25.5 256 16-274 4-268 (280)
121 cd07847 STKc_CDKL1_4 Catalytic 100.0 3.9E-45 8.4E-50 306.5 25.3 254 17-271 1-286 (286)
122 cd06615 PKc_MEK Catalytic doma 100.0 9.2E-45 2E-49 307.4 27.0 254 17-274 1-293 (308)
123 cd05577 STKc_GRK Catalytic dom 100.0 4.3E-45 9.4E-50 305.0 24.7 249 25-274 1-260 (277)
124 cd06655 STKc_PAK2 Catalytic do 100.0 8.4E-45 1.8E-49 305.9 26.0 261 11-276 13-277 (296)
125 cd06631 STKc_YSK4 Catalytic do 100.0 1.4E-44 3.1E-49 299.9 26.8 252 18-271 1-265 (265)
126 cd07878 STKc_p38beta_MAPK11 Ca 100.0 3.4E-45 7.4E-50 314.6 23.9 257 14-275 12-305 (343)
127 cd06632 STKc_MEKK1_plant Catal 100.0 1.3E-44 2.8E-49 298.8 26.4 254 18-271 1-258 (258)
128 cd08220 STKc_Nek8 Catalytic do 100.0 1.5E-44 3.2E-49 298.1 26.2 252 18-271 1-256 (256)
129 cd06605 PKc_MAPKK Catalytic do 100.0 4E-45 8.8E-50 303.1 22.9 255 17-275 1-264 (265)
130 KOG0690 Serine/threonine prote 100.0 1.7E-46 3.7E-51 299.7 13.9 260 13-273 164-429 (516)
131 cd06644 STKc_STK10_LOK Catalyt 100.0 3.1E-44 6.8E-49 302.0 28.4 258 15-275 10-276 (292)
132 cd06654 STKc_PAK1 Catalytic do 100.0 1.8E-44 3.8E-49 304.0 26.9 270 10-286 13-286 (296)
133 cd06610 STKc_OSR1_SPAK Catalyt 100.0 1.6E-44 3.4E-49 299.7 26.2 253 17-271 1-267 (267)
134 cd06630 STKc_MEKK1 Catalytic d 100.0 8.2E-45 1.8E-49 301.7 24.2 254 18-272 1-268 (268)
135 cd08221 STKc_Nek9 Catalytic do 100.0 3.6E-44 7.8E-49 296.0 27.6 252 18-271 1-256 (256)
136 PTZ00266 NIMA-related protein 100.0 9.8E-45 2.1E-49 335.5 26.9 269 8-277 4-304 (1021)
137 cd06651 STKc_MEKK3 Catalytic d 100.0 2.5E-44 5.4E-49 298.6 26.7 254 17-272 2-265 (266)
138 cd07861 STKc_CDK1_euk Catalyti 100.0 1.5E-44 3.2E-49 302.9 25.2 252 18-271 1-285 (285)
139 cd06643 STKc_SLK Catalytic dom 100.0 3.9E-44 8.4E-49 300.0 27.4 256 18-276 6-270 (282)
140 cd06645 STKc_MAP4K3 Catalytic 100.0 1.6E-44 3.5E-49 299.8 25.0 251 16-270 8-267 (267)
141 cd06612 STKc_MST1_2 Catalytic 100.0 2.1E-44 4.5E-49 297.3 25.4 250 16-271 2-256 (256)
142 cd06613 STKc_MAP4K3_like Catal 100.0 2.3E-44 5.1E-49 298.0 25.8 251 16-270 2-262 (262)
143 cd08227 PK_STRAD_alpha Pseudok 100.0 1.8E-44 3.9E-49 308.1 25.8 253 21-274 2-313 (327)
144 cd08218 STKc_Nek1 Catalytic do 100.0 3E-44 6.5E-49 296.4 26.1 252 18-271 1-256 (256)
145 PHA02988 hypothetical protein; 100.0 2.1E-44 4.6E-49 301.4 25.5 240 23-267 26-274 (283)
146 cd07832 STKc_CCRK Catalytic do 100.0 2.3E-44 5.1E-49 301.8 25.7 253 18-272 1-286 (286)
147 cd07841 STKc_CDK7 Catalytic do 100.0 1.7E-44 3.6E-49 304.5 24.9 257 18-275 1-289 (298)
148 cd07850 STKc_JNK Catalytic dom 100.0 1.6E-44 3.5E-49 311.6 25.3 259 14-277 13-320 (353)
149 cd08217 STKc_Nek2 Catalytic do 100.0 4E-44 8.6E-49 296.8 26.7 252 18-271 1-265 (265)
150 PHA03207 serine/threonine kina 100.0 1.6E-44 3.5E-49 315.4 25.4 260 13-282 88-389 (392)
151 cd06656 STKc_PAK3 Catalytic do 100.0 1.3E-44 2.9E-49 304.9 24.0 266 11-281 13-282 (297)
152 cd05579 STKc_MAST_like Catalyt 100.0 1.3E-44 2.7E-49 299.8 23.2 249 25-274 1-263 (265)
153 cd06646 STKc_MAP4K5 Catalytic 100.0 2.2E-44 4.7E-49 299.1 24.6 253 15-270 7-267 (267)
154 cd07839 STKc_CDK5 Catalytic do 100.0 4.1E-45 8.9E-50 306.1 20.4 252 18-271 1-284 (284)
155 cd06640 STKc_MST4 Catalytic do 100.0 1.2E-44 2.5E-49 302.4 22.9 257 16-276 3-261 (277)
156 cd06623 PKc_MAPKK_plant_like C 100.0 3.9E-44 8.5E-49 296.9 25.9 255 17-274 1-262 (264)
157 cd05581 STKc_PDK1 Catalytic do 100.0 7.8E-45 1.7E-49 303.6 21.7 254 17-271 1-280 (280)
158 cd05633 STKc_GRK3 Catalytic do 100.0 4.5E-44 9.8E-49 299.1 25.9 250 24-274 1-261 (279)
159 cd06619 PKc_MKK5 Catalytic dom 100.0 7.4E-44 1.6E-48 297.8 26.8 250 17-274 1-259 (279)
160 PHA03209 serine/threonine kina 100.0 1.5E-44 3.2E-49 311.9 23.2 247 16-273 65-356 (357)
161 KOG0986 G protein-coupled rece 100.0 6.4E-46 1.4E-50 307.6 13.6 260 14-274 182-452 (591)
162 cd07846 STKc_CDKL2_3 Catalytic 100.0 1.3E-44 2.8E-49 303.4 21.7 254 17-271 1-286 (286)
163 cd06652 STKc_MEKK2 Catalytic d 100.0 1E-43 2.2E-48 294.8 26.8 254 17-272 2-265 (265)
164 cd05102 PTKc_VEGFR3 Catalytic 100.0 3E-44 6.4E-49 308.3 24.0 249 16-267 6-329 (338)
165 cd06639 STKc_myosinIIIB Cataly 100.0 1.4E-43 3.1E-48 297.9 27.4 259 10-272 15-291 (291)
166 cd07843 STKc_CDC2L1 Catalytic 100.0 4.7E-44 1E-48 301.1 24.5 254 16-271 4-293 (293)
167 cd06637 STKc_TNIK Catalytic do 100.0 7.7E-44 1.7E-48 296.6 25.4 254 14-271 3-272 (272)
168 cd06606 STKc_MAPKKK Catalytic 100.0 1.5E-43 3.2E-48 292.2 26.9 252 18-271 1-260 (260)
169 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 5.4E-44 1.2E-48 299.7 24.6 258 17-277 1-271 (286)
170 cd06626 STKc_MEKK4 Catalytic d 100.0 1.4E-43 3E-48 293.6 26.7 253 18-271 1-264 (264)
171 cd08215 STKc_Nek Catalytic dom 100.0 1.5E-43 3.2E-48 292.1 26.5 252 18-271 1-258 (258)
172 cd05064 PTKc_EphR_A10 Catalyti 100.0 9.6E-44 2.1E-48 295.1 25.2 249 16-267 4-260 (266)
173 cd05611 STKc_Rim15_like Cataly 100.0 1.2E-43 2.6E-48 293.5 25.6 249 23-275 2-258 (260)
174 KOG0586 Serine/threonine prote 100.0 9.7E-45 2.1E-49 311.1 19.5 266 11-277 50-315 (596)
175 cd05606 STKc_beta_ARK Catalyti 100.0 1.3E-43 2.8E-48 296.2 25.9 251 24-275 1-262 (278)
176 cd05048 PTKc_Ror Catalytic Dom 100.0 1.1E-43 2.3E-48 297.4 25.1 251 15-268 3-279 (283)
177 cd07833 STKc_CDKL Catalytic do 100.0 6E-44 1.3E-48 299.6 23.6 254 17-271 1-288 (288)
178 PHA03211 serine/threonine kina 100.0 7.6E-44 1.6E-48 314.1 25.2 249 14-273 166-460 (461)
179 cd06629 STKc_MAPKKK_Bck1_like 100.0 1.7E-43 3.6E-48 294.6 26.0 254 18-271 2-272 (272)
180 cd06641 STKc_MST3 Catalytic do 100.0 9.4E-44 2E-48 296.9 24.5 254 17-274 4-259 (277)
181 cd06638 STKc_myosinIIIA Cataly 100.0 1.2E-43 2.7E-48 297.4 25.1 261 7-271 8-286 (286)
182 cd06607 STKc_TAO Catalytic dom 100.0 3.7E-43 8E-48 297.5 28.0 258 13-274 11-273 (307)
183 cd07845 STKc_CDK10 Catalytic d 100.0 8.8E-44 1.9E-48 301.6 24.2 258 15-274 5-296 (309)
184 cd05123 STKc_AGC Catalytic dom 100.0 1.2E-43 2.7E-48 291.6 24.4 246 25-271 1-250 (250)
185 cd06917 STKc_NAK1_like Catalyt 100.0 1.5E-43 3.2E-48 295.6 24.9 255 18-275 2-262 (277)
186 cd06648 STKc_PAK_II Catalytic 100.0 3.8E-43 8.1E-48 294.4 27.4 254 17-275 19-276 (285)
187 cd07831 STKc_MOK Catalytic dom 100.0 1.4E-43 3E-48 296.5 24.6 249 19-271 1-282 (282)
188 PTZ00024 cyclin-dependent prot 100.0 1.8E-43 4E-48 303.0 25.8 270 14-284 5-329 (335)
189 cd06658 STKc_PAK5 Catalytic do 100.0 4.8E-44 1E-48 300.8 21.7 264 13-281 18-285 (292)
190 cd06636 STKc_MAP4K4_6 Catalyti 100.0 2E-43 4.4E-48 295.6 25.2 257 11-271 10-282 (282)
191 cd07860 STKc_CDK2_3 Catalytic 100.0 1.2E-43 2.6E-48 297.2 23.6 252 18-271 1-284 (284)
192 KOG0607 MAP kinase-interacting 100.0 5.2E-45 1.1E-49 290.4 14.3 274 12-289 72-381 (463)
193 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 2.2E-43 4.7E-48 295.8 24.9 255 16-274 4-272 (284)
194 cd06642 STKc_STK25-YSK1 Cataly 100.0 4.7E-44 1E-48 298.7 20.6 255 16-274 3-259 (277)
195 cd06617 PKc_MKK3_6 Catalytic d 100.0 3.1E-43 6.6E-48 294.6 25.4 256 17-275 1-268 (283)
196 KOG0574 STE20-like serine/thre 100.0 4.3E-47 9.4E-52 300.4 1.8 259 14-278 30-293 (502)
197 cd06608 STKc_myosinIII_like Ca 100.0 2.9E-43 6.4E-48 293.2 25.0 253 15-271 4-275 (275)
198 cd06627 STKc_Cdc7_like Catalyt 100.0 7.3E-43 1.6E-47 287.6 27.1 252 18-271 1-254 (254)
199 cd08228 STKc_Nek6 Catalytic do 100.0 4.3E-43 9.3E-48 291.3 25.9 250 17-267 2-260 (267)
200 cd05088 PTKc_Tie2 Catalytic do 100.0 1.5E-43 3.3E-48 299.3 23.5 250 16-268 6-276 (303)
201 KOG0604 MAP kinase-activated p 100.0 3.4E-45 7.4E-50 288.9 12.1 254 14-276 58-330 (400)
202 cd08219 STKc_Nek3 Catalytic do 100.0 4.5E-43 9.8E-48 289.3 25.2 249 18-269 1-253 (255)
203 cd07868 STKc_CDK8 Catalytic do 100.0 2.4E-43 5.1E-48 300.1 24.2 244 22-271 6-317 (317)
204 cd06614 STKc_PAK Catalytic dom 100.0 6.3E-43 1.4E-47 293.2 26.4 257 12-273 14-275 (286)
205 PHA03390 pk1 serine/threonine- 100.0 2.1E-43 4.5E-48 293.2 23.1 251 10-273 7-267 (267)
206 cd05122 PKc_STE Catalytic doma 100.0 1E-42 2.2E-47 286.1 26.7 249 18-270 1-253 (253)
207 cd06659 STKc_PAK6 Catalytic do 100.0 2.3E-43 4.9E-48 297.3 23.3 263 16-283 20-286 (297)
208 cd08530 STKc_CNK2-like Catalyt 100.0 4.6E-43 1E-47 289.2 24.5 251 18-271 1-256 (256)
209 cd05096 PTKc_DDR1 Catalytic do 100.0 7.7E-43 1.7E-47 295.2 26.2 250 15-267 3-300 (304)
210 cd06624 STKc_ASK Catalytic dom 100.0 1.4E-42 2.9E-47 288.5 27.2 253 16-271 7-268 (268)
211 cd08225 STKc_Nek5 Catalytic do 100.0 4.3E-43 9.3E-48 289.6 23.9 252 18-271 1-257 (257)
212 cd05052 PTKc_Abl Catalytic dom 100.0 8.5E-43 1.9E-47 288.9 25.8 248 15-267 4-257 (263)
213 cd06647 STKc_PAK_I Catalytic d 100.0 2.8E-43 6.1E-48 296.3 23.2 259 12-275 14-276 (293)
214 cd07858 STKc_TEY_MAPK_plant Ca 100.0 1.5E-43 3.2E-48 303.7 21.7 258 15-274 3-297 (337)
215 cd07835 STKc_CDK1_like Catalyt 100.0 4.9E-43 1.1E-47 293.4 24.1 251 19-271 1-283 (283)
216 KOG0596 Dual specificity; seri 100.0 7.9E-44 1.7E-48 301.5 19.3 258 12-273 356-632 (677)
217 cd07865 STKc_CDK9 Catalytic do 100.0 5.6E-43 1.2E-47 296.7 24.7 259 11-271 6-310 (310)
218 cd07834 STKc_MAPK Catalytic do 100.0 1.7E-43 3.8E-48 302.5 21.7 257 18-276 1-297 (330)
219 KOG0983 Mitogen-activated prot 100.0 3.9E-44 8.3E-49 279.9 16.0 256 18-277 93-358 (391)
220 PLN00009 cyclin-dependent kina 100.0 6.7E-43 1.5E-47 294.2 24.9 256 17-274 2-290 (294)
221 cd07842 STKc_CDK8_like Catalyt 100.0 4.2E-43 9.2E-48 298.3 23.8 253 18-271 1-316 (316)
222 cd06616 PKc_MKK4 Catalytic dom 100.0 4.8E-43 1E-47 294.2 23.7 256 17-275 4-274 (288)
223 cd07844 STKc_PCTAIRE_like Cata 100.0 8.5E-43 1.8E-47 293.1 25.1 253 16-271 4-291 (291)
224 cd07870 STKc_PFTAIRE2 Catalyti 100.0 9.8E-43 2.1E-47 292.8 25.4 253 16-271 4-291 (291)
225 cd05089 PTKc_Tie1 Catalytic do 100.0 9.7E-43 2.1E-47 293.6 25.4 249 17-268 2-271 (297)
226 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 1.9E-42 4.1E-47 290.5 27.1 257 17-277 1-275 (287)
227 cd00192 PTKc Catalytic domain 100.0 1.2E-42 2.5E-47 287.5 25.3 243 23-268 1-260 (262)
228 cd05049 PTKc_Trk Catalytic dom 100.0 9.7E-43 2.1E-47 291.1 25.1 249 16-267 4-276 (280)
229 cd07855 STKc_ERK5 Catalytic do 100.0 1.3E-43 2.9E-48 303.7 20.1 259 15-275 3-301 (334)
230 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.7E-42 5.8E-47 286.1 27.2 253 17-271 2-264 (264)
231 cd07837 STKc_CdkB_plant Cataly 100.0 1E-42 2.3E-47 293.1 25.0 254 17-272 1-295 (295)
232 cd07849 STKc_ERK1_2_like Catal 100.0 4.1E-43 8.8E-48 300.9 22.8 258 15-276 3-300 (336)
233 cd07851 STKc_p38 Catalytic dom 100.0 3.4E-43 7.3E-48 302.1 22.2 263 11-278 9-308 (343)
234 KOG1989 ARK protein kinase fam 100.0 9.5E-44 2.1E-48 316.7 19.3 251 14-271 34-310 (738)
235 cd05093 PTKc_TrkB Catalytic do 100.0 2E-42 4.2E-47 290.5 26.2 248 16-267 4-274 (288)
236 cd07836 STKc_Pho85 Catalytic d 100.0 1.2E-42 2.6E-47 291.1 24.9 251 18-271 1-284 (284)
237 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.8E-42 3.9E-47 285.9 25.5 245 17-267 4-253 (256)
238 cd06657 STKc_PAK4 Catalytic do 100.0 1.4E-42 2.9E-47 291.9 25.2 260 18-282 21-284 (292)
239 PF07714 Pkinase_Tyr: Protein 100.0 2.3E-43 5E-48 291.6 20.1 245 20-267 2-257 (259)
240 cd05106 PTKc_CSF-1R Catalytic 100.0 5.4E-43 1.2E-47 303.7 23.2 250 15-267 36-367 (374)
241 cd07840 STKc_CDK9_like Catalyt 100.0 9.2E-43 2E-47 292.1 23.9 251 19-271 1-287 (287)
242 cd05084 PTKc_Fes Catalytic dom 100.0 2.1E-42 4.7E-47 284.7 25.6 242 23-267 1-248 (252)
243 KOG0579 Ste20-like serine/thre 100.0 1E-44 2.3E-49 311.5 11.9 254 17-274 32-295 (1187)
244 cd05104 PTKc_Kit Catalytic dom 100.0 9E-43 2E-47 302.5 23.9 251 15-268 33-370 (375)
245 cd05033 PTKc_EphR Catalytic do 100.0 2.9E-42 6.3E-47 286.2 25.9 250 16-268 3-261 (266)
246 cd08229 STKc_Nek7 Catalytic do 100.0 1.6E-42 3.5E-47 287.8 24.3 250 17-267 2-260 (267)
247 KOG2345 Serine/threonine prote 100.0 1.9E-44 4.2E-49 277.6 11.7 256 10-268 14-296 (302)
248 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 4.2E-42 9.2E-47 285.2 26.7 250 17-267 2-260 (267)
249 cd05113 PTKc_Btk_Bmx Catalytic 100.0 2E-42 4.3E-47 285.6 24.5 246 17-268 4-254 (256)
250 cd05059 PTKc_Tec_like Catalyti 100.0 2.5E-42 5.4E-47 285.0 25.0 246 17-268 4-254 (256)
251 KOG4721 Serine/threonine prote 100.0 2.3E-44 4.9E-49 305.9 12.9 244 13-269 120-365 (904)
252 cd07854 STKc_MAPK4_6 Catalytic 100.0 1.2E-42 2.6E-47 298.6 23.6 255 15-274 3-306 (342)
253 KOG0577 Serine/threonine prote 100.0 3.7E-44 8.1E-49 305.8 14.0 254 15-273 24-283 (948)
254 cd07880 STKc_p38gamma_MAPK12 C 100.0 2.3E-42 5.1E-47 296.8 25.4 262 11-277 9-307 (343)
255 cd07864 STKc_CDK12 Catalytic d 100.0 1.1E-42 2.3E-47 294.0 23.0 258 12-271 2-302 (302)
256 cd05062 PTKc_IGF-1R Catalytic 100.0 3E-42 6.5E-47 287.8 25.3 252 14-268 3-274 (277)
257 cd05036 PTKc_ALK_LTK Catalytic 100.0 3.2E-42 7E-47 287.6 25.5 251 15-268 4-274 (277)
258 cd07867 STKc_CDC2L6 Catalytic 100.0 1.3E-42 2.7E-47 295.6 23.3 244 22-271 6-317 (317)
259 cd05068 PTKc_Frk_like Catalyti 100.0 4.3E-42 9.3E-47 284.4 25.8 247 15-267 4-256 (261)
260 KOG1026 Nerve growth factor re 100.0 1.8E-43 3.9E-48 313.8 18.5 251 14-267 483-757 (774)
261 cd05148 PTKc_Srm_Brk Catalytic 100.0 1.9E-42 4.1E-47 286.5 23.2 247 16-267 5-256 (261)
262 cd06635 STKc_TAO1 Catalytic do 100.0 1.4E-41 3E-46 289.1 29.0 262 14-279 22-288 (317)
263 cd05613 STKc_MSK1_N N-terminal 100.0 4.4E-42 9.4E-47 288.7 25.6 257 18-274 1-274 (290)
264 cd05072 PTKc_Lyn Catalytic dom 100.0 4.4E-42 9.5E-47 284.3 25.1 247 15-267 4-256 (261)
265 cd06633 STKc_TAO3 Catalytic do 100.0 1E-41 2.2E-46 289.4 27.8 258 14-275 18-280 (313)
266 cd05061 PTKc_InsR Catalytic do 100.0 7E-42 1.5E-46 287.2 26.5 256 15-273 4-285 (288)
267 cd05071 PTKc_Src Catalytic dom 100.0 4.2E-42 9E-47 284.7 24.6 247 14-267 3-255 (262)
268 cd05116 PTKc_Syk Catalytic dom 100.0 7.2E-42 1.6E-46 282.4 25.8 241 24-267 2-250 (257)
269 cd05090 PTKc_Ror1 Catalytic do 100.0 6.7E-42 1.4E-46 286.6 25.8 250 16-268 4-279 (283)
270 cd05039 PTKc_Csk_like Catalyti 100.0 9E-42 2E-46 281.7 26.1 243 16-267 5-251 (256)
271 cd05060 PTKc_Syk_like Catalyti 100.0 1E-41 2.3E-46 281.5 26.4 241 23-267 1-250 (257)
272 cd05108 PTKc_EGFR Catalytic do 100.0 4.7E-42 1E-46 291.9 24.8 249 16-268 6-264 (316)
273 PRK13184 pknD serine/threonine 100.0 5.3E-42 1.2E-46 316.1 26.8 251 16-267 1-284 (932)
274 KOG0584 Serine/threonine prote 100.0 2.1E-43 4.5E-48 303.5 16.3 255 16-274 38-302 (632)
275 cd05094 PTKc_TrkC Catalytic do 100.0 7.8E-42 1.7E-46 287.3 25.3 248 16-267 4-277 (291)
276 cd05091 PTKc_Ror2 Catalytic do 100.0 5.6E-42 1.2E-46 287.0 24.3 249 16-267 4-278 (283)
277 cd07838 STKc_CDK4_6_like Catal 100.0 6.3E-42 1.4E-46 287.1 24.5 250 19-271 1-287 (287)
278 cd07829 STKc_CDK_like Catalyti 100.0 2.2E-42 4.7E-47 289.2 21.6 251 19-271 1-282 (282)
279 cd07852 STKc_MAPK15 Catalytic 100.0 5.2E-42 1.1E-46 294.2 24.4 258 14-274 4-301 (337)
280 KOG4279 Serine/threonine prote 100.0 1E-43 2.3E-48 308.0 13.7 248 24-274 582-838 (1226)
281 cd05032 PTKc_InsR_like Catalyt 100.0 9.1E-42 2E-46 284.8 25.1 251 14-267 3-273 (277)
282 cd05118 STKc_CMGC Catalytic do 100.0 2.8E-42 6.1E-47 288.6 22.1 251 19-271 1-283 (283)
283 cd06634 STKc_TAO2 Catalytic do 100.0 8E-42 1.7E-46 289.4 24.9 256 15-274 13-273 (308)
284 cd08226 PK_STRAD_beta Pseudoki 100.0 6.5E-42 1.4E-46 292.5 24.3 255 22-277 3-317 (328)
285 cd05098 PTKc_FGFR1 Catalytic d 100.0 1.4E-41 3E-46 287.9 25.8 253 12-267 13-294 (307)
286 cd06618 PKc_MKK7 Catalytic dom 100.0 5.9E-42 1.3E-46 288.7 23.4 263 14-279 12-284 (296)
287 cd07830 STKc_MAK_like Catalyti 100.0 5.8E-42 1.3E-46 286.9 23.1 250 19-271 1-283 (283)
288 KOG0193 Serine/threonine prote 100.0 2.7E-43 5.8E-48 301.3 15.1 253 10-267 385-648 (678)
289 cd07877 STKc_p38alpha_MAPK14 C 100.0 6.8E-42 1.5E-46 294.2 24.0 262 12-278 12-310 (345)
290 cd05035 PTKc_Axl_like Catalyti 100.0 1.8E-41 3.9E-46 282.3 25.8 248 19-268 1-268 (273)
291 cd05051 PTKc_DDR Catalytic dom 100.0 1.5E-41 3.2E-46 286.2 25.5 249 16-267 4-292 (296)
292 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 1.7E-41 3.7E-46 280.7 25.3 247 14-267 3-255 (260)
293 smart00219 TyrKc Tyrosine kina 100.0 2.1E-41 4.5E-46 279.5 25.7 246 19-267 1-256 (258)
294 cd05047 PTKc_Tie Catalytic dom 100.0 1.9E-41 4.2E-46 281.9 25.6 242 23-267 1-263 (270)
295 cd05067 PTKc_Lck_Blk Catalytic 100.0 1.5E-41 3.3E-46 281.0 24.8 247 14-267 3-255 (260)
296 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 2.1E-41 4.5E-46 289.1 26.3 257 13-274 6-294 (328)
297 cd05034 PTKc_Src_like Catalyti 100.0 1.8E-41 4E-46 280.6 25.2 248 14-267 3-256 (261)
298 cd05075 PTKc_Axl Catalytic dom 100.0 1.6E-41 3.5E-46 282.6 25.0 248 19-268 1-267 (272)
299 cd05092 PTKc_TrkA Catalytic do 100.0 1.9E-41 4.2E-46 283.4 25.4 248 16-267 4-276 (280)
300 cd05583 STKc_MSK_N N-terminal 100.0 1.1E-41 2.3E-46 286.0 23.8 259 18-276 1-274 (288)
301 cd07879 STKc_p38delta_MAPK13 C 100.0 9.7E-42 2.1E-46 292.9 24.0 258 13-276 11-305 (342)
302 cd05065 PTKc_EphR_B Catalytic 100.0 1.9E-41 4.1E-46 281.8 25.0 249 16-267 3-263 (269)
303 cd05053 PTKc_FGFR Catalytic do 100.0 1.1E-41 2.5E-46 286.6 23.3 255 11-268 6-287 (293)
304 cd05045 PTKc_RET Catalytic dom 100.0 3.2E-41 7E-46 283.4 26.0 247 18-267 1-281 (290)
305 cd05109 PTKc_HER2 Catalytic do 100.0 3.3E-41 7.2E-46 281.8 25.8 248 16-267 6-263 (279)
306 cd05069 PTKc_Yes Catalytic dom 100.0 3.3E-41 7.2E-46 279.0 25.4 246 15-267 4-255 (260)
307 PHA03210 serine/threonine kina 100.0 2.5E-42 5.3E-47 309.4 20.0 260 13-274 144-460 (501)
308 cd05105 PTKc_PDGFR_alpha Catal 100.0 2.3E-41 5E-46 294.9 25.5 251 14-267 34-392 (400)
309 cd05054 PTKc_VEGFR Catalytic d 100.0 1.2E-41 2.7E-46 291.4 23.4 250 16-268 6-329 (337)
310 cd07866 STKc_BUR1 Catalytic do 100.0 6.1E-42 1.3E-46 290.5 21.4 254 16-271 7-311 (311)
311 cd05101 PTKc_FGFR2 Catalytic d 100.0 4E-41 8.7E-46 284.7 26.0 256 10-268 8-292 (304)
312 cd07857 STKc_MPK1 Catalytic do 100.0 2.2E-41 4.7E-46 289.7 24.7 255 18-274 1-298 (332)
313 cd05066 PTKc_EphR_A Catalytic 100.0 4.5E-41 9.7E-46 279.3 25.3 249 16-267 3-261 (267)
314 cd05097 PTKc_DDR_like Catalyti 100.0 3.8E-41 8.2E-46 283.7 25.1 249 16-267 4-291 (295)
315 cd05040 PTKc_Ack_like Catalyti 100.0 4.2E-41 9.1E-46 277.8 24.9 241 23-267 1-253 (257)
316 cd05099 PTKc_FGFR4 Catalytic d 100.0 4.9E-41 1.1E-45 285.4 26.0 252 13-267 8-288 (314)
317 cd08222 STKc_Nek11 Catalytic d 100.0 9.7E-42 2.1E-46 282.1 21.0 252 18-271 1-260 (260)
318 cd05057 PTKc_EGFR_like Catalyt 100.0 7.3E-41 1.6E-45 279.7 26.4 248 16-267 6-263 (279)
319 cd05111 PTK_HER3 Pseudokinase 100.0 7.9E-41 1.7E-45 279.5 26.3 247 17-267 7-263 (279)
320 cd05041 PTKc_Fes_like Catalyti 100.0 8.2E-41 1.8E-45 275.1 26.0 241 23-267 1-247 (251)
321 cd05082 PTKc_Csk Catalytic dom 100.0 6E-41 1.3E-45 276.8 25.0 242 16-267 5-251 (256)
322 KOG0612 Rho-associated, coiled 100.0 4.4E-43 9.6E-48 317.7 13.1 260 14-274 72-344 (1317)
323 cd05115 PTKc_Zap-70 Catalytic 100.0 9.4E-41 2E-45 275.8 26.0 240 24-267 2-250 (257)
324 cd05100 PTKc_FGFR3 Catalytic d 100.0 6.8E-41 1.5E-45 286.9 26.0 256 10-268 5-289 (334)
325 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 6.7E-41 1.5E-45 280.5 25.2 248 16-267 2-276 (283)
326 cd05050 PTKc_Musk Catalytic do 100.0 6.5E-41 1.4E-45 281.3 25.1 250 15-267 3-284 (288)
327 KOG4236 Serine/threonine prote 100.0 3.3E-43 7.1E-48 296.6 11.1 255 14-273 559-824 (888)
328 cd05112 PTKc_Itk Catalytic dom 100.0 8.3E-41 1.8E-45 275.9 25.3 246 17-268 4-254 (256)
329 KOG0194 Protein tyrosine kinas 100.0 6.8E-42 1.5E-46 294.1 19.3 250 17-267 157-415 (474)
330 cd05063 PTKc_EphR_A2 Catalytic 100.0 1.3E-40 2.8E-45 276.6 26.1 250 15-267 3-262 (268)
331 cd05043 PTK_Ryk Pseudokinase d 100.0 9.9E-41 2.1E-45 279.0 25.4 251 14-267 3-271 (280)
332 cd05085 PTKc_Fer Catalytic dom 100.0 2.1E-40 4.6E-45 272.5 26.7 242 23-268 1-247 (250)
333 KOG4645 MAPKKK (MAP kinase kin 100.0 6.9E-44 1.5E-48 326.7 6.5 259 14-273 1232-1499(1509)
334 cd05055 PTKc_PDGFR Catalytic d 100.0 9.5E-41 2.1E-45 282.0 25.2 252 13-267 31-296 (302)
335 cd05073 PTKc_Hck Catalytic dom 100.0 1.4E-40 3.1E-45 275.1 25.7 247 14-267 3-255 (260)
336 cd05046 PTK_CCK4 Pseudokinase 100.0 8.7E-41 1.9E-45 278.7 24.5 249 17-268 5-272 (275)
337 cd05095 PTKc_DDR2 Catalytic do 100.0 1E-40 2.2E-45 281.2 24.8 249 16-267 4-292 (296)
338 cd08216 PK_STRAD Pseudokinase 100.0 1.2E-40 2.5E-45 283.1 25.2 246 29-275 12-302 (314)
339 cd05056 PTKc_FAK Catalytic dom 100.0 1.8E-40 3.8E-45 276.1 25.6 249 15-267 4-260 (270)
340 KOG1095 Protein tyrosine kinas 100.0 1.7E-41 3.6E-46 311.2 21.2 249 16-267 691-956 (1025)
341 cd05610 STKc_MASTL Catalytic d 100.0 1.4E-40 3E-45 306.8 26.8 150 16-165 3-152 (669)
342 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 2.1E-40 4.6E-45 277.6 25.1 248 17-267 4-278 (284)
343 KOG0662 Cyclin-dependent kinas 100.0 1.7E-41 3.6E-46 250.2 15.7 257 17-275 2-290 (292)
344 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 4.7E-41 1E-45 277.8 20.3 239 23-268 1-256 (258)
345 cd08528 STKc_Nek10 Catalytic d 100.0 3.8E-40 8.1E-45 273.9 25.8 250 18-268 1-266 (269)
346 KOG0614 cGMP-dependent protein 100.0 4.7E-43 1E-47 294.2 8.1 261 13-274 416-683 (732)
347 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 4.1E-40 8.8E-45 275.9 25.6 248 16-267 3-278 (284)
348 cd05576 STKc_RPK118_like Catal 100.0 9.3E-41 2E-45 272.5 21.1 229 28-271 4-237 (237)
349 cd05107 PTKc_PDGFR_beta Cataly 100.0 3.8E-40 8.3E-45 287.1 25.7 255 11-268 31-395 (401)
350 cd05083 PTKc_Chk Catalytic dom 100.0 3.9E-40 8.4E-45 271.6 23.9 241 16-267 5-249 (254)
351 cd05103 PTKc_VEGFR2 Catalytic 100.0 2.6E-40 5.6E-45 284.2 23.6 250 16-268 6-335 (343)
352 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 4.4E-40 9.4E-45 274.3 23.9 238 24-268 2-272 (274)
353 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 8.3E-40 1.8E-44 270.9 25.0 239 23-268 1-260 (262)
354 KOG0671 LAMMER dual specificit 100.0 5.7E-42 1.2E-46 278.8 11.6 253 13-273 85-411 (415)
355 cd05058 PTKc_Met_Ron Catalytic 100.0 1.4E-39 3E-44 269.5 25.5 242 23-267 1-254 (262)
356 KOG1187 Serine/threonine prote 100.0 1.7E-40 3.7E-45 283.3 20.5 253 10-267 68-347 (361)
357 cd05110 PTKc_HER4 Catalytic do 100.0 9.7E-40 2.1E-44 276.1 24.9 249 16-268 6-264 (303)
358 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 8.9E-40 1.9E-44 270.1 23.6 236 23-267 1-256 (259)
359 cd05044 PTKc_c-ros Catalytic d 100.0 7.7E-40 1.7E-44 272.1 23.2 242 23-267 1-265 (269)
360 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 8.8E-40 1.9E-44 273.7 23.2 249 16-267 3-278 (284)
361 KOG0696 Serine/threonine prote 100.0 2E-41 4.3E-46 278.5 12.2 260 14-274 346-612 (683)
362 cd05074 PTKc_Tyro3 Catalytic d 100.0 2.4E-39 5.3E-44 269.6 24.4 247 19-267 1-267 (273)
363 KOG1035 eIF-2alpha kinase GCN2 100.0 1.4E-40 3.1E-45 303.5 17.9 254 14-272 476-875 (1351)
364 PHA02882 putative serine/threo 100.0 2.6E-39 5.6E-44 272.3 24.3 253 12-267 7-291 (294)
365 KOG0666 Cyclin C-dependent kin 100.0 3.9E-41 8.5E-46 267.4 12.3 259 14-274 21-343 (438)
366 KOG0603 Ribosomal protein S6 k 100.0 2.6E-40 5.5E-45 285.4 18.1 244 15-271 320-566 (612)
367 smart00220 S_TKc Serine/Threon 100.0 3.4E-39 7.3E-44 263.4 23.3 240 29-271 1-244 (244)
368 KOG0695 Serine/threonine prote 100.0 1.7E-40 3.8E-45 266.7 14.6 259 15-274 248-522 (593)
369 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 2.2E-38 4.7E-43 263.4 26.1 242 23-267 1-265 (269)
370 KOG4257 Focal adhesion tyrosin 100.0 1.2E-39 2.5E-44 279.8 18.5 248 16-267 388-644 (974)
371 cd05042 PTKc_Aatyk Catalytic d 100.0 2.3E-38 5E-43 263.2 25.1 242 23-267 1-265 (269)
372 cd05086 PTKc_Aatyk2 Catalytic 100.0 4.8E-38 1E-42 261.2 25.8 242 23-267 1-264 (268)
373 KOG0196 Tyrosine kinase, EPH ( 100.0 5E-40 1.1E-44 288.1 11.4 248 17-267 629-886 (996)
374 KOG1151 Tousled-like protein k 100.0 1.4E-39 3.1E-44 269.8 12.1 273 13-285 459-758 (775)
375 KOG1006 Mitogen-activated prot 100.0 3.7E-40 8.1E-45 256.5 6.8 254 18-274 65-333 (361)
376 KOG0668 Casein kinase II, alph 100.0 3.8E-39 8.3E-44 246.0 11.5 253 16-277 37-331 (338)
377 KOG0669 Cyclin T-dependent kin 100.0 1.7E-40 3.7E-45 256.7 3.8 258 14-273 14-320 (376)
378 KOG4278 Protein tyrosine kinas 100.0 3.4E-38 7.3E-43 271.1 18.1 249 13-266 263-517 (1157)
379 KOG0199 ACK and related non-re 100.0 1.9E-38 4E-43 275.4 16.1 259 14-276 107-376 (1039)
380 KOG1094 Discoidin domain recep 100.0 2.4E-38 5.3E-43 269.8 16.5 248 16-267 537-799 (807)
381 KOG0665 Jun-N-terminal kinase 100.0 2.1E-38 4.5E-43 252.6 12.0 267 13-285 13-328 (369)
382 KOG0670 U4/U6-associated splic 100.0 5.3E-39 1.2E-43 270.6 8.5 254 13-273 428-751 (752)
383 PLN03225 Serine/threonine-prot 100.0 3.9E-37 8.4E-42 277.7 20.7 254 15-276 130-458 (566)
384 KOG1290 Serine/threonine prote 100.0 4.5E-37 9.7E-42 257.1 19.2 134 13-151 73-222 (590)
385 KOG0608 Warts/lats-like serine 100.0 1.4E-37 3.1E-42 267.5 16.3 257 16-274 628-934 (1034)
386 KOG0587 Traf2- and Nck-interac 100.0 4.2E-37 9.2E-42 273.0 19.5 255 14-272 16-286 (953)
387 KOG4250 TANK binding protein k 100.0 1.2E-37 2.7E-42 271.2 12.2 242 17-260 13-296 (732)
388 PLN03224 probable serine/threo 100.0 1E-35 2.2E-40 262.5 24.0 260 15-274 143-506 (507)
389 PLN00113 leucine-rich repeat r 100.0 1.1E-35 2.3E-40 287.1 19.1 240 14-268 687-947 (968)
390 KOG1027 Serine/threonine prote 100.0 1.4E-36 3.1E-41 268.4 11.3 244 19-274 511-773 (903)
391 KOG2052 Activin A type IB rece 100.0 4.6E-35 9.9E-40 242.7 17.4 254 5-267 194-498 (513)
392 KOG0664 Nemo-like MAPK-related 100.0 7.2E-37 1.6E-41 239.5 4.6 254 18-273 54-348 (449)
393 KOG0200 Fibroblast/platelet-de 100.0 3.8E-34 8.3E-39 260.7 23.0 255 16-275 295-580 (609)
394 cd00180 PKc Catalytic domain o 100.0 6.8E-33 1.5E-37 221.1 23.4 212 25-269 1-215 (215)
395 KOG1152 Signal transduction se 100.0 6.1E-35 1.3E-39 248.8 10.3 202 17-219 561-771 (772)
396 KOG0576 Mitogen-activated prot 100.0 8.8E-36 1.9E-40 257.6 4.8 262 14-279 12-282 (829)
397 KOG1025 Epidermal growth facto 100.0 4.3E-34 9.4E-39 252.2 14.9 246 18-267 697-952 (1177)
398 KOG1167 Serine/threonine prote 100.0 1.2E-34 2.6E-39 239.0 10.4 254 12-273 31-386 (418)
399 KOG3653 Transforming growth fa 100.0 1.1E-33 2.4E-38 236.1 16.0 239 16-263 209-494 (534)
400 KOG0984 Mitogen-activated prot 100.0 5E-33 1.1E-37 209.3 14.2 217 12-231 41-267 (282)
401 smart00221 STYKc Protein kinas 100.0 6.1E-32 1.3E-36 218.3 21.7 214 19-235 1-220 (225)
402 KOG1024 Receptor-like protein 100.0 6.7E-33 1.5E-37 226.7 15.8 255 10-267 277-550 (563)
403 KOG1345 Serine/threonine kinas 100.0 1.3E-31 2.9E-36 209.5 7.4 252 14-272 21-291 (378)
404 PLN00181 protein SPA1-RELATED; 100.0 7.6E-31 1.6E-35 247.6 10.3 193 77-273 33-270 (793)
405 KOG1165 Casein kinase (serine/ 100.0 3.4E-28 7.3E-33 195.6 18.7 251 8-265 19-292 (449)
406 smart00750 KIND kinase non-cat 100.0 3.2E-29 7E-34 195.1 11.9 159 102-273 1-170 (176)
407 KOG1163 Casein kinase (serine/ 100.0 1.1E-27 2.4E-32 184.6 15.7 249 9-264 7-276 (341)
408 KOG1164 Casein kinase (serine/ 100.0 3.7E-27 8E-32 200.3 20.5 246 18-268 19-293 (322)
409 KOG0590 Checkpoint kinase and 99.9 6.4E-29 1.4E-33 224.0 4.3 262 17-279 317-596 (601)
410 KOG1240 Protein kinase contain 99.9 1.2E-28 2.5E-33 224.2 4.9 247 8-268 14-291 (1431)
411 COG0515 SPS1 Serine/threonine 99.9 9.3E-25 2E-29 186.0 25.1 252 19-273 2-280 (384)
412 PF14531 Kinase-like: Kinase-l 99.9 1.2E-26 2.6E-31 189.2 8.8 241 12-259 7-288 (288)
413 PRK09188 serine/threonine prot 99.9 1.7E-25 3.7E-30 190.0 16.2 169 10-189 11-193 (365)
414 KOG0603 Ribosomal protein S6 k 99.9 1.6E-27 3.6E-32 206.4 3.4 242 24-276 1-251 (612)
415 PRK10359 lipopolysaccharide co 99.9 2E-25 4.4E-30 176.8 10.7 176 13-211 27-216 (232)
416 cd05147 RIO1_euk RIO kinase fa 99.9 1.9E-24 4.1E-29 169.3 12.2 144 21-168 1-168 (190)
417 KOG0195 Integrin-linked kinase 99.9 1.2E-24 2.7E-29 170.9 7.1 241 17-266 190-440 (448)
418 cd05145 RIO1_like RIO kinase f 99.9 5.9E-23 1.3E-27 161.4 15.6 145 21-169 1-169 (190)
419 KOG0606 Microtubule-associated 99.9 2.4E-23 5.3E-28 189.5 10.7 222 11-273 77-320 (1205)
420 PRK12274 serine/threonine prot 99.9 5.1E-22 1.1E-26 154.3 15.2 189 19-220 4-210 (218)
421 KOG1166 Mitotic checkpoint ser 99.9 2.1E-22 4.5E-27 186.0 14.2 243 10-267 691-948 (974)
422 PRK10345 hypothetical protein; 99.9 1.4E-20 3E-25 148.8 14.9 138 19-165 4-158 (210)
423 smart00090 RIO RIO-like kinase 99.9 5.7E-21 1.2E-25 154.6 12.8 145 18-167 29-198 (237)
424 KOG4158 BRPK/PTEN-induced prot 99.8 1.1E-20 2.4E-25 156.0 12.6 187 75-263 274-505 (598)
425 PRK14879 serine/threonine prot 99.8 1.8E-19 3.9E-24 144.3 17.4 138 22-166 1-143 (211)
426 KOG1023 Natriuretic peptide re 99.8 9.6E-20 2.1E-24 158.0 12.1 197 71-267 1-219 (484)
427 TIGR03724 arch_bud32 Kae1-asso 99.8 4.7E-19 1E-23 140.6 13.3 133 24-166 1-138 (199)
428 KOG1033 eIF-2alpha kinase PEK/ 99.8 2.4E-20 5.2E-25 159.2 5.3 174 90-271 329-515 (516)
429 cd05144 RIO2_C RIO kinase fami 99.8 7.7E-19 1.7E-23 139.1 12.2 141 18-169 16-177 (198)
430 PRK09605 bifunctional UGMP fam 99.8 1.2E-17 2.6E-22 151.4 19.4 139 17-166 333-476 (535)
431 KOG0590 Checkpoint kinase and 99.8 3.6E-20 7.9E-25 167.5 -0.3 258 15-273 18-291 (601)
432 cd05119 RIO RIO kinase family, 99.8 9.2E-18 2E-22 131.8 12.3 139 21-167 1-164 (187)
433 PRK01723 3-deoxy-D-manno-octul 99.7 7E-17 1.5E-21 131.0 14.5 138 22-166 36-191 (239)
434 KOG1243 Protein kinase [Genera 99.7 3.3E-16 7.2E-21 137.8 16.9 231 19-275 15-253 (690)
435 cd05120 APH_ChoK_like Aminogly 99.7 2E-16 4.3E-21 119.6 12.0 132 21-166 2-138 (155)
436 KOG1266 Protein kinase [Signal 99.7 1.2E-17 2.5E-22 135.1 2.2 236 32-271 81-334 (458)
437 KOG0601 Cyclin-dependent kinas 99.7 8E-17 1.7E-21 140.1 6.8 259 13-275 110-386 (524)
438 cd05146 RIO3_euk RIO kinase fa 99.6 3.7E-14 8E-19 110.3 14.1 143 22-169 2-176 (197)
439 TIGR01982 UbiB 2-polyprenylphe 99.6 3.1E-14 6.8E-19 125.2 14.4 148 16-168 117-308 (437)
440 KOG0606 Microtubule-associated 99.6 1.9E-15 4.1E-20 138.7 4.0 259 15-274 802-1098(1205)
441 PRK04750 ubiB putative ubiquin 99.5 8.4E-15 1.8E-19 130.4 7.5 149 12-168 115-315 (537)
442 COG3642 Mn2+-dependent serine/ 99.5 2.2E-13 4.7E-18 102.6 13.2 135 23-167 2-141 (204)
443 KOG0601 Cyclin-dependent kinas 99.5 1.8E-14 3.9E-19 125.6 5.2 255 12-272 260-518 (524)
444 KOG3087 Serine/threonine prote 99.5 1.7E-12 3.6E-17 97.6 13.7 145 21-167 11-166 (229)
445 cd05151 ChoK Choline Kinase (C 99.5 2.4E-13 5.2E-18 104.9 9.7 127 22-165 3-135 (170)
446 COG4248 Uncharacterized protei 99.4 4E-11 8.7E-16 101.0 15.8 238 19-265 13-293 (637)
447 KOG3741 Poly(A) ribonuclease s 99.4 4.3E-11 9.3E-16 103.1 16.0 212 29-268 288-521 (655)
448 PRK15123 lipopolysaccharide co 99.3 9.7E-11 2.1E-15 96.2 14.9 138 26-165 31-193 (268)
449 cd05154 ACAD10_11_like Acyl-Co 99.3 2.1E-11 4.5E-16 98.2 10.6 140 23-166 4-206 (223)
450 COG0478 RIO-like serine/threon 99.3 4E-11 8.6E-16 95.9 10.6 140 19-168 93-253 (304)
451 PF01163 RIO1: RIO1 family; I 99.3 1E-10 2.2E-15 90.8 12.0 129 32-168 1-157 (188)
452 KOG2137 Protein kinase [Signal 99.3 2.1E-12 4.6E-17 114.5 2.8 149 125-274 107-271 (700)
453 PF06293 Kdo: Lipopolysacchari 99.1 2.2E-09 4.7E-14 85.4 13.3 106 61-166 55-170 (206)
454 PF06176 WaaY: Lipopolysacchar 99.1 1.3E-09 2.8E-14 85.5 10.5 142 13-165 27-182 (229)
455 PRK09902 hypothetical protein; 99.0 8.1E-09 1.8E-13 80.8 12.4 139 26-166 27-179 (216)
456 KOG1035 eIF-2alpha kinase GCN2 98.9 2.2E-08 4.8E-13 94.3 14.3 244 22-274 183-440 (1351)
457 COG0661 AarF Predicted unusual 98.9 7.1E-08 1.5E-12 86.0 16.3 141 23-167 131-315 (517)
458 TIGR02172 Fb_sc_TIGR02172 Fibr 98.9 6.2E-08 1.3E-12 78.1 12.5 133 23-165 7-181 (226)
459 COG1718 RIO1 Serine/threonine 98.8 3.4E-08 7.5E-13 78.5 10.3 140 24-170 55-219 (268)
460 PF01636 APH: Phosphotransfera 98.7 3.7E-07 7.9E-12 74.0 11.5 138 22-166 2-197 (239)
461 COG2112 Predicted Ser/Thr prot 98.6 7.6E-07 1.6E-11 67.1 10.5 132 18-167 23-156 (201)
462 cd05150 APH Aminoglycoside 3'- 98.6 1.3E-06 2.8E-11 71.5 12.4 133 25-165 6-192 (244)
463 KOG1235 Predicted unusual prot 98.5 1.3E-06 2.9E-11 77.8 11.1 142 22-169 166-357 (538)
464 PF10707 YrbL-PhoP_reg: PhoP r 98.5 7.4E-06 1.6E-10 64.3 13.9 134 22-163 6-169 (199)
465 KOG0576 Mitogen-activated prot 98.4 7.5E-08 1.6E-12 85.6 0.8 250 5-273 230-489 (829)
466 PLN02876 acyl-CoA dehydrogenas 98.3 1.3E-05 2.9E-10 76.8 13.8 81 22-104 43-131 (822)
467 cd05155 APH_ChoK_like_1 Unchar 98.3 6.4E-06 1.4E-10 67.0 10.0 73 23-105 3-82 (235)
468 KOG2268 Serine/threonine prote 98.3 8.9E-07 1.9E-11 73.2 4.0 136 19-165 94-250 (465)
469 PF13095 FTA2: Kinetochore Sim 98.2 5.6E-05 1.2E-09 59.0 13.0 130 15-164 35-206 (207)
470 cd05153 HomoserineK_II Homoser 98.1 5.7E-05 1.2E-09 63.6 11.4 136 22-165 19-204 (296)
471 TIGR00938 thrB_alt homoserine 98.1 4.4E-05 9.4E-10 64.7 10.6 158 1-165 1-216 (307)
472 PF12260 PIP49_C: Protein-kina 98.1 2.3E-05 4.9E-10 61.2 8.1 99 65-167 7-112 (188)
473 PRK09550 mtnK methylthioribose 98.0 0.00026 5.7E-09 61.6 14.9 80 22-103 31-117 (401)
474 TIGR02721 ycfN_thiK thiamine k 98.0 3.4E-05 7.4E-10 63.6 8.8 133 24-166 3-175 (256)
475 PRK05231 homoserine kinase; Pr 98.0 0.00025 5.5E-09 60.4 13.8 153 5-165 5-216 (319)
476 cd05157 ETNK_euk Ethanolamine 98.0 8.7E-05 1.9E-09 60.3 10.4 76 22-105 3-80 (235)
477 COG3173 Predicted aminoglycosi 97.9 9.9E-05 2.2E-09 62.0 10.0 141 19-168 27-230 (321)
478 KOG2270 Serine/threonine prote 97.8 0.001 2.3E-08 56.5 14.4 142 23-168 150-315 (520)
479 KOG1093 Predicted protein kina 97.8 0.00013 2.8E-09 64.2 8.4 162 61-274 26-200 (725)
480 cd05156 ChoK_euk Choline Kinas 97.8 0.00022 4.7E-09 60.3 9.5 75 23-105 4-85 (302)
481 KOG1826 Ras GTPase activating 97.7 4E-06 8.6E-11 81.8 -1.5 205 66-271 1278-1495(2724)
482 PLN02756 S-methyl-5-thioribose 97.4 0.0027 5.8E-08 55.4 11.7 77 21-101 36-119 (418)
483 PLN02236 choline kinase 97.4 0.0021 4.6E-08 55.3 10.5 142 17-166 36-231 (344)
484 cd05152 MPH2' Macrolide 2'-Pho 97.3 0.0023 5E-08 53.3 10.0 30 137-166 186-216 (276)
485 PLN02421 phosphotransferase, a 97.3 0.0018 3.8E-08 55.5 9.2 137 22-166 19-213 (330)
486 TIGR01767 MTRK 5-methylthiorib 97.3 0.0063 1.4E-07 52.2 12.0 76 24-101 2-84 (370)
487 TIGR02904 spore_ysxE spore coa 97.1 0.024 5.3E-07 48.1 14.4 30 137-166 197-226 (309)
488 PRK10593 hypothetical protein; 97.1 0.0076 1.7E-07 50.8 10.8 107 18-136 15-127 (297)
489 PRK12396 5-methylribose kinase 97.0 0.0065 1.4E-07 52.7 9.9 78 22-101 34-117 (409)
490 COG3001 Uncharacterized protei 96.9 0.015 3.2E-07 46.4 10.0 77 21-105 20-99 (286)
491 PTZ00384 choline kinase; Provi 96.8 0.031 6.8E-07 48.8 12.2 78 20-105 53-137 (383)
492 COG5072 ALK1 Serine/threonine 96.8 0.014 3E-07 49.8 9.4 119 76-206 284-404 (488)
493 PF03881 Fructosamin_kin: Fruc 96.8 0.0083 1.8E-07 50.1 8.2 75 20-102 20-97 (288)
494 PRK11768 serine/threonine prot 96.6 0.07 1.5E-06 45.6 13.0 71 28-103 36-113 (325)
495 PTZ00296 choline kinase; Provi 96.2 0.2 4.3E-06 44.7 13.7 76 21-104 109-193 (442)
496 COG0510 ycfN Thiamine kinase a 96.0 0.029 6.3E-07 46.5 7.0 45 122-166 137-183 (269)
497 KOG1236 Predicted unusual prot 95.8 0.045 9.7E-07 47.5 7.5 60 91-151 319-379 (565)
498 PRK06148 hypothetical protein; 95.6 0.59 1.3E-05 46.4 15.4 31 136-166 203-236 (1013)
499 TIGR02906 spore_CotS spore coa 95.4 0.043 9.4E-07 46.5 6.1 29 136-165 187-215 (313)
500 PRK10271 thiK thiamine kinase; 95.2 0.018 3.8E-07 44.7 2.8 29 137-166 78-106 (188)
No 1
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.1e-59 Score=397.59 Aligned_cols=264 Identities=39% Similarity=0.697 Sum_probs=250.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|...+.||+|||+.||.+++..+|+.||+|++.+.........+++.+|+++.++|+||||++++++|++.+++|++.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999988888888999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~ 175 (294)
|.|..++|..+++++++++|.+++.++.||+.||.|||+.+|+|||||..|++++++-++||+|||+|+..... ....+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T 177 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT 177 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988755 67788
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
.+|||-|.|||++..... +..+||||+||+||-|+.|++||...+..+....|......+|..++.+.++||.++|+.|
T Consensus 178 lCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~ 256 (592)
T KOG0575|consen 178 LCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPN 256 (592)
T ss_pred ecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCC
Confidence 899999999999997766 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCHhHHhcCCcc-cccCCccccC
Q 022617 256 PMKRITIPEIRQHPWF-QAHLPRYLAV 281 (294)
Q Consensus 256 p~~Rps~~~il~h~~~-~~~~~~~~~~ 281 (294)
|.+|||++++|+|+|| +...|.+.-.
T Consensus 257 P~~Rpsl~~vL~h~Ff~~g~~p~~lp~ 283 (592)
T KOG0575|consen 257 PSERPSLDEVLDHPFFKSGFTPARLPS 283 (592)
T ss_pred cccCCCHHHHhcCHhhhCCCcCCCCCc
Confidence 9999999999999999 5556655544
No 2
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-59 Score=384.29 Aligned_cols=264 Identities=42% Similarity=0.747 Sum_probs=237.7
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccch----HHHHHHHHHHHHHHhCCCCceeEEEEE
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM----EMEEKVRREIKILRLFMHPHIIRLYEV 85 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~ 85 (294)
-....+.+.|.+.+.||+|+||.|-+|..+.+++.||||++........ .....+.+|+++|++|+||||++++++
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 3445688999999999999999999999999999999999987755542 233457799999999999999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeec
Q 022617 86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFG 162 (294)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg 162 (294)
|+.+...|+|+||++||.|.+.+-.++.+.+...+.+++|++.|+.|||+.||+||||||+|||++.+ ..+||+|||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999876 679999999
Q ss_pred ccccccCCCccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhCCCccC---
Q 022617 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTL--- 236 (294)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~--- 236 (294)
+|..........+.+||+.|.|||++.+.. +...+.|||||||++|-+++|.+||....... +.++|..+...+
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 999999889999999999999999996543 33457899999999999999999998765544 888888887644
Q ss_pred -CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 237 -PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 237 -~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+..++.+..+||.+||..||++|||+.|+|+||||+.
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 3578999999999999999999999999999999985
No 3
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-57 Score=366.73 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=236.2
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-eE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-DI 92 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~ 92 (294)
...++.+.++.||+|..|+||+++|+.+++-+|+|++... .+....+++.+|+++++..+||||+.+|+.|..+. .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3445788899999999999999999999999999999433 34466789999999999999999999999999988 49
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
.++||||++|||++++...+.+++..+..++.+++++|.|||+ .+|+||||||+|||++..|.+||+|||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999887666
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCC-CccCCCC-CChhH
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGA 244 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~l 244 (294)
.-++.+||..|||||.+.+..+ +.++||||||+.++|+.+|+.||... +..++...|..+ .+.+|.. +++++
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef 311 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF 311 (364)
T ss_pred hcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 5567889999999999999988 89999999999999999999999764 677777777764 4567776 99999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
++||..||++||.+|||+.|+++|||+++....-
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 9999999999999999999999999999865543
No 4
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-56 Score=363.31 Aligned_cols=260 Identities=38% Similarity=0.682 Sum_probs=242.5
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-.++|+++++||+|+||.|+.++.+++++-||+|++.+..+...........|..+|.+++||+|++++..|+++..+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44679999999999999999999999999999999999998888777889999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~ 172 (294)
+|+||+.||.|...|++.+.+++..++.++.+|+.||.|||++||+|||+||+|||++.+|+++|+|||++...- .+..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~ 181 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA 181 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998543 4455
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CCCCCChhHHHHHHHh
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 251 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~ 251 (294)
....+||+.|||||++.+..+ +.++|+||||+++|+|++|.+||...+...+.+++..+... .+...+.+.+++++++
T Consensus 182 t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~L 260 (357)
T KOG0598|consen 182 TRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKL 260 (357)
T ss_pred cccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHH
Confidence 666799999999999999987 89999999999999999999999999999999999999844 4455999999999999
Q ss_pred cccCCCCCC----CHhHHhcCCccccc
Q 022617 252 LIVDPMKRI----TIPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rp----s~~~il~h~~~~~~ 274 (294)
|+.||++|. ++.+|.+||||+..
T Consensus 261 L~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 261 LKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred hccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999996 68999999999764
No 5
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=5e-55 Score=368.82 Aligned_cols=260 Identities=37% Similarity=0.665 Sum_probs=240.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (294)
.-..+|..++.||.|+|++|++|+++.+++.||||++.+.-+....-.+.+..|-..|.+| .||+|++++..|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3446899999999999999999999999999999999877666666677888999999999 799999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
|+|+||+++|.|.++|.+.+.+++...+.++.+|+.||.|||+.||+||||||+|||++.+++++|.|||.+........
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876532211
Q ss_pred c--------------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC
Q 022617 173 L--------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 238 (294)
Q Consensus 173 ~--------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
. ...+||..|.+||.+..... ++.+|||+|||++|+|+.|.+||.+.+.--..++|+.....+++
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~ 308 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPE 308 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCC
Confidence 1 34679999999999998877 89999999999999999999999999999999999999999999
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+.++.+.+||+++|..||.+|+++++|.+||||...
T Consensus 309 ~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 309 GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 999999999999999999999999999999999865
No 6
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-54 Score=351.71 Aligned_cols=265 Identities=41% Similarity=0.706 Sum_probs=242.3
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.....++|.+.+.||+|+|++||+|+++.++..||||.+.+... .....+.+..|+.+|+.++||||+.+++++..++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34567899999999999999999999999999999999987765 44567888999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC------CcEEEeeecccc
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK------WNVKIADFGLSN 165 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~------~~~~l~dfg~~~ 165 (294)
+|+|||||+||+|.+++.+.+.+++..++.++.||+.|+++||+++|+||||||.|||++.+ -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999875 358999999999
Q ss_pred cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCCh
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSP 242 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~ 242 (294)
...........+|++.|||||++....| +.++|+||+|+++|+|++|+.||+..+..++...+..+.. ..+...+.
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~ 242 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSN 242 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccC
Confidence 9988888888999999999999998888 7899999999999999999999999999999888877663 33456788
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.+.+++...++.+|.+|.++.+-+.|+++.......
T Consensus 243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~ 278 (429)
T KOG0595|consen 243 PLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDR 278 (429)
T ss_pred chhhhhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence 888999999999999999999999999998765443
No 7
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-53 Score=362.89 Aligned_cols=262 Identities=61% Similarity=1.073 Sum_probs=244.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFM-HPHIIRLYEVIET 88 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 88 (294)
.....++|.+.+.||.|+||+|+.|.+..++..||+|++....... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 12 ~~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t 91 (370)
T KOG0583|consen 12 LQLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT 91 (370)
T ss_pred cccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec
Confidence 4577889999999999999999999999999999999876652221 134567789999999999 9999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeecccccc
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIM 167 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~~~~ 167 (294)
...+++||||+.||.|.+++.+.+++.+..+..+++|++.|++|+|+.||+||||||+||+++.+ +++||+|||++...
T Consensus 92 ~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 92 PTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999999998999999999999999999999999999999999999999999 99999999999988
Q ss_pred -cCCCccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCC-ChhH
Q 022617 168 -RDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-SPGA 244 (294)
Q Consensus 168 -~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 244 (294)
.........+|++.|+|||++.+.. +.+.++||||+|+++|.|++|..||+..+...+...+..+...+|..+ +.++
T Consensus 172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 4566777889999999999999887 888999999999999999999999999999999999999999999999 9999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
..++++||..||.+|+|+.+|+.||||+.
T Consensus 252 ~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999999999998
No 8
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=2e-53 Score=334.83 Aligned_cols=267 Identities=39% Similarity=0.729 Sum_probs=248.9
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-.++|...+.||.|+||.|.+++++.+|..||+|++.+..+......+...+|..+|+.+.||+++++++.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 44678999999999999999999999999999999999998888888899999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
+||||.+||.|.+++.+.+++++..++.++.|++.|+.|||+.+|++||+||+|||++.+|.+||+|||+|...... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999877554 5
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
.+.+|||.|+|||++....+ +.++|+|+||+++|||+.|.+||...+...+.++|..+...+|+.+++++++|++++|+
T Consensus 199 ~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQ 277 (355)
T ss_pred EEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHh
Confidence 67889999999999999888 79999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCC-----CHhHHhcCCccccc-----CCccccCCC
Q 022617 254 VDPMKRI-----TIPEIRQHPWFQAH-----LPRYLAVPP 283 (294)
Q Consensus 254 ~~p~~Rp-----s~~~il~h~~~~~~-----~~~~~~~~~ 283 (294)
.|-.+|. -.++|.+||||+.. +.+.+..|-
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~ 317 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPF 317 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCC
Confidence 9999994 46789999999753 455555443
No 9
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.3e-53 Score=367.61 Aligned_cols=261 Identities=53% Similarity=0.924 Sum_probs=249.8
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-.+-|++++.||.|+.|.|-+|++..+|+..|||++.............+.+|+-+|+.+.|||+++++++|+...++|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 44677999999999999999999999999999999998775445556788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
++.||+.||-|++++-+.+++++.+...+++||+.|+.|+|..+|+|+|+||+|++++..+++||+|||+|.....+...
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 99999999999999999999999999999999999999999999999999999999999989999999999988888888
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
.+.+|++.|.+||++.+.+|.+.++||||-|+++|.|++|++||++.+...+..+++.+.+.+|..++.+.++|+.+||.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~ 248 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLD 248 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCHhHHhcCCccccc
Q 022617 254 VDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~~~~ 274 (294)
.||..|.|.++|++|||++..
T Consensus 249 VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 249 VDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred cCccccccHHHHhhCchhhcC
Confidence 999999999999999999775
No 10
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=2.7e-54 Score=340.86 Aligned_cols=271 Identities=26% Similarity=0.498 Sum_probs=233.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
++.|..+.++|+|+||.||+|+++.+|+-||||.+..+. ++....+-..+|+.+|++|+|+|++.++.+|...+.+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999985443 3445567788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCcc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~ 173 (294)
+|||+. ++.+.+++. ..++.+.++.++.|++.|+.|+|+.+++||||||+||+|+.+|.+||+|||+|+... .+...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 999987 666667664 458999999999999999999999999999999999999999999999999999876 45555
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC-----------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----------------- 236 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 236 (294)
...+.|..|+|||.+.+...++...|||++||++.||++|.+.|.+.+..+..-.|......+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 667789999999999986666899999999999999999999999887766665553322111
Q ss_pred --C------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchH
Q 022617 237 --P------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 288 (294)
Q Consensus 237 --~------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~ 288 (294)
| +..+.-+.++++.||..||.+|++.+++|.||||.++..+..+...++.++
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~~~~k~~~~~~ 304 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERELKAKKPNEAE 304 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHHHHHhcccchh
Confidence 1 344567889999999999999999999999999998888877777776653
No 11
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.8e-54 Score=337.61 Aligned_cols=248 Identities=33% Similarity=0.570 Sum_probs=222.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE-EEEcCC-
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE-VIETPS- 90 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~- 90 (294)
..-..+|+++++||.|.||+||++.+..+|..+|.|.+.....+ ....+.+..|+.+|++|+||||+++++ .+.+++
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 34456799999999999999999999999999999999865544 456788999999999999999999988 444444
Q ss_pred eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCeEecCCCcEEEeeec
Q 022617 91 DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR--NM--VVHRDLKPENLLLDSKWNVKIADFG 162 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~--~~--i~h~di~p~nili~~~~~~~l~dfg 162 (294)
-++++||+|++|+|..+++. .+.+++..+|.++.|++.||+.+|. .. ++||||||.||+++.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 49999999999999999974 3469999999999999999999998 44 9999999999999999999999999
Q ss_pred ccccccCCC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CC-CC
Q 022617 163 LSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SH 239 (294)
Q Consensus 163 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~ 239 (294)
+++.+.... ...+.+|||.||+||.+.+.++ +.++||||+||++|||+..+.||.+.+...+.++|..+..+ +| ..
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 999886654 4457789999999999999998 79999999999999999999999999999999999988754 66 67
Q ss_pred CChhHHHHHHHhcccCCCCCCCH
Q 022617 240 LSPGARDLIPRMLIVDPMKRITI 262 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~ 262 (294)
++.++..+|..|+..||+.||+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999999999985
No 12
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-53 Score=352.34 Aligned_cols=261 Identities=34% Similarity=0.510 Sum_probs=227.7
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (294)
...+.++|.+.++||.|.||.||+|+.+.++..||||.+....... + .-.=.+|++.|++++ ||||+++.+++.+++
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-e-e~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-E-ECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-H-HHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3467899999999999999999999999999999999987655442 2 233457999999999 999999999998877
Q ss_pred -eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 91 -DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 91 -~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
.+++|||||+. +|.++++.+ ..+++..++.++.||+++|+|+|++|++|||+||+|||++.+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999964 999999764 579999999999999999999999999999999999999988899999999999988
Q ss_pred CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------- 233 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 233 (294)
........+.|..|+|||++....+++.+.|||++||+++|+.+.++.|.+.+..+.+-+|..-.
T Consensus 162 SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 162 SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 87777788899999999999887777999999999999999999999998877666555542211
Q ss_pred ----ccC-----------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 234 ----YTL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 234 ----~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
+.+ -+..+.++.++|.+||++||++|||+.|+|+||||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 111 135788999999999999999999999999999998753
No 13
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.1e-52 Score=341.75 Aligned_cols=258 Identities=34% Similarity=0.576 Sum_probs=222.0
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC--eEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--DIY 93 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 93 (294)
..+|...+.||+|.||+||++.+..+|..+|+|.+.... ....+.+.+|+.+|++++||||+++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 567999999999999999999999889999999986652 122677999999999999999999999754444 699
Q ss_pred EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccC--
Q 022617 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD-- 169 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~-- 169 (294)
++|||+.+|+|.+++.+.+ .+++..++.+++|++++|.|||++||+|+||||+|||++. ++.+||+|||++.....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999877 7999999999999999999999999999999999999999 79999999999876653
Q ss_pred --CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhC--CCccCCCCCChhH
Q 022617 170 --GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG--GIYTLPSHLSPGA 244 (294)
Q Consensus 170 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~--~~~~~~~~~~~~l 244 (294)
........+|+.|||||++........++|||||||++.||+||+.||.. .......-.+.. ..+.+|..++.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 22234567999999999998643334699999999999999999999987 333333333322 2357788899999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
++|+.+|++.+|.+|||+.++|+|||.+...+
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999998776
No 14
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=1.7e-52 Score=354.90 Aligned_cols=257 Identities=33% Similarity=0.618 Sum_probs=240.9
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+ ...+.+.+|+++++.++||||+.+++.|+...++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 368999999999999999999999999999999998776544 4578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 174 (294)
+||+.| +|..+++.++.++++.+..++.+++.||.|||+.+|.|+|+||.||++..+|.+|++|||+++.....+. ..
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt 158 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT 158 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence 999977 9999999999999999999999999999999999999999999999999999999999999988765543 34
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 254 (294)
...|||.|||||.+.+..+ +..+|+|||||++||++.|++||.......+.+.|..+....|...+.++.+|+..+|.+
T Consensus 159 sikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIK 237 (808)
T ss_pred eccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhc
Confidence 5569999999999998888 899999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCHhHHhcCCcccccC
Q 022617 255 DPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 255 ~p~~Rps~~~il~h~~~~~~~ 275 (294)
||.+|.++.+++.|||.+...
T Consensus 238 dP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred ChhhcccHHHHhcChHHhhhh
Confidence 999999999999999998754
No 15
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=1.9e-51 Score=345.63 Aligned_cols=254 Identities=36% Similarity=0.699 Sum_probs=230.8
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999987655444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 176 (294)
||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~--~~~ 158 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--WTL 158 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc--ccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987654322 234
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 256 (294)
.+++.|+|||++.+..+ +.++||||||+++|+|++|..||.........+.+......++..++..+.+++++||+.||
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp 237 (291)
T cd05612 159 CGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDR 237 (291)
T ss_pred cCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCH
Confidence 57899999999987766 78999999999999999999999998888888888888888888899999999999999999
Q ss_pred CCCCC-----HhHHhcCCcccc
Q 022617 257 MKRIT-----IPEIRQHPWFQA 273 (294)
Q Consensus 257 ~~Rps-----~~~il~h~~~~~ 273 (294)
.+||+ ++++++||||+.
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHccCCccCCHHHHhcCccccC
Confidence 99995 999999999975
No 16
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=3.2e-51 Score=349.79 Aligned_cols=255 Identities=39% Similarity=0.713 Sum_probs=232.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|.+.+.||.|++|.||+|.++.+++.|++|++.............+.+|+.++++++||||+++++++...+..+++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 58899999999999999999999999999999999765544444567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 174 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FT 174 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ce
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987654332 23
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
..+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.......+.+..+...++..++..+.+++.+||+.|
T Consensus 175 ~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253 (329)
T ss_pred ecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcC
Confidence 467899999999987766 7899999999999999999999998888888888888888888889999999999999999
Q ss_pred CCCCCC-----HhHHhcCCcccc
Q 022617 256 PMKRIT-----IPEIRQHPWFQA 273 (294)
Q Consensus 256 p~~Rps-----~~~il~h~~~~~ 273 (294)
|.+||+ ++++++||||++
T Consensus 254 P~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHcCCCCCCCHHHHhcCCccCC
Confidence 999997 799999999976
No 17
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.7e-51 Score=335.96 Aligned_cols=272 Identities=29% Similarity=0.449 Sum_probs=232.7
Q ss_pred CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI 86 (294)
Q Consensus 7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (294)
.+...+-.-.+.|.+.+.||.|..++||+|+..-.++.|+||++..+.+.+. ...+++|+..++.++||||++++..|
T Consensus 16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF 93 (516)
T KOG0582|consen 16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF 93 (516)
T ss_pred cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence 3444556677899999999999999999999999999999999998876653 78999999999999999999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
.....+|+||.+|.+||+.++++..- .+++..+..++++++.||.|||+.|.+|||||+.||||+.+|.|+|+|||.+
T Consensus 94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence 99999999999999999999998753 4899999999999999999999999999999999999999999999999976
Q ss_pred ccccC-CCc----cccccCCCcccCCcc-ccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC-
Q 022617 165 NIMRD-GHF----LKTSCGSPNYAAPEV-ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP- 237 (294)
Q Consensus 165 ~~~~~-~~~----~~~~~~~~~~~aPE~-~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 237 (294)
..... +.. ....+++++|+|||+ ......++.++||||||++..|+.+|..||....+..+.-....+.++.+
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL 253 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence 54332 211 145589999999999 44433448999999999999999999999998877665554444443311
Q ss_pred ---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcccc
Q 022617 238 ---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA 280 (294)
Q Consensus 238 ---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~ 280 (294)
..++..++.++..||.+||.+|||++++|+|+||++..++-..
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence 3567789999999999999999999999999999887655433
No 18
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=3.9e-51 Score=345.19 Aligned_cols=259 Identities=37% Similarity=0.665 Sum_probs=234.4
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.=.++|.+++.||+|+||.||+|+-+.+|+.||+|++.++..........++.|-.+|....+++|++++..|++..++|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 34678999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC----
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---- 169 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~---- 169 (294)
|||||++||++..+|.+.+.|+++.++.++.+++.|+..||+.|++|+||||+|+||+..|++||+|||++.....
T Consensus 218 LiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred EEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999753211
Q ss_pred ------------------CCcc--------------------------ccccCCCcccCCccccCCccCCCchhHHHHHH
Q 022617 170 ------------------GHFL--------------------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 205 (294)
Q Consensus 170 ------------------~~~~--------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 205 (294)
.... .+.+|||.|+|||++.+..+ +...|+|||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ 376 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGC 376 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHHH
Confidence 0000 12358999999999999987 79999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC--CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 206 ILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 206 ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
|+|||+.|.+||...++.+..++|..-. ..+| ..++.+..+||.+||. ||++|.- ++||.+||||+..
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 9999999999999999999988887654 3333 4678999999999999 9999985 9999999999875
No 19
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=9.2e-51 Score=346.23 Aligned_cols=251 Identities=38% Similarity=0.616 Sum_probs=225.6
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||+|+||.||+|.+..+++.|++|++.............+.+|+.++++++||||+++++++...+..+++|||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444445567788999999999999999999999999999999999999
Q ss_pred ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN 181 (294)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~ 181 (294)
+|.+++.+++.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 9999998888899999999999999999999999999999999999999999999999999865322 222334568999
Q ss_pred ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (294)
Q Consensus 182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 260 (294)
|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+......++..++.++.+++.+||..||++||
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred ccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 999999987776 789999999999999999999999888888888888777888889999999999999999999999
Q ss_pred ----CHhHHhcCCccccc
Q 022617 261 ----TIPEIRQHPWFQAH 274 (294)
Q Consensus 261 ----s~~~il~h~~~~~~ 274 (294)
++.++++||||+..
T Consensus 240 ~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 240 GGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCHHHHHcCCCcCCC
Confidence 89999999999763
No 20
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.8e-50 Score=331.31 Aligned_cols=265 Identities=33% Similarity=0.551 Sum_probs=237.0
Q ss_pred CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (294)
Q Consensus 9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (294)
..+...=.+.|++++.||.|.-|+||+|..+.++..+|+|++.+.....+....++..|-++|..++||.++.+++.++.
T Consensus 69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet 148 (459)
T KOG0610|consen 69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET 148 (459)
T ss_pred cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence 45566667889999999999999999999999999999999998888877888899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
++..|++||||.||+|..+++++ +.+++..++.++.+++.||.|||-.||++|||||+|||+.++|+++|+||.++..
T Consensus 149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 99999999999999999999876 4599999999999999999999999999999999999999999999999998642
Q ss_pred ccC-----------------------------------C----------------------CccccccCCCcccCCcccc
Q 022617 167 MRD-----------------------------------G----------------------HFLKTSCGSPNYAAPEVIS 189 (294)
Q Consensus 167 ~~~-----------------------------------~----------------------~~~~~~~~~~~~~aPE~~~ 189 (294)
... . ...+..+||-.|.|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 100 0 0011235788999999999
Q ss_pred CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC--CCChhHHHHHHHhcccCCCCCCC----Hh
Q 022617 190 GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IP 263 (294)
Q Consensus 190 ~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps----~~ 263 (294)
+... +.+.|+|+||+++|||+.|..||.+.+..+...++......+|. ..+..+++||+++|.+||.+|.. +.
T Consensus 309 G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 309 GEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred cCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 8877 89999999999999999999999999999988888777766553 67889999999999999999999 99
Q ss_pred HHhcCCccccc
Q 022617 264 EIRQHPWFQAH 274 (294)
Q Consensus 264 ~il~h~~~~~~ 274 (294)
||.+||||+..
T Consensus 388 eIK~HpFF~gV 398 (459)
T KOG0610|consen 388 EIKRHPFFEGV 398 (459)
T ss_pred HhhcCccccCC
Confidence 99999999875
No 21
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=3.5e-50 Score=344.31 Aligned_cols=260 Identities=33% Similarity=0.584 Sum_probs=232.8
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
...-.++|++.+.||.|+||.||+|.+..++ ..+++|++.............+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 4456678999999999999999999876554 689999987655444445677889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..+++|||+.+++|.+++.+++.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998765432
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
.....+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.....+.+......++..++..+.+++++
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 261 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK 261 (340)
T ss_pred --cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 234568899999999987666 78999999999999999999999998888888888888888888999999999999
Q ss_pred hcccCCCCCC-----CHhHHhcCCccccc
Q 022617 251 MLIVDPMKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 251 ~l~~~p~~Rp-----s~~~il~h~~~~~~ 274 (294)
||+.+|.+|+ +++++++||||++.
T Consensus 262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999995 89999999999864
No 22
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-51 Score=347.89 Aligned_cols=261 Identities=31% Similarity=0.554 Sum_probs=231.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
..-...|...++||+|+.|.||.|....+++.|++|.+....... .+.+.+|+.+++..+|+||+.+++.|...+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 455678999999999999999999999999999999998776544 46789999999999999999999999888999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
|+||||++||+|.+.+... .+++.++..+++++++||+|||..||+|+|||.+|||++.+|.+||+|||++.......
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999999998644 58999999999999999999999999999999999999999999999999987765544
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHHHH
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARDLI 248 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~li 248 (294)
.....+||++|||||+.....| +.+.||||||++++||+.|++||-+.++...+..|... . ...+..++..+++|+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred ccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 5567789999999999998888 89999999999999999999999876666655555433 3 345678999999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.+||..|+++|+++.|||+||||+..-+..
T Consensus 504 ~~cL~~dv~~RasA~eLL~HpFl~~a~p~s 533 (550)
T KOG0578|consen 504 DRCLVVDVEQRASAKELLEHPFLKMAKPES 533 (550)
T ss_pred HHHhhcchhcCCCHHHHhcChhhhhcCCHH
Confidence 999999999999999999999996544333
No 23
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=2.3e-50 Score=313.13 Aligned_cols=255 Identities=33% Similarity=0.540 Sum_probs=223.1
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|...++||+|.||.||+|+|..+|+.||||.+......+ -......+|++.|+.++|+||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 58999999999999999999999999999999998775443 23467789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 174 (294)
||++. +|+..++.. ..++...++.++.+++.+++|||.+.|+||||||+|+||+.+|.+||+|||+++.+.......
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99976 999999754 569999999999999999999999999999999999999999999999999999887655433
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------------
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------- 234 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 234 (294)
..+.|..|+|||.+.+...++...||||.||++.||+.|.+.|.+.+..+....+.....
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 337788999999999887779999999999999999999988888777666655532110
Q ss_pred --c------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 235 --T------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 235 --~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+ +.+..+.+..+++.+|+.+||.+|+++.|+|+|+||++
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 0 11345678899999999999999999999999999986
No 24
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=1.3e-49 Score=333.54 Aligned_cols=256 Identities=27% Similarity=0.467 Sum_probs=222.1
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
.|++.+.||+|+||.||+|.+..+++.|++|.+.............+.+|+.++++++|++++++++++...+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48889999999999999999999999999999876554444445567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999888643 3589999999999999999999999999999999999999999999999999987654444445
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
..++..|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ......+.......+..++.++.+++.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 239 (285)
T cd05631 161 RVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRML 239 (285)
T ss_pred CCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHH
Confidence 578999999999988777 7899999999999999999999986543 23333344444566678899999999999
Q ss_pred cccCCCCCCC-----HhHHhcCCccccc
Q 022617 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
|+.||++||+ ++++++||||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 240 LTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred hhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999997 8999999999875
No 25
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=1.2e-49 Score=337.95 Aligned_cols=249 Identities=33% Similarity=0.604 Sum_probs=224.0
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||+|+||.||+|.+..+++.|++|++.............+.+|+.++++++||||+++++++...+..++++||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999998765444445567788999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCccc
Q 022617 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYA 183 (294)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~ 183 (294)
.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........+++.|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 99998888899999999999999999999999999999999999999999999999999875322 22233456899999
Q ss_pred CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC---
Q 022617 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI--- 260 (294)
Q Consensus 184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp--- 260 (294)
|||.+.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++.+||..||.+||
T Consensus 161 aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 161 APELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred CHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 9999987766 789999999999999999999999888888888888888888889999999999999999999997
Q ss_pred CHhHHhcCCccccc
Q 022617 261 TIPEIRQHPWFQAH 274 (294)
Q Consensus 261 s~~~il~h~~~~~~ 274 (294)
++.++++||||++.
T Consensus 240 ~~~e~l~hp~~~~~ 253 (312)
T cd05585 240 GAQEIKNHPFFSQL 253 (312)
T ss_pred CHHHHHcCCCcCCC
Confidence 57999999999874
No 26
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.6e-49 Score=338.59 Aligned_cols=250 Identities=37% Similarity=0.623 Sum_probs=224.1
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997654444445667788999999999999999999999999999999999999
Q ss_pred ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN 181 (294)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~ 181 (294)
+|..++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 9999998888899999999999999999999999999999999999999999999999998765322 222234568899
Q ss_pred ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (294)
Q Consensus 182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 260 (294)
|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+......++..+++++.+++.+||+.||++||
T Consensus 161 y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 999999987766 789999999999999999999999888888888887777788889999999999999999999998
Q ss_pred ----CHhHHhcCCcccc
Q 022617 261 ----TIPEIRQHPWFQA 273 (294)
Q Consensus 261 ----s~~~il~h~~~~~ 273 (294)
++.++++||||.+
T Consensus 240 ~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 240 GGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 8999999999976
No 27
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=7.3e-52 Score=318.36 Aligned_cols=276 Identities=42% Similarity=0.697 Sum_probs=247.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
-.+.+.|++.+.||+|.|+.|+++.+..+|+.+++|++....+... ..+++.+|+.+-+.|+||||+++++.+.+....
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 3577899999999999999999999999999999999987766554 678999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecccccccC
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRD 169 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~~~~~~~ 169 (294)
|+|+|++.|+.|..-|-.+...++..+-..++||++||.|+|..||+|+|++|+|+++-. ..-+||+|||++.....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999999999887766677889999999999999999999999999999999999943 34599999999998887
Q ss_pred CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC----CCCChhHH
Q 022617 170 GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGAR 245 (294)
Q Consensus 170 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 245 (294)
+......+|+|.|+|||++...++ +..+|||+-|+++|-++.|.+||.+.+...+.+.|+.+...++ +.++++.+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 777778899999999999999988 7899999999999999999999999999999999998886554 57899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHHH
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 290 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~~ 290 (294)
+++++||..||.+|.|+.|.|+|||+++.-..-.....+++.-+-
T Consensus 245 ~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~l 289 (355)
T KOG0033|consen 245 SLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCL 289 (355)
T ss_pred HHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHH
Confidence 999999999999999999999999998865555555566654433
No 28
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=1.9e-49 Score=338.61 Aligned_cols=250 Identities=37% Similarity=0.626 Sum_probs=224.2
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997655444455677888999999999999999999999999999999999999
Q ss_pred ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCCc
Q 022617 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPN 181 (294)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~ 181 (294)
+|..++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........+++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 9999998888899999999999999999999999999999999999999999999999999865322 222234468899
Q ss_pred ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC-
Q 022617 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI- 260 (294)
Q Consensus 182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp- 260 (294)
|+|||.+.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++++||..||.+|+
T Consensus 161 y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 161 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred ccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999987766 789999999999999999999999888888888877777788889999999999999999999997
Q ss_pred ----CHhHHhcCCcccc
Q 022617 261 ----TIPEIRQHPWFQA 273 (294)
Q Consensus 261 ----s~~~il~h~~~~~ 273 (294)
++.++++||||..
T Consensus 240 ~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 240 GGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCHHHHhcCCCcCC
Confidence 8999999999976
No 29
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=2.3e-49 Score=339.20 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=225.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++++...+..++++
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997665444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 176 (294)
||+++++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~ 158 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSV 158 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999876543 23445
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC------CCCChhHHHHH
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP------SHLSPGARDLI 248 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~------~~~~~~l~~li 248 (294)
.+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+..+....+.... ...+ ..++.++.+++
T Consensus 159 ~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li 237 (333)
T cd05600 159 VGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI 237 (333)
T ss_pred ccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence 68899999999988766 789999999999999999999999888777666554322 1111 14588999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCccccc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.+||+.+|++||++.++++||||++.
T Consensus 238 ~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 238 TKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999874
No 30
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-50 Score=346.12 Aligned_cols=260 Identities=35% Similarity=0.620 Sum_probs=241.9
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCe
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD 91 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 91 (294)
..-.++|+++++||+|.||+|+++..+.+++.||||+.++..+-..+..+....|..++.... ||+++.++..|+++++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345678999999999999999999999999999999999998888888899999999888775 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~ 170 (294)
+|+||||+.||++..+ +..+.+++..+..++..++.||.|||++||++||||.+|||++.+|++||+|||++...- .+
T Consensus 444 l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC
Confidence 9999999999995544 345779999999999999999999999999999999999999999999999999997654 56
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
....+.+||+.|+|||++.+..| +.+.|+|+||++||+|+.|..||.+.+.+++...|..+...+|..++.+..+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence 67788899999999999999999 89999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCC-----HhHHhcCCccccc
Q 022617 251 MLIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 251 ~l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
+|..+|++|.- +++|..||||+.+
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999995 5789999999865
No 31
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-50 Score=309.71 Aligned_cols=263 Identities=37% Similarity=0.690 Sum_probs=245.8
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
..-.--.++|.+++.||.|.||.||+|+.+.++--+++|++.++.+......+.+.+|+++...|+||||++++++|-+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 33444567899999999999999999999999999999999988888778889999999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIV--EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~--~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
..+|+++||...|++...+. ....+++...+.++.|++.|+.|+|..+++||||||+|+|++.++.++++|||.+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999998 5567999999999999999999999999999999999999999999999999999877
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
+ .......+||..|.|||...+... +...|+|++|++.|+++.|.+||......+..+.|.+....+|+.++.+..++
T Consensus 175 p-~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl 252 (281)
T KOG0580|consen 175 P-SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL 252 (281)
T ss_pred C-CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence 6 445567889999999999998887 78999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
|.+||.++|.+|.+..|+++|||+.+.
T Consensus 253 I~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 253 ISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999764
No 32
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1e-49 Score=334.14 Aligned_cols=260 Identities=31% Similarity=0.484 Sum_probs=227.0
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
-|+..-.+.|..+++||+|.||.||+|++..+|+.||+|.+..+.... .......+||.+|++|.||||+++.+...+.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~ 188 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSK 188 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEec
Confidence 345566778999999999999999999999999999999998765333 4567788999999999999999999998776
Q ss_pred --CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
..+|+|+|||+. +|.-++.+. -.+++.+++-+++||+.+|.|+|..|++|||||.+||||+.+|.+||+|||+|++
T Consensus 189 ~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred CCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceee
Confidence 689999999987 999998763 3699999999999999999999999999999999999999999999999999996
Q ss_pred ccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617 167 MRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (294)
Q Consensus 167 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 234 (294)
..... .....+.|..|+|||.+.+...++.+.|+||.|||+.||++|++.|.+.+..+.+..|.+.+.
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 65433 345567799999999999888779999999999999999999999999888777777644321
Q ss_pred cCC-------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 TLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+| ..++....+|+..||..||++|.|+.++|+|+||
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 111 3457778899999999999999999999999999
No 33
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-52 Score=341.67 Aligned_cols=276 Identities=26% Similarity=0.389 Sum_probs=240.5
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-...|+..+.||+|.||.||+|.+..+++.||+|++..+... ....++.+|+.++..++++||.++++.+.....+|
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW 87 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence 3455788899999999999999999999999999999876543 45789999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~- 172 (294)
++||||.||++.+.++....+.+.++.-++++++.|+.|||.++.+|+|||+.||++..+|.++|+|||.+........
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 9999999999999998888789999999999999999999999999999999999999999999999999887765443
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHh
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 251 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 251 (294)
..+.+||+.|||||++....| +.++||||||++.++|.+|.+|+....+....-.|-+..+ .+...+++.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 377889999999999997777 7999999999999999999999988777544444444443 33347888999999999
Q ss_pred cccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHHHhh
Q 022617 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 292 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~ 292 (294)
|++||+.||++.++|+|+|++...+.......-+.+++|+.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r~~~~~~ 287 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRAKKTSELKELIDRYKRWRV 287 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhcCCchHHHHHHHHHHHHhh
Confidence 99999999999999999999996555555555555666654
No 34
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=4.4e-49 Score=335.39 Aligned_cols=251 Identities=37% Similarity=0.654 Sum_probs=223.0
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||+|+||+||+|.++.+++.|++|++.............+..|..++..+ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765443334456677788888766 699999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~ 180 (294)
++|.+++.+...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.... .........+++
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999999888889999999999999999999999999999999999999999999999999986532 222333456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.....+.+.......+..++.++.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 239 (320)
T cd05590 161 DYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRL 239 (320)
T ss_pred cccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999987766 789999999999999999999999998888888888888888888999999999999999999999
Q ss_pred CH------hHHhcCCccccc
Q 022617 261 TI------PEIRQHPWFQAH 274 (294)
Q Consensus 261 s~------~~il~h~~~~~~ 274 (294)
++ +++++||||+..
T Consensus 240 ~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 240 GSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 98 899999999764
No 35
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=9.7e-49 Score=333.98 Aligned_cols=256 Identities=36% Similarity=0.585 Sum_probs=227.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-ceeEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~ 96 (294)
+|++.+.||.|+||.||+|.+..+++.|++|++.............+..|..+++.+.|+ +++++++++...+..|++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999765443444556778899999999764 6888999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCcccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~ 175 (294)
||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.... .......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999999888889999999999999999999999999999999999999999999999999886432 2222334
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
..+++.|+|||++.+..+ +.++|+||+|+++|+|++|+.||...+.......+......++..++.++.+++.+||..|
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239 (324)
T ss_pred ecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence 568999999999988776 7899999999999999999999999988888888888888888899999999999999999
Q ss_pred CCCCCCH-----hHHhcCCccccc
Q 022617 256 PMKRITI-----PEIRQHPWFQAH 274 (294)
Q Consensus 256 p~~Rps~-----~~il~h~~~~~~ 274 (294)
|.+|++. .++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 240 PAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999986 899999999763
No 36
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7.1e-50 Score=327.46 Aligned_cols=259 Identities=50% Similarity=0.874 Sum_probs=246.7
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
..+..+|.+.+.||+|.||.|-+|.+...|+.|+||.+.++.+.++.+.-.+++|++++..|+||||+.++.+|+..+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 35667999999999999999999999889999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
.+||||..+|.|.+++.+++.+++.+.+.+++||+.|+.|+|+.+++|+|+|.+|||++.++++||.|||++..+.....
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf 208 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF 208 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhc
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 252 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 252 (294)
..+.+|++.|.+||+.++.+|.++..|.||||+++|-|..|..||++.+...+.++|..+.+.- +.-+.+..-||+.||
T Consensus 209 LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE-P~~PSdA~gLIRwmL 287 (668)
T KOG0611|consen 209 LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE-PETPSDASGLIRWML 287 (668)
T ss_pred HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC-CCCCchHHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999999999999999887643 345677889999999
Q ss_pred ccCCCCCCCHhHHhcCCccc
Q 022617 253 IVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 253 ~~~p~~Rps~~~il~h~~~~ 272 (294)
-.||++|.|+++|.+|=|+.
T Consensus 288 mVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 288 MVNPERRATIEDIASHWWVN 307 (668)
T ss_pred hcCcccchhHHHHhhhheee
Confidence 99999999999999998884
No 37
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=1.7e-49 Score=342.39 Aligned_cols=256 Identities=35% Similarity=0.658 Sum_probs=226.2
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|.+.+.||.|++|+||+|.+..+++.|++|++.............+.+|+.+++.++|+|++++++++...+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999997665444455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987654332
Q ss_pred -------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022617 172 -------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226 (294)
Q Consensus 172 -------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~ 226 (294)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 2234468899999999988766 78999999999999999999999988877777
Q ss_pred HHHhC--CCccCC--CCCChhHHHHHHHhcccCCCCCCC-HhHHhcCCccccc
Q 022617 227 KKIKG--GIYTLP--SHLSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH 274 (294)
Q Consensus 227 ~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps-~~~il~h~~~~~~ 274 (294)
..+.. .....+ ..++.++.++|.+||. +|.+||+ +.++++||||++.
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 66665 333333 3469999999999997 9999999 9999999999864
No 38
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-49 Score=321.34 Aligned_cols=260 Identities=33% Similarity=0.534 Sum_probs=223.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET---- 88 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 88 (294)
-.+..+|...+.||.|++|.|+.|.++.+|+.||+|.+... +.+....++..+|+++|+.++|+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 45667788899999999999999999999999999998633 3455678999999999999999999999999854
Q ss_pred -CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 89 -PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
-+.+|+|+|+|+ .+|...++++..++++.+..++.|++.||.|+|+.+++|||+||+|++++.++.+|++|||+|+..
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 467999999995 499999988888999999999999999999999999999999999999999999999999999987
Q ss_pred cC---CCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617 168 RD---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (294)
Q Consensus 168 ~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 234 (294)
.. .......+.|..|+|||.+.....++.+.||||+||++.||++|+..|.+.+....++.+..-..
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 53 33345567799999999987666668999999999999999999999988765544443322111
Q ss_pred ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
...++.++...+|+++||..||.+|+|++|+|.||||...
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 1115778899999999999999999999999999999765
No 39
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-48 Score=329.84 Aligned_cols=251 Identities=31% Similarity=0.534 Sum_probs=219.9
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCce-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHK-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS- 90 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (294)
..-.....+.+.||.|+||+||.+.+. |+. +++|++......... .+.+.+|+.++++++||||++++|++.++.
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344556677888999999999999985 455 999999877666554 789999999999999999999999999887
Q ss_pred eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeEecCCC-cEEEeeeccccc
Q 022617 91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDSKW-NVKIADFGLSNI 166 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~-i~h~di~p~nili~~~~-~~~l~dfg~~~~ 166 (294)
.+++||||+.+|+|.+++.+ ...++...+..++.||+.|+.|||+.+ |+|+||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999987 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCC-CccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hCCCccCCCCCC
Q 022617 167 MRDG-HFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLS 241 (294)
Q Consensus 167 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 241 (294)
.... .......||..|||||++.+ ..+ +.++||||+|+++|||+||+.||...........+ ....+.++..++
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~ 272 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECP 272 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCC
Confidence 6654 33334689999999999994 466 89999999999999999999999998875555554 344466677899
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+.+..++++||..||..||++.+|+.
T Consensus 273 ~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 273 PHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999999999999999999876
No 40
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=1.8e-48 Score=337.30 Aligned_cols=256 Identities=31% Similarity=0.566 Sum_probs=220.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||+||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+.+...++++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999986432210
Q ss_pred -------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (294)
Q Consensus 172 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 220 (294)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0123468999999999987776 78999999999999999999999988
Q ss_pred CHHHHHHHHhCCC--ccCCC--CCChhHHHHHHHhcccCCC---CCCCHhHHhcCCccccc
Q 022617 221 NIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPM---KRITIPEIRQHPWFQAH 274 (294)
Q Consensus 221 ~~~~~~~~~~~~~--~~~~~--~~~~~l~~li~~~l~~~p~---~Rps~~~il~h~~~~~~ 274 (294)
........+.... ..++. .++.++.+++.+|+. +|. .||++++|++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 8877777776432 33333 468899999999775 344 46899999999999865
No 41
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=4.4e-49 Score=336.25 Aligned_cols=251 Identities=38% Similarity=0.626 Sum_probs=224.3
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||+|+||.||++.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997665444445667788999999999999999999999999999999999999
Q ss_pred ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 103 ELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 103 sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
+|..++.+...+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999999888889999999999999999999997 7999999999999999999999999999865322 22233446899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+.+......++..++.++.+++.+||+.||++|+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 161 EYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred ccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 9999999987766 789999999999999999999999888888888887777788889999999999999999999997
Q ss_pred -----CHhHHhcCCccccc
Q 022617 261 -----TIPEIRQHPWFQAH 274 (294)
Q Consensus 261 -----s~~~il~h~~~~~~ 274 (294)
++.++++||||++.
T Consensus 240 ~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 89999999999864
No 42
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=1.4e-48 Score=332.63 Aligned_cols=251 Identities=35% Similarity=0.570 Sum_probs=222.8
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||.||+|.+..+++.|++|++.............+..|..++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999999999999999999765444444456677888888765 799999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 180 (294)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 999999988888999999999999999999999999999999999999999999999999998754322 2233445789
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.....+.+.......+..++.++.+++.+||+.||++||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~ 239 (321)
T cd05591 161 DYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRL 239 (321)
T ss_pred cccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcC
Confidence 9999999987776 789999999999999999999999999888888888887777888999999999999999999999
Q ss_pred -------CHhHHhcCCccccc
Q 022617 261 -------TIPEIRQHPWFQAH 274 (294)
Q Consensus 261 -------s~~~il~h~~~~~~ 274 (294)
++.++++||||+..
T Consensus 240 ~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 240 GCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CCCCCCCCHHHHhcCCccCCC
Confidence 89999999999763
No 43
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-49 Score=329.30 Aligned_cols=264 Identities=41% Similarity=0.728 Sum_probs=230.1
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-----------hHHHHHHHHHHHHHHhCCCCceeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----------MEMEEKVRREIKILRLFMHPHIIRL 82 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~~~~i~~~ 82 (294)
...++|++.+.||+|.||.|-+|++..+++.||||++.+..... ....+...+|+.++++|.|+||+++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 45679999999999999999999999999999999997554331 1234689999999999999999999
Q ss_pred EEEEEcC--CeEEEEEeccCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617 83 YEVIETP--SDIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (294)
Q Consensus 83 ~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~ 159 (294)
+.+..++ +.+|+|+|||..|.+...- ..++ +++.+++.++.+++.+|.|||.+||+||||||+|+|++.+|++||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 9998654 6799999999987766432 3445 9999999999999999999999999999999999999999999999
Q ss_pred eecccccccCC------CccccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 022617 160 DFGLSNIMRDG------HFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 160 dfg~~~~~~~~------~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~ 230 (294)
|||.+..+..+ ......+|||-|+|||.+.+ ..+.+.+.|||++|+++|.++.|+.||.+....+...+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99998866322 23345789999999999876 4566789999999999999999999999999999999999
Q ss_pred CCCccCCCC--CChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 231 GGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 231 ~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.....+|.. +..+++++|.+||.+||++|.++.+|..|||........
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 988777764 789999999999999999999999999999998764433
No 44
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.7e-48 Score=332.53 Aligned_cols=254 Identities=34% Similarity=0.569 Sum_probs=222.7
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCceeEEEEEEEcCCeEEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
|++.+.||.|++|.||+|.+..+++.|++|++.............+.+|..++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999765443334455666666554 567799999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~ 174 (294)
|||+.+++|...+. .+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 99999999998875 45799999999999999999999999999999999999999999999999998764322 22233
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 254 (294)
...+++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~ 238 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRR 238 (324)
T ss_pred ccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhc
Confidence 4568899999999987766 789999999999999999999999988888888888877778888999999999999999
Q ss_pred CCCCCC-----CHhHHhcCCccccc
Q 022617 255 DPMKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 255 ~p~~Rp-----s~~~il~h~~~~~~ 274 (294)
||.+|| ++.++++||||++.
T Consensus 239 dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 239 NPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999 69999999999874
No 45
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.6e-49 Score=335.23 Aligned_cols=259 Identities=31% Similarity=0.550 Sum_probs=241.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe-EE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-IY 93 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~ 93 (294)
..++|.+++.+|.|+||.+++++++.+++.+++|.+......... .....+|..++++++||||+.+.+.|..++. ++
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 357899999999999999999999999999999999888766654 3488899999999999999999999988888 99
Q ss_pred EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
|+|+||+||+|.+.+.+++ .++++.+..++.|++.|+.|||+..|+|+|||+.||+++.++.++|+|||++.......
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999997654 69999999999999999999999999999999999999999999999999999988776
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 249 (294)
.....+||+.|++||.+.+.++ +.++|||||||++|||++-+++|...+...+..++.... .++|..++.+++.+|+
T Consensus 161 ~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~ 239 (426)
T KOG0589|consen 161 SLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK 239 (426)
T ss_pred hhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence 6778889999999999999999 799999999999999999999999999999999998887 7889999999999999
Q ss_pred HhcccCCCCCCCHhHHhcCCcccccC
Q 022617 250 RMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.||+.+|+.||++.++|.+|.+....
T Consensus 240 ~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 240 SMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHhhcCCccCCCHHHHhhChhhhhHH
Confidence 99999999999999999999887443
No 46
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=1.3e-48 Score=338.42 Aligned_cols=256 Identities=34% Similarity=0.643 Sum_probs=222.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||+||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999886432111
Q ss_pred ----------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCC
Q 022617 172 ----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF 217 (294)
Q Consensus 172 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~ 217 (294)
......+|+.|+|||++.+..+ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 0012358899999999987776 78999999999999999999999
Q ss_pred CCCCHHHHHHHHhCCC--ccCC--CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 218 DDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 218 ~~~~~~~~~~~~~~~~--~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
...+.......+.... ...+ ..+++++.++|.+|+. +|.+|++ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9888777666665432 2222 2568899999999996 8999998 9999999999764
No 47
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=2.5e-48 Score=332.02 Aligned_cols=250 Identities=30% Similarity=0.564 Sum_probs=217.9
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||+|+||.||+|.+..+++.|++|++.............+.+|..+++++ +||||+++++++...+.++++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555555567788999999888 699999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~ 180 (294)
++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .........++.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 9999999888899999999999999999999999999999999999999999999999999986432 222333456889
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
.|+|||++.+..+ +.++|+||||+++|+|++|+.||... ......+.+.......|..++.++.+++.+|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 239 (329)
T cd05588 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999987766 78999999999999999999999632 1223445566666777888999999999999
Q ss_pred cccCCCCCCC------HhHHhcCCcccc
Q 022617 252 LIVDPMKRIT------IPEIRQHPWFQA 273 (294)
Q Consensus 252 l~~~p~~Rps------~~~il~h~~~~~ 273 (294)
|+.||.+|++ ++++++||||+.
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 240 LNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred hccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999997 789999999975
No 48
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=3e-48 Score=330.03 Aligned_cols=251 Identities=37% Similarity=0.633 Sum_probs=223.2
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||+||+|.+..+++.|++|++.............+..|..+++.+ +||||+++++++...+.++++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999999765444444556677888888877 699999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 99999998888899999999999999999999999999999999999999999999999998864322 22223345788
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.......+..++.++.++|.+||..||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (318)
T cd05570 161 DYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRL 239 (318)
T ss_pred cccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcC
Confidence 9999999988776 789999999999999999999999888888888888777777888999999999999999999999
Q ss_pred CH-----hHHhcCCccccc
Q 022617 261 TI-----PEIRQHPWFQAH 274 (294)
Q Consensus 261 s~-----~~il~h~~~~~~ 274 (294)
++ .++++||||+..
T Consensus 240 s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 240 GCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCHHHHhcCCCcCCC
Confidence 99 999999999774
No 49
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=3.3e-48 Score=329.44 Aligned_cols=251 Identities=33% Similarity=0.604 Sum_probs=219.7
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||.||+|.++.+++.|++|++.............+..|..++.. ++|+|++++++++...+..+++|||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999976543222334556677777765 4899999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|..++.+...+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++..... ........++.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 99999998888899999999999999999999999999999999999999999999999998864321 22233456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.....+.+.......+..++.++.+++.+||..||++||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 239 (316)
T cd05620 161 DYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRL 239 (316)
T ss_pred CccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999987776 789999999999999999999999888888888888777777888999999999999999999999
Q ss_pred CH-hHHhcCCccccc
Q 022617 261 TI-PEIRQHPWFQAH 274 (294)
Q Consensus 261 s~-~~il~h~~~~~~ 274 (294)
++ +++++||||+..
T Consensus 240 ~~~~~~~~h~~f~~~ 254 (316)
T cd05620 240 GVVGNIRGHPFFKTI 254 (316)
T ss_pred CChHHHHcCCCcCCC
Confidence 97 589999999774
No 50
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=2.4e-48 Score=326.19 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=211.4
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||+|++|.||+|.++.+++.+++|++...... ....+.+.+|+.+++.++|+||+++++++...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999998654322 234567788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 174 (294)
||++++++..+......+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 999987666655555679999999999999999999999999999999999999999999999999987654322 122
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------------
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------------- 234 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------------- 234 (294)
...++..|+|||++.+..+ +.++|+||||+++|+|++|+.||...+..+....+.....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07848 160 EYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLR 238 (287)
T ss_pred ccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccc
Confidence 3457889999999987766 7899999999999999999999987654433322211100
Q ss_pred -c-----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 -T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 -~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+ ....++.++.+++.+||+.||++|||++++|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 012367789999999999999999999999999998
No 51
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=2.1e-48 Score=331.76 Aligned_cols=250 Identities=34% Similarity=0.597 Sum_probs=219.2
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||+||+|.+..+++.|++|++.............+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46899999999999999999999999997654433333445555544 56789999999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|..++.+++.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ........+++
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233446889
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.||.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 161 EYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred hhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 9999999987766 789999999999999999999999988888888888777777888999999999999999999999
Q ss_pred CH----hHHhcCCcccc
Q 022617 261 TI----PEIRQHPWFQA 273 (294)
Q Consensus 261 s~----~~il~h~~~~~ 273 (294)
++ .++++||||+.
T Consensus 240 ~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 240 GAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCHHHHHcCCCcCC
Confidence 87 69999999975
No 52
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-48 Score=328.93 Aligned_cols=261 Identities=44% Similarity=0.764 Sum_probs=240.3
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (294)
...+...|.+.+.||.|.||.||.|.++.+|+.+|+|++.+...........+.+|+++|+++. |||++.+.+.|++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 4567779999999999999999999999999999999998887766556789999999999999 999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----CcEEEeeeccccc
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIADFGLSNI 166 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----~~~~l~dfg~~~~ 166 (294)
.+++|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+++... +.++++|||++..
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 999999999999999999776 49999999999999999999999999999999999999643 4799999999999
Q ss_pred ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC----CCCCCh
Q 022617 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSP 242 (294)
Q Consensus 167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 242 (294)
..........+||+.|+|||++....+ +...||||+|+++|.|++|..||.+.+.......+..+.+.+ +..++.
T Consensus 189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~ 267 (382)
T KOG0032|consen 189 IKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE 267 (382)
T ss_pred ccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence 888777888899999999999998777 799999999999999999999999998888888888776543 457899
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.+.++|..||..||..|+|+.++|+|||++..
T Consensus 268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999875
No 53
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=4.6e-48 Score=329.68 Aligned_cols=255 Identities=35% Similarity=0.570 Sum_probs=225.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+|++.+.||+|+||.||+|.+..+++.|++|++................|..++..+. |++++++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999999999999999987654433344556677778877774 789999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCcccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~ 175 (294)
||+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875432 222334
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
..+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+......++..++.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~ 239 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 239 (323)
T ss_pred CCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccC
Confidence 568899999999988776 7899999999999999999999999988888888888888888899999999999999999
Q ss_pred CCCCCCH-----hHHhcCCcccc
Q 022617 256 PMKRITI-----PEIRQHPWFQA 273 (294)
Q Consensus 256 p~~Rps~-----~~il~h~~~~~ 273 (294)
|++|++. .++++||||+.
T Consensus 240 p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 240 PGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999984 89999999975
No 54
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=5.1e-48 Score=324.37 Aligned_cols=253 Identities=27% Similarity=0.487 Sum_probs=211.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|+||.||+|.+..++..|++|++...... .....+.+|+.++++++|+||+++++++...+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46799999999999999999999999999999998654321 2235677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+++ +|.+++...+ .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999976 9999887654 47899999999999999999999999999999999999999999999999987543322 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------- 233 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 233 (294)
....+++.|+|||.+.+....+.++||||+|+++|+|++|+.||.+.+..+....+....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 344578899999998765444789999999999999999999998776555443332100
Q ss_pred -c---------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 -Y---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 -~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
. ......+.++.+++.+||+.||.+|||++|+++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0 0113467889999999999999999999999999998
No 55
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=4.9e-48 Score=329.48 Aligned_cols=252 Identities=36% Similarity=0.614 Sum_probs=221.8
Q ss_pred cccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 22 GKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
++.||+|+||.||++.+. .+++.|++|++...... .......+.+|+.+++.++||||+++++.+..++..+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 46789999998754332 22334567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTS 176 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~ 176 (294)
|+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999864322 2223344
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 256 (294)
.+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++.++.+++.+||+.+|
T Consensus 161 ~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 239 (323)
T cd05584 161 CGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNP 239 (323)
T ss_pred CCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCH
Confidence 68899999999987766 78999999999999999999999998888888888888888888999999999999999999
Q ss_pred CCCC-----CHhHHhcCCccccc
Q 022617 257 MKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 257 ~~Rp-----s~~~il~h~~~~~~ 274 (294)
++|| +++++++||||+..
T Consensus 240 ~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 240 SSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred hHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999 89999999999753
No 56
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=5.9e-48 Score=327.89 Aligned_cols=251 Identities=38% Similarity=0.659 Sum_probs=219.1
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||.||+|.+..+++.||+|++................|..++.. .+||||+++++++...+..+++|||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 468999999999999999999999999976543333334455566666654 4799999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 180 (294)
++|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .......+++
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 999999988888999999999999999999999999999999999999999999999999998754322 2334456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+.+.......+......++..++.++.+++.+||..+|++||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~ 239 (316)
T cd05592 161 DYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRL 239 (316)
T ss_pred cccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcC
Confidence 9999999987766 789999999999999999999999988888888888777778888999999999999999999999
Q ss_pred CH-hHHhcCCccccc
Q 022617 261 TI-PEIRQHPWFQAH 274 (294)
Q Consensus 261 s~-~~il~h~~~~~~ 274 (294)
++ .++++||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05592 240 GVDGDIRQHPFFRGI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 86 589999999763
No 57
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=3.3e-48 Score=337.34 Aligned_cols=256 Identities=31% Similarity=0.573 Sum_probs=219.2
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|++++++++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999987654444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999885321100
Q ss_pred -------------------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617 172 -------------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (294)
Q Consensus 172 -------------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 208 (294)
......+++.|+|||++.+..+ +.++||||||+++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0012358899999999987766 78999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhCC--CccCC--CCCChhHHHHHHHhcccCCCCC---CCHhHHhcCCccccc
Q 022617 209 ALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQAH 274 (294)
Q Consensus 209 ~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~~p~~R---ps~~~il~h~~~~~~ 274 (294)
+|++|..||...........+... ...++ ..++.++.++|.+||. +|.+| +++.++++||||++.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999887776666665432 22333 3578999999999997 66665 599999999999853
No 58
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=7.6e-48 Score=335.33 Aligned_cols=257 Identities=31% Similarity=0.524 Sum_probs=218.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
..|.+++.||+|+||+||+|.+..+++.|++|++.............+.+|+.++++++|+||+++++++.+.+.++++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999997765555556678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------ 170 (294)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.+++++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999986432100
Q ss_pred ------------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617 171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (294)
Q Consensus 171 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 208 (294)
.......+++.|+|||.+.+..+ +.++||||||+++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 00113468899999999987766 78999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhC--CCccCC--CCCChhHHHHHHHhc--ccCCCCCCCHhHHhcCCccccc
Q 022617 209 ALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIPRML--IVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 209 ~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l--~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+|++|..||...........+.. .....+ ..++.++.++|.+|+ ..+|..|+++.++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999988776655555442 222333 357899999999955 4455569999999999999763
No 59
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-48 Score=329.93 Aligned_cols=248 Identities=29% Similarity=0.524 Sum_probs=221.5
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-...++.++.||+|.||.||.|.++ ....|++|.+...... .+.+.+|++++++|+|++|++++++|..++.++
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 34456788999999999999999996 4457999998765433 367779999999999999999999999988999
Q ss_pred EEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
|||||+..|+|.++|.. ...+...+.+.++.||+++++||++++++||||...|||++++..+||+|||+++...+..
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 99999999999999986 4568999999999999999999999999999999999999999999999999999665554
Q ss_pred ccccc--cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 FLKTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
..... ..+..|.|||++....+ +.+||+||||++|||++| |+.||.+++..+.++.+..+. .+.|..||.++.++
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 43332 34778999999999988 899999999999999999 999999999999999998776 78889999999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
|..||..+|++|||++.+..
T Consensus 437 M~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred HHHHhhCCcccCCCHHHHHH
Confidence 99999999999999997765
No 60
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=6.4e-48 Score=326.09 Aligned_cols=258 Identities=27% Similarity=0.471 Sum_probs=209.9
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..+++.|++|++...... .....+.+|+.+++.++||||+++++++......+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~ 173 (294)
+||+++ +|.+++... +.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 82 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCCc-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 999965 888877654 56899999999999999999999999999999999999999999999999998654322 222
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCC--C-----------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGG--I----------------- 233 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~--~----------------- 233 (294)
....+++.|+|||++.+....+.++||||||+++|+|++|..||.+... ......+... .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence 3455788999999987655447889999999999999999999976432 2222221100 0
Q ss_pred --cc--CC---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 234 --YT--LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 234 --~~--~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.. .+ ..++.++.+++.+||+.||.+|||+.++++||||++.-+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 00 00 124567889999999999999999999999999988543
No 61
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=6.3e-48 Score=329.41 Aligned_cols=251 Identities=31% Similarity=0.567 Sum_probs=217.0
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||+|+||.||+|.+..+++.|++|++.............+.+|+.++.++ +||||+++++++...+..++++||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876555545567788898888776 799999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233456789
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
.|+|||++.+..+ +.++|+||||+++|+|++|..||.. .......+.+......+|..++..+.+++.+|
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~ 239 (329)
T cd05618 161 NYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSF 239 (329)
T ss_pred cccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 9999999987766 7899999999999999999999952 11223445556666777888999999999999
Q ss_pred cccCCCCCCC------HhHHhcCCccccc
Q 022617 252 LIVDPMKRIT------IPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rps------~~~il~h~~~~~~ 274 (294)
|+.||++||+ +.++++||||+..
T Consensus 240 L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 240 LNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred hcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 9999999998 5799999999763
No 62
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=9.9e-48 Score=322.13 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=220.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..+++.|++|++.............+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 58899999999999999999998999999999876554444445567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|+.+++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||++...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999888653 4589999999999999999999999999999999999999999999999999876654444344
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
..++..|+|||.+.+..+ +.++|+||+|+++|++++|..||.+..... ....+.......+..++..+.+++.+|
T Consensus 161 ~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05605 161 RVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL 239 (285)
T ss_pred ccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence 567899999999987766 788999999999999999999998765433 233344444556667899999999999
Q ss_pred cccCCCCCC-----CHhHHhcCCcccc
Q 022617 252 LIVDPMKRI-----TIPEIRQHPWFQA 273 (294)
Q Consensus 252 l~~~p~~Rp-----s~~~il~h~~~~~ 273 (294)
|..||.+|| ++.++++||||..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 240 LTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999 8999999999976
No 63
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=3e-47 Score=325.71 Aligned_cols=257 Identities=24% Similarity=0.437 Sum_probs=219.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|++.+.||.|++|.||++.+..++..+++|++.... .......+.+|++++++++|+|++++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4579999999999999999999999999999999986542 22345778999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
+|||+++++|.+++.+...+++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~ 159 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cc
Confidence 999999999999998888899999999999999999999986 5999999999999999999999999998765332 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC----------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG---------------------- 231 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~---------------------- 231 (294)
....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+..++...+..
T Consensus 160 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (331)
T cd06649 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238 (331)
T ss_pred ccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccc
Confidence 34568899999999987766 7899999999999999999999976655443322211
Q ss_pred ------------------------CC-ccC-CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 232 ------------------------GI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 232 ------------------------~~-~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.. ... ...++.++.+||.+||+.||++|||+.+|++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 00 011 124678999999999999999999999999999998753
No 64
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1e-47 Score=328.83 Aligned_cols=257 Identities=34% Similarity=0.588 Sum_probs=219.8
Q ss_pred CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (294)
+|++.+.||+|+||.||++.+. .+++.+++|++...... .....+.+..|+.+++.++ |++|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 46789999998654322 2234567788999999995 89999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
+++|||+.+++|.+++.++..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987543222
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARD 246 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~ 246 (294)
......++..|+|||.+.+....+.++||||||+++|+|++|..||... ........+......++..++..+.+
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 2223468999999999886654478999999999999999999999642 33445555666666777889999999
Q ss_pred HHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617 247 LIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 247 li~~~l~~~p~~Rp-----s~~~il~h~~~~~~ 274 (294)
++.+||+.||++|| +++++++||||++.
T Consensus 241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999999999999 88899999999863
No 65
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=8.3e-48 Score=335.36 Aligned_cols=256 Identities=33% Similarity=0.548 Sum_probs=219.5
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|.+++.||+|+||+||+|.+..+++.+++|++.............+.+|+.++++++|+||+++++.+...+.+++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999999999999999987655444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------ 170 (294)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999986432100
Q ss_pred ------------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHH
Q 022617 171 ------------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY 208 (294)
Q Consensus 171 ------------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~ 208 (294)
.......+++.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence 00112357899999999987777 78999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhCCC--ccC--CCCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 209 ALLCGTLPFDDENIPNLFKKIKGGI--YTL--PSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 209 ~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
+|++|..||...+.......+.... ... ...+++++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999998877666555554322 222 2467899999999987 59999997 9999999999764
No 66
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=3.5e-48 Score=331.47 Aligned_cols=257 Identities=28% Similarity=0.504 Sum_probs=221.8
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|.+.+.||.|+||+||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++++...+..+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998665544455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 173 (294)
||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccccCCCcccCCccccC-----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--c--cCCCCCChhH
Q 022617 174 KTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--Y--TLPSHLSPGA 244 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l 244 (294)
....+++.|+|||.+.. ....+.++||||||+++|+|++|..||...........+.... . +....++.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence 23357899999999863 2233688999999999999999999998877776666654432 2 2223578999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.+++..||+ +|.+|||++++++||||+..
T Consensus 241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999999998 99999999999999999863
No 67
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=1.6e-47 Score=325.08 Aligned_cols=251 Identities=36% Similarity=0.614 Sum_probs=218.4
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||+|+||.||+|.+..+++.||+|++................|..+++. ++||||+++++++...+.++++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 468999999999999999999999999876543222334556667777765 5899999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~ 180 (294)
++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 999999988788999999999999999999999999999999999999999999999999998653221 2233456789
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.....+.+.......+..++.++.+++.+||+.+|++||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 239 (316)
T cd05619 161 DYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRL 239 (316)
T ss_pred cccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcC
Confidence 9999999987766 789999999999999999999999888888888887776667778899999999999999999999
Q ss_pred CHh-HHhcCCccccc
Q 022617 261 TIP-EIRQHPWFQAH 274 (294)
Q Consensus 261 s~~-~il~h~~~~~~ 274 (294)
++. ++++||||+..
T Consensus 240 ~~~~~l~~h~~~~~~ 254 (316)
T cd05619 240 GVKGDIRQHPFFREI 254 (316)
T ss_pred CChHHHHcCcccCCC
Confidence 996 89999999774
No 68
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=5.7e-48 Score=335.79 Aligned_cols=256 Identities=31% Similarity=0.525 Sum_probs=219.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++.+..++.++++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987654444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC------
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------ 170 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~------ 170 (294)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999987422100
Q ss_pred --------------------------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh
Q 022617 171 --------------------------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (294)
Q Consensus 171 --------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 212 (294)
.......+++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 00012358899999999987776 789999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhCCC--c--cCCCCCChhHHHHHHHhcccCCCCCC---CHhHHhcCCccccc
Q 022617 213 GTLPFDDENIPNLFKKIKGGI--Y--TLPSHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH 274 (294)
Q Consensus 213 g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~~~ 274 (294)
|+.||......+....+.... . +....++.++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999887766655554322 1 222467899999999987 5999999 99999999999863
No 69
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=1.3e-47 Score=332.33 Aligned_cols=259 Identities=30% Similarity=0.528 Sum_probs=223.1
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-.++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 44578999999999999999999999999999999987554444444566788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-- 171 (294)
+++||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 99999999999998854 468999999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCC--CCChhH
Q 022617 172 FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGA 244 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~~~l 244 (294)
......+++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||...+.......+.... ...+. .++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 123456899999999986532 23689999999999999999999999888777777776533 33333 579999
Q ss_pred HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (294)
Q Consensus 245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~ 273 (294)
.++|.+||+.+|++ |+|+.++++||||+.
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 99999999999988 999999999999986
No 70
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=4.4e-47 Score=319.04 Aligned_cols=255 Identities=42% Similarity=0.748 Sum_probs=230.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.+..+++.+++|++.............+.+|+++++++.||||+++++++...+..++++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999987655444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 176 (294)
||+++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTL 158 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCC
Confidence 99999999999988888999999999999999999999999999999999999999999999999998766444 2334
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCC
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 256 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 256 (294)
.+++.|+|||.+.+... +.++|+||||+++|+|++|..||...+.....+.+..+...++...+..+.+++.+||..+|
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 159 CGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCH
Confidence 57889999999876655 78899999999999999999999888877777777777777888889999999999999999
Q ss_pred CCCC-----CHhHHhcCCccccc
Q 022617 257 MKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 257 ~~Rp-----s~~~il~h~~~~~~ 274 (294)
.+|+ +++++++||||+..
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCcccCCHHHHHcCcccccC
Confidence 9999 89999999999764
No 71
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=2.5e-47 Score=325.01 Aligned_cols=256 Identities=36% Similarity=0.579 Sum_probs=225.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 96 (294)
+|...+.||.|+||+||+|.++.+++.||+|++...........+.+..|..+++.+.| ++++++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47889999999999999999999999999999876543333445667788888888864 77888999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 999999999999888889999999999999999999999999999999999999999999999999987543222 2234
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
..+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||.........+.+.......+..++.++.+++.+||+.+
T Consensus 161 ~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~ 239 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKH 239 (323)
T ss_pred ccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccC
Confidence 457899999999987766 7899999999999999999999999888888888888887888889999999999999999
Q ss_pred CCCCCC-----HhHHhcCCccccc
Q 022617 256 PMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 256 p~~Rps-----~~~il~h~~~~~~ 274 (294)
|.+|++ ..++++||||+..
T Consensus 240 p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 240 PSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HhhCCCCCCCCHHHHhcCcccCCC
Confidence 999997 4789999999874
No 72
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=5e-48 Score=328.82 Aligned_cols=251 Identities=30% Similarity=0.577 Sum_probs=221.4
Q ss_pred cccccccCceEEEEEEE---ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 22 GKTLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
++.||+|+||.||++.+ ..+++.+++|++....... .....+.+|++++++++||||+++++++..++..|+++||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 3578899999997654322 2345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccccc
Q 022617 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSC 177 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~ 177 (294)
+.+++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~ 159 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence 999999999988888999999999999999999999999999999999999999999999999998765433 2233456
Q ss_pred CCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 257 (294)
+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+......++..++.++.+++.+||+.||+
T Consensus 160 g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~ 238 (318)
T cd05582 160 GTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPA 238 (318)
T ss_pred CChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHh
Confidence 7899999999987666 789999999999999999999999988888888888878888888999999999999999999
Q ss_pred CCCC-----HhHHhcCCccccc
Q 022617 258 KRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 258 ~Rps-----~~~il~h~~~~~~ 274 (294)
+||+ +.++++||||+..
T Consensus 239 ~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 239 NRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HcCCCCCCCHHHHhCCCCcCCC
Confidence 9999 7789999999763
No 73
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=3.7e-47 Score=328.69 Aligned_cols=266 Identities=31% Similarity=0.506 Sum_probs=216.3
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC---
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS--- 90 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 90 (294)
.+.++|++.+.||+|+||.||++.+..++..+++|++.... ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 46789999999999999999999999999999999986543 22344567789999999999999999999986443
Q ss_pred ---eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 91 ---DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
..++++||+++ +|.+.+. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 57999999976 6777663 35789999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-----------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK----------------- 230 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~----------------- 230 (294)
..........++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence 44444445567889999999988776 789999999999999999999998765433221111
Q ss_pred -----CCCcc--------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCC
Q 022617 231 -----GGIYT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 284 (294)
Q Consensus 231 -----~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~ 284 (294)
..... .....+.++.+++.+||..||++|||+.|+|+||||+.++......++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~ 331 (359)
T cd07876 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAEAPP 331 (359)
T ss_pred HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcccccCCC
Confidence 00000 0112457789999999999999999999999999999877655444433
No 74
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=1.1e-47 Score=331.94 Aligned_cols=256 Identities=31% Similarity=0.600 Sum_probs=221.5
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||.||+|.+..+++.|++|++.............+.+|+.++..++|++++++++.+...+.++++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997655444455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||++|++|.+++.+.+.+++..++.++.|++.+|.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999876432110
Q ss_pred -------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617 172 -------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (294)
Q Consensus 172 -------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 220 (294)
......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 0112358899999999987776 78999999999999999999999988
Q ss_pred CHHHHHHHHhCCC--ccCCC--CCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 221 NIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 221 ~~~~~~~~~~~~~--~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
........+.... ..++. .++.++.++|.+|+. +|.+|++ ++++++||||++.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence 8777777665422 22333 478899999999874 9999984 8999999999874
No 75
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=1.3e-47 Score=327.14 Aligned_cols=251 Identities=34% Similarity=0.577 Sum_probs=218.4
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHH-HHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIK-ILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||+||+|.+..+++.+++|++.............+..|.. +++.++||||+++++.+...+..+++|||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46899999999999999999999999987654333333445555554 56789999999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|...+.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233456889
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......+...+..+.+++.+||..+|.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 161 EYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred hhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcC
Confidence 9999999988776 789999999999999999999999888888888887777777778999999999999999999999
Q ss_pred CH----hHHhcCCccccc
Q 022617 261 TI----PEIRQHPWFQAH 274 (294)
Q Consensus 261 s~----~~il~h~~~~~~ 274 (294)
++ .++++||||+..
T Consensus 240 ~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 240 GAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 86 589999999863
No 76
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=6e-47 Score=326.58 Aligned_cols=259 Identities=31% Similarity=0.481 Sum_probs=214.5
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
....++|...+.||.|+||.||+|.+..+++.|++|++.... .......+.+|++++++++|+||+++++++...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 344678999999999999999999999999999999985432 234457789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+.+++|.+. ...++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999999999988653 345678889999999999999999999999999999999999999999999987654322
Q ss_pred ccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-hCCCccCCCCCChh
Q 022617 172 FLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKI-KGGIYTLPSHLSPG 243 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~-~~~~~~~~~~~~~~ 243 (294)
......++..|+|||.+.. ..+.+.++||||||+++|+|++|+.||...... .....+ .......+..++.+
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2234568899999998743 233356899999999999999999999743322 222222 22334455678999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
+.++|.+||+.||++|||+.|+++||||......
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 9999999999999999999999999999887533
No 77
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=2.3e-47 Score=325.22 Aligned_cols=250 Identities=33% Similarity=0.576 Sum_probs=217.7
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||.||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++++...+..++++||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999998765443333344555554 467889999999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|...+.+...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233446789
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.......+...+..+.+++.+||+.+|.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 161 EYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred ccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 9999999987766 789999999999999999999999988888888887777778888999999999999999999999
Q ss_pred CH----hHHhcCCcccc
Q 022617 261 TI----PEIRQHPWFQA 273 (294)
Q Consensus 261 s~----~~il~h~~~~~ 273 (294)
++ .++++|+||..
T Consensus 240 ~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 240 GAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCHHHHhCCCCcCC
Confidence 75 59999999974
No 78
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=3e-47 Score=326.84 Aligned_cols=256 Identities=33% Similarity=0.558 Sum_probs=209.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 92 (294)
+|++.+.||.|++|.||+|.+..+++.|++|.+.... ........+.+|+.++++++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 6899999999999999999999999999999986432 2223345788999999999999999999987543 358
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||++ ++|.+++.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 5999999888889999999999999999999999999999999999999999999999999987543221
Q ss_pred ---ccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----------------
Q 022617 172 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK---------------- 230 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~---------------- 230 (294)
......++..|+|||++.+ ..+ +.++||||||+++|+|++|+.||.+.+.......+.
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1133468899999999865 334 789999999999999999999997655332221110
Q ss_pred -----------CCC-c---cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 231 -----------GGI-Y---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 231 -----------~~~-~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
... . ...+.++..+.+++.+||+.||++|||++++++||||+..-.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000 0 011346788999999999999999999999999999977533
No 79
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=5.3e-47 Score=316.94 Aligned_cols=249 Identities=34% Similarity=0.535 Sum_probs=212.7
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|+||+||++.+..+++.+++|.+.............+..|+.++++++|+|++++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998765544444456778899999999999999999999999999999999999999
Q ss_pred HHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cccccCC
Q 022617 105 FDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGS 179 (294)
Q Consensus 105 ~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 179 (294)
...+.. +..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .....++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988743 34689999999999999999999999999999999999999999999999999876543322 2334678
Q ss_pred CcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
+.|+|||.+.+..+ +.++|+||+|+++|+|++|+.||..... ......+.......+..++..+.+++.+||+.|
T Consensus 161 ~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 161 PGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred cCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCC
Confidence 89999999988776 7899999999999999999999976432 233333444445556778999999999999999
Q ss_pred CCCCC-----CHhHHhcCCccccc
Q 022617 256 PMKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 256 p~~Rp-----s~~~il~h~~~~~~ 274 (294)
|++|| +++++++||||+..
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999 78999999999874
No 80
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=4.8e-47 Score=323.80 Aligned_cols=251 Identities=29% Similarity=0.549 Sum_probs=217.7
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||+|+||.||+|.+..+++.+++|++.............+.+|..++.++ .|++|+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788999998888 599999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~ 180 (294)
++|..++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... .........+++
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 9999999888889999999999999999999999999999999999999999999999999986532 222334456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
.|+|||.+.+..+ +.++|+||||+++|+|++|..||... ......+.+.......|..++..+.+++.+||+
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~ 239 (327)
T cd05617 161 NYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLN 239 (327)
T ss_pred ccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhc
Confidence 9999999987766 78999999999999999999999532 223344555555667788899999999999999
Q ss_pred cCCCCCCC------HhHHhcCCccccc
Q 022617 254 VDPMKRIT------IPEIRQHPWFQAH 274 (294)
Q Consensus 254 ~~p~~Rps------~~~il~h~~~~~~ 274 (294)
.||.+|++ ++++++||||+..
T Consensus 240 ~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 240 KDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 99999998 5799999999764
No 81
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=1.8e-48 Score=304.09 Aligned_cols=266 Identities=41% Similarity=0.692 Sum_probs=239.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCC-CCceeEEEEE
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFM-HPHIIRLYEV 85 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~ 85 (294)
.+.+...|.-.+.||.|..+.|-++.++.+++.+++|++...... .....+.-.+|+.+|+++. ||+|+++.++
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ 91 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV 91 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee
Confidence 356778899999999999999999999999999999998643221 2334566678999999885 9999999999
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
|+++..+++|+|.++-|.|.+++.+.-.+++.+.+.+++|+++++.|||..+|+|+|+||+||+++++-+++|+|||+++
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC---
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP--- 237 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 237 (294)
....+......+|||+|.|||.+. +.+.++...|+|+.|++||-++.|.+||......-+...|+.+...+.
T Consensus 172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe 251 (411)
T KOG0599|consen 172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE 251 (411)
T ss_pred ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc
Confidence 999998888899999999999874 333347789999999999999999999999888999999999987654
Q ss_pred -CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 238 -SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 238 -~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
.+++...+++|.+||+.||.+|.|++|+|.||||.+..-.
T Consensus 252 Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 252 WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 5789999999999999999999999999999999766433
No 82
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=3.4e-47 Score=324.62 Aligned_cols=250 Identities=34% Similarity=0.584 Sum_probs=216.8
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHH-HHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREI-KILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|+||+||+|.+..+++.|++|++.............+..|. .+++.++|+||+++++++...+..++++||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998765433323333444444 456889999999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|.+++.+...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..... ........+++
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..++..+.+++.+||+.+|.+||
T Consensus 161 ~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 161 EYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred cccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCC
Confidence 9999999987766 789999999999999999999999888888888877777777788999999999999999999999
Q ss_pred CHh----HHhcCCcccc
Q 022617 261 TIP----EIRQHPWFQA 273 (294)
Q Consensus 261 s~~----~il~h~~~~~ 273 (294)
++. ++++|+||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 240 GAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCHHHHhcCcccCC
Confidence 866 8999999965
No 83
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=3.9e-47 Score=328.99 Aligned_cols=261 Identities=29% Similarity=0.554 Sum_probs=222.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
....++|++.+.||.|+||.||++.+..+++.+++|++.............+.+|+.+++.++||||+++++++..++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34567999999999999999999999999999999998755444444456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 999999999999999864 4689999999999999999999999999999999999999999999999999876543222
Q ss_pred --cccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCC--CCChh
Q 022617 173 --LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPG 243 (294)
Q Consensus 173 --~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~~~ 243 (294)
.....+++.|+|||++.+.. ..+.++|+||||+++|+|++|..||...+.......+.... ...+. .++..
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 23456899999999986543 23689999999999999999999999888777777765433 33333 56889
Q ss_pred HHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617 244 ARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (294)
Q Consensus 244 l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~ 274 (294)
+.+++..||..++.+ |+++.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865543 8999999999999864
No 84
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=2.4e-46 Score=310.05 Aligned_cols=254 Identities=34% Similarity=0.554 Sum_probs=218.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc--hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN--MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
++|.+.+.||.|++|.||.|.+..+++.+++|++....... ......+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57999999999999999999999899999999986543222 2234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL- 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 173 (294)
++|++++++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998654332111
Q ss_pred ---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--CCccCCCCCChhHHHHH
Q 022617 174 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLI 248 (294)
Q Consensus 174 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li 248 (294)
....++..|+|||.+.+... +.++|+||||+++|++++|+.||.............. .....+..++..+.+++
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 22346778999999987765 7899999999999999999999977655544444332 23456678899999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+||..+|++|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
No 85
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=1.7e-46 Score=313.47 Aligned_cols=249 Identities=28% Similarity=0.472 Sum_probs=209.5
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|+||.||++.++.+++.+++|.+.............+..|++++++++||||+++++++......+++|||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998655443333445567799999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcc
Q 022617 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (294)
Q Consensus 105 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 182 (294)
.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886543 5889999999999999999999999999999999999999999999999998766554444445688899
Q ss_pred cCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccC-CCCCChhHHHHHHHhcccCCC
Q 022617 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTL-PSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 183 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~ 257 (294)
+|||++.+..+ +.++|+||+|+++|+|++|..||..... .............. ...++.++.+++.+||+.||+
T Consensus 161 ~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 161 MAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred cCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHh
Confidence 99999987775 7899999999999999999999975432 22323333222222 246899999999999999999
Q ss_pred CCCCH----hHHhcCCccccc
Q 022617 258 KRITI----PEIRQHPWFQAH 274 (294)
Q Consensus 258 ~Rps~----~~il~h~~~~~~ 274 (294)
+||++ +++++||||+..
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hCCCCccchhhhhcChhhcCC
Confidence 99999 678899999875
No 86
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=2.3e-47 Score=326.34 Aligned_cols=250 Identities=32% Similarity=0.563 Sum_probs=215.2
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
||.|+||+||+|.+..+++.|++|++................|..++..+ .||||+++++.+...+..+++|||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999998765443333344455566666655 699999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC-CCccccccCCC
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 180 (294)
++|.+++.+.+.+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... ........++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 99999998888899999999999999999999999999999999999999999999999999865322 22233456899
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCC-CCChhHHHHHHHhcccCCCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKR 259 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~R 259 (294)
.|+|||++.+....+.++||||||+++|+|++|..||.........+.+..+...++. .++.++.+++.+||+.||.+|
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 240 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence 9999999876554478999999999999999999999998888888888776665554 478999999999999999999
Q ss_pred C----CHhHHhcCCccccc
Q 022617 260 I----TIPEIRQHPWFQAH 274 (294)
Q Consensus 260 p----s~~~il~h~~~~~~ 274 (294)
| ++.++++||||+..
T Consensus 241 ~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 241 LGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCHHHHhcCccccCC
Confidence 8 69999999999763
No 87
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=1.5e-46 Score=314.93 Aligned_cols=256 Identities=30% Similarity=0.495 Sum_probs=217.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
.|++.+.||.|+||.||++.+..+++.+++|.+.............+.+|+.++++++|++++++++.+...+..++++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876554444445667789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|+.+++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999999988654 3589999999999999999999999999999999999999999999999999876544433344
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HhCCCccCCCCCChhHHHHHHHh
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKK-IKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
..++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...... ..... ........+..++.++.+++.+|
T Consensus 161 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05630 161 RVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKML 239 (285)
T ss_pred CCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHH
Confidence 568899999999987766 78999999999999999999999764321 11111 12222345567899999999999
Q ss_pred cccCCCCCCC-----HhHHhcCCccccc
Q 022617 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
|+.||++||| +.++++||||+..
T Consensus 240 l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 240 LCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred hhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999 8999999999863
No 88
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.1e-46 Score=319.34 Aligned_cols=269 Identities=26% Similarity=0.470 Sum_probs=221.1
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|.+.+.||.|+||.||+|.++.++..+++|.+...... .....+.+|++++++++|+|++++++++..++..+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 36899999999999999999999999999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+++ +|.+++... ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 999975 888887654 458899999999999999999999999999999999999999999999999987543322 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------c
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~ 234 (294)
....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+.... .
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 334568899999998765444789999999999999999999998766544433332100 0
Q ss_pred -----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcch
Q 022617 235 -----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTM 287 (294)
Q Consensus 235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~ 287 (294)
.....++.++.++|.+||+.||.+|||+.++++||||+....+....|.+-++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~ 305 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESISI 305 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCcceee
Confidence 01134678899999999999999999999999999999887776666665443
No 89
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.3e-46 Score=316.12 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=206.0
Q ss_pred cCCcccccccccCceEEEEEEEcc-CCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEE-----
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIE----- 87 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----- 87 (294)
.+|++.+.||.|+||.||+|.+.. ++..+++|.+....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46789999986543322 2233455677766655 6999999999885
Q ss_pred cCCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
.....++++|++++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 34568999999964 999998653 358999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----------
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------- 234 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 234 (294)
............+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.+....+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhh
Confidence 6654444445568899999999977766 7899999999999999999999988776655554432110
Q ss_pred ----------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 ----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+.++..+.+++.+||+.||++|||+.++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0113467788999999999999999999999999998
No 90
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=1.4e-46 Score=325.76 Aligned_cols=262 Identities=29% Similarity=0.530 Sum_probs=222.5
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
...-.++|++.+.||.|+||.||+|.++.+++.+++|++.............+.+|+.+++.++||||+++++.+...+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34556899999999999999999999999999999999876544444445667889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
.+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 9999999999999999864 468999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccC--CCCCCh
Q 022617 172 --FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTL--PSHLSP 242 (294)
Q Consensus 172 --~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~--~~~~~~ 242 (294)
......+++.|+|||++.... ..+.++||||||+++|+|++|..||...+.......+.... ..+ ...++.
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 276 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 276 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCH
Confidence 223456899999999986532 23689999999999999999999999888777777765433 223 346899
Q ss_pred hHHHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617 243 GARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~--Rps~~~il~h~~~~~~ 274 (294)
++.++|.+||..++.+ |++++++++||||++.
T Consensus 277 ~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 277 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 9999999999854443 7899999999999774
No 91
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=3.9e-46 Score=318.91 Aligned_cols=258 Identities=24% Similarity=0.437 Sum_probs=216.8
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|++.+.||.|+||.||++.+..++..+++|.+.... .......+.+|++++++++|+||+++++++...+..++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4689999999999999999999999999999999886542 22345678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
++||+.+++|.+++.+.+.+++..+..++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~ 159 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 159 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-cc
Confidence 999999999999998888899999999999999999999975 7999999999999999999999999998754332 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------ 229 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~------------------------ 229 (294)
....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...........+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238 (333)
T ss_pred ccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchh
Confidence 33457889999999987665 78999999999999999999999765443332111
Q ss_pred --------------------hCC-CccCC-CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 230 --------------------KGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 230 --------------------~~~-~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
... ....+ ..++.++.+++.+||+.||++|||+.+++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 000 01111 135778999999999999999999999999999987643
No 92
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=3.4e-47 Score=314.53 Aligned_cols=251 Identities=41% Similarity=0.722 Sum_probs=213.0
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
|++.+.||+|++|+||++.+..+++.+++|++......... .....+|+.++++++|+||+++++++...+..++++|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999776544322 33445699999999999999999999999999999999
Q ss_pred cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCCcccccc
Q 022617 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSC 177 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~~~~~~ 177 (294)
+.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+... ..........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999988889999999999999999999999999999999999999999999999999998753 3334445667
Q ss_pred CCCcccCCcccc-CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhCCCccCC----CCCChhHHHHHH
Q 022617 178 GSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLP----SHLSPGARDLIP 249 (294)
Q Consensus 178 ~~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~----~~~~~~l~~li~ 249 (294)
++..|+|||.+. +... +.++|+||||+++++|++|..||....... ............. ...+..+.+++.
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 238 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIK 238 (260)
T ss_dssp SSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHH
T ss_pred ccccccccccccccccc-cccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHH
Confidence 888999999988 4444 899999999999999999999998873322 3322222221111 122489999999
Q ss_pred HhcccCCCCCCCHhHHhcCCcc
Q 022617 250 RMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+||+.||++|||+.++++||||
T Consensus 239 ~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 239 KMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999998
No 93
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=3.8e-47 Score=328.68 Aligned_cols=254 Identities=32% Similarity=0.485 Sum_probs=215.0
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-C-----CceeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-H-----PHIIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~ 86 (294)
+.+..+|.|++.||+|.||.|.+|.|..+++.||||+++... ........|+.+|..|+ | -|+++++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 456679999999999999999999999999999999986443 45677788999999887 3 4899999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CCcEEEeeec
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KWNVKIADFG 162 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~~~~l~dfg 162 (294)
...+++|+|+|.++. +|.++++.++ .++...++.++.||+.+|.+||+.||+|+||||+|||+.. ...+|++|||
T Consensus 258 ~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999999955 9999998774 4889999999999999999999999999999999999975 3479999999
Q ss_pred ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------
Q 022617 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------- 234 (294)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 234 (294)
.++.....-. ....+..|+|||++.+.++ +.+.|||||||++.||++|.+.|.+.+..+.+..|..-..
T Consensus 337 SSc~~~q~vy--tYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 337 SSCFESQRVY--TYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccccCCcce--eeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9998755443 6677889999999999999 7999999999999999999999977765554443321100
Q ss_pred --------------------------------------------cCC-----------CCCChhHHHHHHHhcccCCCCC
Q 022617 235 --------------------------------------------TLP-----------SHLSPGARDLIPRMLIVDPMKR 259 (294)
Q Consensus 235 --------------------------------------------~~~-----------~~~~~~l~~li~~~l~~~p~~R 259 (294)
..| ..-...+.+|+.+||.+||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 001 0123467899999999999999
Q ss_pred CCHhHHhcCCccccc
Q 022617 260 ITIPEIRQHPWFQAH 274 (294)
Q Consensus 260 ps~~~il~h~~~~~~ 274 (294)
+|+.++|+||||+..
T Consensus 494 ~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 494 ITPAQALNHPFLTGT 508 (586)
T ss_pred CCHHHHhcCcccccc
Confidence 999999999999843
No 94
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.3e-46 Score=332.41 Aligned_cols=253 Identities=29% Similarity=0.419 Sum_probs=207.0
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (294)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3457999999999999999999999899999999874332 2345799999999999999998876331
Q ss_pred ---CeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeee
Q 022617 90 ---SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADF 161 (294)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~df 161 (294)
..++++|||+++ +|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 247799999975 88777653 45699999999999999999999999999999999999998664 6999999
Q ss_pred cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------
Q 022617 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------- 233 (294)
Q Consensus 162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 233 (294)
|++.............+++.|+|||++.+....+.++||||||+++|+|++|.+||.+....+....+....
T Consensus 216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~ 295 (440)
T PTZ00036 216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295 (440)
T ss_pred ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 999876554444455678999999998765444789999999999999999999998766544333322100
Q ss_pred ---------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 234 ---------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 234 ---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
..++...+.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 012345678999999999999999999999999999998753
No 95
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=4.5e-47 Score=303.61 Aligned_cols=255 Identities=32% Similarity=0.431 Sum_probs=217.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cCCeEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYV 94 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~l 94 (294)
++|..+..|++|.||.||+|+|+.+++-||+|.+..+.-.. -.--.-.+|+.+|.+.+||||+.+-.+.. .-+.+|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 57999999999999999999999999999999997654221 12234578999999999999999988764 3467999
Q ss_pred EEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617 95 VMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 172 (294)
|||||+. +|..++.+-+ ++...+++-++.|++.|++|||...|+|||+||+|+|++..|.+|++|||+|+....+. .
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9999977 9999998765 79999999999999999999999999999999999999999999999999999887653 3
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc------------------
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------ 234 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------ 234 (294)
....+-|..|+|||.+.+.+.++.+.||||+||++.+++++++.|.+....+.+.+|.....
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 44556799999999999988889999999999999999999999999887776666532110
Q ss_pred -cCC------------C-CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 235 -TLP------------S-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 235 -~~~------------~-~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
.++ . .++..-.+|+..+|.+||.+|.|+.+.|+|+||..
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 000 1 14467779999999999999999999999999977
No 96
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.5e-46 Score=325.72 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=206.2
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|++.+.||.|+||.||+|.+..+++.|++|... ...+.+|++++++++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 4468999999999999999999999999999999642 2346789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC--Cc
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~--~~ 172 (294)
++|++. ++|..++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 999995 589999888788999999999999999999999999999999999999999999999999998643221 22
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHh---------------
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIK--------------- 230 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-------~~~~~~~~~--------------- 230 (294)
.....+++.|+|||++.+..+ +.++||||||+++|+|++|..||.... .......+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 234568999999999987776 789999999999999999998764321 011111100
Q ss_pred -----------CCCcc----CC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 231 -----------GGIYT----LP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 231 -----------~~~~~----~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
..... .+ ...+.++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 00000 00 1346689999999999999999999999999999874
No 97
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=2.6e-46 Score=323.03 Aligned_cols=259 Identities=31% Similarity=0.495 Sum_probs=213.2
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (294)
.+.++|++.+.||.|+||.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 467899999999999999999999998999999999865432 233456778899999999999999999988543
Q ss_pred --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
...++++||+++ +|.+.+.. .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 357999999976 77777643 5889999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------- 232 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 232 (294)
..........++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+..+....+...
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence 55544455678999999999987766 78999999999999999999999876543332211100
Q ss_pred -------Cc--------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 233 -------IY--------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 233 -------~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
.. ..+...+.++.++|.+||+.||++|||+.|+|+||||+.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 00 0011235678999999999999999999999999999877543
No 98
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=6.5e-46 Score=315.68 Aligned_cols=257 Identities=36% Similarity=0.584 Sum_probs=222.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|+||+|.+..+++.+++|.+.............+.+|+++++.++|+||+++++.+...+..++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999889999999998765554456678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--
Q 022617 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-- 172 (294)
Q Consensus 97 e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-- 172 (294)
||+.+++|.+++.+. ..+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 5689999999999999999999999999999999999999999999999998764422111
Q ss_pred ----------------------------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022617 173 ----------------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224 (294)
Q Consensus 173 ----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~ 224 (294)
.....++..|+|||.+.+... +.++||||||+++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 112246778999999987666 789999999999999999999998877776
Q ss_pred HHHHHhCCCccCCC--CCChhHHHHHHHhcccCCCCCCC----HhHHhcCCccccc
Q 022617 225 LFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRIT----IPEIRQHPWFQAH 274 (294)
Q Consensus 225 ~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps----~~~il~h~~~~~~ 274 (294)
....+.......+. ..+..+.+++.+||..+|++||+ ++++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 66666554444443 36899999999999999999999 9999999999885
No 99
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.6e-46 Score=324.01 Aligned_cols=260 Identities=30% Similarity=0.495 Sum_probs=214.4
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (294)
.+.++|++.+.||+|+||.||+|.+..+++.+++|++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 46789999999999999999999999999999999986543 2233456788899999999999999999887543
Q ss_pred --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
...+++|||+++ +|.+.+. ..++...++.++.|++.||.+||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 457999999975 7887774 35789999999999999999999999999999999999999999999999999876
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 233 (294)
..........++..|+|||++.+..+ +.++||||||+++|+|++|+.||...+..+....+....
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence 55444455678899999999988776 789999999999999999999998766544443332110
Q ss_pred --------cc--------------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 234 --------YT--------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 234 --------~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.. .....+..+.++|.+||+.||.+|||+.++|+||||..+....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 328 (364)
T cd07875 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPS 328 (364)
T ss_pred HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcc
Confidence 00 0011345788999999999999999999999999998754433
No 100
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=6.4e-46 Score=311.18 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=220.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
.|+..+.||.|+||+||+|.+..+++.+++|.+.............+.+|+++++.++|++++++.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876554444445667889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|+.+++|.+++... ..+++..+..++.|++.+|.|||+.||+|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 99999999888653 3699999999999999999999999999999999999999999999999999876544333344
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhCCCccCCCCCChhHHHHHHHh
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF----KKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
..++..|+|||.+.+..+ +.++|+||+|+++|++++|..||......... ..+.......+..++.++.+++..|
T Consensus 161 ~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 239 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKML 239 (285)
T ss_pred CCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHH
Confidence 568899999999987766 78999999999999999999999876544332 3333334455667889999999999
Q ss_pred cccCCCCCCC-----HhHHhcCCccccc
Q 022617 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
|+.+|++||+ +.++++|+||+..
T Consensus 240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 240 LTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999 8899999999774
No 101
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=4.5e-46 Score=318.33 Aligned_cols=257 Identities=30% Similarity=0.567 Sum_probs=216.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||+|+||.||++.+..+++.|++|++...........+.+.+|..+++.++|+||+++++++..++.+++|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999987644444445567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 173 (294)
||+.+++|.+++.+ ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976 45789999999999999999999999999999999999999999999999999865543322 1
Q ss_pred ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l 244 (294)
....+++.|+|||++.. ....+.++||||+|+++|+|++|+.||......+....+.... ..++ ..++.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 240 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA 240 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence 22458899999999863 2233678999999999999999999998877766666654322 2222 3478999
Q ss_pred HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (294)
Q Consensus 245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~ 273 (294)
.+++.+||..++++ |+++.++++||||+.
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999988654443 789999999999976
No 102
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=2e-46 Score=303.89 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=219.8
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCC----
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPS---- 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~---- 90 (294)
...|..+++||+|.||+||+|+++.+|+.||+|.+..+.-. +-.-....+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56789999999999999999999999999999999766432 123466789999999999999 999999998776
Q ss_pred --eEEEEEeccCCCChHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 91 --DIYVVMEYVKSGELFDYIVEKG----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 91 --~~~lv~e~~~~~sL~~~l~~~~----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
.+++++||++. +|..++.... .++...++.++.||+.|++|||+.+|+||||||.||+|+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 9999997654 4778899999999999999999999999999999999999999999999999
Q ss_pred ccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--c-------
Q 022617 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--Y------- 234 (294)
Q Consensus 165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~------- 234 (294)
....-+ ......+.|..|+|||++.+....+...||||+||++.||++++..|.+....+....|-... +
T Consensus 168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 876633 335666788999999999988777999999999999999999999999888776666552211 0
Q ss_pred ---------cCC------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 235 ---------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 235 ---------~~~------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.++ +....+..+++.+||+.+|.+|.|+..+|.||||+..
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 000 1223478899999999999999999999999999875
No 103
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=2.2e-46 Score=325.35 Aligned_cols=255 Identities=31% Similarity=0.549 Sum_probs=213.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 92 (294)
+|++.+.||.|+||.||+|.+..+++.|++|.+.... ........+.+|+.+++.++|+||+++++++..+. ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999985432 23334567889999999999999999999998776 78
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+. ++|.+.+.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999996 4899988877889999999999999999999999999999999999999999999999999987543222
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC------------------
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------------ 232 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 232 (294)
......++..|+|||.+.+....+.++||||+|+++|+|++|+.||...+.......+...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 2223456889999999887654478999999999999999999999877655444333210
Q ss_pred -----C---------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 233 -----I---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 233 -----~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
. .......+.++.++|.+||+.||.+|||+.++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 0 01223457889999999999999999999999999999873
No 104
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=1.3e-46 Score=310.95 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=225.3
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+++.+++|++...........+.+.+|++++++++|||++++++.+..+...++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999976655454567889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 177 (294)
|+.+++|.+++.+..++++..+..++.|++.+|.+||+.|++|+||+|+||++++++.++|+|||.+.............
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 99999999999877789999999999999999999999999999999999999999999999999987765544444556
Q ss_pred CCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCCCccCCCCCChhHHHHHHHhccc
Q 022617 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 254 (294)
++..|+|||.+.+... +.++|+||||+++|++++|..||.... ...............+...+..+.++|.+||..
T Consensus 161 ~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 161 GTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239 (258)
T ss_pred CChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccC
Confidence 7889999999887665 789999999999999999999998766 344444444455667778899999999999999
Q ss_pred CCCCCCCH--hHHhcCCcc
Q 022617 255 DPMKRITI--PEIRQHPWF 271 (294)
Q Consensus 255 ~p~~Rps~--~~il~h~~~ 271 (294)
||.+||++ .++++||||
T Consensus 240 ~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ChhHcCCccHHHHhcCCCC
Confidence 99999999 999999998
No 105
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=5e-47 Score=318.91 Aligned_cols=263 Identities=44% Similarity=0.811 Sum_probs=245.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
..+.+=|.+.+.||+|-|+.|-+|++.-+|..|+||++.+...+... -..+.+|+..++.++||||+++|.+......+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceE
Confidence 35677899999999999999999999999999999999988776543 46678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe-cCCCcEEEeeecccccccCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili-~~~~~~~l~dfg~~~~~~~~ 170 (294)
|+|+|.-++|+|.++|-++ ..++++..++++.||+.|+.|+|+..++|+|+||+||.+ ..-|-+||.|||++..+..+
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999999999665 569999999999999999999999999999999999877 55789999999999998888
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
......+|+..|.|||++.+..|..++.||||||+++|.|.+|+.||..-+..+.+..|++.++..|..++.++++||..
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence 88889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCHhHHhcCCcccccCC
Q 022617 251 MLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
||..||++|.+.++|.+++|++..=+
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHhcCchhhccHHHHhccccccCCCC
Confidence 99999999999999999999998533
No 106
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=3.1e-46 Score=333.15 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=207.9
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CceeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~ 86 (294)
+...++|++.+.||.|+||+||+|.+..+++.||||++.... ........|+++++.++| .+++++++++
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 345689999999999999999999999899999999985321 223445667777776654 4588888888
Q ss_pred EcC-CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCC----------
Q 022617 87 ETP-SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKW---------- 154 (294)
Q Consensus 87 ~~~-~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~---------- 154 (294)
... ..+|++++++ |++|.+++.+.+.+++..++.++.|++.||.|||+ .||+|+||||+||+++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 654 5789999998 66999999888889999999999999999999997 5999999999999998765
Q ss_pred ------cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 022617 155 ------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK 228 (294)
Q Consensus 155 ------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~ 228 (294)
.+||+|||.+..... ......+++.|+|||++.+..+ +.++|||||||++|+|++|+.||...+..+....
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 499999998754322 2234568999999999988777 7899999999999999999999987665443333
Q ss_pred HhCCCccCC------------------------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHh
Q 022617 229 IKGGIYTLP------------------------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIR 266 (294)
Q Consensus 229 ~~~~~~~~~------------------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il 266 (294)
+......++ ......+.+||.+||.+||.+|||+.|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 221110000 01134577999999999999999999999
Q ss_pred cCCcccccCCccccCC
Q 022617 267 QHPWFQAHLPRYLAVP 282 (294)
Q Consensus 267 ~h~~~~~~~~~~~~~~ 282 (294)
+||||++..+...+.|
T Consensus 437 ~Hp~~~~~~~~~~~~~ 452 (467)
T PTZ00284 437 THPYVLKYYPECRQHP 452 (467)
T ss_pred cCccccccCCccccCC
Confidence 9999999877554433
No 107
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=8.5e-46 Score=306.72 Aligned_cols=249 Identities=36% Similarity=0.692 Sum_probs=219.8
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|++|.||+|.+..+++.+++|++...........+.+.+|+.++++++|+|++++++.+..++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999766555545567899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccC
Q 022617 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA 184 (294)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~a 184 (294)
.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|++
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 99998888899999999999999999999999999999999999999999999999999887655433334467889999
Q ss_pred CccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh--CCCccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 185 PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 185 PE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
||.+.+..+ +.++|+|++|+++|++++|..||.... .......+. ......+...+.++.+++.+||..+|++||
T Consensus 161 PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 161 PEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCc
Confidence 999876665 788999999999999999999998766 555555555 344566667789999999999999999999
Q ss_pred C-----HhHHhcCCccccc
Q 022617 261 T-----IPEIRQHPWFQAH 274 (294)
Q Consensus 261 s-----~~~il~h~~~~~~ 274 (294)
+ +.|+++||||++.
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999863
No 108
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=2.5e-47 Score=309.09 Aligned_cols=255 Identities=31% Similarity=0.476 Sum_probs=218.7
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--C--
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S-- 90 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~-- 90 (294)
..=.|...+++|+|+||.||.|....+++.+|||.+-.+.. .-.+|+++++.+.||||+++..+|... +
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 34468889999999999999999999999999998754432 335799999999999999999888542 2
Q ss_pred -eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeeccc
Q 022617 91 -DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLS 164 (294)
Q Consensus 91 -~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~ 164 (294)
...+|+||++. ||.+.+.. +..++...++-+..||+.||+|||+.||+||||||.|+|++.+ |.+||+|||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 46789999965 99999974 4678999999999999999999999999999999999999975 89999999999
Q ss_pred ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------- 233 (294)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 233 (294)
.....+....+...+..|+|||.+.+....+.+.||||.||++.||+-|++.|.+.+..+....|.+-.
T Consensus 174 K~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 174 KVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred eeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 999888888888899999999999988877999999999999999999999999887666655542211
Q ss_pred -c-----c------------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 234 -Y-----T------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 234 -~-----~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
. . +....+++..+|+.++|+++|.+|.++.|++.||||..--..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 0 224578899999999999999999999999999999775443
No 109
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=9.9e-46 Score=330.13 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=221.6
Q ss_pred cccCCcccccccccCceEEEEEEEccC-CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALT-GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
....|.+.+.||.|++|.||+|.+..+ +..+++|.+... .......+.+|+.+++.++||||+++++++...+..+
T Consensus 65 ~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~ 141 (478)
T PTZ00267 65 REHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL 141 (478)
T ss_pred cceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence 344599999999999999999998877 778889876433 3334567788999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 94 VVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
++|||+++++|.+++.. ..++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 99999999999988753 34689999999999999999999999999999999999999999999999999976543
Q ss_pred CC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 170 GH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 170 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
.. ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+..+. .+.+..++.++.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 32 1234458999999999987766 789999999999999999999999888777777765544 345667899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
++|.+||..+|++||++.+++.|||++..
T Consensus 301 ~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 301 ALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 99999999999999999999999999643
No 110
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1.1e-45 Score=330.13 Aligned_cols=265 Identities=28% Similarity=0.474 Sum_probs=226.7
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
.......++|++.+.||.|+||+||+|.+..+++.||+|++....... .....+.+|+..+..++|+|+++++..+...
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 344566789999999999999999999999999999999987654432 4456788899999999999999998776433
Q ss_pred C--------eEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617 90 S--------DIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (294)
Q Consensus 90 ~--------~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~ 157 (294)
. .+++++||+.+++|.+++... .++++..++.++.|++.+|.|||+.||+|+||||+||+++.++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEE
Confidence 2 378999999999999998643 4689999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCC---CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-
Q 022617 158 IADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI- 233 (294)
Q Consensus 158 l~dfg~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~- 233 (294)
|+|||++...... .......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+..+.
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~ 262 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 9999998754322 12234568899999999987766 789999999999999999999999888777777665544
Q ss_pred ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.+++..+++++.+++.+||..+|.+||++.++++|||++....
T Consensus 263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 4567789999999999999999999999999999999876543
No 111
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=6.8e-46 Score=311.48 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=204.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEc-----C
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIET-----P 89 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~ 89 (294)
+|++.+.||.|++|+||+|.++.+++.|++|.+....... .....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999999999999999986543221 1223445566666554 79999999998754 3
Q ss_pred CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
...++++|++.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 899988764 34899999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 233 (294)
..........++..|+|||++.+..+ +.++||||+|+++|+|++|..||......+....+....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTL 237 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccc
Confidence 54444445567889999999987766 789999999999999999999998766554443332100
Q ss_pred -------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 -------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 -------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
....+.++..+.+++.+||+.||++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 238 PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00113567788999999999999999999999999998
No 112
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.2e-45 Score=311.92 Aligned_cols=264 Identities=27% Similarity=0.494 Sum_probs=218.5
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|.+.+.||.|++|.||+|.+..+++.|++|.+...... .....+.+|+.++++++|+||+++++++..++..+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 46799999999999999999999989999999998644322 2234667899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+++ +|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 999975 898888654 568999999999999999999999999999999999999999999999999986543222 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------c
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------Y 234 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------~ 234 (294)
....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...+..+....+.... .
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 234567899999998765545789999999999999999999998776554433321100 0
Q ss_pred c-----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617 235 T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282 (294)
Q Consensus 235 ~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~ 282 (294)
. ....++.++.++|.+||..||.+|||+.++++||||+....+....|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~ 300 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCC
Confidence 0 11356788999999999999999999999999999998877666555
No 113
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=7.9e-46 Score=308.90 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=220.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.+++|++.... .......+.+|+++++.++|+|++++++++......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47999999999999999999999999999999986543 2233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
|++++++|.+++... ++++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999998755 88999999999999999999999999999999999999999999999999987765432 2234
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCC-CChhHHHHHHHhcc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLI 253 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~~~l~ 253 (294)
..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... ...+.. ++.++.+++.+||.
T Consensus 158 ~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 236 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLN 236 (274)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhh
Confidence 456788999999987775 799999999999999999999998766555555444433 233334 78899999999999
Q ss_pred cCCCCCCCHhHHhcCCcccccCC
Q 022617 254 VDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.+|++|||++++++||||++...
T Consensus 237 ~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 237 KDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred CChhhCcCHHHHhhChhhcCCCc
Confidence 99999999999999999987543
No 114
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=3.1e-45 Score=304.17 Aligned_cols=253 Identities=30% Similarity=0.529 Sum_probs=217.3
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccc------hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
+|.+.+.||.|++|.||+|.+..+++.+++|.+....... ....+.+.+|+.++++++|+|++++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 5889999999999999999998889999999886543322 2234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
.++++||+++++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999887654211
Q ss_pred c-------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChh
Q 022617 172 F-------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (294)
Q Consensus 172 ~-------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (294)
. .....++..|+|||.+.+..+ +.++|+||+|+++|+|++|+.||...........+... ....+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 112346778999999887766 68899999999999999999999876554444443333 34566778999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+.+++.+||+.+|.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 115
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.5e-45 Score=315.26 Aligned_cols=258 Identities=29% Similarity=0.555 Sum_probs=217.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||+|+||.||++.++.+++.+++|++.............+.+|+.++..++|++++++++.+...+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999986544333344566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cc
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 173 (294)
||+.+++|.+++.+ ...+++..+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999976 4678999999999999999999999999999999999999999999999999986543222 12
Q ss_pred ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l 244 (294)
....+++.|+|||++.. ....+.++|+||||+++|+|++|+.||...+.......+.... ...+ ..++.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~ 240 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence 23468999999999852 2233789999999999999999999999888777777765443 2222 3578999
Q ss_pred HHHHHHhcccCCCC--CCCHhHHhcCCccccc
Q 022617 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQAH 274 (294)
Q Consensus 245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~~ 274 (294)
.+++.+||..++++ |++++++++||||+..
T Consensus 241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99999999765544 7899999999999863
No 116
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=6.2e-45 Score=300.62 Aligned_cols=252 Identities=29% Similarity=0.555 Sum_probs=216.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 96 (294)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999989999999998654432 2345678889999999999999999988764 44689999
Q ss_pred eccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 97 EYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
|++++++|.+++... ..+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 159 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence 999999999999763 458999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHhc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 252 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 252 (294)
....+++.|+|||.+.+..+ +.++|+||+|++++++++|+.||...+.......+..+.. ..+..++..+.+++.+||
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 238 (257)
T cd08223 160 STLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATML 238 (257)
T ss_pred ccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHh
Confidence 33456889999999887766 6889999999999999999999988776666655554443 455678999999999999
Q ss_pred ccCCCCCCCHhHHhcCCcc
Q 022617 253 IVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 253 ~~~p~~Rps~~~il~h~~~ 271 (294)
+.+|++|||+.++++||||
T Consensus 239 ~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 239 SKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ccCcccCCCHHHHhcCCCC
Confidence 9999999999999999997
No 117
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=5.7e-45 Score=300.61 Aligned_cols=252 Identities=31% Similarity=0.507 Sum_probs=220.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|.+.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588899999999999999999999999999998765433 3346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
|+.+++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999764 568999999999999999999999999999999999999999999999999887654332 223
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
...+++.|+|||.+.+... +.++|+||||+++++|++|+.||...+.......+.... ...+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238 (256)
T ss_pred ccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 3457788999999987766 789999999999999999999998887777666665544 34445788999999999999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
.+|++||++.++++|||+
T Consensus 239 ~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 239 KDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCcccCcCHHHHhhCCCC
Confidence 999999999999999995
No 118
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.4e-45 Score=315.26 Aligned_cols=257 Identities=30% Similarity=0.532 Sum_probs=217.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||+|+||.||++.+..+++.|++|++.............+.+|..+++.++|++|+++++++...+..|++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987544333344566788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 173 (294)
||+.|++|.+++.+ ...+++..+..++.|++.+|.+||+.||+|+||||+||+++.++.++|+|||++........ .
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999976 46789999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC---CCCChhH
Q 022617 174 KTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGA 244 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~l 244 (294)
....+++.|+|||++.+. ...+.++|+||+|+++|+|++|+.||...+.......+.... .+++ ..++.++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~ 240 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence 234589999999988642 223678999999999999999999998887777666665433 2333 3468899
Q ss_pred HHHHHHhcccCCCC--CCCHhHHhcCCcccc
Q 022617 245 RDLIPRMLIVDPMK--RITIPEIRQHPWFQA 273 (294)
Q Consensus 245 ~~li~~~l~~~p~~--Rps~~~il~h~~~~~ 273 (294)
.+++.+||..++.+ |++++++++||||+.
T Consensus 241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999876554 568999999999976
No 119
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=6.7e-45 Score=307.92 Aligned_cols=256 Identities=34% Similarity=0.598 Sum_probs=220.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.+..+++.|++|.+.............+.+|+.+++.++|+||+++++.+..++..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
||++|++|.+++.+.+.+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC---
Q 022617 172 -----------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP--- 237 (294)
Q Consensus 172 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 237 (294)
......++..|+|||.+..... +.++|+||||+++|++++|..||.+....+....+.......+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0012245778999999877665 7899999999999999999999998887777777665543322
Q ss_pred CCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCcccc
Q 022617 238 SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQA 273 (294)
Q Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~ 273 (294)
..++.++.+++.+||+.+|++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 257899999999999999999998 789999999954
No 120
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=3.9e-45 Score=305.65 Aligned_cols=256 Identities=31% Similarity=0.445 Sum_probs=219.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||++.+..++..+++|++... .....+.+.+|++++++++|+|++++++.+..+...+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999888999999998543 334456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+++++|.+++.+. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999999999998764 569999999999999999999999999999999999999999999999999876543322 22
Q ss_pred ccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHH
Q 022617 174 KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARD 246 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~ 246 (294)
....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...........+..... ..+..++.++.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence 33457888999998752 22236789999999999999999999988776666666655432 234578899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
++.+||..+|++||++.++++||||.+.
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 241 FLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHhccChhhCcCHHHHhcChhhccc
Confidence 9999999999999999999999999875
No 121
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=3.9e-45 Score=306.48 Aligned_cols=254 Identities=27% Similarity=0.481 Sum_probs=212.1
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.++.+++.+++|++...... ....+.+.+|+.++++++|+|++++++++...+..++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 4799999999999999999999989999999998644321 123456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
||+++++|..++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 999998888887666779999999999999999999999999999999999999999999999999987654433 2223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------c
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------Y 234 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------~ 234 (294)
..++..|+|||.+.+....+.++|+||+|+++|+|++|..||.+....+....+.... .
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI 239 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence 4567889999998765444789999999999999999999998766544333221100 0
Q ss_pred c----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 T----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+ ....++..+.+++.+||+.+|++||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0 012467889999999999999999999999999998
No 122
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=9.2e-45 Score=307.44 Aligned_cols=254 Identities=25% Similarity=0.471 Sum_probs=214.2
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|++++++++||||+++++++..++..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999886432 2234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
||+++++|.+++.+.+.+++..+..++.|++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 157 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANS 157 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-ccc
Confidence 999999999999888889999999999999999999997 589999999999999999999999999886543322 234
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------------------
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------- 233 (294)
..++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccch
Confidence 457889999999877665 789999999999999999999997654433332221110
Q ss_pred ---------------ccCC-CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 234 ---------------YTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 ---------------~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
...+ ..++.++.+++.+||..+|++|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0111 1367789999999999999999999999999999874
No 123
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=4.3e-45 Score=304.97 Aligned_cols=249 Identities=36% Similarity=0.569 Sum_probs=213.8
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|+||+||+|.+..+++.|++|++.............+..|++++++++|||++++++.+...+..|+++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998765444334456667899999999999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcc
Q 022617 105 FDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY 182 (294)
Q Consensus 105 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 182 (294)
.+++.+.. .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997765 6899999999999999999999999999999999999999999999999998766544444445677899
Q ss_pred cCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCC
Q 022617 183 AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMK 258 (294)
Q Consensus 183 ~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 258 (294)
+|||.+.+..+ +.++|+||||+++++|++|+.||..... ......+.......+..++..+.+++.+||+.+|.+
T Consensus 161 ~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 161 MAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred CCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence 99999877665 7899999999999999999999976543 333333334445566778999999999999999999
Q ss_pred CC-----CHhHHhcCCccccc
Q 022617 259 RI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 259 Rp-----s~~~il~h~~~~~~ 274 (294)
|| ++.++++||||++.
T Consensus 240 R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred ccCCCcccHHHHHhChhhhcC
Confidence 99 88889999999653
No 124
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=8.4e-45 Score=305.94 Aligned_cols=261 Identities=31% Similarity=0.519 Sum_probs=222.2
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.......+|++.+.||.|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.++|+|++++++++...+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 344455789999999999999999999999999999999865432 23567889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++||+.+++|.+++.+ ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999998864 46899999999999999999999999999999999999999999999999987754332
Q ss_pred C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHH
Q 022617 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARD 246 (294)
Q Consensus 171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 246 (294)
. ......++..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+.... ...+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHH
Confidence 2 1223457789999999887666 789999999999999999999998876655444443222 2345678899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
+|.+||..+|++||++.++++||||+...+
T Consensus 248 li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 248 FLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 999999999999999999999999987654
No 125
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=1.4e-44 Score=299.88 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=214.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
+|++.+.||.|+||.||+|.+. +++.+++|.+...... .......+.+|++++++++|+|++++++++...+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5899999999999999999874 7888999988654321 22334678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC----
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---- 170 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~---- 170 (294)
++||+.+++|.+++.+..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999988788999999999999999999999999999999999999999999999999988654211
Q ss_pred ---CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---CccCCCCCChhH
Q 022617 171 ---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGA 244 (294)
Q Consensus 171 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 244 (294)
.......++..|+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11223457888999999987766 78999999999999999999999876554433333322 234566789999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+++.+||..+|++||++.++++||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 126
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=3.4e-45 Score=314.64 Aligned_cols=257 Identities=27% Similarity=0.475 Sum_probs=210.9
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (294)
.+.++|++.+.||.|+||+||+|.+..+++.|++|.+..... .......+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 467899999999999999999999999999999999865422 223345677899999999999999999887532
Q ss_pred --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
...+++++++ +++|.+++. ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4578999998 669988875 457999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 233 (294)
... .....++..|+|||++.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 169 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence 432 2344678899999998775444789999999999999999999998765544333321100
Q ss_pred ---------cc--------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 234 ---------YT--------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 234 ---------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.. .....++.+.+++.+||..||.+|||+.++++||||....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 00 0123566788999999999999999999999999998753
No 127
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=1.3e-44 Score=298.77 Aligned_cols=254 Identities=31% Similarity=0.496 Sum_probs=219.5
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
+|+..+.||.|++|.||+|.+..++..+++|.+...... ..+....+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 588899999999999999999888999999998654322 234567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
+||+++++|.+++.+..++++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999876654443445
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--CCccCCCCCChhHHHHHHHhcc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~ 253 (294)
..++..|++||.+......+.++|+||||+++|++++|..||...........+.. .....+..++..+.+++.+||+
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 240 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence 56788899999987655237899999999999999999999977664444444333 2344556788999999999999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
.+|++||++.+++.|||+
T Consensus 241 ~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 241 RDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCcccCcCHHHHhcCCCC
Confidence 999999999999999996
No 128
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.5e-44 Score=298.14 Aligned_cols=252 Identities=34% Similarity=0.597 Sum_probs=220.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+++.+++|.+....... .....+.+|++++++++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 6899999999999999999999999999999987654433 346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCCccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~ 174 (294)
++++++|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY 159 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence 99999999999764 3589999999999999999999999999999999999998654 57999999998765544444
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
...++..|+|||.+.+... +.++|+||+|+++|+|++|..||...+.......+.... .+.+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 238 (256)
T cd08220 160 TVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLN 238 (256)
T ss_pred ccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHcc
Confidence 5567889999999987665 789999999999999999999998877666665554433 44566789999999999999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
.+|++|||+.+++.||||
T Consensus 239 ~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 239 LDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CChhhCCCHHHHhhCCCC
Confidence 999999999999999997
No 129
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=4e-45 Score=303.06 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=217.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.++.+++.+++|.+..... ......+.+|+++++++.|+|++++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 478999999999999999999998999999999865432 244577889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 174 (294)
|++++++|.+++... .++++..++.++.|++.++++||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 999989999999876 789999999999999999999999 99999999999999999999999999988765332222
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCC-CccCCCC-CChhHHHH
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGG-IYTLPSH-LSPGARDL 247 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~~~-~~~~l~~l 247 (294)
...++..|+|||.+.+..+ +.++|+||||+++|++++|..||... ......+.+... ....+.. ++.++.++
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236 (265)
T ss_pred cccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 2567789999999887765 78999999999999999999999654 223333333332 2333344 78899999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
|.+||..+|++|||+.+++.||||+...
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 237 VNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred HHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 9999999999999999999999998753
No 130
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-46 Score=299.73 Aligned_cols=260 Identities=37% Similarity=0.618 Sum_probs=242.9
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
.+-.++|..+++||.|.||.|-+++.+.+++.||+|++.++-+..++....-..|-.+|+..+||.+..+-..|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 35678999999999999999999999999999999999988777777777778899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCC
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~ 171 (294)
|+||||.+||.|.-.+++..-++++..+.+...|+.||.|||+.+|+++|+|.+|.+++.+|++||.|||++... ..+.
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 999999999999999998888999999999999999999999999999999999999999999999999998643 4455
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
.....+|||.|.|||++....+ +.+.|+|.+|++||+|++|++||.+.+...+.+.|.-....+|..++++.+.++..+
T Consensus 324 t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGL 402 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGL 402 (516)
T ss_pred eeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHH
Confidence 6678899999999999999888 899999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-----HhHHhcCCcccc
Q 022617 252 LIVDPMKRIT-----IPEIRQHPWFQA 273 (294)
Q Consensus 252 l~~~p~~Rps-----~~~il~h~~~~~ 273 (294)
|.+||.+|.- +.||.+|+||..
T Consensus 403 L~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 403 LKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred hhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 9999999974 889999999954
No 131
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=3.1e-44 Score=302.02 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=216.5
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..+.|++.+.||.|++|.||+|.+..+++.+++|.+... .......+.+|+.+++.++|+|++++++.+..++..++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998543 33446778889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Cc
Q 022617 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 172 (294)
+|||+++++|..++.+ ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 9999999999887754 456899999999999999999999999999999999999999999999999987654322 22
Q ss_pred cccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHH
Q 022617 173 LKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGAR 245 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 245 (294)
.....++..|+|||.+.+. ...+.++|+||||+++|+|++|..||...........+..... ..+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 2344577899999987522 2226789999999999999999999977665554444443322 23456788999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
+++.+||..+|++||+++++++||||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999999999997643
No 132
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.8e-44 Score=304.01 Aligned_cols=270 Identities=30% Similarity=0.472 Sum_probs=225.1
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
..+.....+|++.+.||.|++|.||++.+..+++.+++|.+...... ....+.+|+.+++.+.|+|++++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 34556678999999999999999999999989999999998654432 346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
...++++||+++++|.+++.+ ..++..++..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999999999854 5689999999999999999999999999999999999999999999999998875432
Q ss_pred CC-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHH
Q 022617 170 GH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGAR 245 (294)
Q Consensus 170 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~ 245 (294)
.. ......+++.|+|||.+.+... +.++|+||+|+++|+|++|..||................ ...+..++..+.
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHH
Confidence 22 1223457889999999887665 789999999999999999999998766544333222221 223456888999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT 286 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~ 286 (294)
+++.+||..+|++||++.++++||||... +.....+|-+
T Consensus 248 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~--~~~~~~~~~~ 286 (296)
T cd06654 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIA--KPLSSLTPLI 286 (296)
T ss_pred HHHHHHCcCCcccCcCHHHHhhChhhhcc--CCccccHHHH
Confidence 99999999999999999999999999875 3344555544
No 133
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=1.6e-44 Score=299.74 Aligned_cols=253 Identities=30% Similarity=0.490 Sum_probs=215.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|+||+|.+..++..+++|++....... ....+.+|++.++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998889999999986543322 5678999999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
|++.+++|.+++.+. ..+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 35899999999999999999999999999999999999999999999999998765443222
Q ss_pred -----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCC-----CCCCh
Q 022617 174 -----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLP-----SHLSP 242 (294)
Q Consensus 174 -----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~-----~~~~~ 242 (294)
....++..|+|||.+......+.++|+||||+++|+|++|+.||...+............. ..+ ..++.
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 2335778999999987664447899999999999999999999987665544444333221 111 25678
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+.+++.+||..||++|||+.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999998
No 134
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=8.2e-45 Score=301.73 Aligned_cols=254 Identities=31% Similarity=0.559 Sum_probs=214.3
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
+|+..+.||.|++|.||++.+..+++.+++|++...... .....+.+.+|++++++++|+|++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999998644321 12345788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCC--
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-- 171 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~-- 171 (294)
++||+.+++|.+++.+.+++++..++.++.|++.|+.+||+.|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999998775 59999999987654321
Q ss_pred ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----hCCCccCCCCCChh
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPG 243 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~ 243 (294)
......++..|+|||.+.+..+ +.++|+||||++++++++|..||...........+ .......+..++.+
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1123356789999999876655 78999999999999999999999654432222211 12234455678899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
+.+++.+||..+|++||++.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999985
No 135
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=3.6e-44 Score=295.95 Aligned_cols=252 Identities=32% Similarity=0.525 Sum_probs=220.7
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||.+.+..+++.+++|.+....... .....+.+|++++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6899999999999999999999999999999987654333 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
|+++++|.+++.+. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999765 458999999999999999999999999999999999999999999999999987654333 223
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~ 253 (294)
...+++.|.|||.+.+... +.++|+||||+++|+|++|..||......+....+..+.. ..+..++.++.+++.+||.
T Consensus 160 ~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcc
Confidence 4457889999999887665 6889999999999999999999988777777666655443 3345678999999999999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
.+|++||++.++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999996
No 136
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=9.8e-45 Score=335.46 Aligned_cols=269 Identities=26% Similarity=0.444 Sum_probs=221.8
Q ss_pred CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 022617 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE 87 (294)
Q Consensus 8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 87 (294)
.....+...++|.+++.||.|+||+||+|.+..++..+++|++....... .....+..|+.++++++||||++++++|.
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 34456777889999999999999999999999999999999987654333 34567889999999999999999999885
Q ss_pred c--CCeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCeEecC--
Q 022617 88 T--PSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRN-------MVVHRDLKPENLLLDS-- 152 (294)
Q Consensus 88 ~--~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~-------~i~h~di~p~nili~~-- 152 (294)
. ...+|+||||+.+++|.++|... ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 46799999999999999998652 5699999999999999999999985 4999999999999964
Q ss_pred ---------------CCcEEEeeecccccccCCCccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCC
Q 022617 153 ---------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLP 216 (294)
Q Consensus 153 ---------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p 216 (294)
.+.++|+|||++.............+++.|+|||++.+. ...+.++|||||||++|+|++|..|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 234899999999766544444455689999999998643 2237899999999999999999999
Q ss_pred CCCCC-HHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 217 FDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 217 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
|.... ...+...+..........++.++.+||..||..+|.+||++.++|.|||++...+.
T Consensus 243 F~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 243 FHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP 304 (1021)
T ss_pred CCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence 97544 34444444443322234678999999999999999999999999999999876554
No 137
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=2.5e-44 Score=298.62 Aligned_cols=254 Identities=33% Similarity=0.549 Sum_probs=212.4
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDI 92 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 92 (294)
.+|++.+.||.|++|.||+|.+..++..+++|.+...... .......+.+|+.++++++|+|++++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3799999999999999999999999999999998654322 22345678899999999999999999998865 4678
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+++++|.+++.+.+.+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999999999887889999999999999999999999999999999999999999999999999986543211
Q ss_pred ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 246 (294)
......++..|+|||.+.+..+ +.++|+||+|+++|++++|+.||............... ...++..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1122346778999999887665 78999999999999999999999876554444433322 23445667888999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
++ +||..+|++||+++++++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 98 67778999999999999999996
No 138
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=1.5e-44 Score=302.88 Aligned_cols=252 Identities=30% Similarity=0.512 Sum_probs=207.7
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... ......+.+|+.++++++|+|++++++++..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999989999999998654322 2334677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 98 ~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
|+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 9974 888888643 468999999999999999999999999999999999999999999999999987543222 12
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC---------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------------------- 232 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 232 (294)
....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||...........+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT 238 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence 23356788999999876554478899999999999999999999765543222111000
Q ss_pred --------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 233 --------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 233 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.......++.++.++|.+||..||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001123578899999999999999999999999999998
No 139
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=3.9e-44 Score=299.98 Aligned_cols=256 Identities=28% Similarity=0.423 Sum_probs=215.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
-|++.+.||.|++|.||++.+..++..+++|.+.... ......+.+|+++++.++|+|++++++++...+..++++|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 4789999999999999999999899999999985432 2345678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-Ccccc
Q 022617 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~ 175 (294)
|+++++|..++.+ ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 162 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence 9999999988754 467899999999999999999999999999999999999999999999999998654322 12234
Q ss_pred ccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617 176 SCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI 248 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 248 (294)
..++..|+|||.+.. ....+.++|+||+|+++|+|++|..||...+.......+.... ...+..++.++.+++
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFL 242 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHH
Confidence 457889999998742 2222678999999999999999999998766655555544332 233556889999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.+||+.+|++||++.++++||||+..-.
T Consensus 243 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 243 KKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 9999999999999999999999987533
No 140
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.6e-44 Score=299.85 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=210.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..+++.+++|++.... ......+.+|+.+++.++|||++++++.+...+..+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 358999999999999999999999899999999986542 22345678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
+||+++++|.+++...+.+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK 164 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999986543222 223
Q ss_pred cccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-----CCCCCChhHHH
Q 022617 175 TSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD 246 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~ 246 (294)
...++..|+|||.+. ...+ +.++|+||||+++|+|++|..||.................. ....++..+.+
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred cccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 345788999999874 2333 67999999999999999999998655433322222222211 11246788999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~ 270 (294)
++.+||+.+|++|||+.++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
No 141
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=2.1e-44 Score=297.27 Aligned_cols=250 Identities=32% Similarity=0.509 Sum_probs=215.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..++..+++|.+.... ....+.+|++++++++|+|++++++++......+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 468999999999999999999998888999999985432 157889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+|++.+++|.+++.. ...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999999999975 4568999999999999999999999999999999999999999999999999987665433 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHHHH
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPR 250 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~ 250 (294)
....++..|+|||.+.+... +.++|+||+|+++|+|++|+.||...........+.... ...+..++.++.+++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 157 NTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred ccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 33446789999999887766 789999999999999999999998765544433332221 22334678899999999
Q ss_pred hcccCCCCCCCHhHHhcCCcc
Q 022617 251 MLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~h~~~ 271 (294)
||+.+|++|||+.+++.||||
T Consensus 236 ~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999997
No 142
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=2.3e-44 Score=297.95 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=215.0
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..+++.+++|++..... ...+.+.+|++++++++|+|++++++++...+..+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999988899999999865432 2467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+++++|.+++... .++++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999999776 789999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCcccCCccccCC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-----cCCCCCChhHH
Q 022617 174 KTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGAR 245 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~ 245 (294)
....++..|+|||.+... .. +.++|+||+|+++|+|++|..||...........+..... ..+..++.++.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred ccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 334567789999998655 45 6889999999999999999999987665554444433311 12234577899
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPW 270 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~ 270 (294)
+++.+||..+|.+|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
No 143
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=1.8e-44 Score=308.15 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=204.0
Q ss_pred cccccccc--CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 21 LGKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 21 ~~~~lg~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
++++||+| ++++||++.++.+++.|++|.+...... ......+.+|+.+++.++||||+++++++..++..++++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 57889999 6789999999999999999998655432 23456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-----
Q 022617 99 VKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----- 171 (294)
Q Consensus 99 ~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----- 171 (294)
+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999999653 458999999999999999999999999999999999999999999999997543221110
Q ss_pred ---ccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-------------
Q 022617 172 ---FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------- 234 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------- 234 (294)
......++..|+|||++.+. ...+.++||||||+++|+|++|..||..............+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 11122356679999998753 2237899999999999999999999976544332222211110
Q ss_pred ---------------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 235 ---------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 235 ---------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+....+++.+.+++.+||+.||++|||+.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112346789999999999999999999999999999874
No 144
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=3e-44 Score=296.43 Aligned_cols=252 Identities=29% Similarity=0.558 Sum_probs=219.2
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.+|.+.+..+++.+++|.+....... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 6899999999999999999999999999999987554332 335678999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-c
Q 022617 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 174 (294)
|+.+++|.+.+.... .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++++|||.+......... .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 999999999987543 5789999999999999999999999999999999999999999999999998765433221 2
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
...++..|+|||.+.+... +.++|+||+|++++++++|..||......+....+..+. ...+..++.++.++|.+||+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 160 TCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred hccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhh
Confidence 3346778999999887765 689999999999999999999998877777666655444 34566789999999999999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
.+|++||++.++++||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
No 145
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=2.1e-44 Score=301.44 Aligned_cols=240 Identities=18% Similarity=0.263 Sum_probs=207.9
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CCeEEEEEec
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEY 98 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~ 98 (294)
..|+.|+++.||+|.+ +|+.|++|.+...........+.+.+|+.++++++||||+++++++.+ ....++++||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999987 688999999976655454556778899999999999999999999866 4578999999
Q ss_pred cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCCCcccccc
Q 022617 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC 177 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 177 (294)
+++++|.+++.+.+.++......++.+++.++.+||+. +++|+||+|+||++++++.++|+|||++....... ....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~ 181 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNV 181 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--cccc
Confidence 99999999998888899999999999999999999984 89999999999999999999999999987543322 2345
Q ss_pred CCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHHHHHHhcc
Q 022617 178 GSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 178 ~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~ 253 (294)
++..|+|||.+.+ ..+ +.++||||||+++|+|++|..||...+..+....+... ....+..++.++.+++.+||+
T Consensus 182 ~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 260 (283)
T PHA02988 182 NFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTS 260 (283)
T ss_pred CcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhc
Confidence 7789999999875 344 78999999999999999999999988877777766432 345555789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 022617 254 VDPMKRITIPEIRQ 267 (294)
Q Consensus 254 ~~p~~Rps~~~il~ 267 (294)
.||++|||+.++++
T Consensus 261 ~dp~~Rps~~ell~ 274 (283)
T PHA02988 261 HDSIKRPNIKEILY 274 (283)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999986
No 146
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=2.3e-44 Score=301.75 Aligned_cols=253 Identities=32% Similarity=0.564 Sum_probs=212.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+++.+++|++....... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999899999999987654322 345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 174 (294)
|+ +++|.+++.. ..++++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 8899999865 4568999999999999999999999999999999999999999999999999987664432 133
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 233 (294)
...++..|+|||.+.+....+.++||||+|+++++|++|..+|...........+....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07832 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238 (286)
T ss_pred cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence 44578899999998765555789999999999999999988887665444333322110
Q ss_pred ---------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 234 ---------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 234 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
.......+..+.+++.+||+.+|.+|||++++++||||.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 001134678899999999999999999999999999983
No 147
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=1.7e-44 Score=304.50 Aligned_cols=257 Identities=33% Similarity=0.498 Sum_probs=213.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... .......+..|++++++++|+|++++++++...+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999989999999999765433 123456677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+ +++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 789999997765 79999999999999999999999999999999999999999999999999987654432 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------------- 233 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------------- 233 (294)
....++..|+|||.+.+....+.++|+||||+++++|++|..+|......+....+....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 233456789999998665444789999999999999999988887665544333332110
Q ss_pred ---c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 234 ---Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 234 ---~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
. ......+..+.++|.+||+.+|++|||+.++++||||++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 01134567899999999999999999999999999999863
No 148
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=1.6e-44 Score=311.57 Aligned_cols=259 Identities=32% Similarity=0.535 Sum_probs=213.3
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (294)
.+.++|++.+.||.|++|.||+|.+..+++.+++|++..... .......+.+|+.++++++|+|++++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999854322 223456677899999999999999999988543
Q ss_pred --CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
...++++||+.+ +|.+.+... ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 357999999965 888887544 899999999999999999999999999999999999999999999999999766
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-------------- 233 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 233 (294)
..........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPT 247 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhh
Confidence 54443344557889999999987776 789999999999999999999997665433322221100
Q ss_pred --------c--------------cC-------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 234 --------Y--------------TL-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 234 --------~--------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
. .. +...+..+.++|.+||+.||++|||+.++|.||||+.|+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 248 VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0 00 11345678999999999999999999999999999987664
No 149
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=4e-44 Score=296.79 Aligned_cols=252 Identities=34% Similarity=0.603 Sum_probs=219.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVV 95 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv 95 (294)
+|++.+.||.|++|.||+|.+..++..+++|++...... ....+.+.+|++++++++|+|++++++++.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999998655433 3345678899999999999999999998753 4568999
Q ss_pred EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCH-----RNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh-----~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
+||+++++|.+++.+ ..++++..++.++.|++.++.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999975 357899999999999999999999 88999999999999999999999999999887
Q ss_pred ccCCCc-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-cCCCCCChhH
Q 022617 167 MRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGA 244 (294)
Q Consensus 167 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l 244 (294)
...... .....++..|+|||.+.+... +.++|+||||+++++|++|..||...+.....+.+..... ..+..++..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238 (265)
T ss_pred ccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence 654433 334567889999999887665 7889999999999999999999998877777777766553 4566889999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+++.+||+.+|++||++.+|++|||+
T Consensus 239 ~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999999999999996
No 150
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.6e-44 Score=315.35 Aligned_cols=260 Identities=25% Similarity=0.390 Sum_probs=210.0
Q ss_pred cccccCCcccccccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
..+..+|.+++.||.|++|.||+|... .++..+++|.+... ....+|+.++++++|+||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345668999999999999999999754 34577999987432 23467999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++|++. ++|.+++.....+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 589999977788999999999999999999999999999999999999999999999999998765433
Q ss_pred Cc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh----CCC-------
Q 022617 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIK----GGI------- 233 (294)
Q Consensus 171 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~----~~~------- 233 (294)
.. .....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.... .....+. ...
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 123468999999999987776 78999999999999999999999654321 1111110 000
Q ss_pred ------------------ccCC-----CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617 234 ------------------YTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 282 (294)
Q Consensus 234 ------------------~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~ 282 (294)
...+ ..++.++.++|.+||..||++|||+.++|.||||++.=+..++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~~ 389 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNIT 389 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcCc
Confidence 0011 234668889999999999999999999999999987544444433
No 151
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.3e-44 Score=304.90 Aligned_cols=266 Identities=30% Similarity=0.484 Sum_probs=222.3
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.......+|++.+.||.|++|.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++|+|++++++++...+
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3456678999999999999999999999889999999998654322 3466788999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++||+++++|.+++.+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999999999999854 56899999999999999999999999999999999999999999999999988654332
Q ss_pred C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHH
Q 022617 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARD 246 (294)
Q Consensus 171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~ 246 (294)
. ......+++.|+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+... . ...+..++..+.+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247 (297)
T ss_pred ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence 2 1223457788999999987666 78999999999999999999999765543322222211 1 1234567889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcccccCCccccC
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV 281 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~ 281 (294)
++.+||..+|++||++.++++||||+...+.+...
T Consensus 248 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~ 282 (297)
T cd06656 248 FLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLT 282 (297)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhcccccccccC
Confidence 99999999999999999999999998765555433
No 152
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=1.3e-44 Score=299.79 Aligned_cols=249 Identities=37% Similarity=0.645 Sum_probs=219.8
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|++|.||++.+..+++.+++|++.............+.+|++++++++|+|++++++.+...+..++++|++.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999998766554445677899999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---------cccc
Q 022617 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKT 175 (294)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---------~~~~ 175 (294)
.+++.+.+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999887889999999999999999999999999999999999999999999999999887543321 1223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCC--ChhHHHHHHHhcc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLI 253 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~ 253 (294)
..++..|++||....... +.++|+||||++++++++|..||...........+.......+... +..+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 456778999999877665 7899999999999999999999998888887777776665555555 8999999999999
Q ss_pred cCCCCCCCH---hHHhcCCccccc
Q 022617 254 VDPMKRITI---PEIRQHPWFQAH 274 (294)
Q Consensus 254 ~~p~~Rps~---~~il~h~~~~~~ 274 (294)
.+|++|||+ .++++||||++.
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCC
Confidence 999999999 999999999864
No 153
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=2.2e-44 Score=299.13 Aligned_cols=253 Identities=24% Similarity=0.343 Sum_probs=211.4
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.++++++|+|++++++++...+..++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 35689999999999999999999998999999999864422 234567889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
++||+++++|.+++..+.++++..+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987653322 22
Q ss_pred ccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-----CCCCCChhHHH
Q 022617 174 KTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARD 246 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~ 246 (294)
....++..|+|||.+.. ....+.++|+||+|+++|+|++|..||...........+...... ....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 33457789999998742 222367899999999999999999999765443333222222211 12346789999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPW 270 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~ 270 (294)
++.+||..+|++|||+++|++|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999997
No 154
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=4.1e-45 Score=306.12 Aligned_cols=252 Identities=29% Similarity=0.535 Sum_probs=207.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 589999999999999999999999999999998654322 2234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 98 YVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
|+++ +|.+++.+ .+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 88887765 5679999999999999999999999999999999999999999999999999987543322 2223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCCC--------------------c
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGI--------------------Y 234 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~--------------------~ 234 (294)
..++..|+|||.+.+....+.++|+||||+++|+|++|..|+. +.+.......+.... .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP 238 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence 4567899999998776555789999999999999999888854 333333322221100 0
Q ss_pred ---------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 ---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+.++.++.+++.+||+.||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0113467899999999999999999999999999998
No 155
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=1.2e-44 Score=302.37 Aligned_cols=257 Identities=28% Similarity=0.455 Sum_probs=220.2
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
...|+..+.||.|++|.||.|.+..++..+++|++..... ......+.+|+.+++++.|+|++++++++..++..+++
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4578899999999999999999998899999999864432 23457888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 174 (294)
+||+++++|.+++.. .++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 999999999999864 5789999999999999999999999999999999999999999999999999866543321 22
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 253 (294)
...++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+... ....+..++..+.+++.+||.
T Consensus 160 ~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06640 160 TFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLN 238 (277)
T ss_pred cccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcc
Confidence 3356778999999877665 78999999999999999999999877666555544333 233445678899999999999
Q ss_pred cCCCCCCCHhHHhcCCcccccCC
Q 022617 254 VDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.+|++||++.++++||||...-.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 239 KDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred cCcccCcCHHHHHhChHhhhcch
Confidence 99999999999999999977643
No 156
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=3.9e-44 Score=296.85 Aligned_cols=255 Identities=34% Similarity=0.562 Sum_probs=221.8
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|.+.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+|+..+++++|+|++++++++...+..++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998655422 44678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc-c
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~ 174 (294)
||+++++|.+++.+..++++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999887889999999999999999999999 99999999999999999999999999998766443332 2
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhCCC-ccCCCC-CChhHHHHHH
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGI-YTLPSH-LSPGARDLIP 249 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~-~~~~~~-~~~~l~~li~ 249 (294)
...++..|+|||.+.+... +.++|+||||+++|+|++|..||... ........+.... ...+.. ++..+.+++.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 237 (264)
T cd06623 159 TFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237 (264)
T ss_pred ceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHH
Confidence 4457789999999877755 78999999999999999999999776 4445555544333 344455 8899999999
Q ss_pred HhcccCCCCCCCHhHHhcCCccccc
Q 022617 250 RMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+||..+|++||++.++++||||+..
T Consensus 238 ~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 238 ACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999763
No 157
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=7.8e-45 Score=303.62 Aligned_cols=254 Identities=36% Similarity=0.698 Sum_probs=225.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (294)
++|.+.+.||.|++|.||+|.+..+++.+++|++.............+.+|.++++++. |+||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999987655444455678889999999999 99999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 172 (294)
||++.+++|.+++.+.+.+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999875543221
Q ss_pred ------------------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617 173 ------------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (294)
Q Consensus 173 ------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 234 (294)
.....++..|+|||....... +.++|+||||++++++++|..||.........+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 122346788999999877655 7899999999999999999999988776666667666677
Q ss_pred cCCCCCChhHHHHHHHhcccCCCCCCCH----hHHhcCCcc
Q 022617 235 TLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 271 (294)
Q Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~il~h~~~ 271 (294)
..+..++..+.+++.+||+.+|++||++ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 7788899999999999999999999999 999999998
No 158
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=4.5e-44 Score=299.05 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=205.2
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHH---HhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKIL---RLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
.||+|+||.||++.+..+++.+++|++...............++..++ ....|++++.+++++...+..+++|||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999989999999998765443322223334444433 34479999999999999999999999999
Q ss_pred CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (294)
Q Consensus 101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 180 (294)
+++|.+++..++.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~ 159 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence 99999999888889999999999999999999999999999999999999999999999999986543322 22345788
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 257 (294)
.|+|||.+......+.++|+||+|+++|+|++|..||.... ..............++..++.++.+++.+||..||.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (279)
T cd05633 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVS 239 (279)
T ss_pred CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHH
Confidence 99999998654434789999999999999999999997543 222222223334456678899999999999999999
Q ss_pred CCC-----CHhHHhcCCccccc
Q 022617 258 KRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 258 ~Rp-----s~~~il~h~~~~~~ 274 (294)
+|| |+.++++||||+..
T Consensus 240 ~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 240 KRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HhcCCCCCCHHHHHhCccccCC
Confidence 999 69999999999884
No 159
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=7.4e-44 Score=297.81 Aligned_cols=250 Identities=28% Similarity=0.455 Sum_probs=209.5
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.+++|++.... .......+.+|++++++++|||++++++++...+..++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986542 2234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 176 (294)
||+++++|..+ ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 99999988654 35788999999999999999999999999999999999999999999999998765332 22345
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhCCC-ccC-CCCCChhHHHH
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-------PNLFKKIKGGI-YTL-PSHLSPGARDL 247 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~-~~~-~~~~~~~l~~l 247 (294)
.++..|+|||.+.+..+ +.++|+||||+++|+|++|..||..... ......+.... ... ....+.++.++
T Consensus 154 ~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (279)
T cd06619 154 VGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232 (279)
T ss_pred CCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence 67889999999987766 7899999999999999999999965321 12222222221 111 23578899999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+.+||..+|++||+++++++||||+..
T Consensus 233 i~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 233 ITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHhhCChhhCCCHHHHhcCcccccc
Confidence 999999999999999999999999765
No 160
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.5e-44 Score=311.89 Aligned_cols=247 Identities=28% Similarity=0.414 Sum_probs=199.8
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
..+|++.+.||.|++|.||+|.+..+++.|++|+.... ....|+.++++++|+||+++++++......+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34799999999999999999999989999999985322 234688999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 174 (294)
+|++.+ +|.+++.+ ...+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+..........
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 999965 88888765 4679999999999999999999999999999999999999999999999999987544333334
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCH----------HHHHHHHhCC---CccCC---
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENI----------PNLFKKIKGG---IYTLP--- 237 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~----------~~~~~~~~~~---~~~~~--- 237 (294)
...++..|+|||++.+..+ +.++||||||+++|+|+++..+ |..... ..+...+... ...++
T Consensus 215 ~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 4568899999999988776 7899999999999999985444 432211 0111111100 00000
Q ss_pred ---------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 238 ---------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 238 ---------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
..++.++.++|.+||+.||.+|||+.|+|+||||++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667778999999999999999999999999986
No 161
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.4e-46 Score=307.58 Aligned_cols=260 Identities=31% Similarity=0.513 Sum_probs=239.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
+-.+.|+..++||.||||.||-++.+.+|+-||+|...+..+..+........|..+|.+++.+.|+.+-..|++.+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 44578899999999999999999999999999999998888888888888999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+|+..|+||+|.-+|.+.+ -+++..+..++.+|+.+|.+||+.+|++||+||+|||+++.|+++|+|+|+|..+....
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 9999999999999998765 69999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCCCCChhHHHH
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
.....+||.+|||||++.+..| +...|+|+|||++|+|+.|+.||.... .+++-+.+......++...+++.+++
T Consensus 342 ~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaksl 420 (591)
T KOG0986|consen 342 PIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSL 420 (591)
T ss_pred ccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHH
Confidence 8888899999999999999987 899999999999999999999997644 34555566677778888999999999
Q ss_pred HHHhcccCCCCCCC-----HhHHhcCCccccc
Q 022617 248 IPRMLIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 248 i~~~l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
.+.+|.+||.+|.- +.++.+||||++.
T Consensus 421 c~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l 452 (591)
T KOG0986|consen 421 CEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL 452 (591)
T ss_pred HHHHHccCHHHhccCCCcCcchhhhCcccccC
Confidence 99999999999986 5689999999874
No 162
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=1.3e-44 Score=303.40 Aligned_cols=254 Identities=29% Similarity=0.473 Sum_probs=211.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.+++|.+....... ...+.+.+|+++++.++|+|++++++++...+..++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999998889999999986543222 34567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
||+++++|..+......+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 999998888887666679999999999999999999999999999999999999999999999999987653322 2223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-------------------Cc--
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-------------------IY-- 234 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~~-- 234 (294)
..++..|+|||.+.+....+.++|+||||+++|+|++|+.||......+....+... ..
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence 456788999999876554478899999999999999999999765543322221110 00
Q ss_pred ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+.++..+.+++.+||..+|++||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123568889999999999999999999999999998
No 163
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1e-43 Score=294.82 Aligned_cols=254 Identities=33% Similarity=0.568 Sum_probs=212.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (294)
.+|++.+.||.|++|.||.+.+..++..|++|.+..... ........+.+|+.+++++.|+|++++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 1223457888999999999999999999988663 568
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+++++|.+++.+...+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999999887888999999999999999999999999999999999999999999999999887543211
Q ss_pred ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 246 (294)
......++..|+|||.+.+... +.++|+||||+++|+|++|+.||............... ....+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1122346788999999877665 78999999999999999999999876544444443322 23345567888999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
++.+|+. +|++||+++++++|||++
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 899999999999999984
No 164
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=3e-44 Score=308.25 Aligned_cols=249 Identities=28% Similarity=0.470 Sum_probs=202.9
Q ss_pred ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (294)
.++|++.+.||.|+||.||+|.+. .++..|++|++.... .......+.+|+.+++++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999752 345679999986432 223356788999999999 899999999988764
Q ss_pred -CeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617 90 -SDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (294)
Q Consensus 90 -~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 111 (294)
..++++|||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4589999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCccc
Q 022617 112 -----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYA 183 (294)
Q Consensus 112 -----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~ 183 (294)
.++++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....... ......++..|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 237778889999999999999999999999999999999999999999999987543221 112233467899
Q ss_pred CCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCC
Q 022617 184 APEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp 260 (294)
|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....+..++..+.+++.+||+.||++||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999987766 789999999999999997 99999875433 333333333 3445667899999999999999999999
Q ss_pred CHhHHhc
Q 022617 261 TIPEIRQ 267 (294)
Q Consensus 261 s~~~il~ 267 (294)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
No 165
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=1.4e-43 Score=297.89 Aligned_cols=259 Identities=26% Similarity=0.442 Sum_probs=214.0
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (294)
..+....++|.+.+.||.|++|.||++.+..+++.+++|++.... .....+.+|+.+++++ +|+|++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 344556889999999999999999999999999999999985432 2245677889999988 79999999999864
Q ss_pred C-----CeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617 89 P-----SDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (294)
Q Consensus 89 ~-----~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~ 159 (294)
. +..++++||+++++|.+++.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 358999999999999998853 3568999999999999999999999999999999999999999999999
Q ss_pred eecccccccCCC-ccccccCCCcccCCccccCCc----cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617 160 DFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (294)
Q Consensus 160 dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 234 (294)
|||.+....... ......++..|+|||.+.... ..+.++|+||||+++|+|++|+.||...........+.....
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~ 250 (291)
T cd06639 171 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP 250 (291)
T ss_pred ecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC
Confidence 999987654322 223345778899999875432 126889999999999999999999987765544444433321
Q ss_pred ---cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 235 ---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 235 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
..+...+..+.++|.+||+.+|++||++.+|++||||+
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445778899999999999999999999999999995
No 166
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=4.7e-44 Score=301.05 Aligned_cols=254 Identities=33% Similarity=0.481 Sum_probs=211.0
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (294)
.++|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.++++++|||++++++++... +..+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35899999999999999999999989999999998755433 22334567899999999999999999998777 8999
Q ss_pred EEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-C
Q 022617 94 VVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~ 171 (294)
+++||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99999975 9999887643 5899999999999999999999999999999999999999999999999988766543 2
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------ 233 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 233 (294)
......++..|+|||.+.+....+.++|+||+|+++|+|++|..||...........+....
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence 22334567889999998765545789999999999999999999998766554443322110
Q ss_pred -------------ccCCCC-CChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 -------------YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 -------------~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..++.. ++..+.++|.+||+.+|++|||+.|++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011122 47889999999999999999999999999998
No 167
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=7.7e-44 Score=296.56 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=210.6
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC---
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP--- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--- 89 (294)
...+.|++.+.||.|++|.||+|.+..+++.+++|++.... .....+.+|+.+++++ +|+|++++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 45678999999999999999999999999999999986442 2245778899999988 699999999998642
Q ss_pred ---CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 90 ---SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
...++++||+++++|.+++... ..+++..+..++.|++.+++|||+.+++|+||+|+||+++.++.++|+|||++
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999763 35899999999999999999999999999999999999999999999999998
Q ss_pred ccccCC-CccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCC
Q 022617 165 NIMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP 237 (294)
Q Consensus 165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~ 237 (294)
...... .......++..|+|||.+... ...+.++|+||+|+++|+|++|..||................ ...+
T Consensus 159 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06637 159 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238 (272)
T ss_pred eecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence 765332 122344578899999998532 223678999999999999999999997665544444333222 1223
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..++..+.+++.+||..+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 4678899999999999999999999999999997
No 168
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=1.5e-43 Score=292.20 Aligned_cols=252 Identities=36% Similarity=0.579 Sum_probs=220.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVV 95 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv 95 (294)
+|++.+.||.|++|.||+|.+..+++.+++|++...... ....+.+.+|++++++++|+|++++++.+... +..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998655432 34568889999999999999999999999888 889999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 172 (294)
+|++++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999998877899999999999999999999999999999999999999999999999999887765543
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHh--CCCccCCCCCChhHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK--GGIYTLPSHLSPGARDLIP 249 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~~~~~l~~li~ 249 (294)
.....++..|+|||.+..... +.++|+||||++++++++|..||.... .......+. ......+...+..+.+++.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345567889999999877665 789999999999999999999998765 233333333 2334566778999999999
Q ss_pred HhcccCCCCCCCHhHHhcCCcc
Q 022617 250 RMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
No 169
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=5.4e-44 Score=299.65 Aligned_cols=258 Identities=28% Similarity=0.467 Sum_probs=215.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.+..++..+++|.+.... .......+.+|++++++++|+|++++++.+..++..++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999899999999885432 2233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 97 EYVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 97 e~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
||+++++|..++... ..+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-L 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-c
Confidence 999999999988653 378999999999999999999997 59999999999999999999999999998755332 2
Q ss_pred cccccCCCcccCCccccCCcc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HhC-CCccCCCCCChh
Q 022617 173 LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK---IKG-GIYTLPSHLSPG 243 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~~~~~~~~~ 243 (294)
.....++..|+|||.+.+... .+.++|+||||+++|+|++|..||........... +.. .....+..++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd06622 158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237 (286)
T ss_pred cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHH
Confidence 233456778999998854332 26789999999999999999999976544433332 222 234556678999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
+.+++.+||..+|++||++.++++||||...-..
T Consensus 238 ~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 238 AQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred HHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 9999999999999999999999999999876433
No 170
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=1.4e-43 Score=293.63 Aligned_cols=253 Identities=31% Similarity=0.569 Sum_probs=215.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..+++.+++|++...... ......+.+|++++++++|+||+++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999889999999998765433 3567889999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---- 173 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~---- 173 (294)
|+.+++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999988777899999999999999999999999999999999999999999999999998766443321
Q ss_pred -ccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhC-CCccCCC--CCChhHHH
Q 022617 174 -KTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKG-GIYTLPS--HLSPGARD 246 (294)
Q Consensus 174 -~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~--~~~~~l~~ 246 (294)
....++..|+|||.+.+.. ..+.++|+||+|++++++++|..||.... .......+.. .....+. .++..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 1245678999999987654 23788999999999999999999997653 2222222222 2233343 34889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
++.+||+.+|++|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
No 171
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.5e-43 Score=292.14 Aligned_cols=252 Identities=34% Similarity=0.611 Sum_probs=221.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..+++.+++|++...... ......+.+|+++++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999988999999998765432 2446778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617 98 YVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (294)
Q Consensus 98 ~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 172 (294)
++++++|.+++.+. ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999764 679999999999999999999999999999999999999999999999999987665443 2
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHh
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 251 (294)
.....+++.|+|||.+.+... +.++|+||+|+++++|++|..||............... ...++..++..+.+++.+|
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (258)
T cd08215 160 AKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSL 238 (258)
T ss_pred ecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 333457888999999877765 78899999999999999999999887776666665544 3455668899999999999
Q ss_pred cccCCCCCCCHhHHhcCCcc
Q 022617 252 LIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h~~~ 271 (294)
|..+|++|||+.++|+||||
T Consensus 239 l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 239 LQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred cCCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
No 172
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=9.6e-44 Score=295.11 Aligned_cols=249 Identities=22% Similarity=0.352 Sum_probs=211.8
Q ss_pred ccCCcccccccccCceEEEEEEEc---cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
..+|++.+.||+|+||.||+|.++ ..+..+++|.+.... .......+.+|+..+++++|||++++++++...+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467999999999999999999865 345689999986542 223346788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++|||+++++|.+++... ..+++..++.++.|++.|+++||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999999999999764 578999999999999999999999999999999999999999999999999876542222
Q ss_pred ccc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 FLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
... ...++..|+|||.+.+..+ +.++||||||+++|++++ |..||......+..+.+..+. .+.+..++..+.++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQL 240 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence 111 2223568999999887766 789999999999999875 999999888887777776553 45667889999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||+.+|++||++.+|++
T Consensus 241 i~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 241 MLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHcCCCchhCCCHHHHHH
Confidence 99999999999999999976
No 173
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=1.2e-43 Score=293.52 Aligned_cols=249 Identities=35% Similarity=0.576 Sum_probs=209.5
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
+.||.|++|.||+|.+..+++.+++|++.............+..|..+ ....+|+|++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 578999999999999998999999999865543332333344445444 3455899999999999999999999999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCc
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN 181 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 181 (294)
++|.+++.+.+++++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... .....++..
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~ 158 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD 158 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence 99999998888899999999999999999999999999999999999999999999999998875433 223356788
Q ss_pred ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----CCCCCChhHHHHHHHhcccCCC
Q 022617 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~ 257 (294)
|+|||.+.+..+ +.++|+||||+++|++++|..||...+.......+...... ....++.++.+++.+||+.+|+
T Consensus 159 y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 237 (260)
T cd05611 159 YLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPA 237 (260)
T ss_pred ccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHH
Confidence 999999887664 78999999999999999999999888777776666544332 2336789999999999999999
Q ss_pred CCCC---HhHHhcCCcccccC
Q 022617 258 KRIT---IPEIRQHPWFQAHL 275 (294)
Q Consensus 258 ~Rps---~~~il~h~~~~~~~ 275 (294)
+||+ ++|+++||||++..
T Consensus 238 ~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 238 KRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HccCCCcHHHHHcChHhhcCC
Confidence 9994 57999999998743
No 174
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=9.7e-45 Score=311.13 Aligned_cols=266 Identities=47% Similarity=0.839 Sum_probs=250.5
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
....-.+.|.+.+.||+|.|++|.++++..++..|++|.+.++..... ....+.+|+++++.++||||++++.+.+...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 456677899999999999999999999999999999999988765553 4455999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.+|+||||+.++.+++++.+++...+..+..++.|++.|++|+|+++|+|+|||++||+++.+-+++|+|||++..+...
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHH
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
......++++.|.|||.+.+..+.+++.|+||+|+++|-|+.|.+||++.....+......+++.++-.++.++.++|++
T Consensus 209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk 288 (596)
T KOG0586|consen 209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK 288 (596)
T ss_pred ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence 88889999999999999999999999999999999999999999999999999999999999999988999999999999
Q ss_pred hcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 251 MLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
+|-.+|.+|++.++|.+|.|....++.
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999776554
No 175
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.3e-43 Score=296.18 Aligned_cols=251 Identities=30% Similarity=0.484 Sum_probs=208.9
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHH---HHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRRE---IKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
.||.|++|.||+|.+..+++.|++|.+................| ...++...|++++++++++...+..++++||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999998999999999876543322222223333 344555679999999999999999999999999
Q ss_pred CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (294)
Q Consensus 101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 180 (294)
|++|.+++.+.+.+++..++.++.|++.++.|||+.+++|+||+|+||+++.++.++|+|||++....... .....++.
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~ 159 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH 159 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcCcCCCc
Confidence 99999999888889999999999999999999999999999999999999999999999999987543322 23446788
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCC
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 257 (294)
.|+|||.+.+....+.++|+||+|+++|+|++|..||... ................+..++.++.+++.+||..+|.
T Consensus 160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~ 239 (278)
T cd05606 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVN 239 (278)
T ss_pred CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHH
Confidence 9999999875543478899999999999999999999765 3344444444445566777899999999999999999
Q ss_pred CCC-----CHhHHhcCCcccccC
Q 022617 258 KRI-----TIPEIRQHPWFQAHL 275 (294)
Q Consensus 258 ~Rp-----s~~~il~h~~~~~~~ 275 (294)
+|| ++.++++||||+...
T Consensus 240 ~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 240 RRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred hccCCCCCCHHHHHhCccccCCC
Confidence 999 999999999998763
No 176
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=1.1e-43 Score=297.42 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=214.6
Q ss_pred cccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
-.++|++.+.||.|++|.||+|.+...+ ..+++|.+.... .......+.+|+.++++++|+|++++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3468999999999999999999876554 679999875432 234456788999999999999999999999988
Q ss_pred CeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC
Q 022617 90 SDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK 153 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~ 153 (294)
+..++++||+.+++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457888999999999999999999999999999999999999
Q ss_pred CcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 022617 154 WNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI 229 (294)
Q Consensus 154 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~ 229 (294)
+.++|+|||++....... ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999987543322 1223345678999999877766 789999999999999998 99999988888877777
Q ss_pred hCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 230 KGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 230 ~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.... ...+..++.++.+++.+||+.+|.+||++.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6544 45567899999999999999999999999999873
No 177
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=6e-44 Score=299.57 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=212.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+.+|++++++++|+|++++++++...+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999998999999999865432 2234578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--ccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~ 174 (294)
||++++.+..+..+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 999987676666666679999999999999999999999999999999999999999999999999987665443 223
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------------
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------- 233 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------- 233 (294)
...++..|+|||.+.+....+.++|+||||+++|+|++|..||......+....+....
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 34567889999999877344789999999999999999999997655443322221100
Q ss_pred -----------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+..++.++.++|.+||..+|++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01123358889999999999999999999999999998
No 178
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.6e-44 Score=314.06 Aligned_cols=249 Identities=24% Similarity=0.413 Sum_probs=202.9
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
....+|.+.+.||.|++|.||+|.+..+++.|++|.... ..+.+|+.++++++|+||+++++++...+..+
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 346689999999999999999999999999999996321 23567999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++++. ++|.+++... ..+++..++.++.|++.+|.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9999996 5888888654 469999999999999999999999999999999999999999999999999987653321
Q ss_pred --ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhCCCc---cCC-
Q 022617 172 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--------NIPNLFKKIKGGIY---TLP- 237 (294)
Q Consensus 172 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--------~~~~~~~~~~~~~~---~~~- 237 (294)
......++..|+|||++.+..+ +.++||||||+++|+|++|..++... ....+.+.+..... .++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1123458999999999988776 78999999999999999876554221 11222222221110 000
Q ss_pred ------------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 238 ------------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 238 ------------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
...+.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 124557899999999999999999999999999975
No 179
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=1.7e-43 Score=294.58 Aligned_cols=254 Identities=30% Similarity=0.487 Sum_probs=211.8
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccc-------hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-------MEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
+|.+.+.||.|++|.||+|.+..+++.+++|.+....... ....+.+.+|++++++++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 5889999999999999999998899999999886432211 113456888999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++||+.+++|.+++.+.+.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred C---ccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCC----CCC
Q 022617 171 H---FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP----SHL 240 (294)
Q Consensus 171 ~---~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~----~~~ 240 (294)
. ......++..|+|||.+.... ..+.++|+||||+++|++++|..||...........+... ....+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 1 122334678899999987654 2378899999999999999999999765544333332211 11222 356
Q ss_pred ChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 241 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+.++.+++.+||..+|++|||+.++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999997
No 180
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=9.4e-44 Score=296.89 Aligned_cols=254 Identities=28% Similarity=0.460 Sum_probs=218.1
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.-|++.+.||.|++|.||+|.+..++..+++|++..... ......+.+|+.++++++|+|++++++++......++++
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 458889999999999999999988999999998754332 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
||+++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence 99999999999854 568999999999999999999999999999999999999999999999999886553322 1223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 254 (294)
..++..|+|||.+.+... +.++|+||||+++|++++|..||...........+.... ...+..++.++.+++.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 356778999999877655 688999999999999999999998776666555554433 335567889999999999999
Q ss_pred CCCCCCCHhHHhcCCccccc
Q 022617 255 DPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 255 ~p~~Rps~~~il~h~~~~~~ 274 (294)
+|++||++.++++||||...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999875
No 181
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=1.2e-43 Score=297.45 Aligned_cols=261 Identities=28% Similarity=0.432 Sum_probs=213.5
Q ss_pred CCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 022617 7 RSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEV 85 (294)
Q Consensus 7 ~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 85 (294)
..-+......++|++.+.||.|++|.||+|.+..+++.+++|++.... .....+..|+.+++++ +|+|+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 83 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGM 83 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence 344566778899999999999999999999999999999999875432 1235677899999999 69999999998
Q ss_pred EE-----cCCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617 86 IE-----TPSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 86 ~~-----~~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~ 156 (294)
+. ..+..++++||+++++|.+++.. ...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE
Confidence 73 34578999999999999998753 3468899999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCC-ccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC
Q 022617 157 KIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG 231 (294)
Q Consensus 157 ~l~dfg~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 231 (294)
+|+|||.+....... ......++..|+|||.+... ...+.++|+||+|+++|+|++|..||..............
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~ 243 (286)
T cd06638 164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR 243 (286)
T ss_pred EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc
Confidence 999999987654322 22344578899999987532 2236789999999999999999999987655443333322
Q ss_pred CC---ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 232 GI---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 232 ~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.. ...+..++..+.+++.+||+.+|++|||+.++++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22 12344567899999999999999999999999999997
No 182
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=3.7e-43 Score=297.55 Aligned_cols=258 Identities=28% Similarity=0.359 Sum_probs=217.1
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
.....+|++.+.||.|++|+||+|.+..+++.|++|++.............+.+|+++++.++|||++++++++...+..
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 45567899999999999999999999989999999998655444445567788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++||+.| ++.+++.. ..++++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 999999975 77777654 457899999999999999999999999999999999999999999999999988654322
Q ss_pred ccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccC-CCCCChhHHHH
Q 022617 172 FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTL-PSHLSPGARDL 247 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~l 247 (294)
....++..|+|||.+.+ ....+.++|+||+|+++|+|++|..||...+.......+.... ... +..++..+.++
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNF 246 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence 23356778999998742 2223689999999999999999999998877655554444322 222 23568899999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+.+||..+|++||++.+++.||||...
T Consensus 247 i~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 247 VDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999874
No 183
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=8.8e-44 Score=301.64 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=211.9
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (294)
-.++|++.+.||.|++|.||+|.+..+++.|++|++....... .......+|+.++++++|+|++++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999999999999999986543222 2233456799999999999999999998654 568
Q ss_pred EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++||+.+ +|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 89888865 3678999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 233 (294)
.......+..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV 242 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence 22233456789999998765545789999999999999999999998877666555443210
Q ss_pred --ccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 234 --YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 --~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
...+ ...+.++.++|.+||..||++|||+.+++.||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0000 1257788999999999999999999999999999864
No 184
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=1.2e-43 Score=291.59 Aligned_cols=246 Identities=42% Similarity=0.718 Sum_probs=221.1
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|++|.||++.+..+++.+++|++.............+..|+.++++++|+|++++++.+..++..++++|++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998776555555677889999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC-CccccccCCCccc
Q 022617 105 FDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYA 183 (294)
Q Consensus 105 ~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~~ 183 (294)
.+++.+...+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 999988878999999999999999999999999999999999999999999999999998766443 2233445778999
Q ss_pred CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCH-
Q 022617 184 APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI- 262 (294)
Q Consensus 184 aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~- 262 (294)
|||...+... +.++|+|+||+++|++++|..||...+.......+.......+...+..+.+++.+||..||++||++
T Consensus 161 ~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 161 APEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred ChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcc
Confidence 9999877665 78899999999999999999999888777777777777777888889999999999999999999999
Q ss_pred --hHHhcCCcc
Q 022617 263 --PEIRQHPWF 271 (294)
Q Consensus 263 --~~il~h~~~ 271 (294)
+++++||||
T Consensus 240 ~~~~l~~~~~f 250 (250)
T cd05123 240 GAEEIKAHPFF 250 (250)
T ss_pred cHHHHHhCCCC
Confidence 999999998
No 185
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=1.5e-43 Score=295.64 Aligned_cols=255 Identities=27% Similarity=0.501 Sum_probs=215.7
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (294)
.|++.+.||.|++|.||+|.+..++..+++|++.... .......+.+|+.+++++. |+|++++++++......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5889999999999999999999899999999986442 2233567888999999987 9999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-c
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-L 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 173 (294)
++||+++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999999865 5789999999999999999999999999999999999999999999999999876544322 2
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCC-CCChhHHHHHHHh
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLIPRM 251 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~ 251 (294)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.... ...+. .++.++.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHH
Confidence 334577889999998765555789999999999999999999998776555444433332 22222 3788999999999
Q ss_pred cccCCCCCCCHhHHhcCCcccccC
Q 022617 252 LIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
|+.||++||++.++++||||++.-
T Consensus 239 l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 239 LDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred cCCCcccCcCHHHHhhChHhhccc
Confidence 999999999999999999997743
No 186
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=3.8e-43 Score=294.41 Aligned_cols=254 Identities=31% Similarity=0.548 Sum_probs=217.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|...+.||.|++|.||++.+..+++.+++|++.... ....+.+.+|+.+++.++|+|++++++++...+..++++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 46677789999999999999998899999999875332 233566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
||+.+++|.+++.. .+++...+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 96 EFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred eccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 99999999999876 678999999999999999999999999999999999999999999999999876543322 1223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC---CCCCChhHHHHHHHhc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRML 252 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l 252 (294)
..++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+.....+. +..++..+.+++.+||
T Consensus 175 ~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 253 (285)
T cd06648 175 LVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRML 253 (285)
T ss_pred ccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHc
Confidence 457889999999877665 789999999999999999999998877666666555443221 2347889999999999
Q ss_pred ccCCCCCCCHhHHhcCCcccccC
Q 022617 253 IVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 253 ~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
..+|++|||+.++++||||++.-
T Consensus 254 ~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 254 VRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred ccChhhCcCHHHHccCcccccCC
Confidence 99999999999999999998843
No 187
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=1.4e-43 Score=296.50 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=204.8
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC--CeEEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDIYVV 95 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv 95 (294)
|++.+.||.|++|.||+|.+..+++.+++|.+....... . .....+|+..++++. |+|++++++++.+. +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999899999999986542221 1 233456888888885 99999999999887 889999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 174 (294)
+||+++ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 999975 888888653 56899999999999999999999999999999999999999 999999999987665444334
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------cc-
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------YT- 235 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~- 235 (294)
...++..|+|||.+......+.++|+||||+++|+|++|..||...+..+....+.... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF 236 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence 44578899999987655445789999999999999999999998766544433332100 00
Q ss_pred ----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 236 ----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 236 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
....++.++.++|.+||..+|++||+++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 113567899999999999999999999999999997
No 188
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=1.8e-43 Score=302.96 Aligned_cols=270 Identities=31% Similarity=0.424 Sum_probs=217.7
Q ss_pred ccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchH-----------HHHHHHHHHHHHHhCCCCceeE
Q 022617 14 MFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------MEEKVRREIKILRLFMHPHIIR 81 (294)
Q Consensus 14 ~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~ 81 (294)
.+.++|.. .+.||.|++|+||+|.+..+++.|++|++......... ....+.+|++++++++|+|+++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 45678875 57799999999999999999999999998654322100 1125778999999999999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (294)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df 161 (294)
+++++...+..++++|++.+ +|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 99999999999999999974 99999988788999999999999999999999999999999999999999999999999
Q ss_pred cccccccCC---------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 022617 162 GLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 226 (294)
Q Consensus 162 g~~~~~~~~---------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~ 226 (294)
|.+...... .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 988755411 11112335778999999876655578999999999999999999999877665544
Q ss_pred HHHhCCCc----------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 227 KKIKGGIY----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 227 ~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
..+..... ......+.++.+++.+||+.+|++|||+++++.||||+.+-.+-
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~ 323 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC 323 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence 43321100 01134578899999999999999999999999999999875543
Q ss_pred ccCCCC
Q 022617 279 LAVPPP 284 (294)
Q Consensus 279 ~~~~~~ 284 (294)
-..|.|
T Consensus 324 ~~~~~~ 329 (335)
T PTZ00024 324 DPSQLP 329 (335)
T ss_pred CcccCC
Confidence 333333
No 189
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=4.8e-44 Score=300.78 Aligned_cols=264 Identities=29% Similarity=0.498 Sum_probs=220.7
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
....+.|.....||.|++|.||++.+..++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+...+..
T Consensus 18 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~ 94 (292)
T cd06658 18 GDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDEL 94 (292)
T ss_pred CchHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeE
Confidence 344567777888999999999999998899999999875432 23456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+++++|.+++. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999999999999885 4568999999999999999999999999999999999999999999999999886543221
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI 248 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 248 (294)
......++..|+|||.+.+..+ +.++|+||+|+++|++++|..||...........+.... ......++..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 1223457889999999877666 789999999999999999999998776655544443322 222335788999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccCCccccC
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV 281 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~ 281 (294)
.+||..+|.+|||++++++||||+..-+..+.+
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~ 285 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPPSCIV 285 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCccccc
Confidence 999999999999999999999999866655433
No 190
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=2e-43 Score=295.58 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=210.3
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 88 (294)
......+.|++.+.||.|++|.||+|.+..+++.+++|++.... .....+..|+.+++++ +|+|++++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34456789999999999999999999999999999999985432 2345678899999888 69999999999842
Q ss_pred -----CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617 89 -----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (294)
Q Consensus 89 -----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df 161 (294)
....+++|||+++++|.+++... ..+++..++.++.|++.++.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 46789999999999999999753 35888899999999999999999999999999999999999999999999
Q ss_pred cccccccCC-CccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c
Q 022617 162 GLSNIMRDG-HFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T 235 (294)
Q Consensus 162 g~~~~~~~~-~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~ 235 (294)
|.+...... .......++..|+|||.+.. ....+.++|+||||+++|+|++|..||...........+..... .
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred cchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 998755322 12234457889999998752 12236789999999999999999999976654443333322221 1
Q ss_pred -CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 236 -LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 236 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
....++.++.++|.+||+.||.+|||+.+|++||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 223578999999999999999999999999999997
No 191
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=1.2e-43 Score=297.21 Aligned_cols=252 Identities=30% Similarity=0.524 Sum_probs=208.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|++++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 58899999999999999999998999999998865432 22234678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 98 YVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
|+. ++|.+++.. ...+++..++.++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589888865 3468999999999999999999999999999999999999999999999999886553322 122
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--------------------
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I-------------------- 233 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~-------------------- 233 (294)
...++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+... .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence 3345778999999876655578899999999999999999999776543332221110 0
Q ss_pred --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
......++.++.++|.+||+.||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01123467889999999999999999999999999998
No 192
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-45 Score=290.39 Aligned_cols=274 Identities=34% Similarity=0.608 Sum_probs=233.7
Q ss_pred ccccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC
Q 022617 12 VDMFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP 89 (294)
Q Consensus 12 ~~~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 89 (294)
...+.+-|++ .+.||+|+++.|-.+....++..|+||++.+. .......+.+|++++.+++ |+||+.++++|+++
T Consensus 72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3446666777 67899999999999999999999999999765 3455789999999999996 99999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc---EEEeeeccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN---VKIADFGLSNI 166 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~---~~l~dfg~~~~ 166 (294)
...|+|+|.+.||+|...|.+++.+++.++.+++++|+.||.+||++||.|+|+||+|||.....+ +||+||.+...
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999976544 89999998754
Q ss_pred ccCCC--------ccccccCCCcccCCcccc----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-------------
Q 022617 167 MRDGH--------FLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------------- 221 (294)
Q Consensus 167 ~~~~~--------~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~------------- 221 (294)
..... ...+.+|+..|||||+.. ...+++.+-|.||||+++|-|++|.+||.++.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 32211 122446788999999863 22334788999999999999999999996653
Q ss_pred --HHHHHHHHhCCCccCCC----CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCcchHH
Q 022617 222 --IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 289 (294)
Q Consensus 222 --~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~~~~~ 289 (294)
...+.+.|+.+.+++|. .++.+..++++.+|..++.+|.++.++++|||++...+. ...|+|.-++|
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e-kalptp~v~~r 381 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE-KALPTPQVLQR 381 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh-ccCCCCccccc
Confidence 56688899999998875 689999999999999999999999999999999988776 45555555444
No 193
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.2e-43 Score=295.75 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=215.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||+|++|+||++.+..+++.+++|++.... .......+.+|+++++.++|+|++++++++...+..+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999899999999886432 233467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 174 (294)
+||+++++|.+++.+.++++...+..++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-~~ 160 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-AD 160 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-cC
Confidence 9999999999999887889999999999999999999997 689999999999999999999999999876543222 22
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHhCC-CccCCC-CCC
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----------NLFKKIKGG-IYTLPS-HLS 241 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-----------~~~~~~~~~-~~~~~~-~~~ 241 (294)
...++..|+|||.+.+... +.++|+||+|+++|++++|..||...... +....+... ....+. .++
T Consensus 161 ~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239 (284)
T ss_pred ccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence 3467889999999877655 78999999999999999999999764431 222222222 222223 378
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.++.+++.+||+.||++|||+.++++|+||.+.
T Consensus 240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 899999999999999999999999999999653
No 194
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=4.7e-44 Score=298.68 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=217.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
...|+..+.||.|++|.||+|.+..++..+++|.+..... ....+.+.+|+.++++++|+|++++++.+..++..+++
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 4568899999999999999999988899999999864432 23456889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 174 (294)
+||+++++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 999999999998854 5689999999999999999999999999999999999999999999999999876543321 22
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
...++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.... ...+..++.++.+++.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3356788999999987765 789999999999999999999997665555444443332 23445678899999999999
Q ss_pred cCCCCCCCHhHHhcCCccccc
Q 022617 254 VDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~~~~ 274 (294)
.+|++||++.++++||||+..
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999764
No 195
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=3.1e-43 Score=294.60 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=207.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHH-HHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKI-LRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
++|++.+.||.|+||.||++.++.+++.|++|.+....... ....+..|+.. ++.+.|+|++++++++...+..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999986543221 23445555554 6677899999999999999999999
Q ss_pred EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
+||++ ++|.+++.. +..+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 488888754 24689999999999999999999997 9999999999999999999999999998765443
Q ss_pred CccccccCCCcccCCccccCC---ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCCccCC-CCCChhH
Q 022617 171 HFLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLP-SHLSPGA 244 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~-~~~~~~l 244 (294)
.......++..|+|||.+.+. ...+.++|+||||+++|+|++|+.||.... .......+.......+ ..++.++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237 (283)
T ss_pred cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence 333334577889999988542 223678999999999999999999996532 2333333332223333 3578999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.+++.+||..+|++||++.++++||||+...
T Consensus 238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 238 QDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9999999999999999999999999998853
No 196
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-47 Score=300.39 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=223.5
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-..-|.++++||.|+||.||+|.++.+|+.+++|.+..+ ...+++..|+.++++++.++++++++.|-....+|
T Consensus 30 ~PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLW 104 (502)
T KOG0574|consen 30 PPEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLW 104 (502)
T ss_pred ChHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceE
Confidence 3445689999999999999999999999999999987544 45789999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~-~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
+|||||+.|++.+.+. +++++++.++..+++..+.+|.|||...-+|+|||..|||++.+|+.||.|||.+........
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999999886 568899999999999999999999999999999999999999999999999999877654432
Q ss_pred -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---ccCCCCCChhHHHHH
Q 022617 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLI 248 (294)
Q Consensus 173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 248 (294)
.+...||+.|+|||++....| ...+||||||++..+|..|++||....+-..+-.+-... +.-|..-+.++.+|+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 356679999999999988878 678999999999999999999997755443332222222 122345678899999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
++||-++|++|.|+.++++|||+++.-..-
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 999999999999999999999999854443
No 197
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=2.9e-43 Score=293.23 Aligned_cols=253 Identities=32% Similarity=0.480 Sum_probs=210.5
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC---
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS--- 90 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~--- 90 (294)
..++|++.+.||.|++|.||+|.++.+++.+++|++..... ....+.+|+.+++++ .|+|++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45899999999999999999999988899999999865432 346788999999999 6999999999996644
Q ss_pred ---eEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 91 ---DIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 91 ---~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
..++++||+++++|.+++.. +..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999865 35789999999999999999999999999999999999999999999999998
Q ss_pred cccccCCC-ccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---c
Q 022617 164 SNIMRDGH-FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---T 235 (294)
Q Consensus 164 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~ 235 (294)
+....... ......++..|+|||.+... ...+.++|+||||++++++++|..||...........+..... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd06608 160 SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239 (275)
T ss_pred ceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCC
Confidence 86543322 22334578889999987532 2236789999999999999999999986655444444443322 1
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+..++.++.+++.+||..||++|||+.++++|||+
T Consensus 240 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 223467899999999999999999999999999996
No 198
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=7.3e-43 Score=287.56 Aligned_cols=252 Identities=33% Similarity=0.552 Sum_probs=219.8
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999989999999999766433 2456789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-cccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTS 176 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 176 (294)
++++++|.+++.+...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999876654332 2334
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK-IKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
.++..|+|||...+... +.++|+|++|++++++++|..||........... ........+..++..+.+++.+||..+
T Consensus 160 ~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 238 (254)
T cd06627 160 VGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKD 238 (254)
T ss_pred ccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCC
Confidence 57889999999877664 7899999999999999999999976554333333 334445566788999999999999999
Q ss_pred CCCCCCHhHHhcCCcc
Q 022617 256 PMKRITIPEIRQHPWF 271 (294)
Q Consensus 256 p~~Rps~~~il~h~~~ 271 (294)
|++|||+.++++||||
T Consensus 239 p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 239 PNLRPTAKQLLKHPWI 254 (254)
T ss_pred hhhCcCHHHHhcCCCC
Confidence 9999999999999997
No 199
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=4.3e-43 Score=291.29 Aligned_cols=250 Identities=28% Similarity=0.490 Sum_probs=211.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.|++|.+.............+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999886554444455677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998853 34589999999999999999999999999999999999999999999999998876543221
Q ss_pred -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCCc-cC-CCCCChhHHHH
Q 022617 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIY-TL-PSHLSPGARDL 247 (294)
Q Consensus 173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~-~~~~~~~l~~l 247 (294)
.....++..|+|||.+.+... +.++|+||+|+++|+|++|..||.... .......+..... +. ...++..+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL 240 (267)
T ss_pred HHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence 223457788999999887666 788999999999999999999996543 3344444443332 22 23577899999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++||++.++++
T Consensus 241 i~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 241 VSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHCCCCcccCcCHHHHHH
Confidence 99999999999999999987
No 200
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=1.5e-43 Score=299.28 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=207.7
Q ss_pred ccCCcccccccccCceEEEEEEEccCCce--EEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK--VAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (294)
.++|++.+.||.|+||.||+|.+..++.. +++|.+. ..........+.+|++++.++ +|+|++++++++...+..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~--~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEec--ccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 35899999999999999999998877765 4666543 222334557788999999999 899999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617 93 YVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~ 156 (294)
++++||+++++|.+++.+.. .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 99999999999999996542 47889999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-c
Q 022617 157 KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-Y 234 (294)
Q Consensus 157 ~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~ 234 (294)
+|+|||++..............+..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+..+.+.... .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 242 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL 242 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcC
Confidence 9999999864322111112223567999998876665 789999999999999998 999998877777666665442 3
Q ss_pred cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..+...+.++.+++.+||+.+|++||++.+++.+
T Consensus 243 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 243 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4455688999999999999999999999999875
No 201
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-45 Score=288.91 Aligned_cols=254 Identities=38% Similarity=0.665 Sum_probs=222.9
Q ss_pred ccccCCcc-cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc---
Q 022617 14 MFLPNYKL-GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET--- 88 (294)
Q Consensus 14 ~~~~~y~~-~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--- 88 (294)
.+.++|++ -++||-|-.|.|..+.++.+++.||+|++.- ..+.++|+++.-.. .|+||+.++++|+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 46777877 5789999999999999999999999998632 36778888876555 59999999999853
Q ss_pred -CCeEEEEEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeec
Q 022617 89 -PSDIYVVMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFG 162 (294)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg 162 (294)
...+.+|||.++||.|.+.++.++. +++.++..+++||..|+.|||+.+|.||||||+|+|++. +..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4678899999999999999988765 999999999999999999999999999999999999975 4569999999
Q ss_pred ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCccCCC
Q 022617 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS 238 (294)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~ 238 (294)
++..........+.+.|+.|.|||++...++ +..-|+||+|+++|-|++|.+||..+. ...+..+|..+.+.+|.
T Consensus 210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~ 288 (400)
T KOG0604|consen 210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE 288 (400)
T ss_pred cccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence 9988776666777888999999999998887 788999999999999999999998754 45677788888877764
Q ss_pred ----CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 239 ----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 239 ----~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.+++..+++|+.+|+.+|.+|.|+.++++|||+.+...
T Consensus 289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 67899999999999999999999999999999977533
No 202
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=4.5e-43 Score=289.25 Aligned_cols=249 Identities=32% Similarity=0.535 Sum_probs=215.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..++..+++|.+..... ....+.+.+|+.++++++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999864432 2345678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 98 YVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 98 ~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
|+++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 99999999988653 458999999999999999999999999999999999999999999999999987654332 222
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
...++..|+|||++.+... +.++|+||+|+++|+|++|..||...+.......+..+. .+.+..++..+.+++.+||+
T Consensus 159 ~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (255)
T cd08219 159 TYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFK 237 (255)
T ss_pred cccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHh
Confidence 3457888999999877765 789999999999999999999999887777666665544 34567788999999999999
Q ss_pred cCCCCCCCHhHHhcCC
Q 022617 254 VDPMKRITIPEIRQHP 269 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~ 269 (294)
.||++|||+.++++--
T Consensus 238 ~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 238 RNPRSRPSATTILSRG 253 (255)
T ss_pred CCcccCCCHHHHhhcc
Confidence 9999999999998743
No 203
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=2.4e-43 Score=300.06 Aligned_cols=244 Identities=30% Similarity=0.503 Sum_probs=191.0
Q ss_pred cccccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEEEEe
Q 022617 22 GKTLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYVVME 97 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 97 (294)
.++||+|+||.||+|.++ .+++.+++|.+..... ...+.+|+.++++++||||+++++++.. ....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999965 3567899998854322 2456789999999999999999998854 456899999
Q ss_pred ccCCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeeccc
Q 022617 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (294)
Q Consensus 98 ~~~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~~ 164 (294)
|+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 898887532 248999999999999999999999999999999999999 45678999999999
Q ss_pred ccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhC
Q 022617 165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIKG 231 (294)
Q Consensus 165 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~~ 231 (294)
....... ......+++.|+|||++.+....+.++||||+|+++|+|++|+.||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 1234467889999999877554578999999999999999999999643211 11111100
Q ss_pred ----------------------------CCcc----------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 232 ----------------------------GIYT----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 232 ----------------------------~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.... .....+.++.+++.+||+.||.+|||++|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 001234568899999999999999999999999998
No 204
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=6.3e-43 Score=293.20 Aligned_cols=257 Identities=33% Similarity=0.528 Sum_probs=221.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.+...+.|.+.+.||.|++|.||++.+..++..+++|++..... ....+.+|++++++++|+|++++++.+...+.
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence 35677889999999999999999999998899999999865432 45678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.++++||+++++|.+++.... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999999999998776 8999999999999999999999999999999999999999999999999987654332
Q ss_pred C-ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-cc--CCCCCChhHHH
Q 022617 171 H-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT--LPSHLSPGARD 246 (294)
Q Consensus 171 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~ 246 (294)
. ......++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+.... .. .+..++.++.+
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 248 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD 248 (286)
T ss_pred hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence 2 1123346778999999887766 789999999999999999999998776655544443322 22 22347899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+|.+||+.+|.+|||+.+++.|+||++
T Consensus 249 li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 249 FLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999999999999999999999999987
No 205
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=2.1e-43 Score=293.20 Aligned_cols=251 Identities=30% Similarity=0.543 Sum_probs=207.8
Q ss_pred CCccccccCCcccccc--cccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh-CCCCceeEEEEEE
Q 022617 10 SGVDMFLPNYKLGKTL--GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL-FMHPHIIRLYEVI 86 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~l--g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~ 86 (294)
+......++|++.+.+ |.|+||.||++.++.++..+++|++........ |...... .+|+|++++++.+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEE
Confidence 3444566788888887 999999999999999999999999865432211 1222221 2699999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccc
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSN 165 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~ 165 (294)
..++..++++||+++++|.+++.++.++++..++.++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999999999998877899999999999999999999999999999999999999988 99999999887
Q ss_pred cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhCCCccCCCCC
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-----LFKKIKGGIYTLPSHL 240 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 240 (294)
...... ...++..|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ..... ......+..+
T Consensus 159 ~~~~~~---~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (267)
T PHA03390 159 IIGTPS---CYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNV 233 (267)
T ss_pred ecCCCc---cCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCccccc
Confidence 654322 2356789999999987766 788999999999999999999997544322 22222 3334555678
Q ss_pred ChhHHHHHHHhcccCCCCCCC-HhHHhcCCcccc
Q 022617 241 SPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQA 273 (294)
Q Consensus 241 ~~~l~~li~~~l~~~p~~Rps-~~~il~h~~~~~ 273 (294)
+..+.++|.+||+.+|.+||+ ++++|+||||++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999999996 699999999974
No 206
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1e-42 Score=286.11 Aligned_cols=249 Identities=34% Similarity=0.572 Sum_probs=214.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
.|.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48889999999999999999988899999999865432 346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccc
Q 022617 98 YVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS 176 (294)
Q Consensus 98 ~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 176 (294)
|+++++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+............
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99999999999776 57999999999999999999999999999999999999999999999999998776554433455
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-CCccCCC--CCChhHHHHHHHhcc
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIYTLPS--HLSPGARDLIPRMLI 253 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~ 253 (294)
.++..|+|||.+.+... +.++|+||||+++++|++|..||...+.......... .....+. .++..+.+++.+||+
T Consensus 158 ~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (253)
T cd05122 158 VGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQ 236 (253)
T ss_pred ecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHcc
Confidence 67889999999877664 7899999999999999999999987644443333332 2222332 348899999999999
Q ss_pred cCCCCCCCHhHHhcCCc
Q 022617 254 VDPMKRITIPEIRQHPW 270 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~ 270 (294)
.||++|||+.++++|||
T Consensus 237 ~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 237 KNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CChhhCCCHHHHhcCCC
Confidence 99999999999999998
No 207
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=2.3e-43 Score=297.35 Aligned_cols=263 Identities=29% Similarity=0.513 Sum_probs=220.8
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
...|.....||.|+||.||+|.+..+++.|++|++..... .....+.+|+.+++.+.|||++++++++..++..+++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 4566777889999999999999988999999999864432 2346688899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
+||+++++|.+++.. ..+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 175 (297)
T cd06659 97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK 175 (297)
T ss_pred EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccc
Confidence 999999999987754 568999999999999999999999999999999999999999999999999886543322 123
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHHHHHHh
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRM 251 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~ 251 (294)
...++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..... ..+..++..+.+++.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 3457889999999987766 7899999999999999999999987766665555543322 22346788999999999
Q ss_pred cccCCCCCCCHhHHhcCCcccccCCccccCCC
Q 022617 252 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 283 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~ 283 (294)
|+.+|++||++.++++||||.+.--..+.+|.
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~~~~~~~~ 286 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGLPECLVPL 286 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCCcccccch
Confidence 99999999999999999999876544554443
No 208
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=4.6e-43 Score=289.15 Aligned_cols=251 Identities=31% Similarity=0.518 Sum_probs=220.2
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||++.+..+++.+++|.+....... .....+.+|++++++++|+|++++++++......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999987554332 345677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 98 YVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 98 ~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
|+++++|.+++.+ ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~ 158 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA 158 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence 9999999999866 356899999999999999999999999999999999999999999999999998776544 33
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML 252 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 252 (294)
....++..|+|||.+.+..+ +.++|+||||++++++++|+.||...+.......+.... ...+..++.++.+++.+||
T Consensus 159 ~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (256)
T cd08530 159 KTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSML 237 (256)
T ss_pred ccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHc
Confidence 34557889999999987766 688999999999999999999999888777666665544 3455678899999999999
Q ss_pred ccCCCCCCCHhHHhcCCcc
Q 022617 253 IVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 253 ~~~p~~Rps~~~il~h~~~ 271 (294)
..+|++|||+.++++||++
T Consensus 238 ~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 238 QVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCcccCCCHHHHhcCCCC
Confidence 9999999999999999985
No 209
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=7.7e-43 Score=295.22 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=204.4
Q ss_pred cccCCcccccccccCceEEEEEEEcc----------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 78 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 78 (294)
..++|++.+.||+|+||.||+|.+.. ++..|++|++.... .......+.+|+.++++++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999998642 23469999986542 2334567889999999999999
Q ss_pred eeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617 79 IIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-------------------RLQEDEARNFFQQIISGVEYCHRNMVV 139 (294)
Q Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~ 139 (294)
|+++++++...+..++++||+.+++|.+++.... .++...++.++.|++.||.|||+.|++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 357788999999999999999999999
Q ss_pred ecCCCCCCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CC
Q 022617 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GT 214 (294)
Q Consensus 140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~ 214 (294)
|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+....+ +.++|+||||+++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCC
Confidence 999999999999999999999999875533221 122234678999999877666 789999999999999986 67
Q ss_pred CCCCCCCHHHHHHHHhC--------CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 215 LPFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 215 ~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.||.............. .....+..++..+.+++.+||+.+|++|||+.+|.+
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 78877665555443321 112334678899999999999999999999999954
No 210
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=1.4e-42 Score=288.51 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=208.1
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.+.......||+|++|.||+|.+..++..+++|.+.... ....+.+.+|+.++++++|+||+++++++..++..+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 344455678999999999999999899999999875432 23456888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC
Q 022617 96 MEYVKSGELFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l--~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~ 171 (294)
+||+.+++|.+++... .++ ++..+..++.|++.|+++||+.|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 9999999999999764 455 78889999999999999999999999999999999976 6789999999887553322
Q ss_pred c-cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HhCCCccCCCCCChhHHH
Q 022617 172 F-LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNL--FKK-IKGGIYTLPSHLSPGARD 246 (294)
Q Consensus 172 ~-~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~l~~ 246 (294)
. .....++..|+|||.+.... ..+.++|+||+|+++|+|++|..||........ ... ........+..++.++.+
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence 1 22334688999999986533 236889999999999999999999975432221 111 122234556778899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
++.+||..+|++|||+.+++.||||
T Consensus 244 li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999999997
No 211
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=4.3e-43 Score=289.56 Aligned_cols=252 Identities=29% Similarity=0.566 Sum_probs=215.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|.+.+.||.|++|.||++.++.++..+++|.+....... .....+.+|+++++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5889999999999999999999999999999987654322 234677899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-EEEeeecccccccCCCc-c
Q 022617 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHF-L 173 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-~~l~dfg~~~~~~~~~~-~ 173 (294)
|+.+++|.+++.+.. .+++..+..++.|++.++.+||+.+++|+||+|+||++++++. ++|+|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999987643 4789999999999999999999999999999999999988764 69999998876544322 2
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRML 252 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 252 (294)
....++..|+|||.+.+..+ +.++|+||+|++++++++|..||...+.......+.... .+....++.++.+++.+||
T Consensus 160 ~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 238 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLF 238 (257)
T ss_pred cccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHh
Confidence 23357788999999877665 789999999999999999999998777666665554433 3445678899999999999
Q ss_pred ccCCCCCCCHhHHhcCCcc
Q 022617 253 IVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 253 ~~~p~~Rps~~~il~h~~~ 271 (294)
..+|++|||+.++++||||
T Consensus 239 ~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 239 KVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ccChhhCcCHHHHhhCCCC
Confidence 9999999999999999997
No 212
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=8.5e-43 Score=288.95 Aligned_cols=248 Identities=25% Similarity=0.436 Sum_probs=213.8
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
-..+|.+.+.||.|++|.||+|.++.+++.+++|.+.... .....+.+|++++++++|+|++++++++......++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3457899999999999999999999899999999975432 235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++||+++++|.+++... ..+++..++.++.|++.+|++||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999999998654 3588999999999999999999999999999999999999999999999999876544322
Q ss_pred cc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHH
Q 022617 173 LK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 248 (294)
.. ....+..|+|||.+.+... +.++||||||+++|+|++ |..||.+....+....+... ....+..++.++.+++
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 21 1223557999999877766 788999999999999998 99999888777777766654 3556678899999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||+.+|++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999976
No 213
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=2.8e-43 Score=296.28 Aligned_cols=259 Identities=32% Similarity=0.507 Sum_probs=216.7
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
+....++|++.+.||.|++|.||++.+..+++.+++|.+.... ......+.+|+.++++++|||++++++++...+.
T Consensus 14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~ 90 (293)
T cd06647 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE 90 (293)
T ss_pred ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence 4455689999999999999999999998889999999985432 2234678889999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
.++++||+++++|.+++.+ ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 9999999999999999864 457899999999999999999999999999999999999999999999999876543322
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-C--ccCCCCCChhHHHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG-I--YTLPSHLSPGARDL 247 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~l 247 (294)
......++..|++||.+..... +.++|+||+|+++|++++|..||...........+... . ...+..++..+.++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 2233457778999999877666 78999999999999999999999876544333222221 1 12234567889999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
+.+||..+|++||++.+++.||||+...
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999999998743
No 214
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=1.5e-43 Score=303.69 Aligned_cols=258 Identities=33% Similarity=0.526 Sum_probs=211.8
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (294)
+..+|++.+.||.|++|+||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+|++++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 56789999999999999999999999999999999865422 223356677899999999999999999887543
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
...++++||+. ++|.+++.+.+++++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 59999998888899999999999999999999999999999999999999999999999999876543
Q ss_pred C-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-----------------
Q 022617 170 G-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG----------------- 231 (294)
Q Consensus 170 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~----------------- 231 (294)
. .......++..|+|||.+......+.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence 3 2223345678899999886543347899999999999999999999976543222211110
Q ss_pred --------CC------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 232 --------GI------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 232 --------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.. ......++.++.+++.+||+.+|++|||+.++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 01124578899999999999999999999999999999764
No 215
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=4.9e-43 Score=293.38 Aligned_cols=251 Identities=31% Similarity=0.537 Sum_probs=208.2
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
|++.+.||.|++|.||+|.++.+++.|++|++...... ......+.+|+++++.++|+|++++++++...+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 78899999999999999999999999999998654322 22345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cccc
Q 022617 99 VKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKT 175 (294)
Q Consensus 99 ~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 175 (294)
++ ++|.+++.... .+++..++.++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 59999997765 68999999999999999999999999999999999999999999999999986543221 1223
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-----------------------
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG----------------------- 232 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~----------------------- 232 (294)
..++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07835 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP 238 (283)
T ss_pred cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence 345788999998876544478899999999999999999999776543322221110
Q ss_pred --C----ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 233 --I----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 233 --~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
. ......++..+.+++.+||+.+|.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 01124567889999999999999999999999999998
No 216
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=7.9e-44 Score=301.54 Aligned_cols=258 Identities=28% Similarity=0.419 Sum_probs=209.3
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPS 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 90 (294)
+.+-...|.+++.||+||.+.||++... +.+-|++|.+..... +......+..|+.+|.+|+ |.+|+++++|-..++
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 4566779999999999999999999975 445566666544333 3456788999999999997 799999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
.+|+|||+-+ .+|..+|++... .+.-.++.++.||+.|+.++|++||+|.||||.|+++-.+ .+||+|||.|.....
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG-~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG-RLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee-eEEeeeechhcccCc
Confidence 9999999874 599999987654 3445889999999999999999999999999999999665 899999999987765
Q ss_pred CC---ccccccCCCcccCCccccCCcc----------CCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCCC--
Q 022617 170 GH---FLKTSCGSPNYAAPEVISGKLY----------AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGI-- 233 (294)
Q Consensus 170 ~~---~~~~~~~~~~~~aPE~~~~~~~----------~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~-- 233 (294)
.+ .....+||+-||+||.+..... .+.++|||||||++|+|+.|+.||.... ...-+..|....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~ 591 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHE 591 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcc
Confidence 44 3467789999999999842211 2678999999999999999999996533 333333444432
Q ss_pred ccCCCCCCh-hHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 234 YTLPSHLSP-GARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 234 ~~~~~~~~~-~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+++|..-+. ++.++++.||+.||++||++.++|+|||++-
T Consensus 592 Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 592 IEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 345543333 3999999999999999999999999999977
No 217
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=5.6e-43 Score=296.71 Aligned_cols=259 Identities=28% Similarity=0.460 Sum_probs=206.5
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
......++|++.+.||.|++|.||+|.+..+++.|++|.+....... .....+.+|++++++++|||++++++++....
T Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 6 PFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred cccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 34556778999999999999999999999999999999986443221 22345668999999999999999999886543
Q ss_pred --------eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617 91 --------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (294)
Q Consensus 91 --------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df 161 (294)
..++++||+.+ +|.+.+... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999965 888887654 36899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--
Q 022617 162 GLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-- 234 (294)
Q Consensus 162 g~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 234 (294)
|.+........ .....++..|+|||.+.+....+.++|+||+|+++|+|++|..||...+.......+.....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99875533221 12234577899999887654447889999999999999999999977654433322211100
Q ss_pred -----------------cCC-------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 -----------------TLP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 -----------------~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..+ ...+..+.++|.+||..||.+|||++++++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 1235667899999999999999999999999998
No 218
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=1.7e-43 Score=302.54 Aligned_cols=257 Identities=35% Similarity=0.552 Sum_probs=217.0
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 92 (294)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+.+|+.+++.++|+|++++.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999986543 22344577899999999999999999999987765 78
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
+++++|+.+ +|.+++.+..++++..++.++.|++.+|.+||+.|++|+||+|.||+++.++.++|+|||.+.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 899999877789999999999999999999999999999999999999999999999999988765443
Q ss_pred ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------- 234 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 234 (294)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+.....
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 233345678899999998774448899999999999999999999987766554444332110
Q ss_pred -----------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 235 -----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 235 -----------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
.....++.++.+++.+||+.+|++||++++++.||||++.-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 011346788999999999999999999999999999987544
No 219
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-44 Score=279.88 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=219.3
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+..++..||+|..|+|+++..+++|.-.|||.+.... +.+..+++.+.+.+..... +|+|++.+|+|..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4566788999999999999999999999999987553 5566788888888876665 899999999999999999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 174 (294)
|.|.. .++.++++ .+++++..+-.+...++.||.||.+ +||+|+|+||+|||+++.|++||+|||.+...-.+..+.
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 99954 77777765 4679999999999999999999995 579999999999999999999999999999998998899
Q ss_pred cccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhCCCc-cCC--CCCChhHHHH
Q 022617 175 TSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY-TLP--SHLSPGARDL 247 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~-~~~--~~~~~~l~~l 247 (294)
...|.+.|||||.+.. .+| +.++|+||||+.++||.||+.||.+. ...++...+.+..+ .++ ..+++.+.+|
T Consensus 250 rsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f 328 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF 328 (391)
T ss_pred cccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence 9999999999999853 344 78999999999999999999999873 34444555544443 333 2489999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
+..||++|+.+||...++|+|||+....+-
T Consensus 329 v~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a 358 (391)
T KOG0983|consen 329 VKDCLTKDHRKRPKYNKLLEHPFIKRYETA 358 (391)
T ss_pred HHHHhhcCcccCcchHHHhcCcceeecchh
Confidence 999999999999999999999999775443
No 220
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=6.7e-43 Score=294.18 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=209.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|+||+|.++.+++.+++|.+...... ......+.+|++++++++|+|++++++++......++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 6899999999999999999999989999999998654322 233466788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC-c
Q 022617 97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-F 172 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~-~ 172 (294)
||+++ +|.+.+..... +++..++.++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||++....... .
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 99965 88888765443 578888999999999999999999999999999999985 5579999999987543322 1
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------------
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------- 233 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 233 (294)
.....++..|+|||.+.+....+.++|+||+|+++|+|++|..||......+....+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 2234567899999998765545789999999999999999999998765544433321100
Q ss_pred --c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 234 --Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 --~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
. ......+.++.+++.+||+.+|++||++.++++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 0 0123567889999999999999999999999999999863
No 221
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=4.2e-43 Score=298.29 Aligned_cols=253 Identities=30% Similarity=0.491 Sum_probs=204.6
Q ss_pred CCcccccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIY 93 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 93 (294)
+|++.+.||+|++|.||+|.+.. ++..|++|.+.............+.+|+.++++++|||++++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 7899999998764323333456778899999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC----CCcEEEeeeccc
Q 022617 94 VVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS----KWNVKIADFGLS 164 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~----~~~~~l~dfg~~ 164 (294)
+|+|++++ +|.+++... ..+++..++.++.|++.++.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 787777532 26899999999999999999999999999999999999999 899999999998
Q ss_pred ccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH--
Q 022617 165 NIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---------LFKKI-- 229 (294)
Q Consensus 165 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~---------~~~~~-- 229 (294)
........ .....++..|+|||.+.+....+.++|+||||+++++|++|+.||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76543221 2233567889999988765544789999999999999999999997543221 00000
Q ss_pred ------------------------hCCCccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 230 ------------------------KGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 230 ------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.......+ ...+..+.+++.+||+.||++|||+.++++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00000111 1466789999999999999999999999999998
No 222
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=4.8e-43 Score=294.20 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=209.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv 95 (294)
++|...+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+.++.++. |+|++++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677889999999999999999999999999998654322 34567888999999996 99999999999989999999
Q ss_pred EeccCCCChHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 96 MEYVKSGELFDYIV-----EKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 96 ~e~~~~~sL~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
+|++.+ ++.++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 7766542 235689999999999999999999974 999999999999999999999999999876554
Q ss_pred CCccccccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCC-CccC----CCCCC
Q 022617 170 GHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGG-IYTL----PSHLS 241 (294)
Q Consensus 170 ~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~----~~~~~ 241 (294)
........++..|+|||.+.+. ...+.++|+||+|+++|+|++|+.||..... ......+... .... +..++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4433444678889999998765 2347899999999999999999999976432 1222222221 1122 22478
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.++.+++.+||+.+|++|||++++++||||+...
T Consensus 241 ~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 241 PSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 8999999999999999999999999999998754
No 223
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=8.5e-43 Score=293.14 Aligned_cols=253 Identities=30% Similarity=0.535 Sum_probs=204.8
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.++.+++.|++|.+....... ....+.+|++++++++|+||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 478999999999999999999999899999999986543221 223466899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+.+ +|.+++.+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999975 999988654 468999999999999999999999999999999999999999999999999886543221 11
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCC--------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGG-------------------- 232 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~-------------------- 232 (294)
....++..|+|||.+.+....+.++|+||+|+++|+|++|..||.... ..+....+...
T Consensus 161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07844 161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240 (291)
T ss_pred cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence 223457789999998765444788999999999999999999996554 22222111100
Q ss_pred -Cc---------cCCCCCC--hhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 233 -IY---------TLPSHLS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 233 -~~---------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.. ......+ .++.+++.+||..+|++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0001233 788899999999999999999999999998
No 224
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=9.8e-43 Score=292.77 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=203.2
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..+++.+++|++...... .....+.+|+.+++.++|+|++++++++..++..+++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999989999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 96 MEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
+||+. ++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 99996 577776654 3567888999999999999999999999999999999999999999999999886543221 22
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhC------------------CCc
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKG------------------GIY 234 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~------------------~~~ 234 (294)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||...... +....+.. ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (291)
T cd07870 161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240 (291)
T ss_pred CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence 33346789999999876544477899999999999999999999764421 11111100 000
Q ss_pred c-----CC---------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 T-----LP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
. .+ ...+.++.+++.+|+..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 1235688999999999999999999999999998
No 225
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=9.7e-43 Score=293.61 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=208.1
Q ss_pred cCCcccccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (294)
++|++.+.||.|++|.||+|.++.++. .+++|.+... ......+.+.+|+++++++ +|||++++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999877665 4677776422 2223456788999999999 6999999999999989999
Q ss_pred EEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617 94 VVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~ 157 (294)
+++||+++++|.+++.+.. .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 478899999999999999999999999999999999999999999
Q ss_pred EeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-cc
Q 022617 158 IADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT 235 (294)
Q Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~ 235 (294)
|+|||++..............+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+.... ..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC
Confidence 999999864322211122223457999999877766 789999999999999997 999998888777776665543 44
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.+..++..+.+++.+||+.+|.+|||++++++.
T Consensus 239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566789999999999999999999999999774
No 226
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1.9e-42 Score=290.45 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=211.1
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--CCeEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--PSDIYV 94 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~l 94 (294)
++|...+.||.|++|.||++.+..+++.+++|.+..... ......+.+|++++++++|+||+++++++.. .+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 478899999999999999999998999999999864422 2445778999999999999999999998854 347899
Q ss_pred EEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 95 VMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
++||+++++|.+++.. ...+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999988753 345889999999999999999999999999999999999999999999999998654332
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhCCC-ccCC------C
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-----NIPNLFKKIKGGI-YTLP------S 238 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~-----~~~~~~~~~~~~~-~~~~------~ 238 (294)
.. ....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+.... ..++ .
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred cc-ccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 21 23346778999999887766 78999999999999999999999765 2233333333311 1111 1
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
..++.+.+++.+||..+|++|||+.|+++||||++...+
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 245689999999999999999999999999999776554
No 227
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=1.2e-42 Score=287.46 Aligned_cols=243 Identities=28% Similarity=0.486 Sum_probs=212.9
Q ss_pred ccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617 23 KTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
+.||.|++|.||+|.+... +..+++|.+....... ....+.+|+++++.++|+|++++++++......++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 8899999986554322 4678899999999999999999999999999999999999
Q ss_pred CCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 100 KSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 100 ~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998766543
Q ss_pred C---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHH
Q 022617 171 H---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGAR 245 (294)
Q Consensus 171 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 245 (294)
. ......++..|+|||.+....+ +.++|+||||+++|+|++ |..||.........+.+... ....+..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 2 2234456788999999877655 789999999999999999 69999988888777777643 3456678899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcC
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h 268 (294)
+++.+||+.+|++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
No 228
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=9.7e-43 Score=291.12 Aligned_cols=249 Identities=28% Similarity=0.441 Sum_probs=213.0
Q ss_pred ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.++|.+.+.||.|++|.||+|.+.. ++..+++|.+.... .....+.+.+|++++++++|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998743 35789999986443 2234578899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617 91 DIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~ 156 (294)
..++++||+++++|.+++...+ .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997542 37888999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC
Q 022617 157 KIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 232 (294)
Q Consensus 157 ~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~ 232 (294)
+|+|||.+........ ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999875432221 123334678999999987776 789999999999999998 99999888888777777765
Q ss_pred Cc-cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 233 IY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 233 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.. ..+..++..+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 54 345678999999999999999999999999986
No 229
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=1.3e-43 Score=303.67 Aligned_cols=259 Identities=31% Similarity=0.500 Sum_probs=212.2
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CC
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PS 90 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 90 (294)
+.++|.+.+.||.|++|.||+|.++.+++.|++|++..... .......+.+|+.++++++|+||+++++++.. ..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 45899999999999999999999999999999999865432 22345677889999999999999999988753 35
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.+++++||+. ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 6899999996 599999987788999999999999999999999999999999999999999999999999998654332
Q ss_pred Cc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--------------
Q 022617 171 HF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-------------- 231 (294)
Q Consensus 171 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------- 231 (294)
.. .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 21 12345788999999986644447899999999999999999999976654332221110
Q ss_pred ------------CCcc-----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 232 ------------GIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 232 ------------~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.... .....+.++.++|.+||+.+|++||++.+++.||||++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0000 1145688999999999999999999999999999997653
No 230
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=2.7e-42 Score=286.12 Aligned_cols=253 Identities=32% Similarity=0.557 Sum_probs=213.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeeccc--ccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK--IKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDI 92 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 92 (294)
.+|++.+.||.|++|.||+|.+..+++.+++|.+.... .........+.+|++++++++|+|++++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875431 12234457888999999999999999999998654 468
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++|++++++|.+++.+.+.+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999999999887889999999999999999999999999999999999999999999999999987543211
Q ss_pred ---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHH
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARD 246 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 246 (294)
......++..|+|||.+.+... +.++|+||||++++++++|+.||...........+... ...++..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1123346788999999987665 78999999999999999999999876655544444322 24457788999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
++.+||+ +|..||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999985
No 231
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=1e-42 Score=293.13 Aligned_cols=254 Identities=31% Similarity=0.475 Sum_probs=205.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCe----
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSD---- 91 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---- 91 (294)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.+. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999765432 2223467788999999996 5999999999876665
Q ss_pred -EEEEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccc
Q 022617 92 -IYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLS 164 (294)
Q Consensus 92 -~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~ 164 (294)
.++++||+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888888643 35799999999999999999999999999999999999998 889999999988
Q ss_pred ccccCC-CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------
Q 022617 165 NIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------- 233 (294)
Q Consensus 165 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 233 (294)
...... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 754322 111223457789999998765444789999999999999999999998765444332221100
Q ss_pred ----------c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 234 ----------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 234 ----------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
. .....++.++.++|.+||..+|.+||++.+++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0 00134788899999999999999999999999999995
No 232
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=4.1e-43 Score=300.89 Aligned_cols=258 Identities=35% Similarity=0.559 Sum_probs=208.0
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (294)
+.++|++.+.||.|++|.||+|.+..+++.|++|++... ........+.+|+.++++++|+|++++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 568999999999999999999999999999999998532 2223456678899999999999999999886543
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
...++++|++.+ +|.+.+. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred ceEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 358999999965 8888774 45789999999999999999999999999999999999999999999999999865432
Q ss_pred CCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---------------
Q 022617 170 GHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------------- 230 (294)
Q Consensus 170 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~--------------- 230 (294)
... .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 221 1223567889999987654444789999999999999999999997654332221110
Q ss_pred CCC-----------c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 231 GGI-----------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 231 ~~~-----------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
... . ...+..+.++.+++.+||+.+|++|||+.++++||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000 0 011346788999999999999999999999999999987753
No 233
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=3.4e-43 Score=302.13 Aligned_cols=263 Identities=30% Similarity=0.475 Sum_probs=216.5
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
....+.++|++.+.||.|++|.||+|.+..+++.|++|++.... ........+.+|+.++++++|+|++++.+++...+
T Consensus 9 ~~~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ceecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 34567889999999999999999999999899999999986542 22234566788999999999999999988776554
Q ss_pred e------EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 91 D------IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 91 ~------~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
. .++++|++ +++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 3 89999999 5599998864 57899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (294)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 234 (294)
...... .....++..|+|||.+.+....+.++|+||||+++|++++|+.||...........+.....
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 765433 22345677899999986544447899999999999999999999977665444433322110
Q ss_pred ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.....++..+.+++.+||+.+|++|||+.+++.||||+++..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 11124688999999999999999999999999999999886654
No 234
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=9.5e-44 Score=316.68 Aligned_cols=251 Identities=31% Similarity=0.486 Sum_probs=208.1
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEE-EEEc---
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYE-VIET--- 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~-~~~~--- 88 (294)
+=..+++|.+.|.+|||+.||+|.+...+..||+|.+.. .++...+.+.+|++++++|+ |+||+.+++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~---~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV---NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec---CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 334578899999999999999999987779999999853 36678899999999999998 999999999 3321
Q ss_pred C---CeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeee
Q 022617 89 P---SDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADF 161 (294)
Q Consensus 89 ~---~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~df 161 (294)
. -.+.++||||+|+.|-+++..+ ..|++.++++|+.|+++|+++||... |+|||||-+||||+.+|++|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1 2478999999999999999753 45999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCccc----------cccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 022617 162 GLSNIMRDGHFLK----------TSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI 229 (294)
Q Consensus 162 g~~~~~~~~~~~~----------~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~ 229 (294)
|.++......... ...-|+.|+|||.+. .....+.++|||+|||++|.||....||+...... |
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----I 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----I 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----E
Confidence 9987543222111 113589999999863 34444899999999999999999999998764433 4
Q ss_pred hCCCccCC--CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 230 KGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 230 ~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..+.+.+| +.++..+.+||+.||+.||++||++.|++.+-+-
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~ 310 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE 310 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence 45555555 4799999999999999999999999998875443
No 235
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=2e-42 Score=290.53 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=210.5
Q ss_pred ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
..+|.+.+.||.|++|.||++.+. .++..+++|.+... .....+.+.+|++++++++|+|++++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 457999999999999999999853 34556889987533 2234567899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617 91 DIYVVMEYVKSGELFDYIVEKG-------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~-------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~ 157 (294)
..++++||+++++|.+++...+ .+++..++.++.|++.||++||+.|++|+||+|+||+++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999997543 389999999999999999999999999999999999999999999
Q ss_pred EeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC
Q 022617 158 IADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 233 (294)
Q Consensus 158 l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~ 233 (294)
|+|||.+........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999999875532221 122234668999999887665 789999999999999998 999998887777777776655
Q ss_pred -ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 234 -YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 234 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
...+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3445678899999999999999999999999865
No 236
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=1.2e-42 Score=291.15 Aligned_cols=251 Identities=32% Similarity=0.557 Sum_probs=208.2
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
+|++.+.||.|++|.||+|.+..++..+++|++...... .....+.+|+.++++++|+|++++++++...+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999998655322 224567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-cc
Q 022617 98 YVKSGELFDYIVEK---GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FL 173 (294)
Q Consensus 98 ~~~~~sL~~~l~~~---~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 173 (294)
|+.+ +|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9975 898888654 358999999999999999999999999999999999999999999999999986543321 12
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------------c-
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------------Y- 234 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~- 234 (294)
....++..|++||.+.+....+.++|+|+||+++|++++|..||...+..+....+.... .
T Consensus 158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07836 158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT 237 (284)
T ss_pred ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence 234467789999998765544789999999999999999999998765544333321100 0
Q ss_pred ----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 ----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+.++..+.+++.+||+.||.+||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999998
No 237
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=1.8e-42 Score=285.89 Aligned_cols=245 Identities=29% Similarity=0.526 Sum_probs=209.2
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|+||.||++.++ ++..+++|.+..... ....+.+|+.++++++|||++++++++...+..++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56899999999999999999876 456799998754332 2457888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 174 (294)
||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 999999999998653 468999999999999999999999999999999999999999999999999887653332221
Q ss_pred -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 251 (294)
...++..|+|||.+.+..+ +.++|+||+|+++|++++ |+.||...+..+....+..+. ...+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 2234567999999887666 789999999999999999 999999888777777776554 344566788999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 022617 252 LIVDPMKRITIPEIRQ 267 (294)
Q Consensus 252 l~~~p~~Rps~~~il~ 267 (294)
|+.+|++|||+.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999986
No 238
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=1.4e-42 Score=291.88 Aligned_cols=260 Identities=30% Similarity=0.519 Sum_probs=217.7
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
.|.....||.|++|.||++.+..+++.+++|.+.... ......+.+|+.+++.++|+|++++++++...+..++++|
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 3444578999999999999999899999999875332 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 176 (294)
|+++++|.+++. +..+++..+..++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 98 ~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 98 FLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 999999999874 4568999999999999999999999999999999999999999999999999876543321 22234
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---cCCCCCChhHHHHHHHhcc
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~ 253 (294)
.++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..... .....++..+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 56788999999876665 7899999999999999999999987766555554443322 2234678899999999999
Q ss_pred cCCCCCCCHhHHhcCCcccccCCccccCC
Q 022617 254 VDPMKRITIPEIRQHPWFQAHLPRYLAVP 282 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~~~~~~~~~~~~ 282 (294)
.+|.+||++.++++||||....+..+.++
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~~~~~~ 284 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPPSCIVP 284 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCCccccc
Confidence 99999999999999999999876655433
No 239
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=2.3e-43 Score=291.62 Aligned_cols=245 Identities=37% Similarity=0.565 Sum_probs=204.4
Q ss_pred cccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 20 KLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 20 ~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+..+.+.+|++.+++++||||+++++++...+..+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 35688999999999999987 44578999998442 2334478899999999999999999999999988889999
Q ss_pred EeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-- 171 (294)
+||+.+++|.+++... ..++...++.++.|++.||.|||+.+++|++|+++||+++.++.+||+|||++.......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999876 679999999999999999999999999999999999999999999999999987662221
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 248 (294)
..........|+|||.+....+ +.++||||||+++|++++ |+.||...........+.... ...+..++..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 1233346678999999877766 799999999999999999 789999888888888876655 345667999999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||..+|++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
No 240
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=5.4e-43 Score=303.69 Aligned_cols=250 Identities=28% Similarity=0.459 Sum_probs=204.2
Q ss_pred cccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (294)
-.++|++.+.||.|+||.||+|.+... +..|++|.+...... .....+.+|+.+++.+ +|+||+++++.+..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 345799999999999999999986443 357999998654322 3356788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 111 (294)
....+++|||+.+++|.+++...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 99999999999999999998542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc---cc
Q 022617 112 -------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KT 175 (294)
Q Consensus 112 -------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~~ 175 (294)
.++++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......... ..
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 13678889999999999999999999999999999999999999999999998755332211 12
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HhCC-CccCCCCCChhHHHHHHHhc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGG-IYTLPSHLSPGARDLIPRML 252 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~li~~~l 252 (294)
..++..|+|||++.+..+ +.++||||||+++|+|++ |..||........... +... ....+...+.++.+++.+||
T Consensus 274 ~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 352 (374)
T cd05106 274 ARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCW 352 (374)
T ss_pred CCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHc
Confidence 224567999999877666 789999999999999997 9999977554333323 2222 23345567899999999999
Q ss_pred ccCCCCCCCHhHHhc
Q 022617 253 IVDPMKRITIPEIRQ 267 (294)
Q Consensus 253 ~~~p~~Rps~~~il~ 267 (294)
+.+|.+|||+.++++
T Consensus 353 ~~dp~~RPs~~~l~~ 367 (374)
T cd05106 353 NLEPTERPTFSQISQ 367 (374)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999976
No 241
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=9.2e-43 Score=292.11 Aligned_cols=251 Identities=31% Similarity=0.532 Sum_probs=209.7
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--CeEEEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--SDIYVVM 96 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~ 96 (294)
|.+.+.||.|++|.||+|.+..+++.+++|.+.... ........+.+|+++++.++|+|++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 778999999999999999999889999999997654 2233456788899999999999999999999887 8999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cc
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FL 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 173 (294)
||+++ +|.+++.+. ..+++..++.++.|++.|+++||+.|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 99975 899888665 579999999999999999999999999999999999999999999999999987665433 12
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-------------------
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------------- 234 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 234 (294)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.....
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 3344577899999876554447899999999999999999999987665554443322110
Q ss_pred ------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 ------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 ------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.+...++..+.+++.+||+.+|++||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0001137889999999999999999999999999997
No 242
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=2.1e-42 Score=284.72 Aligned_cols=242 Identities=29% Similarity=0.501 Sum_probs=204.5
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|++++++++|+||+++++++...+..++++||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999899999999875332 2344577899999999999999999999999999999999999999
Q ss_pred ChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc---cccC
Q 022617 103 ELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCG 178 (294)
Q Consensus 103 sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~---~~~~ 178 (294)
+|.+++.+.. .+++..++.++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+.......... ....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 9999997644 58999999999999999999999999999999999999999999999999987543322111 1122
Q ss_pred CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcccCC
Q 022617 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (294)
Q Consensus 179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p 256 (294)
+..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999887766 789999999999999997 99999877766655555433 345566789999999999999999
Q ss_pred CCCCCHhHHhc
Q 022617 257 MKRITIPEIRQ 267 (294)
Q Consensus 257 ~~Rps~~~il~ 267 (294)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
No 243
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-44 Score=311.49 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=221.6
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+-|.|+..||.|+||.||+|..+.++-..+-|++. ....+..+++.-|+++|..+.||+|+++++.|...+.+|++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 45788899999999999999999888888889884 344566788899999999999999999999988899999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCccc
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~~~ 174 (294)
|+|+||-++..+-. ...+++.++..+++|++.||.|||+.+|+|+|+|..|||++-+|.++|.|||.+.... .....+
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99999999887754 5679999999999999999999999999999999999999999999999999875432 223446
Q ss_pred cccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc---CCCCCChhHHH
Q 022617 175 TSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARD 246 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~ 246 (294)
...|||+|||||+.. ..+| ++++||||||+++.+|..+.+|....++...+-++.+..++ -|+.-+..+.+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred cccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 678999999999863 3445 79999999999999999999999888877777777665543 35677889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
|+.+||.+||..||++.+||+||||++.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999864
No 244
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=9e-43 Score=302.51 Aligned_cols=251 Identities=29% Similarity=0.465 Sum_probs=205.4
Q ss_pred cccCCcccccccccCceEEEEEEE-----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEH-----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET 88 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 88 (294)
-.++|++.+.||.|+||.||+|.+ ..++..|++|++..... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 345899999999999999999974 34566899999864332 23356788999999999 89999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhC--------------------------------------------------------
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKG-------------------------------------------------------- 112 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~-------------------------------------------------------- 112 (294)
....+++|||+++++|.+++.+..
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 999999999999999999986421
Q ss_pred -------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617 113 -------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (294)
Q Consensus 113 -------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~- 172 (294)
.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 367888999999999999999999999999999999999999999999999876543221
Q ss_pred --cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 173 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...... ...+.+..+. ...+...+.++.++
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 349 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI 349 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence 112234567999999987766 789999999999999998 89999765433 3334444332 33455678899999
Q ss_pred HHHhcccCCCCCCCHhHHhcC
Q 022617 248 IPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h 268 (294)
+.+||+.||++|||+.++++.
T Consensus 350 i~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 350 MKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999863
No 245
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=2.9e-42 Score=286.22 Aligned_cols=250 Identities=27% Similarity=0.440 Sum_probs=212.3
Q ss_pred ccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
.++|++.+.||.|+||.||+|.++.+ ...+++|.+.... .......+.+|+.++++++|+|++++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4579999876432 233456788899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++|++.+++|.+++... +.++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999988764211
Q ss_pred c---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617 172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD 246 (294)
Q Consensus 172 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 246 (294)
. ......+..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+... ..+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 112233568999999887666 789999999999999998 99999887777777776654 34556678999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcC
Q 022617 247 LIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h 268 (294)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999874
No 246
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=1.6e-42 Score=287.82 Aligned_cols=250 Identities=29% Similarity=0.500 Sum_probs=210.8
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||++.+..++..+++|.+......+......+.+|+.+++.++|+|++++++++..++..++++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 68999999999999999999998899999999887654444455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
|++++++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998864 3458999999999999999999999999999999999999999999999999887654322
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhCCCc-cC-CCCCChhHHHH
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI--PNLFKKIKGGIY-TL-PSHLSPGARDL 247 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~--~~~~~~~~~~~~-~~-~~~~~~~l~~l 247 (294)
......++..|+|||.+.+... +.++|+||+|+++|+|++|..||..... ......+..... +. +..++..+.++
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 240 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 240 (267)
T ss_pred ccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence 1223457889999999877666 7889999999999999999999975432 333333433222 22 23578899999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++|||+.+|++
T Consensus 241 i~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 241 VNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHhcCCCcccCCCHHHHHH
Confidence 99999999999999998765
No 247
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-44 Score=277.59 Aligned_cols=256 Identities=29% Similarity=0.397 Sum_probs=208.8
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
..+-+-.+||++.+.||.|||+.||++++..+++.||+|.+.+.. .+..+...+|++..++++|||+++++++....
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 344556789999999999999999999999999999999997665 34578999999999999999999998876433
Q ss_pred -----CeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEE
Q 022617 90 -----SDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 90 -----~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l 158 (294)
...|++++|+..|||.+.+++. ..+++.++..++.+++.||.+||+.. ++|+||||.||++++.+.+++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3489999999999999999753 36999999999999999999999998 999999999999999999999
Q ss_pred eeecccccccCCCc----------cccccCCCcccCCcccc--CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 022617 159 ADFGLSNIMRDGHF----------LKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-- 224 (294)
Q Consensus 159 ~dfg~~~~~~~~~~----------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~-- 224 (294)
.|||.++...-.-. ......+..|+|||.+. .....+.++|||||||++|.||.|..||+..-...
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS 250 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS 250 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence 99999876532211 11234688999999875 23334789999999999999999999995422111
Q ss_pred HHHHHhCCC--ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 225 LFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 225 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
+.-.+..+. ++..+.++..+.++|+.||+.||.+||++.+++.+
T Consensus 251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 000112222 23335699999999999999999999999999864
No 248
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=4.2e-42 Score=285.20 Aligned_cols=250 Identities=30% Similarity=0.497 Sum_probs=212.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||.|++|.||+|.+..+++.+++|.+.............+.+|++++++++|++++++++++...+..++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999899999999987554444455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 97 EYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 97 e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
||+++++|.+++.+ ...+++..++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999864 24589999999999999999999999999999999999999999999999999876543321
Q ss_pred -cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhCCC-ccCCC-CCChhHHHH
Q 022617 173 -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGI-YTLPS-HLSPGARDL 247 (294)
Q Consensus 173 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-~~~~~l~~l 247 (294)
.....++..|.|||.+.+..+ +.++|+||||+++|+|++|..||.... .....+.+..+. .+.+. .++..+.++
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDL 240 (267)
T ss_pred ccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHH
Confidence 223457788999999887766 789999999999999999999996543 333444443332 23333 678899999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++|||+.+|++
T Consensus 241 i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 241 VSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHcCCCcccCCCHHHHHH
Confidence 99999999999999999876
No 249
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=2e-42 Score=285.64 Aligned_cols=246 Identities=26% Similarity=0.475 Sum_probs=208.5
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++|++.+.||+|++|.||.+.+. .+..+++|.+..... ....+.+|+.++++++||||+++++++......++++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 57899999999999999999875 345699998764432 2356889999999999999999999999888999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 174 (294)
||+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 999999999999764 468999999999999999999999999999999999999999999999999887554332211
Q ss_pred -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 251 (294)
...++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 2234567999999987666 789999999999999998 999998877776666665544 334556789999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 022617 252 LIVDPMKRITIPEIRQH 268 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h 268 (294)
|..+|.+||++.+|+++
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999864
No 250
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=2.5e-42 Score=285.03 Aligned_cols=246 Identities=25% Similarity=0.480 Sum_probs=209.4
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|++.+.||.|++|.||++.++ ++..+++|.+...... ...+.+|+++++.++|+|++++++++...+..++++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999886 5668999997543322 346778999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc-
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK- 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~- 174 (294)
|++++++|.+++..+ ..+++..++.++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 999999999999754 468999999999999999999999999999999999999999999999999987654332211
Q ss_pred -cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617 175 -TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 175 -~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 251 (294)
....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+.... ...+..++..+.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 1123457999999887766 789999999999999999 899998877777777666553 455667899999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 022617 252 LIVDPMKRITIPEIRQH 268 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h 268 (294)
|..+|++|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999874
No 251
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-44 Score=305.91 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=216.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
++-.+...-++-||+|+.|.||+++. .++.||||.+. +.-..+|+-|++|+|+||+.+.++|...-.+
T Consensus 120 eiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkGVCtqsPcy 187 (904)
T KOG4721|consen 120 EIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKGVCTQSPCY 187 (904)
T ss_pred cCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEeeeecCCcee
Confidence 44455566678899999999999986 56789999752 2234678999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
|||||||..|.|...|+...+++......|..+|+.++.|||.+.|+|+|||.-||||+.+..+||+|||-+........
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST 267 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST 267 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987766666
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhHHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPR 250 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 250 (294)
.....||..|||||++...+. +.+.||||||+++|||+||..||.+.+...++=-+-.+. .+.|..++..++-|+++
T Consensus 268 kMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kq 346 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQ 346 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHH
Confidence 677789999999999999888 899999999999999999999998877666543333322 56788999999999999
Q ss_pred hcccCCCCCCCHhHHhcCC
Q 022617 251 MLIVDPMKRITIPEIRQHP 269 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~h~ 269 (294)
||+..|.+||++.+||.|-
T Consensus 347 cw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 347 CWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred HHhcCCCCCccHHHHHHHH
Confidence 9999999999999999874
No 252
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=1.2e-42 Score=298.60 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=207.0
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP----- 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 89 (294)
+.++|.+.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+.+|++++++++|+|++++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 56899999999999999999999999999999999865432 3456788899999999999999998776443
Q ss_pred ---------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEe
Q 022617 90 ---------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIA 159 (294)
Q Consensus 90 ---------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~ 159 (294)
...++++||+++ +|.+++. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++. ++.++|+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 357899999974 8988875 457899999999999999999999999999999999999974 5578999
Q ss_pred eecccccccCCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--
Q 022617 160 DFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-- 233 (294)
Q Consensus 160 dfg~~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-- 233 (294)
|||.+........ .....++..|+|||.+......+.++||||||+++|+|++|+.||...........+....
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 9999875532211 1223467789999987654444789999999999999999999997665444333322110
Q ss_pred -----------------------c-----cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 234 -----------------------Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 -----------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
. .....++.++.+++.+||+.||.+|||+.++++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123567889999999999999999999999999999864
No 253
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-44 Score=305.78 Aligned_cols=254 Identities=30% Similarity=0.382 Sum_probs=224.0
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
-...|.-++.||.|+||.||.|+|..+.+.|+||.+..+.....+-.+++..|+..|++++|||++.+-++|..+...|+
T Consensus 24 PEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWL 103 (948)
T KOG0577|consen 24 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWL 103 (948)
T ss_pred HHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHH
Confidence 34568888999999999999999999999999999988877777778999999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
|||||-| |-.+++.- .+++.+.+|..+..+.+.+|+|||+.+.+|+|||..|||+++.|.|||+|||.+......
T Consensus 104 VMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 104 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 9999954 99998864 578999999999999999999999999999999999999999999999999998765433
Q ss_pred ccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCC-CCChhHHHHH
Q 022617 174 KTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLI 248 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li 248 (294)
++.+|||.|||||++. .+.| +-+.||||||+++.++...++|+.+++.-...-.|..+. +.+.. .-+..+.+|+
T Consensus 180 nsFvGTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 180 NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hcccCCccccchhHheecccccc-CCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 4678999999999974 3334 678999999999999999999988887666666665443 44443 4577899999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
..||++-|.+|||.+++|+|+|+..
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhcc
Confidence 9999999999999999999999976
No 254
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=2.3e-42 Score=296.84 Aligned_cols=262 Identities=30% Similarity=0.465 Sum_probs=214.6
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.+..+.++|++.+.||.|++|.||++.+..+++.|++|++.... ........+.+|+.+++.++|+||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 34557899999999999999999999999999999999985432 22334567889999999999999999999986543
Q ss_pred ------eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 91 ------DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 91 ------~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
..++++|++ +++|.+++. +..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 458999999 669988875 467899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----------
Q 022617 165 NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------- 234 (294)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 234 (294)
...... .....++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL 243 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 755332 22335678899999987644447899999999999999999999987654433332211110
Q ss_pred ---------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 235 ---------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 235 ---------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
.....++..+.+++.+||..||++|||+.+++.||||+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 1124567889999999999999999999999999999887443
No 255
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=1.1e-42 Score=294.00 Aligned_cols=258 Identities=31% Similarity=0.518 Sum_probs=211.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS- 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 90 (294)
.....++|++.+.||.|++|.||+|.++.+++.|++|.+...... ......+.+|++++++++|||++++++++....
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 456678999999999999999999999989999999998654322 223456778999999999999999999887654
Q ss_pred ---------eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617 91 ---------DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (294)
Q Consensus 91 ---------~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d 160 (294)
..++++||+++ ++...+.+. ..+++..++.++.|++.||++||+.|++|+||+|+||++++++.++|+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence 79999999976 777777654 4689999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCc--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc----
Q 022617 161 FGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---- 234 (294)
Q Consensus 161 fg~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---- 234 (294)
||.+........ ......+..|+|||.+.+....+.++|+||||+++++|++|+.||...........+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999876543321 12223567899999886554447899999999999999999999987665444433322110
Q ss_pred --------------------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 --------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.....++..+.+++.+||+.+|.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0112468899999999999999999999999999997
No 256
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=3e-42 Score=287.82 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=209.9
Q ss_pred ccccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (294)
...++|++.+.||.|++|.||+|.+.. ++..+++|.+.... .......+.+|+.+++.++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998642 34679999875332 22234568899999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l 158 (294)
.+..++++||+.+++|.+++.+.. .++...+..++.|++.++.|||+.|++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999986532 2567788999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-
Q 022617 159 ADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI- 233 (294)
Q Consensus 159 ~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~- 233 (294)
+|||++......... ....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999998654332211 12234668999999887665 789999999999999999 799998887777776655443
Q ss_pred ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
...+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 45566788999999999999999999999999864
No 257
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=3.2e-42 Score=287.62 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=210.7
Q ss_pred cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
-.++|++.+.||.|++|.||+|.+.. ++..+++|.+.... .......+.+|+.++++++|+|++++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34689999999999999999999976 67789999875432 223346688899999999999999999999888
Q ss_pred CeEEEEEeccCCCChHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEe
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKG-------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIA 159 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~-------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~ 159 (294)
...++++||+.+++|.+++.+.. .+++..+..++.|++.++.|||+.+++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999997653 488999999999999999999999999999999999998754 59999
Q ss_pred eecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-Cc
Q 022617 160 DFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY 234 (294)
Q Consensus 160 dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~ 234 (294)
|||++......... .....+..|+|||++.+..+ +.++||||||+++|+|++ |..||...........+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998765322211 12223457999999987766 789999999999999997 99999887777766655443 34
Q ss_pred cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5567789999999999999999999999999985
No 258
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.3e-42 Score=295.56 Aligned_cols=244 Identities=28% Similarity=0.476 Sum_probs=189.9
Q ss_pred cccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE--cCCeEEEEEe
Q 022617 22 GKTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE--TPSDIYVVME 97 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e 97 (294)
..+||.|+||.||+|.+.. ++..+++|.+.... ....+.+|++++++++|||++++++++. .....++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 3579999999999999654 55789999875432 1345778999999999999999999884 3567899999
Q ss_pred ccCCCChHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe----cCCCcEEEeeeccc
Q 022617 98 YVKSGELFDYIVEK---------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL----DSKWNVKIADFGLS 164 (294)
Q Consensus 98 ~~~~~sL~~~l~~~---------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili----~~~~~~~l~dfg~~ 164 (294)
|+++ +|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9965 888877521 248899999999999999999999999999999999999 45678999999999
Q ss_pred ccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHh-
Q 022617 165 NIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------NLFKKIK- 230 (294)
Q Consensus 165 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------~~~~~~~- 230 (294)
....... ......++..|+|||.+.+....+.++||||||+++|+|++|..||...... .....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 7654322 1223457889999999877554478999999999999999999999643211 0000000
Q ss_pred ---------------------------CCCc----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 231 ---------------------------GGIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 231 ---------------------------~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.... ......+..+.+++.+||..||.+|||+.|+|+||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000 0011234568899999999999999999999999998
No 259
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=4.3e-42 Score=284.40 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=210.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|++.+.||.|++|.||+|.+. +++.+++|.+..... ..+.+.+|+.++++++|+|++++++++...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999975 456799999865432 24668889999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++|++.+++|.+++.... .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 999999999999997654 689999999999999999999999999999999999999999999999999876643222
Q ss_pred cc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617 173 LK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 248 (294)
.. ....+..|+|||.+.+... +.++|+||||+++|+|++ |+.||...........+.... .+.+..++..+.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11 1122357999999887666 789999999999999999 999998887777666665442 345567899999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||+.+|++||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
No 260
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=1.8e-43 Score=313.81 Aligned_cols=251 Identities=28% Similarity=0.477 Sum_probs=221.6
Q ss_pred ccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (294)
.-..+-+..+.||+|.||.||+|+.. .....||||.++.. .+.....++++|++++..++||||++++|+|..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 33456777899999999999999754 23457999987543 233467899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKG--------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~--------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~ 154 (294)
.+-+++|+|||..|+|.++|..+. +++..+...++.||+.++.||.++.++|+||-++|+||.++-
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999996432 288899999999999999999999999999999999999999
Q ss_pred cEEEeeecccccccCCCccc---cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617 155 NVKIADFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 155 ~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 230 (294)
.|||+|||+++......+.. ...-+.+|||||.+..+++ +.+|||||+|+++||+++ |+.||.+...++.++.+.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 99999999998776555432 3345789999999999999 899999999999999999 999999999999999998
Q ss_pred CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+. .+.|.++|.++.+||..||+.+|++||++.||-.
T Consensus 720 ~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 720 AGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 777 5778899999999999999999999999999843
No 261
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=1.9e-42 Score=286.46 Aligned_cols=247 Identities=24% Similarity=0.481 Sum_probs=212.5
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
..+|++.+.||.|++|.||+|.+.. +..+++|++..... .....+.+|+.+++.++|+|++++++++...+..+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4679999999999999999999986 88899999865432 2356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-
Q 022617 96 MEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF- 172 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~- 172 (294)
+||+++++|.+++.+. ..++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999753 4589999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~ 250 (294)
.....++..|+|||.+....+ +.++|+||||+++|+|++ |..||...........+... ..+.+..++..+.+++.+
T Consensus 161 ~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05148 161 SSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLE 239 (261)
T ss_pred ccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHH
Confidence 112234568999999877665 788999999999999998 89999887777666666544 345567889999999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 022617 251 MLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~ 267 (294)
||+.+|++|||+.+|++
T Consensus 240 ~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 240 CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HcCCCchhCcCHHHHHH
Confidence 99999999999999876
No 262
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.4e-41 Score=289.15 Aligned_cols=262 Identities=27% Similarity=0.345 Sum_probs=219.0
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.....|...+.||.|++|.||++.+..++..+++|.+.............+.+|++++++++|+|++++++++......+
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 44566899999999999999999999899999999987654444455677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
+++||+.| +|.+.+.. ..++++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99999976 77777754 466899999999999999999999999999999999999999999999999987654322
Q ss_pred cccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--cCCCCCChhHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li 248 (294)
....++..|+|||.+.. ....+.++|+||+|+++|+|++|..||...........+..... .....++..+.+++
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 23456788999998742 22237889999999999999999999987766555555544332 22346788999999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~ 279 (294)
.+||+.+|.+||++.++++|+|+....+...
T Consensus 258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 258 DSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred HHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 9999999999999999999999977655543
No 263
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=4.4e-42 Score=288.70 Aligned_cols=257 Identities=32% Similarity=0.590 Sum_probs=215.9
Q ss_pred CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (294)
+|++.+.||.|++|.||.|.+. .++..|++|++...... .......+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 47889999998654322 222346678899999999 589999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH- 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~- 171 (294)
++++||+.+++|.+++....++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987653322
Q ss_pred -ccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGAR 245 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
......++..|+|||.+.... ..+.++|+||||+++|+|++|..||... ........+.....+.+..++..+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence 122344778999999986532 2367899999999999999999999643 2344455555555666778899999
Q ss_pred HHHHHhcccCCCCCC-----CHhHHhcCCccccc
Q 022617 246 DLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH 274 (294)
Q Consensus 246 ~li~~~l~~~p~~Rp-----s~~~il~h~~~~~~ 274 (294)
+++.+||+.+|++|| ++.++++||||+..
T Consensus 241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 999999999999997 89999999999875
No 264
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=4.4e-42 Score=284.32 Aligned_cols=247 Identities=26% Similarity=0.478 Sum_probs=210.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
-.++|++.+.||.|++|.||+|.+. ++..+++|.+.... ...+.+.+|+.++++++|+|++++++.+...+..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 3568999999999999999999975 56679999875432 235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++|++.+++|.+++.+. ..++...+..++.|++.++.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999999753 4588899999999999999999999999999999999999999999999999976544322
Q ss_pred c--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 248 (294)
. ....++..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+.... .+....++.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 1 12234567999999877665 788999999999999998 999998877777666665443 344457889999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||..+|++|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999875
No 265
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=1e-41 Score=289.42 Aligned_cols=258 Identities=26% Similarity=0.336 Sum_probs=214.4
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...+.|...+.||.|++|+||+|.+..+++.+++|++.............+.+|+++++.++|+|++++++++......+
T Consensus 18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 34445778889999999999999999899999999987655444445567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
+++||+.+ ++.+++.. ..++++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 98 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 98 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred EEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 99999965 78777765 45689999999999999999999999999999999999999999999999998764322
Q ss_pred cccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-cc-CCCCCChhHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YT-LPSHLSPGARDLI 248 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li 248 (294)
.....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+.... .. ....++..+.+++
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV 253 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 234457789999999742 2223678999999999999999999998766555444443322 22 2235678899999
Q ss_pred HHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 249 PRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.+||+.+|.+||++.++++||||+..-
T Consensus 254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 254 DYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999999998743
No 266
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=7e-42 Score=287.17 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=212.0
Q ss_pred cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
-.++|++.+.||.|++|.||+|.++. .+..+++|.+.... .......+.+|+.+++.++|+|++++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45789999999999999999997652 34579999875432 222345678899999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEe
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIA 159 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~ 159 (294)
+..++++||+.+++|.+++.+.. ..+...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567888999999999999999999999999999999999999999
Q ss_pred eecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-Cc
Q 022617 160 DFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IY 234 (294)
Q Consensus 160 dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~ 234 (294)
|||++........ .....++..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+... ..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL 240 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999875433221 111234567999999887666 789999999999999998 89999888877776665543 34
Q ss_pred cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc------CCcccc
Q 022617 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA 273 (294)
Q Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~------h~~~~~ 273 (294)
..+..++..+.+++.+||+.+|++|||+.++++ ||||++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 556678899999999999999999999999987 888865
No 267
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=4.2e-42 Score=284.67 Aligned_cols=247 Identities=27% Similarity=0.475 Sum_probs=207.4
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...++|++.+.||.|++|.||+|.+..+ ..+++|.+..... ....+.+|++++++++|+|++++++.+. ....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3457899999999999999999998755 4699999864332 2356888999999999999999999875 45689
Q ss_pred EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++||+++++|.+++.+. ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999753 357899999999999999999999999999999999999999999999999987654332
Q ss_pred cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
.. ....++..|+|||...+..+ +.++|+||||+++|++++ |..||...........+.... .+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 21 12334567999999877766 789999999999999999 899998877766666665432 34456789999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||+.+|++||++.+++.
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999887
No 268
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=7.2e-42 Score=282.45 Aligned_cols=241 Identities=25% Similarity=0.426 Sum_probs=204.0
Q ss_pred cccccCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 24 TLGIGSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
.||+|+||.||+|.+ ..++..+++|++.... ......+.+.+|+.+++.+.|+|++++++++. .+..++++||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 4567889999986443 23345678899999999999999999999875 4567899999999
Q ss_pred CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----cccc
Q 022617 102 GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSC 177 (294)
Q Consensus 102 ~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~ 177 (294)
++|.+++.+...+++..+..++.|++.++.+||+.|++|+||+|.||+++.++.++|+|||.+......... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999988788999999999999999999999999999999999999999999999999998765433211 1112
Q ss_pred CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccC
Q 022617 178 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 178 ~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~ 255 (294)
++..|+|||.+..... +.++|+||||+++|+|++ |..||...........+..+. .+.+..++.++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 3468999999876655 789999999999999998 999998877777777776544 4566789999999999999999
Q ss_pred CCCCCCHhHHhc
Q 022617 256 PMKRITIPEIRQ 267 (294)
Q Consensus 256 p~~Rps~~~il~ 267 (294)
|++||++.+|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999998865
No 269
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=6.7e-42 Score=286.58 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=209.8
Q ss_pred ccCCcccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.++|++.+.||+|+||.||+|.+. .++..+++|.+.... .......+.+|+.++++++|+|++++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 367999999999999999999853 355789999986432 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHh-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617 92 IYVVMEYVKSGELFDYIVEK-----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~-----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~ 154 (294)
.++++||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 99999999999999998532 2377888999999999999999999999999999999999999
Q ss_pred cEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617 155 NVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 155 ~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 230 (294)
.++|+|||++....... ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.......+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999987653322 1222334567999999877665 789999999999999998 999998877666666655
Q ss_pred CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
... .+.+..++..+.+++.+||+.+|.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45567789999999999999999999999999874
No 270
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=9e-42 Score=281.65 Aligned_cols=243 Identities=28% Similarity=0.543 Sum_probs=211.6
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.. .++.+++|.+..... ..+.+.+|+.++++++|+|++++++++......+++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 56899999999999999999986 478899999864432 457788999999999999999999999988999999
Q ss_pred EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
+|++++++|.+++.... .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999999997665 689999999999999999999999999999999999999999999999999876633222
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHh
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 251 (294)
....+..|+|||.+....+ +.++|+||||++++++++ |..||...........+... ....+..++..+.+++.+|
T Consensus 158 -~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC 235 (256)
T ss_pred -cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence 2334567999999876666 689999999999999997 99999888877777766554 3445567899999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 022617 252 LIVDPMKRITIPEIRQ 267 (294)
Q Consensus 252 l~~~p~~Rps~~~il~ 267 (294)
|..+|++|||+.++++
T Consensus 236 l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 236 WELDPAKRPTFKQLRE 251 (256)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999986
No 271
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=1e-41 Score=281.46 Aligned_cols=241 Identities=26% Similarity=0.445 Sum_probs=204.3
Q ss_pred ccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617 23 KTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
+.||.|++|.||+|.+...+ ..+++|.+...... .....+.+|+++++++.|+|++++++++. .+..++++||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998755433 34567889999999999999999999876 45689999999
Q ss_pred CCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc----c
Q 022617 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----T 175 (294)
Q Consensus 100 ~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~----~ 175 (294)
.+++|.+++.+...+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999887889999999999999999999999999999999999999999999999999987654332211 1
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcc
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 253 (294)
..++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+.......+.... .+.+..++..+.+++.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 112357999999877766 789999999999999998 999998887777766665543 35566788999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 022617 254 VDPMKRITIPEIRQ 267 (294)
Q Consensus 254 ~~p~~Rps~~~il~ 267 (294)
.+|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999876
No 272
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=4.7e-42 Score=291.91 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=208.2
Q ss_pred ccCCcccccccccCceEEEEEEEccCCce----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHK----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
..+|++.+.||+|+||.||+|.+..++.. |++|++... ........+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35799999999999999999998666554 899987533 2234457788999999999999999999998764 5
Q ss_pred EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.+++++++.+++|.+++... ..++...++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 67999999999999999764 45889999999999999999999999999999999999999999999999999865432
Q ss_pred Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
... .....+..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+.... .+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 221 12223567999999987766 789999999999999998 999998877766655554433 455667889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcC
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h 268 (294)
+++.+||..+|.+||++.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999885
No 273
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=5.3e-42 Score=316.06 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=206.1
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||+|.+..+++.|++|++...........+.+.+|++++++++|||++++++++..++..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 37899999999999999999999999999999998755434444567789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 96 MEYVKSGELFDYIVEK-----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~-----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
|||++|++|.+++.+. ...+...+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23456678899999999999999999999999999999999999999999998
Q ss_pred ccccCC-------------------CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 022617 165 NIMRDG-------------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNL 225 (294)
Q Consensus 165 ~~~~~~-------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~ 225 (294)
...... .......+++.|+|||.+.+..+ +.++||||||+++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 755211 01112358999999999987776 7899999999999999999999977554333
Q ss_pred HHHHh-CCCc--cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 226 FKKIK-GGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 226 ~~~~~-~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..... .... .....++..+.+++.+||..||++||+..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22211 1111 112467889999999999999999987655443
No 274
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=2.1e-43 Score=303.45 Aligned_cols=255 Identities=29% Similarity=0.543 Sum_probs=221.2
Q ss_pred ccCC-cccccccccCceEEEEEEEccCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe--
Q 022617 16 LPNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD-- 91 (294)
Q Consensus 16 ~~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 91 (294)
.++| +....||+|.|-+||+|.|..+|..||--.+....+. .....+.+..|+.+|+.|+|+||++++++|.+...
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 3444 4578999999999999999999998886655444333 33456899999999999999999999999987654
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecC-CCcEEEeeeccccccc
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDS-KWNVKIADFGLSNIMR 168 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~-~~~~~l~dfg~~~~~~ 168 (294)
+.+|+|.+..|+|..++++.+.++...++.|++||+.+|.|||++. |+|||||.+||+|+. .|.|||+|+|+|+...
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999999999999999999999999999999886 999999999999986 5899999999999887
Q ss_pred CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCcc--CCCCCChhHH
Q 022617 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYT--LPSHLSPGAR 245 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~--~~~~~~~~l~ 245 (294)
.+.... ..|||.|||||.+. ..| +...||||||++|+||.|+..||.. .+...+.+++..+..+ +..--.++++
T Consensus 198 ~s~aks-vIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 198 KSHAKS-VIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred ccccce-eccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 766554 78999999999987 445 7899999999999999999999975 6677788888777643 3344578999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+||.+||.. .++|||+.|+|+||||...
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999 9999999999999999885
No 275
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=7.8e-42 Score=287.32 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=209.7
Q ss_pred ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.++|.+.+.||.|++|.||+|.+.. ++..+++|.+.... ....+.+.+|+..+++++|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 4578999999999999999998542 44568888874332 233567889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~ 154 (294)
..++++||+++++|.+++.... .+++..++.++.|++.++.+||+.|++|+||+|+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999997543 378899999999999999999999999999999999999999
Q ss_pred cEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 155 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 230 (294)
.++|+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.........+.+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999875533221 122345678999999887665 789999999999999998 999998888777777666
Q ss_pred CCCc-cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 231 GGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 231 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+.. ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6553 345567899999999999999999999999977
No 276
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=5.6e-42 Score=287.04 Aligned_cols=249 Identities=24% Similarity=0.408 Sum_probs=211.2
Q ss_pred ccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
..+|++.+.||.|++|.||+|.+..+ ++.+++|++.... .......+.+|..+++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45789999999999999999987543 5789999986442 2234567889999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW 154 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~ 154 (294)
..++++||+.+++|.+++... ..++...++.++.|++.||.+||+.|++|+||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 999999999999999998532 3478888999999999999999999999999999999999999
Q ss_pred cEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 022617 155 NVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 155 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~ 230 (294)
.++|+|||++........ .....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....+..+.+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999998775433221 123345678999999877666 789999999999999998 889998888888777776
Q ss_pred CCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 231 GGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 231 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
... .+.+..++.++.+++.+||+.+|.+||++.+|+.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 655 3456789999999999999999999999999987
No 277
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=6.3e-42 Score=287.10 Aligned_cols=250 Identities=33% Similarity=0.516 Sum_probs=205.5
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC---CCCceeEEEEEEEcCCe----
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF---MHPHIIRLYEVIETPSD---- 91 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---- 91 (294)
|++.+.||.|++|.||+|.++.+++.+++|.+......+ .....+.+|+.+++++ .|+|++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 788999999999999999998889999999986543222 2234556677776655 59999999999987776
Q ss_pred -EEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 92 -IYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 92 -~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
.++++|++.+ +|.+++.+.. .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8999887643 48999999999999999999999999999999999999999999999999987765
Q ss_pred CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc--------------
Q 022617 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-------------- 234 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 234 (294)
.........++..|+|||.+.+... +.++|+||+|+++|+|++|..||......+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237 (287)
T ss_pred CCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccc
Confidence 4433344456788999999987766 7899999999999999999999987766555544432100
Q ss_pred -------------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 -------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 -------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
......+..+.+++.+||+.||++||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0001345778899999999999999999999999997
No 278
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=2.2e-42 Score=289.19 Aligned_cols=251 Identities=31% Similarity=0.568 Sum_probs=210.2
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
|++.+.||.|++|.||+|.+..+++.+++|++.... ........+..|+.++++++|+|++++++++...+..++++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999987654 2223356778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (294)
Q Consensus 99 ~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 176 (294)
+++ +|.+++.+. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 975 999999876 579999999999999999999999999999999999999999999999999987654332 22334
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--------------------c--
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------------Y-- 234 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------------~-- 234 (294)
..+..|+|||.+.+....+.++|+||||++++++++|..||...........+.... .
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07829 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK 238 (282)
T ss_pred ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence 456789999998766444789999999999999999999998766554443332100 0
Q ss_pred -------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 -------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
...+..+..+.+++.+||..+|++||+++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0012347789999999999999999999999999998
No 279
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=5.2e-42 Score=294.20 Aligned_cols=258 Identities=34% Similarity=0.521 Sum_probs=210.1
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC--C
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP--S 90 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~ 90 (294)
.+.++|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++ +|+||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 467899999999999999999999988899999998854322 223345677899999999 999999999998643 4
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++|++++ +|..++.+. .+++...+.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 68999999975 999988665 7889999999999999999999999999999999999999999999999988755332
Q ss_pred C------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------
Q 022617 171 H------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------- 233 (294)
Q Consensus 171 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 233 (294)
. ......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...........+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 2 12233567889999988665555789999999999999999999997654433322211100
Q ss_pred --------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 234 --------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 --------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
......++.++.+++.+||+.+|++|||+.++++||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 01113468899999999999999999999999999999775
No 280
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-43 Score=307.98 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=215.5
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCC
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGE 103 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~s 103 (294)
+||+|.||+||-|+|.++...++||.+.... ....+.+.+|+.+.++|+|.||++++|.+.+++.+-+.||..+|||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6899999999999999999999999985432 2346889999999999999999999999999999999999999999
Q ss_pred hHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccccccc-CCCccccccC
Q 022617 104 LFDYIVEK-GRL--QEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMR-DGHFLKTSCG 178 (294)
Q Consensus 104 L~~~l~~~-~~l--~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~-~~~~~~~~~~ 178 (294)
|.+++.+. +|+ ++..+..+.+||+++|.|||+..|+|+|||-.||+|+. .|.+||+|||-+.... -.....+..|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 99999765 677 78899999999999999999999999999999999975 6889999999887653 3344566779
Q ss_pred CCcccCCcccc-CCccCCCchhHHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHh-CCCccCCCCCChhHHHHHHHhccc
Q 022617 179 SPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFKKIK-GGIYTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 179 ~~~~~aPE~~~-~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~--~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~ 254 (294)
|..|||||++. +...++.++|||||||++.||.||++||... ....+.+.=+ +.-+++|..++.+.+.||.+|+.+
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFep 818 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEP 818 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence 99999999985 4444588999999999999999999999753 3444444322 333678889999999999999999
Q ss_pred CCCCCCCHhHHhcCCccccc
Q 022617 255 DPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 255 ~p~~Rps~~~il~h~~~~~~ 274 (294)
+|.+||++.++|..||++..
T Consensus 819 d~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 819 DPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CcccCccHHHhccCcccccC
Confidence 99999999999999999887
No 281
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=9.1e-42 Score=284.80 Aligned_cols=251 Identities=25% Similarity=0.382 Sum_probs=212.2
Q ss_pred ccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 88 (294)
...++|++.+.||.|++|.||++.+...+ ..+++|.+.... .......+.+|+.+++.++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 34578999999999999999999986443 789999975432 22334677889999999999999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKG----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l 158 (294)
....++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999999996432 3677889999999999999999999999999999999999999999
Q ss_pred eeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-
Q 022617 159 ADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI- 233 (294)
Q Consensus 159 ~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~- 233 (294)
+|||.+........ .....++..|+|||.+.+... +.++||||||+++|++++ |..||...+.....+.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99999875543321 122335678999999876665 789999999999999998 999998888777777666443
Q ss_pred ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 234 YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 234 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
...+..++..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4567778999999999999999999999999986
No 282
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=2.8e-42 Score=288.64 Aligned_cols=251 Identities=34% Similarity=0.559 Sum_probs=210.7
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|++++++++|+|++++++++..++..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999989999999998655432 23456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccccc
Q 022617 99 VKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTS 176 (294)
Q Consensus 99 ~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 176 (294)
+++ +|.+++.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 976 88888865 3578999999999999999999999999999999999999999999999999987665443 22334
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------------
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------------- 233 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------------- 233 (294)
.++..|+|||.+.+....+.++|+||||+++|++++|+.||...+..+....+....
T Consensus 159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05118 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238 (283)
T ss_pred cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence 567789999998776444889999999999999999999998766554433321110
Q ss_pred -------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 -------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
....+.++.++.++|.+||+.||.+||++.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00113467889999999999999999999999999997
No 283
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=8e-42 Score=289.44 Aligned_cols=256 Identities=27% Similarity=0.345 Sum_probs=213.8
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
....|+..+.||.|++|.||+|.+..+++.+++|.+.............+.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 45568899999999999999999998999999999865443344445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 95 VMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
++||+.+ ++.+.+.. ..++++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9999975 88777654 456899999999999999999999999999999999999999999999999988754332
Q ss_pred ccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c-CCCCCChhHHHHHH
Q 022617 174 KTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIP 249 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~ 249 (294)
....++..|+|||.+.+ ....+.++||||||+++|+|++|..||...........+..... . ....++..+.++|.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 248 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD 248 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHH
Confidence 23356789999998742 22236789999999999999999999977665554444433332 2 23468889999999
Q ss_pred HhcccCCCCCCCHhHHhcCCccccc
Q 022617 250 RMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+||+.+|++||++.++++|||+...
T Consensus 249 ~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 249 SCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999874
No 284
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=6.5e-42 Score=292.51 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=203.6
Q ss_pred ccccccc--CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617 22 GKTLGIG--SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 22 ~~~lg~g--~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
.+.||.| ++++||+|.+..+++.|++|++....... ...+.+.+|+.+++.++|+||+++++++...+..++++||+
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence 4567776 88999999999999999999987554333 34578899999999999999999999999999999999999
Q ss_pred CCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-----
Q 022617 100 KSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----- 172 (294)
Q Consensus 100 ~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----- 172 (294)
.+++|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999998764 3489999999999999999999999999999999999999999999999975432211110
Q ss_pred ---cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC---------------
Q 022617 173 ---LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--------------- 233 (294)
Q Consensus 173 ---~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 233 (294)
.....++..|+|||++.+.. ..+.++||||+|+++|+|++|..||................
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEES 241 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhh
Confidence 01112345699999987642 23688999999999999999999997765433332221111
Q ss_pred --------------------------------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 234 --------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 234 --------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
.+.+..++..+.+++.+||+.||++|||+.++++||||++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 242 RMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 01112356789999999999999999999999999999886543
No 285
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=1.4e-41 Score=287.92 Aligned_cols=253 Identities=27% Similarity=0.459 Sum_probs=212.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEE
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLY 83 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 83 (294)
.....++|.+.+.||+|+||.||+|.+.. +...+++|.+.... .......+.+|+++++++ +|+|+++++
T Consensus 13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34556899999999999999999998643 22469999986442 223356788899999999 799999999
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617 84 EVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (294)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n 147 (294)
+++...+..++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 91 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 99999999999999999999999997542 37888999999999999999999999999999999
Q ss_pred eEecCCCcEEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617 148 LLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (294)
Q Consensus 148 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~ 223 (294)
|+++.++.++|+|||.+......... .....+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999998755432211 11223467999999887666 789999999999999998 89999888877
Q ss_pred HHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 224 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+....+.... ...+..++.++.+++.+||..+|++|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 7777666554 3556778999999999999999999999999987
No 286
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=5.9e-42 Score=288.74 Aligned_cols=263 Identities=29% Similarity=0.424 Sum_probs=212.4
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (294)
.-.++|++.+.||.|++|.||+|.+..+++.+++|.+...... .....+..|+.++.+.. |+|++++++++......
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 3457899999999999999999999988999999998654322 23455666776666664 99999999999999999
Q ss_pred EEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 93 YVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
++++|++.+ ++.+++.. ..++++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999954 78887765 4578999999999999999999997 59999999999999999999999999998765544
Q ss_pred CccccccCCCcccCCccccCCc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCC-ccCC--CCCChh
Q 022617 171 HFLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGI-YTLP--SHLSPG 243 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~-~~~~--~~~~~~ 243 (294)
.......++..|+|||.+.+.. ..+.++|+||||+++|+|++|+.||..... .+....+.... ...+ ..++.+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHH
Confidence 4334445678899999986543 236789999999999999999999976322 23333333322 2222 347889
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~ 279 (294)
+.+++.+||..+|++||++++++.||||+...+...
T Consensus 249 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284 (296)
T ss_pred HHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence 999999999999999999999999999987655443
No 287
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=5.8e-42 Score=286.87 Aligned_cols=250 Identities=36% Similarity=0.523 Sum_probs=206.9
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEe
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e 97 (294)
|++.+.||.|++|+||+|.+..+++.+++|.+...... .......+|+..+++++ |+|++++++++...+..++++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999888999999997644321 12234456889999999 9999999999999999999999
Q ss_pred ccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc
Q 022617 98 YVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 175 (294)
|+ +++|.+.+.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 99 669999887654 789999999999999999999999999999999999999999999999999876655444445
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC----------------------
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---------------------- 233 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~---------------------- 233 (294)
..++..|+|||.+......+.++|+||||+++++|++|+.||......+....+....
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 5678889999988655445789999999999999999999997665443332221100
Q ss_pred --------ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 234 --------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 234 --------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.......+..+.+++.+||+.+|++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00112336789999999999999999999999999997
No 288
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-43 Score=301.34 Aligned_cols=253 Identities=25% Similarity=0.419 Sum_probs=212.4
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
.+-++..++..+.+.||+|.||+||+|.+- -.||||++....... +..+.++.|+.++++-+|.||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 445677888999999999999999999974 359999998776555 4789999999999999999999999999888
Q ss_pred CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
.. .||+.+|+|.+|..++.-. ..+.....+.|++|+++++.|||.++|+|+|+|..||++.++++|+|+|||++....
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 77 8999999999999998533 458889999999999999999999999999999999999999999999999987543
Q ss_pred ---CCCccccccCCCcccCCccccC--CccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----ccCCC
Q 022617 169 ---DGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPS 238 (294)
Q Consensus 169 ---~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~ 238 (294)
.........+...|+|||++.. ....+..+|+|++|+++|||++|.+||.....+.++-.+-.+. .....
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhc
Confidence 2222233447789999999752 2333789999999999999999999999655555444443332 22335
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.++.++++|+..||++++++||.+.+||.
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 78899999999999999999999999987
No 289
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=6.8e-42 Score=294.20 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=211.7
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-- 89 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 89 (294)
+..+.++|.+.+.||+|++|.||+|.+..+++.|++|++..... .......+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 35677999999999999999999999988999999999865322 223356678899999999999999999987532
Q ss_pred ----CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 90 ----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 90 ----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
+..+++++++ +++|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3478888887 6699888754 468999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------------
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------ 233 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 233 (294)
..... .....++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+.......+....
T Consensus 169 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 169 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 64332 2234567889999998664444788999999999999999999997655443332221100
Q ss_pred -----------cc--------CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCcc
Q 022617 234 -----------YT--------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 278 (294)
Q Consensus 234 -----------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~ 278 (294)
.. .....+.++.++|.+||..||.+||++.++++||||++...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 00 0123577899999999999999999999999999999866544
No 290
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=1.8e-41 Score=282.33 Aligned_cols=248 Identities=26% Similarity=0.452 Sum_probs=207.0
Q ss_pred CcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe----
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD---- 91 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 91 (294)
|++.+.||.|+||.||.|.+..+ +..+++|.+...... ......+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987654 378999998654332 2345678999999999999999999998765443
Q ss_pred --EEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 92 --IYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 92 --~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
.++++||+.+++|..++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+|||.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988542 3589999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCC
Q 022617 164 SNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPS 238 (294)
Q Consensus 164 ~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~ 238 (294)
+......... .....+..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+..+ ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8765433221 11224568999999876655 789999999999999999 99999887777776666544 355667
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.++..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999873
No 291
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=1.5e-41 Score=286.23 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=208.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCC----------------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTG----------------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 79 (294)
.++|++.+.||.|+||.||+|.+...+ ..+++|.+..... ......+.+|++++++++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 4578998764432 2446788899999999999999
Q ss_pred eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
+++++++......++++|++.+++|.+++.+.. .+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999997765 689999999999999999999999999999999999
Q ss_pred EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 022617 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~ 223 (294)
+++.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ +..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875533321 122335678999999877665 789999999999999998 78888776666
Q ss_pred HHHHHHhCC--------CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 224 NLFKKIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 224 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
......... ....+..++.++.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 655554322 12334567889999999999999999999999975
No 292
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=1.7e-41 Score=280.65 Aligned_cols=247 Identities=27% Similarity=0.484 Sum_probs=208.2
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...++|++.+.||.|++|.||+|.+. .+..+++|.+...... ...+.+|+.++++++|+|++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999876 5667999998654332 356889999999999999999999875 45688
Q ss_pred EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++||+.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998753 358999999999999999999999999999999999999999999999999987654322
Q ss_pred cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHH
Q 022617 172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 247 (294)
.. ....++..|+|||.+.+... +.++|+||||+++|++++ |..||...+..+....+... ..+.+...+..+.++
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11 11223457999999876665 789999999999999999 99999887777777766543 345566789999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++|||+.++++
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999875
No 293
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=2.1e-41 Score=279.52 Aligned_cols=246 Identities=31% Similarity=0.512 Sum_probs=211.8
Q ss_pred CcccccccccCceEEEEEEEccCC----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTG----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
+++.+.||.|++|.||++.+...+ ..+++|.+..... ......+.+|+.+++.++|+|++++++++...+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467889999999999999998766 8899999854432 2256788999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++|++.+++|.+++..... +++..++.++.|++.++++||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976544 89999999999999999999999999999999999999999999999999876654422
Q ss_pred ccc--ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHH
Q 022617 173 LKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~~~--~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 248 (294)
... ..++..|+|||.+.+..+ +.++|+||||+++++|++ |..||.........+.+.... ...+..++.++.+++
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLM 237 (258)
T ss_pred cccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHH
Confidence 221 235678999999866555 789999999999999998 899998877777777665544 445567899999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||+.+|++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999986
No 294
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=1.9e-41 Score=281.91 Aligned_cols=242 Identities=26% Similarity=0.442 Sum_probs=200.7
Q ss_pred ccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEEecc
Q 022617 23 KTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
+.||.|++|.||+|.+..++. .+++|.+... ........+.+|+++++++ .|||++++++++...+..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999987775 4577876422 2234456788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 100 KSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 100 ~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
.+++|.+++..+. .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999996543 378899999999999999999999999999999999999999999999998
Q ss_pred cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCC
Q 022617 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLS 241 (294)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 241 (294)
+..............+..|+|||.+....+ +.++|+||||+++|+|++ |..||...+.......+... ....+..++
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCD 237 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCC
Confidence 753321111111223557999999876665 789999999999999997 99999887777766666543 344556788
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.++.+++.+||..+|.+|||+.+++.
T Consensus 238 ~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 238 DEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999999999999999986
No 295
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=1.5e-41 Score=280.96 Aligned_cols=247 Identities=28% Similarity=0.508 Sum_probs=209.2
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...++|++.++||.|++|.||+|.+. +++.+++|.+...... ...+.+|+.++++++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 46788999999999999999999875 5778999998644322 357888999999999999999999874 46789
Q ss_pred EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++|++.+++|.+++... ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 358899999999999999999999999999999999999999999999999987654222
Q ss_pred c--cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
. .....++..|+|||.+..... +.++|+||||+++|++++ |+.||...+.......+.... .+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 112234568999999877665 789999999999999998 999998887777766665443 45566788999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999876
No 296
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=2.1e-41 Score=289.14 Aligned_cols=257 Identities=32% Similarity=0.502 Sum_probs=209.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-CCe
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-PSD 91 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 91 (294)
-.+.++|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|||++++.+++.. .+.
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3467899999999999999999999999999999998764422 22345678889999999999999999999865 567
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
.++++|+++ ++|.+++. ..++++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 85 ~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~- 161 (328)
T cd07856 85 IYFVTELLG-TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ- 161 (328)
T ss_pred EEEEeehhc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence 899999994 58988875 456888999999999999999999999999999999999999999999999998754322
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--------------------
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-------------------- 231 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 231 (294)
.....++..|+|||.+.+....+.++|+||||+++|++++|..||...........+..
T Consensus 162 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 162 -MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred -cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 22345677899999986644447899999999999999999999976554221111100
Q ss_pred ----C--Ccc-----CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 232 ----G--IYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 232 ----~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
. ... ....++..+.++|.+||+.+|++||++.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 0 000 113567899999999999999999999999999999764
No 297
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=1.8e-41 Score=280.57 Aligned_cols=248 Identities=27% Similarity=0.478 Sum_probs=212.1
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...++|.+.+.||.|++|.||+|.+. +++.+++|.+..... ..+.+.+|+.++++++|+|++++++++......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45679999999999999999999976 557799999865432 2467889999999999999999999999889999
Q ss_pred EEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++|++++++|.+++.+.. .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 68999999999999999999999999999999999999999999999999987654321
Q ss_pred cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
.. .....+..|+|||.+.+... +.++|+||+|++++++++ |+.||.+.........+.... .+.+...+.++.++
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11 12223567999999887665 789999999999999998 999998888777777766543 45566789999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||+.+|++||++.++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999875
No 298
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=1.6e-41 Score=282.60 Aligned_cols=248 Identities=27% Similarity=0.471 Sum_probs=205.4
Q ss_pred CcccccccccCceEEEEEEEccCCc--eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------C
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S 90 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (294)
|.+.+.||.|++|.||+|.+..++. .+++|.+.... ........+.+|+.+++.++|+||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4678999999999999999877665 58999886542 2334467788999999999999999999986432 3
Q ss_pred eEEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 91 DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
..++++||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||.+
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 468999999999999987431 34789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCC
Q 022617 165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSH 239 (294)
Q Consensus 165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 239 (294)
........ ......++.|++||...+..+ +.++|+||||+++|++++ |..||...........+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76543321 112234668999999887766 789999999999999999 899998877777666666543 355677
Q ss_pred CChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 240 LSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
++..+.+++.+||+.+|++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
No 299
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=1.9e-41 Score=283.39 Aligned_cols=248 Identities=28% Similarity=0.449 Sum_probs=208.1
Q ss_pred ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
..+|++.+.||.|+||.||++... .++..+++|.+.... ......+.+|+++++.++|+||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 467899999999999999999743 345678889875332 234568899999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617 91 DIYVVMEYVKSGELFDYIVEKG---------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~---------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~ 155 (294)
..++++||+.+++|.+++.+.+ .+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 9999999999999999997643 3788999999999999999999999999999999999999999
Q ss_pred EEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617 156 VKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (294)
Q Consensus 156 ~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~ 231 (294)
++|+|||++........ .....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999865432221 112234578999999887766 789999999999999998 9999987776666665554
Q ss_pred CC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 232 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.. ...+..++..+.+++.+||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 43 4456678999999999999999999999999975
No 300
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=1.1e-41 Score=286.04 Aligned_cols=259 Identities=32% Similarity=0.555 Sum_probs=215.6
Q ss_pred CCcccccccccCceEEEEEEEc---cCCceEEEEEeeccccc-chHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHA---LTGHKVAIKILNRRKIK-NMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 92 (294)
+|++.+.||.|++|.||++.+. .+++.+++|++...... .......+.+|++++.++ +|+|++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 46688999998654322 223456778899999999 589999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++++||+.+++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999998876533221
Q ss_pred --cccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhCCCccCCCCCChhHH
Q 022617 173 --LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGAR 245 (294)
Q Consensus 173 --~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
.....++..|++||.+.+.. ..+.++|+||||+++|+|++|..||... ......+.+.....+.+..++.++.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 240 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence 22234688999999986554 2368899999999999999999999643 2334444555555666778899999
Q ss_pred HHHHHhcccCCCCCCC---HhHHhcCCcccccCC
Q 022617 246 DLIPRMLIVDPMKRIT---IPEIRQHPWFQAHLP 276 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps---~~~il~h~~~~~~~~ 276 (294)
+++.+||+.+|++||| +.++++||||+....
T Consensus 241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999999999999998 567899999988643
No 301
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=9.7e-42 Score=292.95 Aligned_cols=258 Identities=32% Similarity=0.498 Sum_probs=209.0
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--- 89 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (294)
..+.++|.+.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred hccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 3557899999999999999999999988999999999865422 223345678999999999999999999988654
Q ss_pred ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
...++++|++.. +|.+++ ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 346899999964 777665 34689999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------
Q 022617 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------- 233 (294)
Q Consensus 167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 233 (294)
.... .....++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+....
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 4322 2233567789999998764444789999999999999999999998766443333221100
Q ss_pred ----------c--------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 234 ----------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 234 ----------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
. ...+..+..+.++|.+||+.||++||++.+++.||||+...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 001246778999999999999999999999999999988644
No 302
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=1.9e-41 Score=281.81 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=210.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
.++|++.+.||.|++|.||+|.+..+++ .|++|.+.... .......+..|+.++++++|||++++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3568999999999999999999876664 59999986432 234457889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++||+++++|.+++... +.++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999998753 568999999999999999999999999999999999999999999999999886543322
Q ss_pred cccc---cc---CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChh
Q 022617 172 FLKT---SC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPG 243 (294)
Q Consensus 172 ~~~~---~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 243 (294)
.... .. .+..|+|||.+.+..+ +.++|+||+|+++|++++ |..||.........+.+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 1111 11 1347999999887766 789999999999999886 99999888777777766544 24555678999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 022617 244 ARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
No 303
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=1.1e-41 Score=286.56 Aligned_cols=255 Identities=27% Similarity=0.472 Sum_probs=213.6
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE 84 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 84 (294)
..+.-.++|++.+.||+|++|.||++.+.... ..+++|.+.... .......+.+|+++++++ +|+|++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34555678999999999999999999876433 679999886432 223346788999999999 7999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 85 VIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
++...+..++++||+.+++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 3588999999999999999999999999999999999
Q ss_pred EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~ 224 (294)
+++.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|++++ |..||.......
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999876543321 112224567999999877666 789999999999999997 999998887777
Q ss_pred HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
....+.... ...+..++..+.+++.+||..+|++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 777665544 34566788999999999999999999999999874
No 304
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=3.2e-41 Score=283.43 Aligned_cols=247 Identities=30% Similarity=0.465 Sum_probs=206.7
Q ss_pred CCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
+|++.+.||.|+||.||+|.+... ...+++|.+.... .......+.+|+.+++.+.||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 588999999999999999987532 2468888875432 123356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 93 YVVMEYVKSGELFDYIVEK------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~------------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
++++||+.+++|.+++... .+++...++.++.|++.++.+||+.|++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2478889999999999999999999999999999999
Q ss_pred EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~ 224 (294)
++++++.++|+|||++........ ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432221 122234568999999876665 789999999999999998 999998888777
Q ss_pred HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+.+.... ...+..++.++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 776665432 4456678999999999999999999999999987
No 305
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=3.3e-41 Score=281.79 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=208.2
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
..+|++.+.||.|++|+||+|.+..+++ .|++|++.... .......+.+|+.+++.+.|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 4689999999999999999999876666 47899875432 23345678899999999999999999999875 45
Q ss_pred EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.+++++++++++|.+++..+ +.+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 77899999999999999764 56899999999999999999999999999999999999999999999999998765432
Q ss_pred Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
... .....+..|+|||...+..+ +.++||||||+++|++++ |..||...........+.... .+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221 12234568999999877766 789999999999999998 999998877766666555543 455667899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~ 267 (294)
+++.+||..||++||++.++++
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999985
No 306
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=3.3e-41 Score=278.97 Aligned_cols=246 Identities=28% Similarity=0.476 Sum_probs=206.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
..++|.+.+.||.|++|.||+|.+..+ ..+++|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 457899999999999999999998654 4689998754332 2356788999999999999999998875 456889
Q ss_pred EEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
+|||+.+++|.+++.+. ..++...+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999999754 3478999999999999999999999999999999999999999999999999876543221
Q ss_pred c--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHH
Q 022617 173 L--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLI 248 (294)
Q Consensus 173 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 248 (294)
. ....++..|+|||...+... +.++|+||||+++|+|++ |..||...........+... ..+.+...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 1 12234567999998877665 789999999999999999 99999887777766666544 2345567899999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 022617 249 PRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 249 ~~~l~~~p~~Rps~~~il~ 267 (294)
.+||..+|++||+++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999886
No 307
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=2.5e-42 Score=309.44 Aligned_cols=260 Identities=24% Similarity=0.424 Sum_probs=195.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCc-eEEEE--------------EeecccccchHHHHHHHHHHHHHHhCCCC
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGH-KVAIK--------------ILNRRKIKNMEMEEKVRREIKILRLFMHP 77 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~-~~~~K--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~ 77 (294)
+.+.++|++.+.||+|+||+||+|..+.... ..+.| .+.............+.+|+.++++++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 4566899999999999999999987643221 11122 11111111223456688999999999999
Q ss_pred ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC
Q 022617 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS 152 (294)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~ 152 (294)
||+++++++...+..+++++++.+ +|.+++... .......++.++.|++.||.|||+.||+|+||||+||+++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999955 777776432 12346678889999999999999999999999999999999
Q ss_pred CCcEEEeeecccccccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCC--H-HHHH
Q 022617 153 KWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDEN--I-PNLF 226 (294)
Q Consensus 153 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~--~-~~~~ 226 (294)
++.++|+|||++....... ......++..|+|||++.+..+ +.++||||||+++|+|++|..+ +.... . ..+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 9999999999997664332 2223568999999999988776 7899999999999999997754 43221 1 1121
Q ss_pred HHHhCCC---ccC----------------------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 227 KKIKGGI---YTL----------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 227 ~~~~~~~---~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
+.+.... ..+ ....+.++.+++.+||+.||.+|||+.|+|.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 1111000 000 01345677888999999999999999999999999764
No 308
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=2.3e-41 Score=294.85 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=205.0
Q ss_pred ccccCCcccccccccCceEEEEEEEccC-----CceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALT-----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (294)
.-.++|++.+.||.|+||.||+|.+... +..|++|++.... .....+.+.+|+++++++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3356888999999999999999987433 3469999986432 2233567889999999996 999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHh--------------------------------------------------------
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEK-------------------------------------------------------- 111 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~-------------------------------------------------------- 111 (294)
.....+++|||+.+++|.+++..+
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617 112 ----------------------------------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (294)
Q Consensus 112 ----------------------------------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~ 151 (294)
..+++..+..++.|++.||.|||+.+++|+||+|+||+++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1367788899999999999999999999999999999999
Q ss_pred CCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH-HHH
Q 022617 152 SKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP-NLF 226 (294)
Q Consensus 152 ~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~-~~~ 226 (294)
.++.++|+|||++........ .....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...... ...
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 999999999999875533221 122335678999999887766 789999999999999997 99999765433 333
Q ss_pred HHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 227 KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 227 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+..+ ....+..++.++.+++.+||+.+|++|||+.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333333 34455678999999999999999999999998876
No 309
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=1.2e-41 Score=291.42 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=202.9
Q ss_pred ccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 88 (294)
.++|++.+.||.|+||.||+|.+.. +++.|++|.+.... .....+.+.+|+.+++++ .|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 4589999999999999999997533 34789999986432 123356778899999999 79999999998754
Q ss_pred CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 111 (294)
...+++++||+++++|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45688999999999999998542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---ccccccCCCcccC
Q 022617 112 ----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAA 184 (294)
Q Consensus 112 ----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~a 184 (294)
.+++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....... ......++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 257889999999999999999999999999999999999999999999999987653221 1122334668999
Q ss_pred CccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617 185 PEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRIT 261 (294)
Q Consensus 185 PE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps 261 (294)
||++.+..+ +.++||||||+++|+|++ |..||..... ......+.... ...+...+.++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999987776 789999999999999998 9999976443 23333333332 3345567889999999999999999999
Q ss_pred HhHHhcC
Q 022617 262 IPEIRQH 268 (294)
Q Consensus 262 ~~~il~h 268 (294)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999874
No 310
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=6.1e-42 Score=290.46 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=203.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------ 89 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 89 (294)
.++|++.+.||.|++|.||+|.++.+++.+++|.+......+ .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 589999999999999999999999999999999986543222 1234567899999999999999999887443
Q ss_pred --CeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 90 --SDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 90 --~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
..++++++|+.+ +|...+.. ...+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 346999999965 77777654 35799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCcc------------ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617 167 MRDGHFL------------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (294)
Q Consensus 167 ~~~~~~~------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 234 (294)
....... ....+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.+.....+.+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4332211 1123467799999887654447899999999999999999999987665443333221000
Q ss_pred -----------------------cC-------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 235 -----------------------TL-------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 235 -----------------------~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
.. .......+.+++.+||..+|++|||+.+++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 00 02344678899999999999999999999999998
No 311
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4e-41 Score=284.73 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=214.3
Q ss_pred CCccccccCCcccccccccCceEEEEEEEc-------cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeE
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHA-------LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR 81 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 81 (294)
...+.-.++|.+.+.||.|+||.||+|.+. .++..+++|.+.... .......+.+|+.+++.+ +|+||++
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~ 85 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 85 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchh
Confidence 345677899999999999999999999753 233478999875332 223457788999999999 7999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP 145 (294)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p 145 (294)
+++++......++++||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++|+||+|
T Consensus 86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999999997642 367788899999999999999999999999999
Q ss_pred CCeEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022617 146 ENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (294)
Q Consensus 146 ~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~ 221 (294)
+||+++.++.++|+|||.+........ .....++..|+|||++.+..+ +.++||||||+++|++++ |..||....
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999876543221 112234567999999987766 788999999999999998 889998888
Q ss_pred HHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 222 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..+..+.+.... ...+..++..+.+++.+||..+|++|||+.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 888877776544 34456789999999999999999999999999873
No 312
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=2.2e-41 Score=289.71 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=205.6
Q ss_pred CCcccccccccCceEEEEEEEccC--CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc----CC
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALT--GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET----PS 90 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~ 90 (294)
+|++.+.||.|++|.||++.+..+ ++.+++|.+.... ......+.+.+|+.+++++ .|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999877 8899999975432 2223456778899999999 59999999987532 24
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
..++++++++ ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788999986 599999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred Cc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC-------------
Q 022617 171 HF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG------------- 232 (294)
Q Consensus 171 ~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~------------- 232 (294)
.. .....++..|+|||.+.+....+.++|+||+|+++|++++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 223357889999998766444478999999999999999999999765533322221110
Q ss_pred ---------------C---ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 233 ---------------I---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 233 ---------------~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
. ......++..+.+++.+||+.+|++|||+.+++.||||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 01123467899999999999999999999999999999754
No 313
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=4.5e-41 Score=279.26 Aligned_cols=249 Identities=27% Similarity=0.451 Sum_probs=209.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
.++|++.+.||.|+||.||+|.+..++. .+++|.+.... .......+.+|+.++++++|||++++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3689999999999999999998864443 68999875432 123356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++||+++++|.+++.+. +.++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999987654322
Q ss_pred cc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 172 FL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 172 ~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
.. .....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+.... .+.+..++..+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 11 11122457999999987666 789999999999999887 999998877766666665543 344567889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~ 267 (294)
+++.+||+.+|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999876
No 314
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=3.8e-41 Score=283.67 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=203.8
Q ss_pred ccCCcccccccccCceEEEEEEEccC--------------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALT--------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIR 81 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~--------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 81 (294)
.++|++.+.||+|+||.||+|.+... ...|++|.+.... .......+.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 36899999999999999999987543 2358999986432 2234567889999999999999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCChHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeE
Q 022617 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLL 149 (294)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nil 149 (294)
+++++...+..++++||+.+++|.+++.... .+++..+..++.|++.|+.|||+.|++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986432 3678889999999999999999999999999999999
Q ss_pred ecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 022617 150 LDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPN 224 (294)
Q Consensus 150 i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~ 224 (294)
++.++.++|+|||++........ .....++..|+|||.+.+..+ +.++|+||||+++++|++ +..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999875433221 112234568999999887766 789999999999999988 678887766555
Q ss_pred HHHHHhC--------CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 225 LFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 225 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
....+.. .....+..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5444321 112334567899999999999999999999999975
No 315
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=4.2e-41 Score=277.79 Aligned_cols=241 Identities=28% Similarity=0.458 Sum_probs=204.5
Q ss_pred ccccccCceEEEEEEEcc-CCc--eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEecc
Q 022617 23 KTLGIGSFGKVKIAEHAL-TGH--KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
+.||.|++|.||+|.+.. .+. .+++|.+...... ...+.+.+|+.++++++|+|++++++++.. ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 332 5899998765543 556788999999999999999999999987 8899999999
Q ss_pred CCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC----cc
Q 022617 100 KSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FL 173 (294)
Q Consensus 100 ~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~----~~ 173 (294)
.+++|.+++.++. .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999997754 68999999999999999999999999999999999999999999999999987654321 11
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC--CccCCCCCChhHHHHHHH
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPR 250 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 250 (294)
....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||......+..+.+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 12345678999999887766 788999999999999998 99999887777766665532 233455678999999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 022617 251 MLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~ 267 (294)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999976
No 316
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.9e-41 Score=285.43 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=210.3
Q ss_pred cccccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYE 84 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 84 (294)
+.-.++|.+.+.||.|++|.||+|.+.. ....+++|.+.... .......+.+|+.+++++ +|+||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4456789999999999999999998632 34568999875432 223456788899999999 5999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 85 VIETPSDIYVVMEYVKSGELFDYIVEK----------------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~----------------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
++...+..++++||+.+++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999889999999999999999999653 2478889999999999999999999999999999999
Q ss_pred EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 022617 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPN 224 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~ 224 (294)
+++.++.++|+|||.+........ .....++..|+|||.+.+..+ +.++||||||+++|++++ |..||......+
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999875543221 111223457999999887665 789999999999999999 899998888777
Q ss_pred HHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 225 LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 225 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+.+.... ...+..++.++.+++.+||+.+|++|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 777766554 3456678899999999999999999999999886
No 317
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=9.7e-42 Score=282.10 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=209.6
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeeccccc--chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
+|.+.+.||.|++|.||++.+...+..+++|+....... .......+..|+.++++++|||++++++++......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999999877776777766432221 112344567789999999999999999999888999999
Q ss_pred EeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 96 MEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+||+.+++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998853 356899999999999999999999999999999999999975 579999999887653322
Q ss_pred -ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHH
Q 022617 172 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIP 249 (294)
Q Consensus 172 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 249 (294)
......++..|+|||.+.+... +.++|+||+|+++|++++|..||...........+..+. ...+..++.++.++|.
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 238 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQ 238 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHH
Confidence 2234456788999999876655 678999999999999999999998766665555554433 4455678899999999
Q ss_pred HhcccCCCCCCCHhHHhcCCcc
Q 022617 250 RMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 250 ~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+||..+|++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 239 SMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999997
No 318
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=7.3e-41 Score=279.73 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=210.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.++|++.+.||+|+||.||+|.++.++. .+++|....... ......+.+|+.++++++|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4789999999999999999999876654 588898754432 3455778899999999999999999999887 78
Q ss_pred EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.++++||+.+++|.+++.++ ..+++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999999999999764 46899999999999999999999999999999999999999999999999998765432
Q ss_pred Ccc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 171 HFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 171 ~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
... .....+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+.... .+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211 11123457999999876666 789999999999999998 999999888777777666543 455667889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~ 267 (294)
+++.+||..+|.+||++.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999887
No 319
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=7.9e-41 Score=279.54 Aligned_cols=247 Identities=24% Similarity=0.361 Sum_probs=204.9
Q ss_pred cCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
++|++.+.||.|++|+||+|.+..+++ .+++|.+... ........+..|+..++++.|+||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 588999999999999999999877766 4677776422 122334677888889999999999999998754 557
Q ss_pred EEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
++++|++.+++|.+++... ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence 7899999999999999754 568999999999999999999999999999999999999999999999999987553222
Q ss_pred c---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617 172 F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (294)
Q Consensus 172 ~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 246 (294)
. .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.+.........+..+. ...+..++.++.+
T Consensus 164 ~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (279)
T cd05111 164 KKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM 242 (279)
T ss_pred cccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence 1 122335668999999987766 789999999999999998 999998887766666555443 3445667889999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~ 267 (294)
++.+||..+|.+|||+.++++
T Consensus 243 li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 243 VMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999977
No 320
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=8.2e-41 Score=275.10 Aligned_cols=241 Identities=27% Similarity=0.447 Sum_probs=205.1
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||.|++|.||+|.+.. ++.|++|.+...... .....+.+|+++++++.|+|++++++++...+..++++|++.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 478999999999999876 899999988654332 34578899999999999999999999999999999999999999
Q ss_pred ChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc---ccccC
Q 022617 103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCG 178 (294)
Q Consensus 103 sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~ 178 (294)
+|.+++.+. ..++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......... .....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999998653 46889999999999999999999999999999999999999999999999998755422211 11223
Q ss_pred CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHHHHHHhcccCC
Q 022617 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDP 256 (294)
Q Consensus 179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p 256 (294)
+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....+..++.++.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 457999999877665 789999999999999998 89999887766666666543 244566788999999999999999
Q ss_pred CCCCCHhHHhc
Q 022617 257 MKRITIPEIRQ 267 (294)
Q Consensus 257 ~~Rps~~~il~ 267 (294)
++|||+.++++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
No 321
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=6e-41 Score=276.78 Aligned_cols=242 Identities=27% Similarity=0.524 Sum_probs=205.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEE-EcCCeEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVI-ETPSDIYV 94 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~l 94 (294)
..+|++.+.||.|++|.||++.. .+..+++|.+... ...+.+.+|+.++++++|+|++++++++ ...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 46899999999999999999976 4778999987432 2246788999999999999999999875 45567899
Q ss_pred EEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 95 VMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
++||+++++|.+++.+.. .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999999997643 37899999999999999999999999999999999999999999999999887543322
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 250 (294)
.....+..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...........+..+. ...+..++..+.+++.+
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ 234 (256)
T ss_pred -CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 22234567999999877665 789999999999999997 999998877777776665543 34556789999999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 022617 251 MLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~ 267 (294)
||+.+|++|||+.++++
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 99999999999999976
No 322
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.4e-43 Score=317.71 Aligned_cols=260 Identities=33% Similarity=0.573 Sum_probs=229.0
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
+-.++|.++++||+|+||.|.+++++.+++-||+|++.+-..-.+....-+..|-.++..-+.+=|+.++..|.+++++|
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY 151 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY 151 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence 44578999999999999999999999999999999987654444455677888889988888889999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-CCCc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-~~~~ 172 (294)
+||||+.||+|-.++.+..++|+.-++.++..|+.||..||+.|++||||||+|||++..|+++|+|||.+-... ++..
T Consensus 152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 999999999999999988899999999999999999999999999999999999999999999999999887665 3333
Q ss_pred -cccccCCCcccCCcccc----CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCC--CccCC--CCCChh
Q 022617 173 -LKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPG 243 (294)
Q Consensus 173 -~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~ 243 (294)
.+..+|||.|.+||++. +...++...|+||+|+++|+|+.|..||......+...+|+.. ...+| ..++.+
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSee 311 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEE 311 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHH
Confidence 34557999999999985 2133478999999999999999999999999888888888766 45666 578999
Q ss_pred HHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 244 ARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 244 l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
.++||.+.+ -+|+.|.. +++|.+||||.+.
T Consensus 312 akdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 312 AKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred HHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 999999988 56889998 9999999999763
No 323
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=9.4e-41 Score=275.79 Aligned_cols=240 Identities=26% Similarity=0.444 Sum_probs=200.3
Q ss_pred cccccCceEEEEEEEc--cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCC
Q 022617 24 TLGIGSFGKVKIAEHA--LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKS 101 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (294)
.||.|+||.||+|.+. ..+..+++|++.... .....+.+.+|+.++++++|+|++++++++. ....++++||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999775 344569999886442 2344567899999999999999999999886 4578999999999
Q ss_pred CChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc----ccc
Q 022617 102 GELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTS 176 (294)
Q Consensus 102 ~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~ 176 (294)
++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......... ...
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999875 456899999999999999999999999999999999999999999999999998754332211 111
Q ss_pred cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhccc
Q 022617 177 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIV 254 (294)
Q Consensus 177 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 254 (294)
..+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+..+. ...+..++.++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 22468999999877665 789999999999999996 999998887777766665543 455677899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 022617 255 DPMKRITIPEIRQ 267 (294)
Q Consensus 255 ~p~~Rps~~~il~ 267 (294)
+|++||++.++++
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999865
No 324
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=6.8e-41 Score=286.91 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=213.0
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccC-------CceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeE
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALT-------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIR 81 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 81 (294)
........+|++.+.||.|+||.||+|.+... ...+++|.+.... .......+.+|+++++++ +|+||++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 44556667899999999999999999986432 2368999875432 223457888999999999 7999999
Q ss_pred EEEEEEcCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 022617 82 LYEVIETPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP 145 (294)
Q Consensus 82 ~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p 145 (294)
+++++...+..++++||+++++|.+++.+.. .++...+..++.|++.||.|||+.|++|+||+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 9999999999999999999999999997532 367788899999999999999999999999999
Q ss_pred CCeEecCCCcEEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 022617 146 ENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN 221 (294)
Q Consensus 146 ~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~ 221 (294)
+||+++.++.++|+|||.+......... ....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999998765432211 11223457999999987766 788999999999999998 899999888
Q ss_pred HHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 222 IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 222 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..+....+.... ...+..++.++.+++.+||..+|.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 888777766543 45566788999999999999999999999999885
No 325
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=6.7e-41 Score=280.50 Aligned_cols=248 Identities=29% Similarity=0.414 Sum_probs=198.4
Q ss_pred ccCC-cccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--
Q 022617 16 LPNY-KLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET-- 88 (294)
Q Consensus 16 ~~~y-~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 88 (294)
.++| ++.+.||.|+||+||++. ...++..+++|++.... .......+.+|++++++++|||++++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3566 999999999999998765 33467789999986442 12345678889999999999999999998765
Q ss_pred CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
....++++||+.+++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 3468999999999999999865 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH--H-------------HHHHH
Q 022617 169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP--N-------------LFKKI 229 (294)
Q Consensus 169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~--~-------------~~~~~ 229 (294)
.... .....++..|+|||.+..... +.++||||||+++|+|++|..||...... + ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence 3221 112234567999999877665 78999999999999999999998543211 0 11111
Q ss_pred h-CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 230 K-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 230 ~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
. ....+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1112335678899999999999999999999999986
No 326
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=6.5e-41 Score=281.30 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=209.9
Q ss_pred cccCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
-.++|++.+.||.|++|.||+|.+.. ++..+++|.+.... .......+.+|+.+++++.|+|++++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35689999999999999999998743 56789999986432 223456788999999999999999999999998
Q ss_pred CeEEEEEeccCCCChHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKG----------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPEN 147 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~----------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~n 147 (294)
...++++||+++++|.+++.... .+++..++.++.|++.+|.+||+.|++|+||+|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999996432 36788899999999999999999999999999999
Q ss_pred eEecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 022617 148 LLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIP 223 (294)
Q Consensus 148 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~ 223 (294)
|+++.++.++|+|||.+........ ......+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999998865432211 112234567999999877766 789999999999999997 88899887777
Q ss_pred HHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 224 NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 224 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+....+..+. .+.+..++.++.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777666554 3445678899999999999999999999999875
No 327
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-43 Score=296.63 Aligned_cols=255 Identities=37% Similarity=0.661 Sum_probs=223.7
Q ss_pred ccccCCcc--cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 14 MFLPNYKL--GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 14 ~~~~~y~~--~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.+..=|++ .+.||+|.||+||-|+++.+|+.||||++.+..+... ....++.|+.+|+++.||+|+.+--.|+.++.
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 33444555 6899999999999999999999999999988776653 35889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHH-H-HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC---CcEEEeeeccccc
Q 022617 92 IYVVMEYVKSGELFDYI-V-EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK---WNVKIADFGLSNI 166 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l-~-~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~---~~~~l~dfg~~~~ 166 (294)
+++|||.+.| +..++| . +.+.+++...+.++.||+.||.|||.++|+|+|+||+|||+... -.+||+|||+++.
T Consensus 638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999977 555555 3 34679999999999999999999999999999999999999764 3699999999999
Q ss_pred ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc----CCCCCCh
Q 022617 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSP 242 (294)
Q Consensus 167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~ 242 (294)
++........+||+.|.|||++....+ ...-||||.|+++|--++|.-||.. .+++..+|+...+- .+..++.
T Consensus 717 IgEksFRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~ 793 (888)
T KOG4236|consen 717 IGEKSFRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISP 793 (888)
T ss_pred cchhhhhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCH
Confidence 998888889999999999999999888 6889999999999999999999854 34555666655543 3457899
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+..++|..+|+..-.+|-|..+.|+|||+++
T Consensus 794 ~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 9999999999999999999999999999976
No 328
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=8.3e-41 Score=275.86 Aligned_cols=246 Identities=26% Similarity=0.487 Sum_probs=209.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|++.+.||.|++|.||++.+. .+..+++|.+...... ...+.+|++++++++|+|++++++++......++++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 57899999999999999999885 4678999987544322 356888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc--c
Q 022617 97 EYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--L 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~ 173 (294)
||+.+++|.+++... .+++++.++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 999999999998764 4689999999999999999999999999999999999999999999999998875533221 1
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 251 (294)
.....+..|+|||.+.+..+ +.++|+||||+++|++++ |..||.........+.+..+. ...+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12234568999999877665 789999999999999998 999998888777777776543 334556789999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 022617 252 LIVDPMKRITIPEIRQH 268 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h 268 (294)
|+.+|++|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999863
No 329
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.8e-42 Score=294.11 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=217.7
Q ss_pred cCCcccccccccCceEEEEEEEccCCc---e-EEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGH---K-VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~---~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
++-.+.++||+|+||.||+|..+..+. . ||+|....+.........++.+|..++++++||||++++|+.....-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345566999999999999998765432 3 899988765555667889999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++||+|.||+|.++|++++ .++..+...++.+.+.+|+|||+++++||||-.+|+|++.++.+||+|||+++....-.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999999876 49999999999999999999999999999999999999999999999999987654111
Q ss_pred ccc-cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC-CC-ccCCCCCChhHHHH
Q 022617 172 FLK-TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG-GI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~~-~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~l~~l 247 (294)
... ....+..|+|||.+....+ +.++||||+|+++||+++ |..||.+....+....+.. +. .+.+...+.++..+
T Consensus 317 ~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 317 MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 111 2235679999999998866 899999999999999999 8999999999999998843 33 45667889999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+|+..+|++||++.++.+
T Consensus 396 ~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHhccCChhhccCHHHHHH
Confidence 99999999999999998876
No 330
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=1.3e-40 Score=276.59 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=209.9
Q ss_pred cccCCcccccccccCceEEEEEEEccCCc---eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGH---KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
..++|+..+.||.|++|.||+|.+..++. .+++|.+.... .......+..|++++++++|+|++++.+++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34688999999999999999999876554 68999875432 22335678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.++++|++++++|.+++... +.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999754 56899999999999999999999999999999999999999999999999998755332
Q ss_pred Ccc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhH
Q 022617 171 HFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGA 244 (294)
Q Consensus 171 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 244 (294)
... .....+..|+|||.+....+ +.++|+||||+++|++++ |..||...........+.... .+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 111 11122457999999877666 789999999999999997 999998877777777765543 34445688999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+++.+||+.+|++||++.++++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999999999986
No 331
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=9.9e-41 Score=279.05 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=210.1
Q ss_pred ccccCCcccccccccCceEEEEEEEcc----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET- 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 88 (294)
.-.++|++.+.||+|+||.||+|.+.. .+..+++|.+... ........+.+|+.++++++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 446789999999999999999999875 2577889987532 233456778899999999999999999998765
Q ss_pred CCeEEEEEeccCCCChHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEee
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIAD 160 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~d 160 (294)
+...+++++++.+++|.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56788999999999999998653 3588999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-cc
Q 022617 161 FGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YT 235 (294)
Q Consensus 161 fg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~ 235 (294)
||++......... ....++..|+|||.+.+..+ +.++||||||+++|++++ |+.||...........+..+. ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA 239 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence 9998755332211 12234567999999877665 789999999999999998 999998877777666665543 34
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 236 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 236 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+..++.++.+++.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 45677899999999999999999999999986
No 332
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=2.1e-40 Score=272.47 Aligned_cols=242 Identities=26% Similarity=0.465 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
+.||.|++|.||++... ++..+++|.+.... .......+.+|+.++++++|+|++++++++...+..++++||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999865 67889999876442 2233456889999999999999999999999999999999999999
Q ss_pred ChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc--cccCC
Q 022617 103 ELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGS 179 (294)
Q Consensus 103 sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~ 179 (294)
+|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......... ....+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 999998654 457899999999999999999999999999999999999999999999999986543322111 12235
Q ss_pred CcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCC
Q 022617 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPM 257 (294)
Q Consensus 180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~ 257 (294)
..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+.... ...+..++..+.+++.+||+.+|+
T Consensus 158 ~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 236 (250)
T cd05085 158 IKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE 236 (250)
T ss_pred ccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence 67999999877665 789999999999999998 999998877766666665443 345667899999999999999999
Q ss_pred CCCCHhHHhcC
Q 022617 258 KRITIPEIRQH 268 (294)
Q Consensus 258 ~Rps~~~il~h 268 (294)
+||++.++++.
T Consensus 237 ~Rp~~~~l~~~ 247 (250)
T cd05085 237 NRPKFSELQKE 247 (250)
T ss_pred cCCCHHHHHHH
Confidence 99999999763
No 333
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-44 Score=326.67 Aligned_cols=259 Identities=29% Similarity=0.501 Sum_probs=230.0
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
-+.-++.-..+||.|.||.||.|.+.++|...|+|.+...... ....+.+.+|..++..++|||+++++++-...+..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3445788889999999999999999999999999998766544 566788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-- 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-- 171 (294)
|.||||++|+|.++++...-.++.....+..|++.+++|||+.||+|+||||.||+++.+|.+|++|||.|....+..
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999999999999887778888889999999999999999999999999999999999999999999998765442
Q ss_pred ---ccccccCCCcccCCccccCCc--cCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhCCCccCCCCCChhH
Q 022617 172 ---FLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHLSPGA 244 (294)
Q Consensus 172 ---~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
......||+.|||||++.+.+ ...-++|||||||++.||+||+.||.. +.+.-+...-...++++|..++++-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 234567999999999997543 346789999999999999999999975 4456666677778889999999999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
++|+++||..||+.|.++.||++|-|-+.
T Consensus 1471 ~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1471 RDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999999999999999999999998754
No 334
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=9.5e-41 Score=282.05 Aligned_cols=252 Identities=31% Similarity=0.464 Sum_probs=207.1
Q ss_pred cccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 86 (294)
....++|.+.+.||.|++|.||++.+. .++..+++|.+.... .....+.+.+|+.+++++ +|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 455678999999999999999999752 345579999875432 223456788999999999 799999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
...+..++++||+.+++|.+++.... .+++..+..++.|++.++.|||+.+++|+||+|+||+++.++.++++|||.+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997543 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhCC-CccCCC
Q 022617 165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGG-IYTLPS 238 (294)
Q Consensus 165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~-~~~~~~-~~~~~~ 238 (294)
........ .....++..|+|||.+.+... +.++||||+|+++|++++ |..||......... ..+..+ ....+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 75533221 112234678999999887766 789999999999999998 99999876544433 333322 223445
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+.++.+++.+||..+|++|||+.++++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 67899999999999999999999999986
No 335
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.4e-40 Score=275.14 Aligned_cols=247 Identities=26% Similarity=0.477 Sum_probs=207.9
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...++|++.+.||.|++|.||++.+. .+..+++|.+.... .....+.+|+.++++++|+|++++++++.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 46789999999999999999999865 55679999875432 234678889999999999999999999877 7789
Q ss_pred EEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC
Q 022617 94 VVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 171 (294)
+++||+++++|.+++.+. ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999763 357888999999999999999999999999999999999999999999999887654322
Q ss_pred cc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 172 FL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 172 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
.. ....++..|+|||.+..... +.++|+||||+++|++++ |..||...+.......+.... .+.+...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 235 (260)
T ss_pred cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence 11 12234567999999877665 788999999999999998 999998887777776665543 34456788999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||..+|++||++.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 236 MMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999998865
No 336
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=8.7e-41 Score=278.66 Aligned_cols=249 Identities=25% Similarity=0.447 Sum_probs=210.5
Q ss_pred cCCcccccccccCceEEEEEEEcc-----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHAL-----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.+|++.+.||.|+||.||+|+++. +.+.+++|.+.... .......+.+|+.++++++|+|++++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 689999999999999999999753 34678999875432 22356788999999999999999999999998899
Q ss_pred EEEEEeccCCCChHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeec
Q 022617 92 IYVVMEYVKSGELFDYIVEKG---------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFG 162 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg 162 (294)
.++++||+++++|.+++.... .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 999999999999999997655 68999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC--ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCc--cCC
Q 022617 163 LSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY--TLP 237 (294)
Q Consensus 163 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~--~~~ 237 (294)
++....... ......++..|+|||.+.+... +.++|+||||+++|++++ |..||...........+..... ..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd05046 163 LSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVP 241 (275)
T ss_pred cccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCC
Confidence 876443222 1223345667999999877665 688999999999999998 8899987776676666664443 345
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..++..+.+++.+||+.+|++|||+.++++.
T Consensus 242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 6788999999999999999999999999874
No 337
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=1e-40 Score=281.20 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=202.6
Q ss_pred ccCCcccccccccCceEEEEEEEcc----------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHAL----------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 79 (294)
.++|++.+.||.|+||.||++.+.. ++..+++|++.... .......+.+|++++++++|+|+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4689999999999999999986532 23468999876432 23345788899999999999999
Q ss_pred eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKG-----------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-----------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
+++++++...+..++++||+.+++|.+++.+.. .+++..++.++.|++.|+.+||+.|++|+||+|+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997542 366778999999999999999999999999999999
Q ss_pred EecCCCcEEEeeecccccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 022617 149 LLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIP 223 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~ 223 (294)
+++.++.++|+|||.+........ ......+..|++||......+ +.++|+||||+++|+|++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875433221 112223567999998776666 789999999999999998 78898776555
Q ss_pred HHHHHHh--------CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 224 NLFKKIK--------GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 224 ~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
....... ....+.+..++..+.+++.+||+.||++||++.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443321 1123445678899999999999999999999999875
No 338
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=1.2e-40 Score=283.14 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=195.7
Q ss_pred CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 022617 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (294)
Q Consensus 29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 108 (294)
+++.||.+++..+++.+++|++..... .......+.+|+++++.++|+||+++++++...+..++++||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445667777777899999999876532 2345678999999999999999999999999999999999999999999999
Q ss_pred HHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--------ccccccC
Q 022617 109 VEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCG 178 (294)
Q Consensus 109 ~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~ 178 (294)
.+. ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++++||+.+....... ......+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 764 458899999999999999999999999999999999999999999999999876442211 1122345
Q ss_pred CCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhCCCc----------------------
Q 022617 179 SPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGGIY---------------------- 234 (294)
Q Consensus 179 ~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~---------------------- 234 (294)
+..|+|||.+... ...+.++|+||+|+++|+|++|..||......... +.+.....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6789999998653 22367899999999999999999999865543322 22211100
Q ss_pred -----------cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 235 -----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 235 -----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.....++.++.+++.+||..||++|||+.++|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00112345788999999999999999999999999998643
No 339
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=1.8e-40 Score=276.11 Aligned_cols=249 Identities=29% Similarity=0.472 Sum_probs=207.9
Q ss_pred cccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
-..+|.+.+.||.|++|.||+|.+... ...+++|.+.... .....+.+.+|+.++++++|+|++++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987544 3468899875432 23445688899999999999999999999875 55
Q ss_pred EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.++++||+.+++|.+++.+.. .++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997644 5899999999999999999999999999999999999999999999999998765433
Q ss_pred Cccc--cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCCCChhHHH
Q 022617 171 HFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARD 246 (294)
Q Consensus 171 ~~~~--~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 246 (294)
.... ....+..|+|||.+....+ +.++|+||||+++|++++ |..||......+....+... ..+.+..++..+.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred cceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 2211 2223457999999876665 789999999999999986 99999887776666665544 34566788999999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~ 267 (294)
++.+|+..+|++|||+.++++
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999886
No 340
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-41 Score=311.24 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=218.1
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc-----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH-----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
..+-+....||+|.||.||.|....... .|++|.+. ...+.....++.+|..++++++||||++++|++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~--~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK--RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc--ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 4566778899999999999998654332 37777764 4455677899999999999999999999999999999
Q ss_pred eEEEEEeccCCCChHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 91 DIYVVMEYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
..++++|||.||+|..+|++. ..++...+..++.|++.++.||++++++|+||..+|+|++....+||+|||+
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999999865 2488999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCccccc---cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHhCCCccCCC
Q 022617 164 SNIMRDGHFLKTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFK-KIKGGIYTLPS 238 (294)
Q Consensus 164 ~~~~~~~~~~~~~---~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~~~ 238 (294)
|+......+.... ..+..|||||.+....+ +.++||||||+++||+++ |..||...+..+... -...++.+.|.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~ 927 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS 927 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC
Confidence 9965544332222 34579999999998878 899999999999999999 999999988888777 56677788899
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.|+..+.++|..||+.+|++||++..|++
T Consensus 928 ~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 928 YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999999999999999999999988
No 341
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=1.4e-40 Score=306.83 Aligned_cols=150 Identities=29% Similarity=0.591 Sum_probs=139.7
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|.+.+.||.|+||+||+|.+..+++.|++|++.............+..|+.+++.++|+||+++++.+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999766555555667889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
|||+.|++|.+++...+.+++..++.++.||+.||.|||..||+|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999864
No 342
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=2.1e-40 Score=277.63 Aligned_cols=248 Identities=27% Similarity=0.434 Sum_probs=200.5
Q ss_pred cCCcccccccccCceEEEEEEE----ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC--C
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEH----ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--S 90 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 90 (294)
.-|++.+.||+|++|.||+|.. ..++..+++|.+.... .......+.+|+++++++.|+|++++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999974 4567889999986442 233456789999999999999999999998765 5
Q ss_pred eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccC
Q 022617 91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~ 169 (294)
..++++||++|++|.+++.+. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 689999999999999999765 3589999999999999999999999999999999999999999999999999876543
Q ss_pred CCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHh
Q 022617 170 GHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE---------------NIPNLFKKIK 230 (294)
Q Consensus 170 ~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~---------------~~~~~~~~~~ 230 (294)
... .....++..|+|||.+.+..+ +.++||||||+++|+++++..|.... ........+.
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 221 123345667999999877665 78999999999999999977654221 1111122222
Q ss_pred CC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 231 GG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 231 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+ ..+.+..++..+.+++.+||+.+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22 23445678999999999999999999999999987
No 343
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-41 Score=250.15 Aligned_cols=257 Identities=29% Similarity=0.532 Sum_probs=221.3
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
.+|+-.++||+|.+|+|++|++..+++-|++|.+..+.-++ -.-....+|+-+++.++|.||+++++...+++.+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46888899999999999999999999999999997765333 23467789999999999999999999999999999999
Q ss_pred eccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-ccc
Q 022617 97 EYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLK 174 (294)
Q Consensus 97 e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~~~ 174 (294)
|+|.. +|..+..+ ++.++.+.++.++.|++.++.+.|++++.|+|+||.|.+|+.+|.+|+.|||+++.+.-+- ..+
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys 159 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS 159 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence 99965 88887754 6789999999999999999999999999999999999999999999999999998776543 445
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-------cc----CC-----
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-------YT----LP----- 237 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-------~~----~~----- 237 (294)
..+.|..|++|.++.+.+..+...|+||-||++.|+.. |++.|.+.+..+...+|.... ++ +|
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 56678899999999999888999999999999999998 888899988888777763211 10 00
Q ss_pred -------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 238 -------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 238 -------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
+.++..-++++.++|.-+|.+|.++++.++||||.+.-
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 23344556899999999999999999999999998754
No 344
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=4.7e-41 Score=277.77 Aligned_cols=239 Identities=20% Similarity=0.300 Sum_probs=195.9
Q ss_pred ccccccCceEEEEEEEccCCc-------eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 23 KTLGIGSFGKVKIAEHALTGH-------KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
+.||.|+||.||+|.+...+. .+++|.+... .....+.+.+|..+++.+.|||++++++++..+...+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998865443 3788876433 223456788899999999999999999999998999999
Q ss_pred EeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--------EEEeeeccccc
Q 022617 96 MEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--------VKIADFGLSNI 166 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--------~~l~dfg~~~~ 166 (294)
|||+++++|.+++..++ .+++..+..++.|++.+++|||+.|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999997654 5899999999999999999999999999999999999987664 69999998765
Q ss_pred ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhCCCccCCCCCChhHH
Q 022617 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR 245 (294)
Q Consensus 167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 245 (294)
.... ....++..|+|||.+.+....+.++|+||||+++|++++| ..|+.......... ........+...+.++.
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWTELA 233 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcHHHH
Confidence 4322 2234677899999997655447899999999999999998 56666655544333 33344556667788999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcC
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h 268 (294)
+++.+||+.+|++|||+++|++.
T Consensus 234 ~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999874
No 345
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=3.8e-40 Score=273.95 Aligned_cols=250 Identities=29% Similarity=0.508 Sum_probs=209.5
Q ss_pred CCcccccccccCceEEEEEEEcc-CCceEEEEEeecccc-------cchHHHHHHHHHHHHHHh-CCCCceeEEEEEEEc
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI-------KNMEMEEKVRREIKILRL-FMHPHIIRLYEVIET 88 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 88 (294)
+|++.+.||.|++|.||++.+.. .++.+++|.+..... ........+.+|+.++.+ ++|+|++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 58999999999999999999987 678899998854321 122345567778887765 789999999999999
Q ss_pred CCeEEEEEeccCCCChHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 89 PSDIYVVMEYVKSGELFDYIVE----KGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~----~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
.+..++++||+.+++|.+++.. ...+++..++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CC-CCCC
Q 022617 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LP-SHLS 241 (294)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~ 241 (294)
+.............++..|++||.+.+..+ +.++|+||||+++|++++|..||...........+...... .+ ..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYS 239 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCC
Confidence 876654433345567889999999987666 78999999999999999999999887776666665544422 22 2578
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.++.+++.+||+.||++||++.++..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 899999999999999999999998753
No 346
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-43 Score=294.24 Aligned_cols=261 Identities=33% Similarity=0.613 Sum_probs=243.4
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
+.-..+.+++..||.|+||.|=++..+.....+|+|++.+..+.+....+.+..|-.++..++.++|++++..|.+.+++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34556788899999999999999988766667999999888888878888999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
|++||-|-||.|+..+..++.+.+...+.++..+++|+.|||.+||+++|+||+|.+++.+|-+||.|||++.....+..
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC--ccCCCCCChhHHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPR 250 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 250 (294)
..+.+||+.|.|||++.+... +.+.|+|+||+++|||++|.+||.+.++....+.|.++. +.+|..++....++|++
T Consensus 576 TwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~ 654 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKK 654 (732)
T ss_pred eeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHH
Confidence 999999999999999987766 799999999999999999999999999999999888776 67889999999999999
Q ss_pred hcccCCCCCCC-----HhHHhcCCccccc
Q 022617 251 MLIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 251 ~l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
+++.+|.+|.- +.+|.+|-||..+
T Consensus 655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 655 LCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred HHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 99999999997 8899999999764
No 347
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=4.1e-40 Score=275.89 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=198.9
Q ss_pred ccCCcccccccccCceEEEEEE----EccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--C
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAE----HALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P 89 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 89 (294)
..+|++.+.||+|+||.||.+. +..++..|++|.+.... ......+.+|++++++++|+|++++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 3589999999999999999997 44578899999975432 3345778899999999999999999998743 3
Q ss_pred CeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
..+++++||+++++|.+++.+. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999999764 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcc----ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHH
Q 022617 169 DGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN----------------LFKK 228 (294)
Q Consensus 169 ~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~----------------~~~~ 228 (294)
..... .....+..|+|||.+.+..+ +.++|+||||+++++|++|..++....... +.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 32211 11123446999999877666 789999999999999999877654322110 1111
Q ss_pred HhC-CCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 229 IKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 229 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+.. ...+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 123445678899999999999999999999999976
No 348
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=9.3e-41 Score=272.52 Aligned_cols=229 Identities=24% Similarity=0.396 Sum_probs=190.9
Q ss_pred cCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHH
Q 022617 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDY 107 (294)
Q Consensus 28 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~ 107 (294)
|.++.||++.++.+++.+++|.+.... ...+|...+....|||++++++++...+..++++||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 889999999999999999999986542 122334444556799999999999999999999999999999999
Q ss_pred HHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCcc
Q 022617 108 IVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEV 187 (294)
Q Consensus 108 l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~ 187 (294)
+.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+....... .....+..|+|||.
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~ 153 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEV 153 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--ccCCcCccccCCcc
Confidence 9888889999999999999999999999999999999999999999999999999875543321 23345667999999
Q ss_pred ccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCH-----
Q 022617 188 ISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----- 262 (294)
Q Consensus 188 ~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----- 262 (294)
..+... +.++|+||+|+++|++++|..|+....... ........+..++..+.+++.+||+.||++||++
T Consensus 154 ~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 154 GGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred cCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 876666 788999999999999999998875432211 0111234566788999999999999999999985
Q ss_pred hHHhcCCcc
Q 022617 263 PEIRQHPWF 271 (294)
Q Consensus 263 ~~il~h~~~ 271 (294)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999997
No 349
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=3.8e-40 Score=287.07 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=207.8
Q ss_pred CccccccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEE
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYE 84 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 84 (294)
....-.++|.+.+.||.|+||.||+|.+. ..++.|++|++..... ....+.+.+|+.++.++. |+||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 34555678999999999999999999864 3456899999965432 223457889999999997 999999999
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHHhC----------------------------------------------------
Q 022617 85 VIETPSDIYVVMEYVKSGELFDYIVEKG---------------------------------------------------- 112 (294)
Q Consensus 85 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------------------------------------------------- 112 (294)
++...+..++++||+.+++|.+++.+++
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999999999999999999999986432
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 022617 113 ----------------------------------------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE 146 (294)
Q Consensus 113 ----------------------------------------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ 146 (294)
.++...++.++.|++.||.|||+.+++|+||+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566678889999999999999999999999999
Q ss_pred CeEecCCCcEEEeeecccccccCCC---ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH
Q 022617 147 NLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI 222 (294)
Q Consensus 147 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~ 222 (294)
||+++.++.++|+|||++....... ......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999987543211 1122345678999999987665 789999999999999998 8999976554
Q ss_pred HHHH-HHHhCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 223 PNLF-KKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 223 ~~~~-~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.+.. ..+..+ ....+..++.++.+++.+||..+|.+||++.+|++.
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4433 333333 244566789999999999999999999999999874
No 350
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=3.9e-40 Score=271.62 Aligned_cols=241 Identities=27% Similarity=0.499 Sum_probs=204.4
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.++|++.+.||.|++|.||.+.. +++.+++|.+.... ....+.+|+.++++++|+|++++++++..+ ..+++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999874 67789999875432 245788899999999999999999998654 57899
Q ss_pred EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
+||+.+++|.+++.... .+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~ 154 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--V 154 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--C
Confidence 99999999999997643 4789999999999999999999999999999999999999999999999988654322 1
Q ss_pred ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHh
Q 022617 174 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 251 (294)
.....+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+..++..+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 22334568999999877666 789999999999999997 999998888777777665543 334567889999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 022617 252 LIVDPMKRITIPEIRQ 267 (294)
Q Consensus 252 l~~~p~~Rps~~~il~ 267 (294)
|+.+|++||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999876
No 351
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=2.6e-40 Score=284.16 Aligned_cols=250 Identities=28% Similarity=0.452 Sum_probs=200.7
Q ss_pred ccCCcccccccccCceEEEEEEEc-----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEc-
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA-----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIET- 88 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 88 (294)
.++|++.+.||.|+||.||+|.+. .+++.|++|.+..... ......+.+|+.++.++ +|+|++++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 468999999999999999999853 4567899999864432 23356788999999999 58999999998754
Q ss_pred CCeEEEEEeccCCCChHHHHHHh---------------------------------------------------------
Q 022617 89 PSDIYVVMEYVKSGELFDYIVEK--------------------------------------------------------- 111 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~~--------------------------------------------------------- 111 (294)
....++++||+++++|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45688999999999999998642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---cccccC
Q 022617 112 ----------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCG 178 (294)
Q Consensus 112 ----------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~ 178 (294)
..++...+..++.|++.|++|||+.|++|+||+|+||+++.++.++|+|||++........ .....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1357778889999999999999999999999999999999999999999999875432211 112234
Q ss_pred CCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHHhCC-CccCCCCCChhHHHHHHHhcccC
Q 022617 179 SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENI-PNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 179 ~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~-~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
+..|+|||.+.+..+ +.++|+||||+++|++++ |..||..... ......+..+ ....+...++++.+++..||+.+
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 567999999877766 789999999999999997 9999976543 2333333332 33445567889999999999999
Q ss_pred CCCCCCHhHHhcC
Q 022617 256 PMKRITIPEIRQH 268 (294)
Q Consensus 256 p~~Rps~~~il~h 268 (294)
|++|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999985
No 352
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=4.4e-40 Score=274.28 Aligned_cols=238 Identities=21% Similarity=0.278 Sum_probs=192.0
Q ss_pred cccccCceEEEEEEEccC------------------------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce
Q 022617 24 TLGIGSFGKVKIAEHALT------------------------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI 79 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~------------------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 79 (294)
+||+|+||.||+|....+ ...+++|++.... ......+.+|+.+++.++|+||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975321 2358888875432 2334677888999999999999
Q ss_pred eEEEEEEEcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC----
Q 022617 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---- 154 (294)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---- 154 (294)
+++++++......++||||+++++|..++.+ .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 45689999999999999999999999999999999999997643
Q ss_pred ---cEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh
Q 022617 155 ---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIK 230 (294)
Q Consensus 155 ---~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~ 230 (294)
.++++|||.+...... ....++..|+|||.+.+....+.++|+||||+++|+++ +|..||.............
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 235 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 3799999987543221 22345678999998876544478999999999999985 6999998766554433322
Q ss_pred CCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 231 GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 236 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 236 -KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -hccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2334445567789999999999999999999999875
No 353
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=8.3e-40 Score=270.87 Aligned_cols=239 Identities=21% Similarity=0.308 Sum_probs=192.6
Q ss_pred ccccccCceEEEEEEEcc------------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 23 KTLGIGSFGKVKIAEHAL------------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
+.||.|++|.||+|.... ....+++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 22358888875432 234567888999999999999999999999988
Q ss_pred eEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc-------EEEeeec
Q 022617 91 DIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN-------VKIADFG 162 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~-------~~l~dfg 162 (294)
..++++||+++++|..++.+. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999988653 56899999999999999999999999999999999999987654 8999999
Q ss_pred ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhCCCccCCCCCC
Q 022617 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLS 241 (294)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
.+...... ....++..|+|||.+......+.++||||||+++|+|+ +|..||......+... ............+
T Consensus 158 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (262)
T cd05077 158 IPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQCMLVTPSC 233 (262)
T ss_pred CCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhcCccCCCCCh
Confidence 88654221 23346778999998875444478999999999999998 5888887665444332 2223333334456
Q ss_pred hhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 242 PGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 242 ~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.++.+++.+||+.||.+||++.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 789999999999999999999999875
No 354
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.7e-42 Score=278.78 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=208.4
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC--Cc----eeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PH----IIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~----i~~~~~~~ 86 (294)
+.+.++|.++..+|+|.||.|..+.|..++..+|||++..-. ...+...-|++++.++.+ |+ ++.+.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 567899999999999999999999999999999999985322 345666779999999842 32 67777889
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC------------
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS------------ 152 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~------------ 152 (294)
...++.|+|+|.+ |.|+.+++.+++ +++...++.++.|++.++++||+.+++|.|+||+||++.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 669999998764 5889999999999999999999999999999999999832
Q ss_pred --------CCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 022617 153 --------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN 224 (294)
Q Consensus 153 --------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~ 224 (294)
+..++++|||.|+..... ....+.|.-|+|||++.+-.+ +...|+||+||+++|+++|...|..++..+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHH
Confidence 234899999999865433 366778999999999999988 788999999999999999999998776544
Q ss_pred ---HHHHHhCCCc------------------cCC-------------------------CCCChhHHHHHHHhcccCCCC
Q 022617 225 ---LFKKIKGGIY------------------TLP-------------------------SHLSPGARDLIPRMLIVDPMK 258 (294)
Q Consensus 225 ---~~~~~~~~~~------------------~~~-------------------------~~~~~~l~~li~~~l~~~p~~ 258 (294)
+.+.+....+ ..+ ...-.+|.+|+++||.+||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 4443322110 000 011235789999999999999
Q ss_pred CCCHhHHhcCCcccc
Q 022617 259 RITIPEIRQHPWFQA 273 (294)
Q Consensus 259 Rps~~~il~h~~~~~ 273 (294)
|+|+.|+|.||||+.
T Consensus 397 RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 397 RITLREALSHPFFAR 411 (415)
T ss_pred cccHHHHhcCHHhhc
Confidence 999999999999975
No 355
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.4e-39 Score=269.50 Aligned_cols=242 Identities=27% Similarity=0.414 Sum_probs=196.1
Q ss_pred ccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEE-cCCeEEEEEec
Q 022617 23 KTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIE-TPSDIYVVMEY 98 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~ 98 (294)
+.||+|+||.||+|.+.. .+..+++|.+... ........+.+|+.+++.++|||++++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998653 3457999987432 22334567888999999999999999999765 45568899999
Q ss_pred cCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-----
Q 022617 99 VKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----- 172 (294)
Q Consensus 99 ~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~----- 172 (294)
+.+++|.+++.+. ...+...+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999999764 3467778889999999999999999999999999999999999999999999875432211
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPR 250 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 250 (294)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+.... ...+..++..+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112234668999999877666 789999999999999999 567777777666666555443 33455678999999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 022617 251 MLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~ 267 (294)
||..+|++||++.++++
T Consensus 238 cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 238 CWHPKPEMRPTFSELVS 254 (262)
T ss_pred HcCCChhhCCCHHHHHH
Confidence 99999999999999987
No 356
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-40 Score=283.26 Aligned_cols=253 Identities=27% Similarity=0.419 Sum_probs=203.5
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
..+....++|.-...||.|+||+||+|... ++..||||.+....... ..++.+|++++.+++|||+++++|||.+.
T Consensus 68 ~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 68 DELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred HHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 344556678999999999999999999986 44889999775443221 45699999999999999999999999988
Q ss_pred C-eEEEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCeEecCCCcEEEeeecc
Q 022617 90 S-DIYVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNM---VVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 90 ~-~~~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~---i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
+ ..++|+||+..|+|.+++.... ++++....+|+.+++.||+|||... |+|+|||++|||++++...||+|||+
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGL 223 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGL 223 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccC
Confidence 8 5999999999999999997654 8999999999999999999999854 99999999999999999999999999
Q ss_pred cccccC-CCccccc-cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHH-HHhCCC-
Q 022617 164 SNIMRD-GHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN------IPNLFK-KIKGGI- 233 (294)
Q Consensus 164 ~~~~~~-~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~------~~~~~~-~~~~~~- 233 (294)
+...+. ....... .+|.+|++||....+.. +.++||||+|++++|+++|+.+.+... ..+... .+....
T Consensus 224 a~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~ 302 (361)
T KOG1187|consen 224 AKLGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL 302 (361)
T ss_pred cccCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence 976655 4433333 79999999999987666 789999999999999999998887532 112111 122211
Q ss_pred -----ccCC-CCCC--h---hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 234 -----YTLP-SHLS--P---GARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 234 -----~~~~-~~~~--~---~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+. ..++ . .+..+..+|++.+|.+||+..++++
T Consensus 303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2233 2 3557788899999999999998755
No 357
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=9.7e-40 Score=276.09 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=205.3
Q ss_pred ccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
..+|++.+.||+|++|.||+|.+..++. .+++|.+.... .......+.+|+.+++.++|+|++++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3578899999999999999999877775 46888775432 223345688899999999999999999998654 4
Q ss_pred EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.+++++++++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 678999999999999987643 5899999999999999999999999999999999999999999999999998765432
Q ss_pred Cc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHH
Q 022617 171 HF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGAR 245 (294)
Q Consensus 171 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 245 (294)
.. .....++..|+|||.+.+... +.++||||||+++|++++ |..||.+.........+.... .+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 21 112234568999999877666 789999999999999997 999998876666555554433 445567889999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcC
Q 022617 246 DLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 246 ~li~~~l~~~p~~Rps~~~il~h 268 (294)
+++.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999998873
No 358
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=8.9e-40 Score=270.05 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=192.3
Q ss_pred ccccccCceEEEEEEEccCC----------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 23 KTLGIGSFGKVKIAEHALTG----------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
+.||.|+||.||+|.+..++ ..+++|++..... ....+.+|+.++++++|+|++++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 3477787643321 15778899999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-------cEEEeeeccc
Q 022617 93 YVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-------NVKIADFGLS 164 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-------~~~l~dfg~~ 164 (294)
++++||+++++|.+++.... .++...+..++.|++.+|.|||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999887 7999999998
Q ss_pred ccccCCCccccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCccCCCCCCh
Q 022617 165 NIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 242 (294)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (294)
..... .....++..|+|||.+.+. ...+.++|+||||+++|++++ |..||.............. ....+.....
T Consensus 156 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 231 (259)
T cd05037 156 ITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMPDCA 231 (259)
T ss_pred ccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCCCch
Confidence 76543 2233456689999998766 334789999999999999999 6888876654333333322 2222223347
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+.+++.+||..+|++|||+.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHH
Confidence 8999999999999999999999986
No 359
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=7.7e-40 Score=272.05 Aligned_cols=242 Identities=26% Similarity=0.440 Sum_probs=201.2
Q ss_pred ccccccCceEEEEEEEccCC------ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 23 KTLGIGSFGKVKIAEHALTG------HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+.||.|++|.||+|.+.... ..+++|.+.... .......+.+|+.+++.++|+||+++++++......++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986443 678999875432 1233567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-----cEEEeeeccc
Q 022617 97 EYVKSGELFDYIVEK-------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-----NVKIADFGLS 164 (294)
Q Consensus 97 e~~~~~sL~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-----~~~l~dfg~~ 164 (294)
||+++++|.+++.+. ..+++..+..++.|++.++.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 2378889999999999999999999999999999999999877 8999999998
Q ss_pred ccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCC-CccCCCC
Q 022617 165 NIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSH 239 (294)
Q Consensus 165 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 239 (294)
........ ......+..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+... ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75533221 112234678999999987766 789999999999999998 99999877766666555433 3455667
Q ss_pred CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
++..+.+++.+||..+|++||++.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999876
No 360
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=8.8e-40 Score=273.69 Aligned_cols=249 Identities=30% Similarity=0.456 Sum_probs=203.8
Q ss_pred ccCCcccccccccCceEEEEEEEc----cCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc--C
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHA----LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET--P 89 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 89 (294)
.+.|++.+.||.|++|.||+|... .+++.+++|++...... .....+.+|+++++.+.|+|++++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 34788999998655432 346789999999999999999999999877 5
Q ss_pred CeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
...++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997654 58999999999999999999999999999999999999999999999999987664
Q ss_pred CCCc----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Q 022617 169 DGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---------------NLFKKI 229 (294)
Q Consensus 169 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---------------~~~~~~ 229 (294)
.... ......+..|++||...+... +.++|+||||+++++|++|..|+...... ...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 2221 112234557999999877665 78999999999999999999998653221 122222
Q ss_pred hCC-CccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 230 KGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 230 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
... ..+.+..++.++.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 222 23445567889999999999999999999999986
No 361
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2e-41 Score=278.52 Aligned_cols=260 Identities=37% Similarity=0.578 Sum_probs=235.0
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (294)
+-..+|..+.+||.|+||.|.+|..+.+.+.||||++.++-+......+--..|..+|.... -|.+++++..|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34568999999999999999999999999999999998876665555666667777777665 47889999999999999
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCC
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~ 171 (294)
|+||||++||+|-..++.-+.+.+..+..++.+|+-+|-+||++||+++|+|..|||++.+|++||.|||++... ....
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 999999999999999999899999999999999999999999999999999999999999999999999998643 2334
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
...+..||+.|+|||++..+++ +.+.|+|++|+++|||+.|+.||++.+..++.+.|+.....+|..++.+..++....
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ 584 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGL 584 (683)
T ss_pred ceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHH
Confidence 4567789999999999999998 899999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCC-----HhHHhcCCccccc
Q 022617 252 LIVDPMKRIT-----IPEIRQHPWFQAH 274 (294)
Q Consensus 252 l~~~p~~Rps-----~~~il~h~~~~~~ 274 (294)
|.+.|.+|.- -++|..||||+.+
T Consensus 585 ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 585 LTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred hhcCCccccCCCCccccchhhCcchhhc
Confidence 9999999986 3579999999754
No 362
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=2.4e-39 Score=269.61 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=202.1
Q ss_pred CcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----
Q 022617 19 YKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS----- 90 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 90 (294)
|++.+.||.|++|.||+|.+.. ++..+++|++...... ....+.+.+|++++++++|||++++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6788999999999999998643 4678999998654333 334677889999999999999999999885432
Q ss_pred -eEEEEEeccCCCChHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 91 -DIYVVMEYVKSGELFDYIVEK------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 91 -~~~lv~e~~~~~sL~~~l~~~------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
..+++++|+.+++|.+++... ..++...++.++.|++.+++|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247889999999999887532 1478899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCc---cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCC
Q 022617 164 SNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPS 238 (294)
Q Consensus 164 ~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~ 238 (294)
+........ ......+..|++||.+..... +.++|+||||+++|+|++ |..||...+..+....+.... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 876533221 112234567999999877666 688999999999999999 899998877766666554433 34456
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
..+..+.+++.+||+.+|++|||+.+++.
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 78899999999999999999999999876
No 363
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.4e-40 Score=303.52 Aligned_cols=254 Identities=31% Similarity=0.554 Sum_probs=208.3
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP---- 89 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 89 (294)
....+|..++.||+||||.||+++++-+|..||||.+.... ......++.+|+.++.+|+||||++++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 36678899999999999999999999999999999997765 446678999999999999999999988643110
Q ss_pred --------------------------------------------------------------------------------
Q 022617 90 -------------------------------------------------------------------------------- 89 (294)
Q Consensus 90 -------------------------------------------------------------------------------- 89 (294)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred -----------------------------------CeEEEEEeccCCCChHHHHHHhCCC-CHHHHHHHHHHHHHHHHHH
Q 022617 90 -----------------------------------SDIYVVMEYVKSGELFDYIVEKGRL-QEDEARNFFQQIISGVEYC 133 (294)
Q Consensus 90 -----------------------------------~~~~lv~e~~~~~sL~~~l~~~~~l-~~~~~~~~~~ql~~~l~~L 133 (294)
..+||.||||+..+|.+++.++... .....|+++++|++||+|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0268999999886666666555443 4889999999999999999
Q ss_pred HhCCceecCCCCCCeEecCCCcEEEeeeccccccc-------------------CCCccccccCCCcccCCccccCCc--
Q 022617 134 HRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-------------------DGHFLKTSCGSPNYAAPEVISGKL-- 192 (294)
Q Consensus 134 h~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~~~-- 192 (294)
|+.|++||||||.||+++.++.|||+|||+++... +.......+||..|+|||.+.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998721 001123446899999999998766
Q ss_pred cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCCCccCCCCC----ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 193 YAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHL----SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 193 ~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.++.++||||||++++||+. ||. .+.....+..+.++..+.+..+ -+.-..+|++||+.||.+|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 34899999999999999985 454 4666777777777776665222 234468999999999999999999999
Q ss_pred CCccc
Q 022617 268 HPWFQ 272 (294)
Q Consensus 268 h~~~~ 272 (294)
+.||-
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99995
No 364
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=2.6e-39 Score=272.31 Aligned_cols=253 Identities=18% Similarity=0.202 Sum_probs=193.6
Q ss_pred ccccccCCcccccccccCceEEEEEEEccC---CceEEEEEeecccccchHH--------HHHHHHHHHHHHhCCCCcee
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEM--------EEKVRREIKILRLFMHPHII 80 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~--------~~~~~~e~~~l~~l~~~~i~ 80 (294)
.+...++|++.+.||+|+||+||+|.+..+ +..+++|+........... ......+...+..+.|++++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 456678999999999999999999998777 6677777653322110000 01122333445667899999
Q ss_pred EEEEEEEcCC----eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617 81 RLYEVIETPS----DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 81 ~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~ 156 (294)
++++.+.... ..+++++++. .++.+.+......++..++.++.|++.++.|||+.+++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9998765433 3467888874 4788877766667889999999999999999999999999999999999999999
Q ss_pred EEeeecccccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHH---
Q 022617 157 KIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPN--- 224 (294)
Q Consensus 157 ~l~dfg~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~--- 224 (294)
+|+|||++....... ......+++.|+|||+..+..+ +.++||||||+++|+|++|..||.... ...
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999987653211 1122358899999999887776 799999999999999999999998763 222
Q ss_pred -----HHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 225 -----LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 225 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
....+...... ...++.++.+++..|++.+|++||++.+|++
T Consensus 245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 245 AAKCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HhHHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22333333322 3456899999999999999999999999875
No 365
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=3.9e-41 Score=267.35 Aligned_cols=259 Identities=31% Similarity=0.488 Sum_probs=206.9
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET- 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 88 (294)
.-...|.+...||+|.+|.||+|..+.++. .+|+|.+.-+.-. .-.....-+|+.+++.++|+|++.+..++.+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 345689999999999999999996554443 6899988655221 1234677899999999999999999998876
Q ss_pred CCeEEEEEeccCCCChHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC----CcEEEe
Q 022617 89 PSDIYVVMEYVKSGELFDYIVE-----KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK----WNVKIA 159 (294)
Q Consensus 89 ~~~~~lv~e~~~~~sL~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~----~~~~l~ 159 (294)
+..+++++||.+. +|++.|.- ...++...++.++.||+.++.|||+..++|||+||.||++..+ |.+||+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEee
Confidence 8899999999976 99999963 2469999999999999999999999999999999999999877 899999
Q ss_pred eecccccccCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---------HHHHH
Q 022617 160 DFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---------IPNLF 226 (294)
Q Consensus 160 dfg~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---------~~~~~ 226 (294)
|+|+++.+.++- ..+..+-|..|+|||.+.+....+.+.|+|++||++.||++.++.|.+.. ..+..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999998876543 23445678899999999999888999999999999999999988884421 11111
Q ss_pred HHHhCC--C-----cc----CC--------------------------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCC
Q 022617 227 KKIKGG--I-----YT----LP--------------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP 269 (294)
Q Consensus 227 ~~~~~~--~-----~~----~~--------------------------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~ 269 (294)
.+|..- . ++ +| ..-++...+++.+||..||.+|.|++++++|+
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 111100 0 00 00 11234467999999999999999999999999
Q ss_pred ccccc
Q 022617 270 WFQAH 274 (294)
Q Consensus 270 ~~~~~ 274 (294)
||+..
T Consensus 339 yF~~d 343 (438)
T KOG0666|consen 339 YFTED 343 (438)
T ss_pred ccccC
Confidence 99875
No 366
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-40 Score=285.38 Aligned_cols=244 Identities=36% Similarity=0.603 Sum_probs=209.8
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (294)
+.+.|.+...+|.|+|+.|-.+.+..+++.+++|++..+. ....+|+.++... .|+|++++.+.+.+....|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999987652 2234556444444 6999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEe-cCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili-~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
+|||.+.|+-+.+.+...+... .++..|+.+|+.|+.+||.+|++|||++|+|||+ .+.++++|+|||.+......
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999988888776554444 7788899999999999999999999999999999 58899999999999876555
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhCCCccCCCCCChhHHHHHHHh
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPSHLSPGARDLIPRM 251 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~ 251 (294)
..+.+-|..|.|||++....+ +.+.||||||+++|+|++|..||...... ++...+..+... ..++.+.++|+++|
T Consensus 470 ~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~L 546 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQL 546 (612)
T ss_pred hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHHHHh
Confidence 334456889999999997777 89999999999999999999999876555 555666555443 78899999999999
Q ss_pred cccCCCCCCCHhHHhcCCcc
Q 022617 252 LIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 252 l~~~p~~Rps~~~il~h~~~ 271 (294)
|+.||.+||++.+++.||||
T Consensus 547 L~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 547 LQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCChhhCcChhhhccCcch
Confidence 99999999999999999999
No 367
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=3.4e-39 Score=263.45 Aligned_cols=240 Identities=51% Similarity=0.873 Sum_probs=210.2
Q ss_pred CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHH
Q 022617 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI 108 (294)
Q Consensus 29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l 108 (294)
++|.||+|.+..+++.+++|++........ ...+.+|++.+++++|+|++++++++......++++|++++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 578999999988899999999865543221 578899999999999999999999999889999999999999999999
Q ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccc
Q 022617 109 VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI 188 (294)
Q Consensus 109 ~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~ 188 (294)
.....++...++.++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+.............++..|++||..
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 87766899999999999999999999999999999999999999999999999999877665444556678899999998
Q ss_pred cCCccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCccCCCC---CChhHHHHHHHhcccCCCCCCCHhH
Q 022617 189 SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIVDPMKRITIPE 264 (294)
Q Consensus 189 ~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ 264 (294)
..... +.++|+|++|++++++++|..||.. .......+.+.......... ++.++.+++.+||..+|++||++.+
T Consensus 159 ~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ 237 (244)
T smart00220 159 LGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEE 237 (244)
T ss_pred ccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHH
Confidence 86666 6799999999999999999999987 66666666666555443333 8899999999999999999999999
Q ss_pred HhcCCcc
Q 022617 265 IRQHPWF 271 (294)
Q Consensus 265 il~h~~~ 271 (294)
+++||||
T Consensus 238 ~~~~~~~ 244 (244)
T smart00220 238 ALQHPFF 244 (244)
T ss_pred HhhCCCC
Confidence 9999997
No 368
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-40 Score=266.68 Aligned_cols=259 Identities=29% Similarity=0.546 Sum_probs=232.3
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 93 (294)
=..+|+++++||+|+++.|.+++++++.+-|++|+++++.+.+.+.+...+.|..+..+- +||.++-++.+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 356899999999999999999999999999999999999888888888888898888765 5899999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc-cCCCc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~ 172 (294)
+|.||.+||+|--.++++..++++.++.+...|+.||.|||+.||+++|+|..||+++..|++||.|+|+.... ..+..
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998653 45566
Q ss_pred cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHhCCCccCCCCCChhH
Q 022617 173 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--------ENIPNLFKKIKGGIYTLPSHLSPGA 244 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l 244 (294)
.++.+||+-|.|||++.+..+ +...|+|+||++|++|+.|+.||+- +...-+.+.|.......|..++-..
T Consensus 408 tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvka 486 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKA 486 (593)
T ss_pred cccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhh
Confidence 778899999999999999998 8999999999999999999999953 2233345556666677888888889
Q ss_pred HHHHHHhcccCCCCCCC------HhHHhcCCccccc
Q 022617 245 RDLIPRMLIVDPMKRIT------IPEIRQHPWFQAH 274 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps------~~~il~h~~~~~~ 274 (294)
..+++..|++||.+|.. +.++..|+||+..
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 99999999999999975 7789999999753
No 369
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=2.2e-38 Score=263.41 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=190.3
Q ss_pred ccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617 23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
+.||+|+||.||+|.+.. ++..+++|.+..... ......+.+|+.++++++|||++++++++.+....++++||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 468999999999998643 446789998754432 2234578889999999999999999999998899999999999
Q ss_pred CCChHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (294)
Q Consensus 101 ~~sL~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 172 (294)
+++|.+++.... ..+...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999999996532 356677889999999999999999999999999999999999999999998865432221
Q ss_pred cccccCCCcccCCccccCCc------cCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH-HhCCCc-----cCCCC
Q 022617 173 LKTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKK-IKGGIY-----TLPSH 239 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~-~~~~~~-----~~~~~ 239 (294)
.....++..|+|||.+.+.. ..+.++|+||||+++|+|++ |..||......+.... +..... .....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 12234567899999885421 12678999999999999996 9999977655444332 222222 12235
Q ss_pred CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
.+..+.++++.|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999975
No 370
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-39 Score=279.83 Aligned_cols=248 Identities=30% Similarity=0.474 Sum_probs=214.7
Q ss_pred ccCCcccccccccCceEEEEEEEccC--C--ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALT--G--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~--~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
.......+.||.|.||.||.|....- | -.||||..+.+. ..+..+.+..|..++++++||||++++|+|.+ +-
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 34455677899999999999986432 2 358889876543 23347889999999999999999999999974 68
Q ss_pred EEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 92 IYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
.|+|||.++-|.|..+++.++ .++......++.||+.||+|||+..++||||-.+||++....-+||+|||+++.....
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 999999999999999998764 5888999999999999999999999999999999999999888999999999988776
Q ss_pred Ccccccc--CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617 171 HFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (294)
Q Consensus 171 ~~~~~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 246 (294)
.+..... .+.-|||||.++-..+ +.++|+|.||++|||++. |..||.+....+.+..+.++. .+.|++||+.+..
T Consensus 545 ~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYs 623 (974)
T KOG4257|consen 545 AYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYS 623 (974)
T ss_pred chhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHH
Confidence 6544333 3668999999987777 789999999999999988 999999999888888887655 7889999999999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~ 267 (294)
++.+||+++|.+||.+.+|..
T Consensus 624 lmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 624 LMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHhccCcccCCcHHHHHH
Confidence 999999999999999888644
No 371
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=2.3e-38 Score=263.22 Aligned_cols=242 Identities=22% Similarity=0.345 Sum_probs=190.3
Q ss_pred ccccccCceEEEEEEEcc--CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617 23 KTLGIGSFGKVKIAEHAL--TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+..++.++|+||+++++.+......++++||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997532 33467888764332 23345667889999999999999999999999999999999999
Q ss_pred CCChHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc---
Q 022617 101 SGELFDYIVEKG-----RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--- 172 (294)
Q Consensus 101 ~~sL~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 172 (294)
+++|.+++.... ..++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999997643 245778889999999999999999999999999999999999999999998864322211
Q ss_pred cccccCCCcccCCccccC------CccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-hCCCc-----cCCCC
Q 022617 173 LKTSCGSPNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIY-----TLPSH 239 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~-~~~~~-----~~~~~ 239 (294)
.....++..|+|||++.. ....+.++||||||+++|+|++ |..||......+..... ..... ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 122334667999998742 2233678999999999999999 88899877655544443 22222 22346
Q ss_pred CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 240 LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
++..+.+++..|+ .||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999876
No 372
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=4.8e-38 Score=261.19 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=189.6
Q ss_pred ccccccCceEEEEEEEccCC--ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccC
Q 022617 23 KTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
+.||.|+||.||++....++ ..+++|.+.... .......+.+|+.+++.++|||++++++.+......++++||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 36899999999999754332 345666654332 22345788899999999999999999999999999999999999
Q ss_pred CCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC---cc
Q 022617 101 SGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FL 173 (294)
Q Consensus 101 ~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~---~~ 173 (294)
+++|.+++.+. ...+...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999999754 235677888999999999999999999999999999999999999999999875432211 12
Q ss_pred ccccCCCcccCCccccCC------ccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC------ccCCCCC
Q 022617 174 KTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI------YTLPSHL 240 (294)
Q Consensus 174 ~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 240 (294)
....++..|+|||++... ...+.++||||||+++|+|++ +..||......+....+.... ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 234567889999987432 112578999999999999997 677887766655555433221 2233457
Q ss_pred ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+..+.+++..|| .+|++||++.++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999976
No 373
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=5e-40 Score=288.14 Aligned_cols=248 Identities=28% Similarity=0.459 Sum_probs=220.5
Q ss_pred cCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
...+|.++||.|.||.||.+..+..+ ..||||.++... .+....++..|..++-++.||||+++.|+....+-++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 35678999999999999999987655 469999985432 3345788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
|++|||+.|+|+.+|..+ +.++..++.-|++.|+.++.||.+.|++||||..+|||++.+-.+|++|||+++...+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999999754 6799999999999999999999999999999999999999999999999999997755441
Q ss_pred c--ccc--cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617 173 L--KTS--CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (294)
Q Consensus 173 ~--~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 246 (294)
. ... ..+.+|.|||.+...++ +.++|+||+|++|||.|+ |..||-.+...+.++.+..+. .+.|-+||..|.+
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~q 865 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQ 865 (996)
T ss_pred ccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHH
Confidence 1 111 23579999999999998 899999999999999998 999999999999999998776 5677799999999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 022617 247 LIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~ 267 (294)
|+..||++|-.+||.+.||++
T Consensus 866 LMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 866 LMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHHhhcCCCHHHHHH
Confidence 999999999999999999876
No 374
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-39 Score=269.83 Aligned_cols=273 Identities=29% Similarity=0.470 Sum_probs=223.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc----chHHHHHHHHHHHHHHhCCCCceeEEEEEEE-
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK----NMEMEEKVRREIKILRLFMHPHIIRLYEVIE- 87 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 87 (294)
..+.++|-++.+||.|||+.||+|.|....+.|++|+-...... .....+...+|+.+.+.|.||.|+++++++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 35778999999999999999999999988899999997543211 2234566789999999999999999999995
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEec---CCCcEEEeeec
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLD---SKWNVKIADFG 162 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~---~~~~~~l~dfg 162 (294)
+...+|-|+|||+|.+|+-+++.++.+++.+++.++.||+.||.||.+.. |+|-|+||.|||+- ..|.+||.|||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 45678999999999999999999999999999999999999999999765 99999999999994 45789999999
Q ss_pred ccccccCCCcc--------ccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHH--
Q 022617 163 LSNIMRDGHFL--------KTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKK-- 228 (294)
Q Consensus 163 ~~~~~~~~~~~--------~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~-- 228 (294)
++......... +...||..|+|||.+.- .+-.+.+.|+||+|+++|.++.|+.||..+.. .++++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99887654332 23357889999999753 23336789999999999999999999976532 333322
Q ss_pred HhC-CC--ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccccCCCCc
Q 022617 229 IKG-GI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 285 (294)
Q Consensus 229 ~~~-~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~~~~~~~ 285 (294)
|.+ .. ++..+.++++..+||++||++.-++|.+..++..||||..+..+....-.|.
T Consensus 699 IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rrs~s~gs~~ 758 (775)
T KOG1151|consen 699 ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRRSVSTGSPA 758 (775)
T ss_pred hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhhccccCCCc
Confidence 222 22 4455689999999999999999999999999999999987665554444433
No 375
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-40 Score=256.50 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=210.7
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+.+-+..||.|+||+|++..++.+|+..|||.+..... ....+++..|.+...+- +.|||++++|..-.++..|+.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 45567789999999999999999999999999976543 23456777777765544 5899999999998899999999
Q ss_pred eccCCCChHHHHH-----HhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 97 EYVKSGELFDYIV-----EKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 97 e~~~~~sL~~~l~-----~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
|.|+. ||+.+-+ .+..++++.+-.+....+.||.||.. ..|+|||+||+|||++..|.+||+|||.+....++
T Consensus 143 ELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 143 ELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred HHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 99964 8877654 24569999999999999999999985 57999999999999999999999999999888777
Q ss_pred CccccccCCCcccCCccccCCc-cCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhCCCccC---C---CCCCh
Q 022617 171 HFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL---P---SHLSP 242 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~---~---~~~~~ 242 (294)
-......|...|+|||.+.... .++.++|+||||+++||+.||+.||.. ++..+.+..+..+.++. + -.++.
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 7777788999999999986433 247899999999999999999999875 33344444444444322 1 24788
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
.+..+|..||.+|-+.||.+.+++++||++.-
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 99999999999999999999999999999653
No 376
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=3.8e-39 Score=246.00 Aligned_cols=253 Identities=26% Similarity=0.496 Sum_probs=209.9
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcC--CeE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETP--SDI 92 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~ 92 (294)
.++|++++++|+|.++.|+.|.+..+++.+++|++.+-. -+.+.+|+++|+.|. +|||++++++..++ +..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 468999999999999999999998899999999986543 478999999999998 99999999998664 456
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH 171 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~ 171 (294)
.+++|+.+..+...+ -..++...+...+.+++.||.|+|+.||+|+|+||.|++|+. ...++|+|+|+|.+...+.
T Consensus 111 aLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 799999987554444 356788899999999999999999999999999999999986 4579999999999988877
Q ss_pred ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhCC-------------CccC-
Q 022617 172 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGG-------------IYTL- 236 (294)
Q Consensus 172 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~-------------~~~~- 236 (294)
..+..+.+..|.-||.+..-...+.+-|+|||||++..|+..+.||. +.+..+..-+|.+- ...+
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ld 267 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLD 267 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCC
Confidence 77788888899999999877666899999999999999999988884 33333322222110 0000
Q ss_pred -----------------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCc
Q 022617 237 -----------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 277 (294)
Q Consensus 237 -----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~ 277 (294)
....+++..+++.++|..|-++|+|+.|++.||||......
T Consensus 268 p~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 268 PQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred hhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 12356899999999999999999999999999999875443
No 377
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.7e-40 Score=256.75 Aligned_cols=258 Identities=28% Similarity=0.473 Sum_probs=210.6
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc-----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----- 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 88 (294)
...+.|.-..+||+|.||.||+|+.+.+++.|++|.+..+.-.. -.-....+|+++|..|+|+|++.++.+|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 45678889999999999999999999999999998764432111 123456789999999999999998877632
Q ss_pred ---CCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 89 ---PSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 89 ---~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
...+|+|+++|.. +|.-++.+. ..++..++..++++++.+|.|+|...|+|+|+|+.|++|+.+|.++|+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 3458999999976 999999765 56999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCc-----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC------
Q 022617 165 NIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------ 233 (294)
Q Consensus 165 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------ 233 (294)
+.+..+.. ....+.|..|++||.+.+...+++..|||+-||++.+|+++.+.+.++.....+..|..-+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76543322 1233458899999999988888999999999999999999999998887666554443211
Q ss_pred -cc---------------CCC-------------CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 234 -YT---------------LPS-------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 234 -~~---------------~~~-------------~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
++ ++. .-+++..++++.+|..||.+|+++.++++|.||..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 10 110 11346679999999999999999999999999966
No 378
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-38 Score=271.08 Aligned_cols=249 Identities=25% Similarity=0.431 Sum_probs=220.3
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
++-..+.....+||.|.||.||.+.|+...-.|+||.+..+. ...+++..|..+++.++|||+++++++|..+--.
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 344455666789999999999999999888899999875443 3478999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 93 YVVMEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
|||+|||..|+|.++|.+.. .++.-.+..|+.||..|+.||..++++|+||-..|+|+.++..+|+.|||+++.....
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999999997643 4777788899999999999999999999999999999999999999999999987665
Q ss_pred Ccc--ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHH
Q 022617 171 HFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARD 246 (294)
Q Consensus 171 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 246 (294)
.+. ..--.+.-|.|||.+....+ +.++|+|+||+++||+.| |-.||.+.+.......+.++. ..-|.+|++.+.+
T Consensus 419 TYTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYe 497 (1157)
T KOG4278|consen 419 TYTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYE 497 (1157)
T ss_pred ceecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHH
Confidence 543 23335678999999988888 899999999999999999 999999999999888887665 6778899999999
Q ss_pred HHHHhcccCCCCCCCHhHHh
Q 022617 247 LIPRMLIVDPMKRITIPEIR 266 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il 266 (294)
|+++||+++|.+||++.+|-
T Consensus 498 LMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 498 LMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHhcCCcccCccHHHHH
Confidence 99999999999999999873
No 379
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.9e-38 Score=275.45 Aligned_cols=259 Identities=28% Similarity=0.415 Sum_probs=222.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCC---ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTG---HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
+-.++.+..++||+|.||.|++|.|+..+ ..||||++....... ...++.+|..++.+|+|+|++++||+..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34567788999999999999999987543 368999986554332 67899999999999999999999999886 7
Q ss_pred eEEEEEeccCCCChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 91 DIYVVMEYVKSGELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
...+|+|.+..|||.+.|.+ ...+....+-.++.||+.|+.||..++++|+|+-..|+++-....+||+|||+.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78899999999999999976 3457788888999999999999999999999999999999988899999999998776
Q ss_pred CCCccc----cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCCh
Q 022617 169 DGHFLK----TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSP 242 (294)
Q Consensus 169 ~~~~~~----~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 242 (294)
.+...- ......-|+|||.+...++ +.++|+|++|+++|||++ |+.||.+.....+++.+.++. .+.|..|+.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 544321 1123568999999999998 899999999999999999 999999999999999887543 677889999
Q ss_pred hHHHHHHHhcccCCCCCCCHhHHhcCCcccccCC
Q 022617 243 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 243 ~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~ 276 (294)
++.+++..||..+|.+|||+..|....+.....+
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~eaqp 376 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP 376 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence 9999999999999999999999987666655443
No 380
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-38 Score=269.81 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=215.1
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
.+...+.++||+|.||.|.+|.-. .+..||+|..+..... .....+.+|+++|.+|+||||+.++++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 456788999999999999999874 4688999998766433 4468999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcc
Q 022617 96 MEYVKSGELFDYIVEKG--RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL 173 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~--~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 173 (294)
+||++.|+|.+++..+. .+......+++.||+.+++||.+.+++||||.++|+|++.++++||+|||+++....+...
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999998873 3456677889999999999999999999999999999999999999999999866544433
Q ss_pred ---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhCC--------CccCCCCC
Q 022617 174 ---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--GTLPFDDENIPNLFKKIKGG--------IYTLPSHL 240 (294)
Q Consensus 174 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~--g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 240 (294)
...+.+.+|+|+|.+..+++ +.++|+|++|+++||+++ ...||.....++..++.... ....|..+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 23356789999999988888 799999999999999876 89999998888877765332 23567889
Q ss_pred ChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 241 SPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 241 ~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+.++.+++.+||..+-++||+++++-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999999855
No 381
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-38 Score=252.60 Aligned_cols=267 Identities=31% Similarity=0.540 Sum_probs=220.4
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC---
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP--- 89 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 89 (294)
-.+..+|.-++.+|.|.- .|..|.|.-.++++++|....+ +.+....+...+|+.++..++|+|+++.+.++.-.
T Consensus 13 ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 13 FTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 345678999999999998 8999999999999999998766 44455678899999999999999999999998432
Q ss_pred ---CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 90 ---SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 90 ---~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
...|++||++.. +|...+. ..++-+.+..++.|++.++.+||+.||+|||+||+||++..++..|+.|||++..
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 458999999965 9998886 4578889999999999999999999999999999999999999999999999988
Q ss_pred ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-------------
Q 022617 167 MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI------------- 233 (294)
Q Consensus 167 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 233 (294)
........+.+.+..|+|||++.+..+ ....||||+||++.+|++|+..|.+.+..+...++....
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 776667778889999999999988875 789999999999999999999997765444333321110
Q ss_pred --------------cc----CC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc-CCccccCCC
Q 022617 234 --------------YT----LP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH-LPRYLAVPP 283 (294)
Q Consensus 234 --------------~~----~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~-~~~~~~~~~ 283 (294)
.. +| ..-...+++++.+||..||++|.|++++|+||||+-| -+.....|+
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~ 326 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPP 326 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCC
Confidence 00 00 1123457899999999999999999999999999955 244455555
Q ss_pred Cc
Q 022617 284 PD 285 (294)
Q Consensus 284 ~~ 285 (294)
|.
T Consensus 327 pe 328 (369)
T KOG0665|consen 327 PE 328 (369)
T ss_pred Cc
Confidence 55
No 382
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=5.3e-39 Score=270.58 Aligned_cols=254 Identities=28% Similarity=0.480 Sum_probs=215.2
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC------CceeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH------PHIIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~ 86 (294)
+.+..+|.+....|.|=|++|..|.|...|..||||++.... ...+.=..|+++|++|.. -++++++..|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 467789999999999999999999999999999999985433 334566789999999963 4789999899
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeec
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFG 162 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg 162 (294)
...+++|+|+|.+. .+|.+.+++.+ .|....+..++.|++-||..|.+.|++|.||||.|||+++. ..+||||||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 99999999999995 59999998754 38888999999999999999999999999999999999875 568999999
Q ss_pred ccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCC-----
Q 022617 163 LSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----- 237 (294)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 237 (294)
.|.....+... ++..+..|+|||++.+.+| +...|+||.||++||+.||+..|.+.....++.-.+....++|
T Consensus 583 SA~~~~eneit-PYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 583 SASFASENEIT-PYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred ccccccccccc-HHHHHHhccCcceeecCcc-cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 99877655433 4445668999999999998 7999999999999999999999998887777776654443333
Q ss_pred ------------------------------------------------CCCC-------hhHHHHHHHhcccCCCCCCCH
Q 022617 238 ------------------------------------------------SHLS-------PGARDLIPRMLIVDPMKRITI 262 (294)
Q Consensus 238 ------------------------------------------------~~~~-------~~l~~li~~~l~~~p~~Rps~ 262 (294)
..++ ..+.+|+..||..||++|.|+
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0111 257789999999999999999
Q ss_pred hHHhcCCcccc
Q 022617 263 PEIRQHPWFQA 273 (294)
Q Consensus 263 ~~il~h~~~~~ 273 (294)
.++|.||||+.
T Consensus 741 nqAL~HpFi~~ 751 (752)
T KOG0670|consen 741 NQALKHPFITE 751 (752)
T ss_pred HHHhcCCcccC
Confidence 99999999974
No 383
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=3.9e-37 Score=277.73 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=174.0
Q ss_pred cccCCcccccccccCceEEEEEEEccC----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE-----
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV----- 85 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~----- 85 (294)
-.++|.+.+.||+|+||.||+|.+..+ +..|++|.+....... ....+ .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 456899999999999999999999888 8999999874322111 11111 1111111222111111
Q ss_pred -EEcCCeEEEEEeccCCCChHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 022617 86 -IETPSDIYVVMEYVKSGELFDYIVEKGR--------------------LQEDEARNFFQQIISGVEYCHRNMVVHRDLK 144 (294)
Q Consensus 86 -~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~ 144 (294)
.......++++||+++++|.+++..... .....+..++.|++.+|.|||+.||+|+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999999865321 1133466899999999999999999999999
Q ss_pred CCCeEecC-CCcEEEeeecccccccCC--CccccccCCCcccCCccccCCcc---------------------CCCchhH
Q 022617 145 PENLLLDS-KWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLY---------------------AGPEVDV 200 (294)
Q Consensus 145 p~nili~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~---------------------~~~~~Di 200 (294)
|+|||++. ++.+||+|||++...... .......+++.|+|||.+..... .+.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 578999999999754322 22234567889999997532211 1235699
Q ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc---------------------cCCCCCChhHHHHHHHhcccCCCCC
Q 022617 201 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------------------TLPSHLSPGARDLIPRMLIVDPMKR 259 (294)
Q Consensus 201 ~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~~p~~R 259 (294)
||+||++|+|+++..+++.. .......+..... ...........+||.+||+.||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999977665332 1111111111100 0001112334589999999999999
Q ss_pred CCHhHHhcCCcccccCC
Q 022617 260 ITIPEIRQHPWFQAHLP 276 (294)
Q Consensus 260 ps~~~il~h~~~~~~~~ 276 (294)
||+.++|+||||+..-.
T Consensus 442 ~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 442 ISAKAALAHPYFDREGL 458 (566)
T ss_pred CCHHHHhCCcCcCCCCc
Confidence 99999999999987533
No 384
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.5e-37 Score=257.15 Aligned_cols=134 Identities=28% Similarity=0.474 Sum_probs=116.6
Q ss_pred cccc-cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-----C---CceeEEE
Q 022617 13 DMFL-PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-----H---PHIIRLY 83 (294)
Q Consensus 13 ~~~~-~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~ 83 (294)
+.+. ++|.+.++||.|-|+|||+|.|....+.||+|+.+... ...+....||++|++++ + .+|++++
T Consensus 73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll 148 (590)
T KOG1290|consen 73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL 148 (590)
T ss_pred ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence 4666 89999999999999999999999999999999976443 45677889999998874 2 4699999
Q ss_pred EEEEc----CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEec
Q 022617 84 EVIET----PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLD 151 (294)
Q Consensus 84 ~~~~~----~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~ 151 (294)
+.|.. ..++|+|+|++ |.+|..+|+.. +.++...+++|++|++.+|.|||. .||+|.||||+|||+.
T Consensus 149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 99854 56899999999 66999999865 459999999999999999999995 6899999999999983
No 385
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.4e-37 Score=267.51 Aligned_cols=257 Identities=30% Similarity=0.538 Sum_probs=218.6
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
..-|..++.||-|+||.|.++...+++..||+|.+.+..+-.+.....++.|-.+|..-..+-|++++..|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 44578889999999999999998889999999999888887778888889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc-------
Q 022617 96 MEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------- 168 (294)
Q Consensus 96 ~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~------- 168 (294)
|+|+.||++-.+|-+-+-++++.++.++.++..|+.+.|+.|++|+||||+||||+.+|++||.|||+++-+.
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999976431
Q ss_pred --CCC----------------------------------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh
Q 022617 169 --DGH----------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC 212 (294)
Q Consensus 169 --~~~----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 212 (294)
++. .....+||+-|+|||++....+ +...|+||.|+++|+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhh
Confidence 000 0012258999999999988877 678899999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhCC----CccCCCCCChhHHHHHHHhcccCCCCCCC---HhHHhcCCccccc
Q 022617 213 GTLPFDDENIPNLFKKIKGG----IYTLPSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH 274 (294)
Q Consensus 213 g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~h~~~~~~ 274 (294)
|+.||-.....+...++..= -++.-..++.+..++|.+++ -+++.|.- ++++..||||+.+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgI 934 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGI 934 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCcccccc
Confidence 99999776655544333211 13334578999999998865 45777874 6789999999875
No 386
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.2e-37 Score=272.95 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=214.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEc----
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIET---- 88 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---- 88 (294)
.-.+.|.+.+.||.|.+|.||+++++.+++..|+|+..... +..+++..|+++++.+. |||++.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 44568999999999999999999999999999999976543 23467888999998875 8999999999843
Q ss_pred -CCeEEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 89 -PSDIYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 89 -~~~~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
++.+|+|||+|.|||.-+++++- ..+.++.+..++..++.++.+||+..++|+|||=.||+++.++.+||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 56899999999999999999763 468899999999999999999999999999999999999999999999999987
Q ss_pred cccCC-CccccccCCCcccCCccccCC----ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc-c--CC
Q 022617 166 IMRDG-HFLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-T--LP 237 (294)
Q Consensus 166 ~~~~~-~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~ 237 (294)
..... ...+...||++|||||++... ...+.++|+||||++..||.-|.+|+..+.+...+-.|-...+ . -|
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp 251 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRP 251 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccch
Confidence 66433 344677899999999998522 2225789999999999999999999988766554444433322 1 12
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccc
Q 022617 238 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
..-+.++.++|..||-+|..+||+..++|+|||++
T Consensus 252 ~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 252 KKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred hhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 34567899999999999999999999999999998
No 387
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=271.20 Aligned_cols=242 Identities=32% Similarity=0.506 Sum_probs=197.2
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC------C
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP------S 90 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 90 (294)
.-|...+.||.|+||.||+++++.+|..||||.+.... .....+...+|++++++++|+||++++++-+.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 66778899999999999999999999999999987654 223467888999999999999999999875432 3
Q ss_pred eEEEEEeccCCCChHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC--CC--cEEEeeecc
Q 022617 91 DIYVVMEYVKSGELFDYIVE---KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS--KW--NVKIADFGL 163 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~---~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~--~~--~~~l~dfg~ 163 (294)
.-.++||||.||+|...+.+ ...+++.+++.++.++..||.|||+.||+||||||.||++.. +| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46799999999999999964 345999999999999999999999999999999999999943 23 479999999
Q ss_pred cccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhCC------
Q 022617 164 SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP-----NLFKKIKGG------ 232 (294)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~-----~~~~~~~~~------ 232 (294)
|+...++....+.+||..|.+||.+....+.+...|.||+|+++|++.||..||...... .+...+.+.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 999999888889999999999999986555588999999999999999999999654322 222222111
Q ss_pred --------------CccCCCCCChh----HHHHHHHhcccCCCCCC
Q 022617 233 --------------IYTLPSHLSPG----ARDLIPRMLIVDPMKRI 260 (294)
Q Consensus 233 --------------~~~~~~~~~~~----l~~li~~~l~~~p~~Rp 260 (294)
..+.+..++.. +-..+..+|..+|.+|-
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11223333433 33567778888999887
No 388
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=1e-35 Score=262.54 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=185.9
Q ss_pred cccCCcccccccccCceEEEEEEEc----------------cCCceEEEEEeecccccchH-----------HHHHHHHH
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHA----------------LTGHKVAIKILNRRKIKNME-----------MEEKVRRE 67 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~----------------~~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e 67 (294)
-.++|++.++||+|+||+||+|.+. ..++.|+||.+......... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3679999999999999999999752 24467999998643211100 11223346
Q ss_pred HHHHHhCCCCc-----eeEEEEEEEc--------CCeEEEEEeccCCCChHHHHHHhC----------------------
Q 022617 68 IKILRLFMHPH-----IIRLYEVIET--------PSDIYVVMEYVKSGELFDYIVEKG---------------------- 112 (294)
Q Consensus 68 ~~~l~~l~~~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~---------------------- 112 (294)
+.++.+++|.+ ++++++++.. ....++|+||+++++|.+++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 66667776654 3566676643 356899999999999999886321
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCcccc--ccCCCcccCCccc
Q 022617 113 --RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVI 188 (294)
Q Consensus 113 --~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~--~~~~~~~~aPE~~ 188 (294)
.++...++.++.|++.+|.|||+.+++|+||||+||+++.++.++|+|||++........... ...++.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 235567888999999999999999999999999999999999999999999865433222222 2347899999987
Q ss_pred cCCcc---------------------CCCchhHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHhCCC--
Q 022617 189 SGKLY---------------------AGPEVDVWSCGVILYALLCGTL-PFDDENIP-----------NLFKKIKGGI-- 233 (294)
Q Consensus 189 ~~~~~---------------------~~~~~Di~slG~ll~~l~~g~~-p~~~~~~~-----------~~~~~~~~~~-- 233 (294)
..... .....|+||+|+++++|+++.. |+...... ...+......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 53221 0124699999999999999875 66432110 1111111122
Q ss_pred ccCCCCCChhHHHHHHHhcccCC---CCCCCHhHHhcCCccccc
Q 022617 234 YTLPSHLSPGARDLIPRMLIVDP---MKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 234 ~~~~~~~~~~l~~li~~~l~~~p---~~Rps~~~il~h~~~~~~ 274 (294)
+......+....+++.+||..+| .+|+|+.|+|+||||...
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 23334678899999999999866 689999999999999653
No 389
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=1.1e-35 Score=287.10 Aligned_cols=240 Identities=21% Similarity=0.297 Sum_probs=187.3
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.+...|+..+.||+|+||.||+|.+..++..|++|.+..... ....|++.+++++||||+++++++...+..+
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 344567888899999999999999988999999998753321 1124578899999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH---RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh---~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
+||||+++++|.+++. .+++..+..++.|++.|++||| +.+++|+||||+||+++.++..++. ++........
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999999999999995 3788999999999999999999 6699999999999999988877765 5544322111
Q ss_pred CccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhC---------CCc--
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKG---------GIY-- 234 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~---------~~~-- 234 (294)
....++..|+|||++.+..+ +.++||||+|+++|||++|+.||+... .......... ...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 12356789999999987776 789999999999999999999985421 1111111100 000
Q ss_pred --cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 235 --TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 235 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
..+.....++.+++.+||+.+|++|||+.++++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011122356789999999999999999999874
No 390
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-36 Score=268.38 Aligned_cols=244 Identities=33% Similarity=0.490 Sum_probs=193.7
Q ss_pred CcccccccccCce-EEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEE
Q 022617 19 YKLGKTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 19 y~~~~~lg~g~~~-~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~ 96 (294)
|.-.+.+|.|+.| .||+|.. .++.||||.+-.+. ..-+.+|+..|+..+ ||||+++++.-.+.+..|++.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 4446778899987 4689986 67899999874332 457789999999885 999999999988899999999
Q ss_pred eccCCCChHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---C--CcEEEeeecccccc
Q 022617 97 EYVKSGELFDYIVEKGR----LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---K--WNVKIADFGLSNIM 167 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~----l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~--~~~~l~dfg~~~~~ 167 (294)
|.|. .+|.++++.... ......+.++.|++.||++||+.+|+|||+||.||||+. + .+++|+|||++...
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9996 599999986411 122445789999999999999999999999999999975 3 46899999999876
Q ss_pred cCCC----ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCcc---CCCC
Q 022617 168 RDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT---LPSH 239 (294)
Q Consensus 168 ~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~---~~~~ 239 (294)
..+. ......|+.+|.|||++..... ..+.|||||||++|+.++ |.+||...-..+ .+|..+... +.+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEPL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeeccC
Confidence 5432 2345578999999999987766 678999999999999999 599996543322 234444332 2222
Q ss_pred CChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 240 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
...+..+||.+|+.++|..||++.++|.||||=..
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 22388999999999999999999999999999443
No 391
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.6e-35 Score=242.73 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=198.2
Q ss_pred CCCCCCCcc-----ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHh--CCCC
Q 022617 5 SNRSSSGVD-----MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRL--FMHP 77 (294)
Q Consensus 5 ~~~~~~~~~-----~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~ 77 (294)
+++|.++.. .+..+..+.+.||+|.||.||+|.+ .|+.||||+|.... +....+|.++.+. |+|+
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHE 265 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHE 265 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccc
Confidence 556666664 5667899999999999999999998 57889999985432 4567777777764 5899
Q ss_pred ceeEEEEEEEcC----CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-----C---CceecCCCC
Q 022617 78 HIIRLYEVIETP----SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-----N---MVVHRDLKP 145 (294)
Q Consensus 78 ~i~~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-----~---~i~h~di~p 145 (294)
||+.+++.-... ..+|+|++|.+.|||.|+|.+ ..++.+...+++..++.+|++||. + .|.|||||.
T Consensus 266 NILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 266 NILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 999999875433 358999999999999999976 689999999999999999999994 2 399999999
Q ss_pred CCeEecCCCcEEEeeecccccccCCC-----ccccccCCCcccCCccccCCc----cC-CCchhHHHHHHHHHHHHhC--
Q 022617 146 ENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKL----YA-GPEVDVWSCGVILYALLCG-- 213 (294)
Q Consensus 146 ~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~----~~-~~~~Di~slG~ll~~l~~g-- 213 (294)
.|||++.++.+.|+|+|+|....... ..+..+||.+|||||++.... +. -..+||||||.++||+.-.
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 99999999999999999987654432 346778999999999985321 11 2468999999999998842
Q ss_pred --------CCCCCC-----CCHHHHHHHHhC--CCccCCCC-----CChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 214 --------TLPFDD-----ENIPNLFKKIKG--GIYTLPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 214 --------~~p~~~-----~~~~~~~~~~~~--~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
++||.+ .+.+++.+.+-. ..+..|.. .-..+..+|+.||-.+|.-|.|+--|.+
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 667754 234555544322 22333322 1235678999999999999999887654
No 392
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.2e-37 Score=239.48 Aligned_cols=254 Identities=30% Similarity=0.528 Sum_probs=207.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC-----CeE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP-----SDI 92 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 92 (294)
+.+-.+-||.|.||.||.+.|..+|+.|++|.+..- ..+....+.+.+|+++|..++|.|++..+++..-+ ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 445578899999999999999999999999988543 34455678899999999999999999988776433 347
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
|+++|.+.. +|..+|-+...++.+.++-++.||+.+|.|||+.+|.|+||||.|.+++.+..+||+|||+++..+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 788999965 9999998888999999999999999999999999999999999999999999999999999987654332
Q ss_pred --cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-----------------
Q 022617 173 --LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----------------- 233 (294)
Q Consensus 173 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~----------------- 233 (294)
....+-|.+|+|||.+.+....+.+.||||.||++.|++..+..|...++....+.|.+-.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 2233567899999999998888999999999999999999999986655444333332110
Q ss_pred ------ccCC-----------CCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 234 ------YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 234 ------~~~~-----------~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
...| ..-..+...++..++..||+.|.+..+.+.|++...
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 0001 123446678889999999999999999999999843
No 393
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-34 Score=260.66 Aligned_cols=255 Identities=31% Similarity=0.516 Sum_probs=214.8
Q ss_pred ccCCcccccccccCceEEEEEEEcc-------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHAL-------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (294)
..+..+.+.||+|.||.|++|.... ....||||........ ...+.+..|+++++.+. |+|++.+++.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3444677799999999999997431 1456889987544322 56788999999999886 999999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEKG----------------RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD 151 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~~----------------~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~ 151 (294)
..+.++++.||+..|+|.+++.+++ .++...+..++.||+.++.||++.+++|||+-.+||+++
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 9999999999999999999997655 388899999999999999999999999999999999999
Q ss_pred CCCcEEEeeecccccccCCCccc--ccc--CCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC-HHHH
Q 022617 152 SKWNVKIADFGLSNIMRDGHFLK--TSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN-IPNL 225 (294)
Q Consensus 152 ~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~-~~~~ 225 (294)
.+..+|++|||+++......... ... -+..|||||.+....+ +.++|+||+|+++||+++ |..||.+.. ..++
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 99999999999998654443322 122 3567999999998777 899999999999999999 999998855 6666
Q ss_pred HHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 226 FKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 226 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
.+.+..+. ...|..++.++.++++.||+.+|++||++.++.+ +|...+
T Consensus 532 ~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~~l 580 (609)
T KOG0200|consen 532 LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEKHL 580 (609)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHHHH
Confidence 76666665 5778899999999999999999999999999987 666543
No 394
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=100.00 E-value=6.8e-33 Score=221.13 Aligned_cols=212 Identities=49% Similarity=0.817 Sum_probs=186.8
Q ss_pred ccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEeccCCCCh
Q 022617 25 LGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGEL 104 (294)
Q Consensus 25 lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL 104 (294)
||.|.+|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++++++++++......++++|++++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999986554321 357889999999999999999999999998999999999998999
Q ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeecccccccCCC-ccccccCCCc
Q 022617 105 FDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPN 181 (294)
Q Consensus 105 ~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~ 181 (294)
.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+....... ..........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9999765 47899999999999999999999999999999999999999 8999999999987665443 1233456789
Q ss_pred ccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCC
Q 022617 182 YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 261 (294)
Q Consensus 182 ~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 261 (294)
|.+||........+.+.|+|++|++++++ ..+.+++..|++.+|++||+
T Consensus 159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R~~ 207 (215)
T cd00180 159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKRPS 207 (215)
T ss_pred ccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccCcC
Confidence 99999987763447899999999999998 78899999999999999999
Q ss_pred HhHHhcCC
Q 022617 262 IPEIRQHP 269 (294)
Q Consensus 262 ~~~il~h~ 269 (294)
+.++++++
T Consensus 208 ~~~l~~~~ 215 (215)
T cd00180 208 AKEILEHL 215 (215)
T ss_pred HHHHhhCC
Confidence 99999875
No 395
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-35 Score=248.83 Aligned_cols=202 Identities=33% Similarity=0.575 Sum_probs=181.4
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHH-----HHHHHHHHHHHHhCC---CCceeEEEEEEEc
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEM-----EEKVRREIKILRLFM---HPHIIRLYEVIET 88 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~-----~~~~~~e~~~l~~l~---~~~i~~~~~~~~~ 88 (294)
..|...+.+|.|+||.|++|.++.++..|++|.+.++++-.... ...+-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35999999999999999999999999999999987765443222 234667999999998 9999999999999
Q ss_pred CCeEEEEEeccC-CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 89 PSDIYVVMEYVK-SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 89 ~~~~~lv~e~~~-~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
++.+|+++|..+ |.+|.++|+....+++.+.+.+++|++.++++||+.||+|||||-+||.++.+|-+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999764 5689999999999999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617 168 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (294)
Q Consensus 168 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~ 219 (294)
.. ...+..+||..|.|||++.+.+|.+..-|||+||+++|-+.....||.+
T Consensus 721 ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 721 KS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 44 3456778999999999999999999999999999999999999999864
No 396
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=8.8e-36 Score=257.63 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=221.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
.-.++|..+..+|+|.+|.||+|+|+.+++..++|+++... .....-+.+|+-+++.++|+||+.+++.+.....+|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 45678999999999999999999999999999999996553 344678889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC-c
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~-~ 172 (294)
+.||||+|++|.+.-.-.+++++.++..+.+..+++++|||+.|-+|||||-.||++++.|.+++.|||.+......- .
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 999999999999987777899999999999999999999999999999999999999999999999999876553322 2
Q ss_pred cccccCCCcccCCcccc---CCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccC-----CCCCChhH
Q 022617 173 LKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL-----PSHLSPGA 244 (294)
Q Consensus 173 ~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l 244 (294)
.....|++.|+|||+.. ...+ ....|||++|+...++-..+.|.....+........+..+.. +..-++.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 34557999999999852 3334 578999999999999998888865554444444443333322 23457789
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617 245 RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279 (294)
Q Consensus 245 ~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~ 279 (294)
.+|++.+|.++|++||+++.+|.|||....++...
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl 282 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRL 282 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHH
Confidence 99999999999999999999999999988876543
No 397
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-34 Score=252.22 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=210.6
Q ss_pred CCcccccccccCceEEEEEEEccCCc----eEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGH----KVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 93 (294)
..+-+++||+|+||+||+|.+--.++ +|++|++.... ..+...++.+|.-.+.+++|+|++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 45667899999999999998864454 58888876443 3345688999999999999999999999997654 88
Q ss_pred EEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 94 VVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
||++|+++|+|.++++.+ .++-....+.|..||++++.|||++.++||||-.+|||+++-..+|+.|||++........
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999754 5688899999999999999999999999999999999999999999999999987643322
Q ss_pred c---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHH
Q 022617 173 L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDL 247 (294)
Q Consensus 173 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 247 (294)
. ....-.+-|+|-|.+....+ +.++|+||+|+++||++| |..|+.+....++-..+..+. .+-|+.++.++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 1 11223567888888888877 899999999999999999 999999999999888887655 67788999999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 022617 248 IPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~ 267 (294)
+.+||-.|+..||+++++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999998765
No 398
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=1.2e-34 Score=238.98 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=203.0
Q ss_pred ccccccCCcccccccccCceEEEEEEEcc---CCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHAL---TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (294)
+..+...|+++++||.|.|++||++.+.. .+..|++|.+...... ..+..|+++|..+. +.||+++.+++.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 44677889999999999999999999877 6788999998765433 56899999999996 789999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI 166 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~ 166 (294)
.++...+|+||++...-.++.. .++..++..+++.++.||.++|..||+|+||||+|++.+. .++..|+|||++..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999999988777764 3678899999999999999999999999999999999975 57899999999862
Q ss_pred cc-----------------C----------------C------------CccccccCCCcccCCccccCCccCCCchhHH
Q 022617 167 MR-----------------D----------------G------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVW 201 (294)
Q Consensus 167 ~~-----------------~----------------~------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 201 (294)
.. . + .......||++|+|||++......+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10 0 0 0011224899999999998877778999999
Q ss_pred HHHHHHHHHHhCCCCCCCC--CHHH------------HH--------------------------------HHHhCCCc-
Q 022617 202 SCGVILYALLCGTLPFDDE--NIPN------------LF--------------------------------KKIKGGIY- 234 (294)
Q Consensus 202 slG~ll~~l~~g~~p~~~~--~~~~------------~~--------------------------------~~~~~~~~- 234 (294)
|-|+++..+++++.||... +... +. +.+.....
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999998321 1000 00 00000000
Q ss_pred ----cC-CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 235 ----TL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 235 ----~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
.. ....+..+.+++.+||..||.+|.|++++|+||||.+
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 00 0123557889999999999999999999999999974
No 399
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-33 Score=236.12 Aligned_cols=239 Identities=23% Similarity=0.364 Sum_probs=187.0
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHH--hCCCCceeEEEEEEEcCC---
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILR--LFMHPHIIRLYEVIETPS--- 90 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~--- 90 (294)
.......++||+|.||.||+|+. +++.||||++.... .+.+..|.++.+ .++|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 56778899999999999999987 56899999986543 355666666665 457999999998865443
Q ss_pred -eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCCeEecCCCcEEEee
Q 022617 91 -DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR---------NMVVHRDLKPENLLLDSKWNVKIAD 160 (294)
Q Consensus 91 -~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~---------~~i~h~di~p~nili~~~~~~~l~d 160 (294)
.+++|++|.+.|+|-++|+. ..++.....+++..++.+|+|||+ -.|+|||||..|||+.+|+++.|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 79999999999999999965 468999999999999999999995 3599999999999999999999999
Q ss_pred ecccccccCCC---ccccccCCCcccCCccccCCccCC-----CchhHHHHHHHHHHHHhCCCCCC--------------
Q 022617 161 FGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAG-----PEVDVWSCGVILYALLCGTLPFD-------------- 218 (294)
Q Consensus 161 fg~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~ll~~l~~g~~p~~-------------- 218 (294)
||+|..+.... .....+||.+|||||++.+...-. .+.||||+|.++||+++....++
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998775433 223478999999999986532211 46899999999999998644332
Q ss_pred ---CCCHHHHHHHHh--CCCccCCC-----CCChhHHHHHHHhcccCCCCCCCHh
Q 022617 219 ---DENIPNLFKKIK--GGIYTLPS-----HLSPGARDLIPRMLIVDPMKRITIP 263 (294)
Q Consensus 219 ---~~~~~~~~~~~~--~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ 263 (294)
....+++...+. +.++.++. .....+.+.++.||+.||+.|.|+.
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 112334444332 33333332 3455788999999999999999975
No 400
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=5e-33 Score=209.35 Aligned_cols=217 Identities=23% Similarity=0.413 Sum_probs=179.9
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcCC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETPS 90 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 90 (294)
+++-.+...-...||+|++|.|-+.++..+|+-.|+|.+...- . ....+++.+|+.+..+. .+|+++.+++.+....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-N-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-C-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 5555666777888999999999999999999999999986543 2 23456677777776655 5899999999998899
Q ss_pred eEEEEEeccCCCChHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 91 DIYVVMEYVKSGELFDYIV----EKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~----~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
.+|+.||.++. ||..+-. ..+.+++..+-+++..++.||.|||++ .++|||+||+||||+.+|++|++|||.+.
T Consensus 119 dvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999999965 8877653 457799999999999999999999965 79999999999999999999999999998
Q ss_pred cccCCCccccccCCCcccCCccccC---CccCCCchhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhC
Q 022617 166 IMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG 231 (294)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~ll~~l~~g~~p~~~-~~~~~~~~~~~~ 231 (294)
...++-......|...|+|||.+.. .+.++.++||||||+++.||.+++.||+. ..+.+.++++..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 8877776666789999999998753 22347899999999999999999999974 344444444433
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=100.00 E-value=6.1e-32 Score=218.29 Aligned_cols=214 Identities=49% Similarity=0.809 Sum_probs=185.3
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
|++.+.||.|+++.||++.+..+++.+++|.+...... ...+.+.+|++.+++++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999888999999998755432 2467889999999999999999999999988999999999
Q ss_pred cCCCChHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCC--cccc
Q 022617 99 VKSGELFDYIVEKGR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKT 175 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~ 175 (294)
+.+++|.+++..... +++..++.++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+....... ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999987766 8999999999999999999999999999999999999999999999999988765543 3344
Q ss_pred ccCCCcccCCccc-cCCccCCCchhHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHhCCCcc
Q 022617 176 SCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYT 235 (294)
Q Consensus 176 ~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~--~~~~~~~~~~~~~~~~ 235 (294)
..++..|++||.+ ..... +.++|+|+||++++++++|+.||.. .+...+.+.+..+...
T Consensus 159 ~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred eeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 5677889999998 44444 6799999999999999999999977 4555777777776643
No 402
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=100.00 E-value=6.7e-33 Score=226.75 Aligned_cols=255 Identities=18% Similarity=0.281 Sum_probs=213.0
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCC-----ceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEE
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTG-----HKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYE 84 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 84 (294)
+++.....|++..-++.+|.||.||.|.+.+.. +.+.+|.+... -+.-....+..|.-++..+.|||++.+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 344556678888999999999999999776433 34556654211 12234577888888999999999999999
Q ss_pred EEEc-CCeEEEEEeccCCCChHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc
Q 022617 85 VIET-PSDIYVVMEYVKSGELFDYIVEK--------GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN 155 (294)
Q Consensus 85 ~~~~-~~~~~lv~e~~~~~sL~~~l~~~--------~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~ 155 (294)
+..+ ...-+.++.+.+-++|..++.-. ..++..++..++.|++.|++|||+.|++|.||-.+|.+|++.-+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 8754 45678889999999999999721 24778889999999999999999999999999999999999999
Q ss_pred EEEeeecccccccCCCcc---ccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhC
Q 022617 156 VKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKG 231 (294)
Q Consensus 156 ~~l~dfg~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~ 231 (294)
+||+|=.+++......++ +..-.+..||+||.+....+ +.++|+||||+++|||+| |+.||...++.++..-+++
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD 513 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc
Confidence 999999999877655443 23334678999999998888 799999999999999999 9999999999999998888
Q ss_pred CC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 232 GI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 232 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
+. ..-|-+||.++..++.-||...|++||+++|+..
T Consensus 514 GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 76 5667899999999999999999999999999865
No 403
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.97 E-value=1.3e-31 Score=209.53 Aligned_cols=252 Identities=29% Similarity=0.467 Sum_probs=190.7
Q ss_pred ccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEE-EEcCCe
Q 022617 14 MFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEV-IETPSD 91 (294)
Q Consensus 14 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~~~~ 91 (294)
.+.+.|.|.+.||.|.||.+-+|.|+.+++.+++|.++.+.. ...++.+|+.---.|. |.||+.-++. |++.+.
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 577899999999999999999999999999999999876653 3567777766444443 7888876654 677788
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEec--CCCcEEEeeecccccccC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~--~~~~~~l~dfg~~~~~~~ 169 (294)
+++++||++.|+|.+-+.. ..+-+...+.++.|++.|+.|+|+++++|||||.+||||- +.-++||+|||.+...+.
T Consensus 97 YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 9999999999999988754 3467888999999999999999999999999999999993 334799999999875432
Q ss_pred CCccccccCCCcccCCccccC----CccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhCCC---ccCC
Q 022617 170 GHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCGTLPFDDEN-----IPNLFKKIKGGI---YTLP 237 (294)
Q Consensus 170 ~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-----~~~~~~~~~~~~---~~~~ 237 (294)
.....--...|.+||.+.. .-...+.+|+|.||++++.+++|+.||.... .....+-..... +...
T Consensus 176 --tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F 253 (378)
T KOG1345|consen 176 --TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKF 253 (378)
T ss_pred --eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhh
Confidence 1222223557889997642 2223578999999999999999999995321 111222222222 2333
Q ss_pred CCCChhHHHHHHHhcccCCCCCC---CHhHHhcCCccc
Q 022617 238 SHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQ 272 (294)
Q Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~ 272 (294)
..+++.+..++++-|..+|++|- ++....+..|..
T Consensus 254 ~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 254 NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 56788999999999999999994 344444455553
No 404
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.97 E-value=7.6e-31 Score=247.62 Aligned_cols=193 Identities=17% Similarity=0.198 Sum_probs=140.3
Q ss_pred CceeEEEEEE-------EcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 022617 77 PHIIRLYEVI-------ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENL 148 (294)
Q Consensus 77 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~ni 148 (294)
+||.++++++ .....++.++|++ +++|.+++.. ...+++.+++.++.||+.||.|||++||+|+||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 4566666655 2234577788888 5599999965 34589999999999999999999999999999999999
Q ss_pred EecCCCc-------------------EEEeeecccccccCCC-----------------ccccccCCCcccCCccccCCc
Q 022617 149 LLDSKWN-------------------VKIADFGLSNIMRDGH-----------------FLKTSCGSPNYAAPEVISGKL 192 (294)
Q Consensus 149 li~~~~~-------------------~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~~~aPE~~~~~~ 192 (294)
|++..+. ++++|||++....... ......+++.|+|||++.+..
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 191 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS 191 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence 9965444 5555555554211000 001124677899999998887
Q ss_pred cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 193 YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 193 ~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
+ +.++|||||||++|||++|..|+..... ....+.... .+...........++.+||..+|.+||++.|+++||||
T Consensus 192 ~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 192 S-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred C-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhh
Confidence 7 7899999999999999999888653221 111221111 11111234566789999999999999999999999999
Q ss_pred cc
Q 022617 272 QA 273 (294)
Q Consensus 272 ~~ 273 (294)
..
T Consensus 269 ~~ 270 (793)
T PLN00181 269 NE 270 (793)
T ss_pred hh
Confidence 76
No 405
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.96 E-value=3.4e-28 Score=195.55 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=208.6
Q ss_pred CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEE
Q 022617 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVI 86 (294)
Q Consensus 8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 86 (294)
++++..++...|+++++||.|+||.++.+.+--++++||||.-... +....++.|+...+.|. .++|+.++.+.
T Consensus 19 s~s~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFG 93 (449)
T KOG1165|consen 19 SSSGVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG 93 (449)
T ss_pred CCCCceEecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeec
Confidence 5567789999999999999999999999999999999999975322 23578888999988886 59999999999
Q ss_pred EcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-----CcEEEee
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIAD 160 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-----~~~~l~d 160 (294)
.+..+-.+|+|.+ |.||+++..= ...++...+..++.|++.-+.++|++.++++||||+|+||... ..+.++|
T Consensus 94 qeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 94 QEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred cccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEe
Confidence 9999999999999 6799999864 4569999999999999999999999999999999999999643 3589999
Q ss_pred ecccccccCCCc--------cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH
Q 022617 161 FGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN---IPNLFKKI 229 (294)
Q Consensus 161 fg~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~---~~~~~~~~ 229 (294)
||++....++.. ..+..||.+||+-....+.+. +.+.|+-+||.++++.+-|.+||.+.. ...-.++|
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 999987654432 234568999999999888877 899999999999999999999997743 44444555
Q ss_pred hCCCccC-----CCCCChhHHHHHHHhcccCCCCCCCHhHH
Q 022617 230 KGGIYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEI 265 (294)
Q Consensus 230 ~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~i 265 (294)
-..+... -.++|.++..-++-.-..+-.+-|+.+-+
T Consensus 252 Ge~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 252 GETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred ccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 4433322 25678888888888888888888886644
No 406
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.96 E-value=3.2e-29 Score=195.08 Aligned_cols=159 Identities=24% Similarity=0.293 Sum_probs=128.0
Q ss_pred CChHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCC
Q 022617 102 GELFDYIVEK-GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP 180 (294)
Q Consensus 102 ~sL~~~l~~~-~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 180 (294)
|||.+++.++ .++++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 5899999764 56999999999999999999999998 999999999999999 99887654322 25789
Q ss_pred cccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhCCCccC-------CCCCCh--hHHHHHHH
Q 022617 181 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI-PNLFKKIKGGIYTL-------PSHLSP--GARDLIPR 250 (294)
Q Consensus 181 ~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-------~~~~~~--~l~~li~~ 250 (294)
.|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+....... +...+. ++.+++.+
T Consensus 69 ~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 69 YFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred cccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 9999999988777 7899999999999999999999975432 22223322221111 112333 69999999
Q ss_pred hcccCCCCCCCHhHHhcCCcccc
Q 022617 251 MLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 251 ~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
||..+|.+||++.++++|+|+..
T Consensus 148 cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 148 CASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999864
No 407
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.96 E-value=1.1e-27 Score=184.65 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=202.1
Q ss_pred CCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC-CceeEEEEEEE
Q 022617 9 SSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH-PHIIRLYEVIE 87 (294)
Q Consensus 9 ~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~ 87 (294)
+..--...+.|+++++||+|+||.+|+|....+|..||||+-...-. ...+..|..+.+.|++ .+|+.+..++.
T Consensus 7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 33445678899999999999999999999999999999998643321 3467788889998885 78999999999
Q ss_pred cCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC---CCcEEEeeecc
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS---KWNVKIADFGL 163 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~---~~~~~l~dfg~ 163 (294)
+..+-.+||+.+ |.||+++..- ...++...+.-++-|++.-++|+|.++++|+||||+|+++.- ..++.|+|||+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 999999999999 6799999863 456899999999999999999999999999999999999953 45699999999
Q ss_pred cccccCCC--------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhCC
Q 022617 164 SNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP---NLFKKIKGG 232 (294)
Q Consensus 164 ~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~---~~~~~~~~~ 232 (294)
+....+.. ......||.+|.+-....+... +.+.|+-|+|.++.+.--|.+||.+.... .-.++|...
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek 239 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK 239 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence 97654322 1234468889998888776665 78999999999999999999999875433 333444444
Q ss_pred CccC-----CCCCChhHHHHHHHhcccCCCCCCCHhH
Q 022617 233 IYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPE 264 (294)
Q Consensus 233 ~~~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~~ 264 (294)
+... -.++|.++.-.+.-|-..--++-|+..-
T Consensus 240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 4333 3578999999999999998899998553
No 408
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.96 E-value=3.7e-27 Score=200.33 Aligned_cols=246 Identities=23% Similarity=0.309 Sum_probs=194.0
Q ss_pred CCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCC----CCceeEEEEEE-EcCCe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM----HPHIIRLYEVI-ETPSD 91 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~ 91 (294)
+|++.+.||+|+||.||.+.+..++ ..+|+|+........ ...+..|..++..+. .+++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987664 578899875442221 126778888888886 36899999999 57788
Q ss_pred EEEEEeccCCCChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-----CcEEEeeeccc
Q 022617 92 IYVVMEYVKSGELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-----WNVKIADFGLS 164 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-----~~~~l~dfg~~ 164 (294)
-++||+.+ |.+|.++.... +.++...+..++.|++.+|.+||+.|++||||||.|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 67999988654 469999999999999999999999999999999999999754 46999999999
Q ss_pred cccc---CCC-------c-cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC--
Q 022617 165 NIMR---DGH-------F-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-- 231 (294)
Q Consensus 165 ~~~~---~~~-------~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-- 231 (294)
+... ... . .....||..|.++.+..+... +.+.|+||++.++.+++.|.+||..............
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8321 110 1 123458999999999888877 8999999999999999999999976553222222211
Q ss_pred --CCcc-CCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 232 --GIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 232 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
.... .....+.++..+...+-..+...+|+...+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1111 234566788888888888999999998887663
No 409
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.95 E-value=6.4e-29 Score=224.03 Aligned_cols=262 Identities=34% Similarity=0.525 Sum_probs=207.4
Q ss_pred cCC-cccccccccCceEEEEEEEccCCceEEEEEeec---ccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeE
Q 022617 17 PNY-KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNR---RKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDI 92 (294)
Q Consensus 17 ~~y-~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~---~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 92 (294)
+.| .....+|.|.+|.|+.+......+.+..|.+.. ...........+..|+-+-..+.|+|++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 445 568889999999888888776666666666542 1222223333377788888899999987766655554444
Q ss_pred EEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc
Q 022617 93 YVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF 172 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 172 (294)
.-.||||++ +|..++.+.+.++..++--+++|++.++.|+|+.|+.|+|+|++|++++.+|.+|++|||.+.....+..
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 445999999 9999998887899999999999999999999999999999999999999999999999999876654332
Q ss_pred -----cccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH--------HhCCCccCCC
Q 022617 173 -----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KK--------IKGGIYTLPS 238 (294)
Q Consensus 173 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~--------~~~~~~~~~~ 238 (294)
.....++..|.|||++.+..+.....||||.|+++..|.+|+.||......+.. .. +..+...+..
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS 555 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence 345568899999999999999888999999999999999999999754433221 11 1111223335
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccCCccc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 279 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~~~~~ 279 (294)
.++.+.+.+|.+||+.+|.+|.|+++|++.+||+.+--+.+
T Consensus 556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v 596 (601)
T KOG0590|consen 556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHV 596 (601)
T ss_pred hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEe
Confidence 67888999999999999999999999999999998765544
No 410
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.95 E-value=1.2e-28 Score=224.21 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=191.6
Q ss_pred CCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeeccc-ccchHHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 022617 8 SSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRK-IKNMEMEEKVRREIKILRLFMHPHIIRLYEVI 86 (294)
Q Consensus 8 ~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 86 (294)
...-+..+..+|...+.||++.|=.|.+|++. .|. |++|++-+.. .-+.....+-..+++ ....++||++++.-.-
T Consensus 14 ~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~ 90 (1431)
T KOG1240|consen 14 VEVYFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL 90 (1431)
T ss_pred HHHHhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH
Confidence 33444556668999999999999999999985 444 9999996553 112222333334444 5667899999998887
Q ss_pred EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 87 ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 87 ~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
...+..|++-+|... +|.|.+..+..+..-+.+.++.|++.|+..+|+.||+|||||.+||||+.-+.+.|+||..-..
T Consensus 91 ~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 91 VTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred HhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCC
Confidence 888889999999976 9999999888899999999999999999999999999999999999999999999999986532
Q ss_pred c--cCC------CccccccCCCcccCCccccCC----------ccCCCchhHHHHHHHHHHHHh-CCCCCCCC-------
Q 022617 167 M--RDG------HFLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSCGVILYALLC-GTLPFDDE------- 220 (294)
Q Consensus 167 ~--~~~------~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~ll~~l~~-g~~p~~~~------- 220 (294)
. +.. ..+++.....+|.|||.+... ..-+++.||||+||++.|+++ |++||.-.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~ 249 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS 249 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence 2 111 123444556799999987531 113678999999999999998 89888322
Q ss_pred ----CHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 221 ----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 221 ----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
+.+...+.| -+..++.++..|++.||++|.++++.|+-
T Consensus 250 ~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222222222 23478999999999999999999999885
No 411
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.94 E-value=9.3e-25 Score=186.03 Aligned_cols=252 Identities=39% Similarity=0.653 Sum_probs=209.2
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC-ceeEEEEEEEcCCeEEEEEe
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP-HIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 97 (294)
|.+.+.||.|+|+.||.+.+. ..+++|.+.............+.+|..+++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999986 77899998776555444678899999999999988 79999999987777899999
Q ss_pred ccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC-cEEEeeecccccccCCC--
Q 022617 98 YVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-- 171 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~~~~-- 171 (294)
++.++++.+++.... .++......++.|++.++.++|..+++|+|++|+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998776664 799999999999999999999999999999999999999988 79999999987554332
Q ss_pred -----ccccccCCCcccCCccccCC--ccCCCchhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhCCCcc-CCCC
Q 022617 172 -----FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYT-LPSH 239 (294)
Q Consensus 172 -----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~-~~~~ 239 (294)
......++..|++||.+.+. .......|+|++|++++++++|..||.... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 23566789999999999874 344789999999999999999999987665 34555544444433 2221
Q ss_pred CC--------hhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 240 LS--------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 240 ~~--------~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
.. ..+.+++..++..+|..|.+..+...+++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11 47899999999999999999999888866644
No 412
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.94 E-value=1.2e-26 Score=189.17 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=157.9
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC----------CceeE
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH----------PHIIR 81 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~~ 81 (294)
...........+.||.|+++.||.+.|..+++.+++|++...........+.+++|.-....+.+ -.++.
T Consensus 7 ~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 7 LGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp SS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred CCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 34444566778999999999999999999999999999987764455566777776655444322 23333
Q ss_pred EEEEEEcC------------C-----eEEEEEeccCCCChHHHHHH---hCC----CCHHHHHHHHHHHHHHHHHHHhCC
Q 022617 82 LYEVIETP------------S-----DIYVVMEYVKSGELFDYIVE---KGR----LQEDEARNFFQQIISGVEYCHRNM 137 (294)
Q Consensus 82 ~~~~~~~~------------~-----~~~lv~e~~~~~sL~~~l~~---~~~----l~~~~~~~~~~ql~~~l~~Lh~~~ 137 (294)
.++..... + ..+++++-+.+ +|.++++- ... +.......+..|++..+++||..|
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 33332211 1 24678888854 88888642 222 223334566799999999999999
Q ss_pred ceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCC-------ccCCCchhHHHHHHHHHHH
Q 022617 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-------LYAGPEVDVWSCGVILYAL 210 (294)
Q Consensus 138 i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~ll~~l 210 (294)
++|+||+|+|++++.+|.+.|+||+.....+.... ....+..|.|||..... -..+.+.|.|+||+++|.|
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999999987765443222 13445778999875321 1226788999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCC
Q 022617 211 LCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (294)
Q Consensus 211 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 259 (294)
+++..||............ +..-.++|+.++.||..+|+.+|.+|
T Consensus 244 WC~~lPf~~~~~~~~~~~~----f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEWD----FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGGG----GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccccc----chhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999866443332221 11122789999999999999999987
No 413
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.94 E-value=1.7e-25 Score=190.02 Aligned_cols=169 Identities=18% Similarity=0.200 Sum_probs=131.2
Q ss_pred CCccccccCCcccccccccCceEEEEEEEcc-CCceEEEEEeecccc--cchHHHHHHHHHHHHHHhCCCCceeE-EEEE
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKI--KNMEMEEKVRREIKILRLFMHPHIIR-LYEV 85 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~-~~~~ 85 (294)
+....+.++|++.+.||+|+||+||+|.+.. +++.++||+...... ........+.+|++++++++|+|+++ +++.
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3456788999999999999999999999876 677789998653211 12234567999999999999999885 4432
Q ss_pred EEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeEecCCCcEEEeeeccc
Q 022617 86 IETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 86 ~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di-~p~nili~~~~~~~l~dfg~~ 164 (294)
+..+++|||+.|++|... . +.. ...++.+++.+|.+||+.||+|+|| ||+||+++.++.++|+|||++
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999899632 1 111 2467889999999999999999999 999999999999999999999
Q ss_pred ccccCCCcc---------ccccCCCcccCCcccc
Q 022617 165 NIMRDGHFL---------KTSCGSPNYAAPEVIS 189 (294)
Q Consensus 165 ~~~~~~~~~---------~~~~~~~~~~aPE~~~ 189 (294)
......... ....+++.|++||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 865433211 1234567789999874
No 414
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.93 E-value=1.6e-27 Score=206.37 Aligned_cols=242 Identities=31% Similarity=0.544 Sum_probs=207.0
Q ss_pred cccccCceEEEEEEE---ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEecc
Q 022617 24 TLGIGSFGKVKIAEH---ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~---~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~ 99 (294)
.+|.|.+|.|+++.- ...++.+++|+..+......... .-..|-.++...+ ||.+++++..++.+...+++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 368899999987642 34567788888766544433322 4445667777776 999999999999999999999999
Q ss_pred CCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCC
Q 022617 100 KSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS 179 (294)
Q Consensus 100 ~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 179 (294)
.|+.|...+.....+.+.....+...++-++.++|+.+++|+|+|++||+++.+|++++.|||++...-..... +|+
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt 156 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGT 156 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccc
Confidence 99999999888888889999999999999999999999999999999999999999999999998766443332 789
Q ss_pred CcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCC
Q 022617 180 PNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR 259 (294)
Q Consensus 180 ~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 259 (294)
..|||||+.. .+..+.|.||+|+++++|++|..||.. +....|.+....+|...+...++++..++..+|.+|
T Consensus 157 ~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nr 229 (612)
T KOG0603|consen 157 YEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENR 229 (612)
T ss_pred hhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHH
Confidence 9999999998 236789999999999999999999987 777888888899999999999999999999999999
Q ss_pred CC-----HhHHhcCCcccccCC
Q 022617 260 IT-----IPEIRQHPWFQAHLP 276 (294)
Q Consensus 260 ps-----~~~il~h~~~~~~~~ 276 (294)
.- +.++++|+||+.+.-
T Consensus 230 Lg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 230 LGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hccCcchhHHHhccchheeeeH
Confidence 86 479999999988743
No 415
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.93 E-value=2e-25 Score=176.84 Aligned_cols=176 Identities=16% Similarity=0.152 Sum_probs=136.3
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHH------HHHHHHHHHhCCCCceeEEEEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK------VRREIKILRLFMHPHIIRLYEVI 86 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~~ 86 (294)
+.+.++|++.+.+|.|+||.||++.+ ++..+++|++............. +.+|+..+.++.|+++..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 46789999999999999999999765 46689999997665444333333 57899999999999999998886
Q ss_pred EcC--------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617 87 ETP--------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 87 ~~~--------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l 158 (294)
... +..+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|+|++|+||+++.+| ++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l 175 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI 175 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence 533 35789999999999988742 233 2456999999999999999999999999999988 999
Q ss_pred eeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHH
Q 022617 159 ADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 211 (294)
Q Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~ 211 (294)
+|||............. ......+ ..++|+|+||+++....
T Consensus 176 iDfg~~~~~~e~~a~d~-----------~vler~y-~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 176 IDLSGKRCTAQRKAKDR-----------IDLERHY-GIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EECCCcccccchhhHHH-----------HHHHhHh-cccccccceeEeehHHH
Confidence 99998765432221111 2222334 37899999999887654
No 416
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.92 E-value=1.9e-24 Score=169.30 Aligned_cols=144 Identities=22% Similarity=0.247 Sum_probs=113.1
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccchH-----------------------HHHHHHHHHHHHHhCCCC
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-----------------------MEEKVRREIKILRLFMHP 77 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~ 77 (294)
+...||+|++|.||+|.+. +|+.|++|++......... .......|++.+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3568999999999999997 8999999999765321111 012334599999999887
Q ss_pred ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCeEecCCCcE
Q 022617 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L-h~~~i~h~di~p~nili~~~~~~ 156 (294)
++..+..+... ..+++|||++|+++........+++...+..++.|++.+|.++ |+.|++|+||||+||++++ +.+
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~v 156 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GKL 156 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-CcE
Confidence 76444333222 2379999999877766544567899999999999999999999 7999999999999999984 689
Q ss_pred EEeeeccccccc
Q 022617 157 KIADFGLSNIMR 168 (294)
Q Consensus 157 ~l~dfg~~~~~~ 168 (294)
+|+|||++....
T Consensus 157 ~LiDFG~a~~~~ 168 (190)
T cd05147 157 YIIDVSQSVEHD 168 (190)
T ss_pred EEEEccccccCC
Confidence 999999987543
No 417
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.91 E-value=1.2e-24 Score=170.92 Aligned_cols=241 Identities=23% Similarity=0.374 Sum_probs=192.0
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+...+..+|.....|..|++++. |..++.|++....... ....++..|+-.|+-+.||||+++++.|.++-.+.++.
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~is 266 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIIS 266 (448)
T ss_pred hhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEee
Confidence 45566788899999999999985 4557788876665544 23567888999999999999999999999999999999
Q ss_pred eccCCCChHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEe--eecccccccCC
Q 022617 97 EYVKSGELFDYIVEKGR--LQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIA--DFGLSNIMRDG 170 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~--l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~--dfg~~~~~~~~ 170 (294)
.|++.+||...+..... .+..++.+++.+++.+++|||+.. |.--.+....++|+++-+.+|+ |--++...
T Consensus 267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--- 343 (448)
T ss_pred eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec---
Confidence 99999999999975433 677789999999999999999875 4445788999999998766554 32222111
Q ss_pred CccccccCCCcccCCccccCCcc--CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hCCCccCCCCCChhHHH
Q 022617 171 HFLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARD 246 (294)
Q Consensus 171 ~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~ 246 (294)
....-.+.|++||.++..+. +-.++|+|||++++||+.|...||....+-+.--++ ..-....|++.+..+..
T Consensus 344 ---~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~k 420 (448)
T KOG0195|consen 344 ---VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNK 420 (448)
T ss_pred ---cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHH
Confidence 12234678999999875433 246789999999999999999999887665544433 34457889999999999
Q ss_pred HHHHhcccCCCCCCCHhHHh
Q 022617 247 LIPRMLIVDPMKRITIPEIR 266 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il 266 (294)
++.-|++.||.+||.+..|+
T Consensus 421 lm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 421 LMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHhcCCCCcCCCcceeh
Confidence 99999999999999988764
No 418
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.90 E-value=5.9e-23 Score=161.44 Aligned_cols=145 Identities=17% Similarity=0.214 Sum_probs=114.7
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccch-----------------------HHHHHHHHHHHHHHhCCCC
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----------------------EMEEKVRREIKILRLFMHP 77 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~~~ 77 (294)
+...||+|++|.||+|.+. +|+.|++|++........ .....+..|+..+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999876521100 0122346789999999999
Q ss_pred ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcE
Q 022617 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~ 156 (294)
++..+..+.... .+++|||++|+++.........++......++.|++.++.++|. .|++|+||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 875554443332 47999999987665443345678889999999999999999999 9999999999999999 7899
Q ss_pred EEeeecccccccC
Q 022617 157 KIADFGLSNIMRD 169 (294)
Q Consensus 157 ~l~dfg~~~~~~~ 169 (294)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999976543
No 419
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.89 E-value=2.4e-23 Score=189.45 Aligned_cols=222 Identities=36% Similarity=0.607 Sum_probs=172.1
Q ss_pred CccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC
Q 022617 11 GVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPS 90 (294)
Q Consensus 11 ~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 90 (294)
.-.-...+|..++.|..|++|.||+++|+.+.++|++|+ .+.. .+.+- ++..-..|.++
T Consensus 77 ~~~p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--------lilRn--ilt~a~npfvv---------- 135 (1205)
T KOG0606|consen 77 RRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--------LILRN--ILTFAGNPFVV---------- 135 (1205)
T ss_pred ccCCCccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--------hhhhc--cccccCCccee----------
Confidence 344566789999999999999999999999999999954 2221 11111 12222222222
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccccCC
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG 170 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~ 170 (294)
++-...++.-++++.+. +.++.|||+.||+|+|++|+|.+|+.-|++|+.|||++......
T Consensus 136 -----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 -----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred -----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 24444455555555443 78899999999999999999999999999999999987543211
Q ss_pred C---------------ccccc-cCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCc
Q 022617 171 H---------------FLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY 234 (294)
Q Consensus 171 ~---------------~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~ 234 (294)
. ...+. ++++.|.|||++....| +...|+|+||+++|+.+-|..||.+...++++..+..+..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 1 11222 68999999999988878 7889999999999999999999999999999998877765
Q ss_pred cCCC---CCChhHHHHHHHhcccCCCCCC---CHhHHhcCCcccc
Q 022617 235 TLPS---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQA 273 (294)
Q Consensus 235 ~~~~---~~~~~l~~li~~~l~~~p~~Rp---s~~~il~h~~~~~ 273 (294)
..+. .++++.++++.++|+.+|..|. .+.++..|+||+.
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 5553 5788999999999999999997 4668889999975
No 420
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.89 E-value=5.1e-22 Score=154.26 Aligned_cols=189 Identities=16% Similarity=0.118 Sum_probs=138.9
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccch-HHHHHHHHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMH-PHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~ 96 (294)
..+...|++|+||+||.+.. .+.+++.+.+.....-.. -....+.+|++++++|.| +++++++++ +..+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678899999999997765 667788776644332111 122357899999999964 789999886 4568999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeEecCCCcEEEeeecccccccCCCcc--
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGHFL-- 173 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di-~p~nili~~~~~~~l~dfg~~~~~~~~~~~-- 173 (294)
+|+.|.+|...+.. ....++.|++.++.++|+.|++|+|| +|+||+++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999888754321 12357789999999999999999999 799999999999999999999754432210
Q ss_pred ------------ccccCCCcccCCccccCC-ccCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 022617 174 ------------KTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTLPFDDE 220 (294)
Q Consensus 174 ------------~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~p~~~~ 220 (294)
.....++.+++|+...-- ...-.+.++++.|.-+|.++|+..+...+
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 011246677777654322 12126789999999999999998886443
No 421
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.89 E-value=2.1e-22 Score=186.01 Aligned_cols=243 Identities=22% Similarity=0.298 Sum_probs=187.0
Q ss_pred CCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcC
Q 022617 10 SGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETP 89 (294)
Q Consensus 10 ~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 89 (294)
..+..-+..|.|.+.||.|++|.||.|.+.+ ++.||||+-.....-+-.....+...++ .+ --+.|+.+...+.-.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQ 766 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccC
Confidence 3456667899999999999999999999876 9999999987766554444444444444 11 124566666666667
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-------CCcEEEeeec
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIADFG 162 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-------~~~~~l~dfg 162 (294)
+..++++||.+.|||.+++...+.+++..+..++.|++..+..||..+|+||||||+|+++.. ...++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 888899999999999999998888999999999999999999999999999999999999942 2359999999
Q ss_pred cccc---ccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCC
Q 022617 163 LSNI---MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 239 (294)
Q Consensus 163 ~~~~---~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
.+.. +.+.......+.+-.+-.+|.+.+.++ ++.+|.|+|+.+++-|+.|+.. +...........+
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~----------q~~~g~~~~~~~~ 915 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM----------EVKNGSSWMVKTN 915 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH----------HhcCCcceecccc
Confidence 8754 345666777888999999999999999 8999999999999999998532 1122222222222
Q ss_pred CC-----hhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 240 LS-----PGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 240 ~~-----~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
++ .....++..+|+.|-..-|.+.+|..
T Consensus 916 ~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 916 FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred chhhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 22 23457888899866666666666543
No 422
>PRK10345 hypothetical protein; Provisional
Probab=99.86 E-value=1.4e-20 Score=148.80 Aligned_cols=138 Identities=27% Similarity=0.399 Sum_probs=107.7
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-----CCCceeEEEEEEEcCC---
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-----MHPHIIRLYEVIETPS--- 90 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~--- 90 (294)
..-.+.||+|+++.||. +..++.. +||++..... ...+.+.+|+..++.+ .||||++++++++++.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 34567899999999995 7767665 6998865432 2346789999999999 5799999999998874
Q ss_pred eEE-EEEec--cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCeEecC----CCcEEEee-e
Q 022617 91 DIY-VVMEY--VKSGELFDYIVEKGRLQEDEARNFFQQIISGV-EYCHRNMVVHRDLKPENLLLDS----KWNVKIAD-F 161 (294)
Q Consensus 91 ~~~-lv~e~--~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l-~~Lh~~~i~h~di~p~nili~~----~~~~~l~d-f 161 (294)
.++ +|+|| +.++||.+++++. .+++. ..++.+++.++ .|||+.+|+|+||||+||+++. ++.++|+| |
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 333 78999 4478999999653 45555 35577777777 9999999999999999999974 33799999 5
Q ss_pred cccc
Q 022617 162 GLSN 165 (294)
Q Consensus 162 g~~~ 165 (294)
|...
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 5443
No 423
>smart00090 RIO RIO-like kinase.
Probab=99.86 E-value=5.7e-21 Score=154.58 Aligned_cols=145 Identities=19% Similarity=0.206 Sum_probs=115.5
Q ss_pred CCcccccccccCceEEEEEE-EccCCceEEEEEeecccccch---------------------HHHHHHHHHHHHHHhCC
Q 022617 18 NYKLGKTLGIGSFGKVKIAE-HALTGHKVAIKILNRRKIKNM---------------------EMEEKVRREIKILRLFM 75 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~-~~~~~~~~~~K~~~~~~~~~~---------------------~~~~~~~~e~~~l~~l~ 75 (294)
-|++.+.||.|++|.||+|. +..+|+.|++|++........ .....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 667899999999875432100 01234578999999997
Q ss_pred CC--ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeEecC
Q 022617 76 HP--HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNM-VVHRDLKPENLLLDS 152 (294)
Q Consensus 76 ~~--~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~-i~h~di~p~nili~~ 152 (294)
+. .++++++. ...++||||++|.+|.........+.......++.|++.++.+||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34555543 234799999999888776544555667778899999999999999999 99999999999999
Q ss_pred CCcEEEeeecccccc
Q 022617 153 KWNVKIADFGLSNIM 167 (294)
Q Consensus 153 ~~~~~l~dfg~~~~~ 167 (294)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 789999999988654
No 424
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.85 E-value=1.1e-20 Score=156.03 Aligned_cols=187 Identities=26% Similarity=0.424 Sum_probs=142.9
Q ss_pred CCCceeEEEEEEEc---------------------------CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHH
Q 022617 75 MHPHIIRLYEVIET---------------------------PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQII 127 (294)
Q Consensus 75 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~ 127 (294)
+||||+++.+.|.+ +..+|++|..+.. ||..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 49999999877632 3468999999865 999999654 457778888999999
Q ss_pred HHHHHHHhCCceecCCCCCCeEec--CCC--cEEEeeecccccccC-------CCccccccCCCcccCCccccCCc----
Q 022617 128 SGVEYCHRNMVVHRDLKPENLLLD--SKW--NVKIADFGLSNIMRD-------GHFLKTSCGSPNYAAPEVISGKL---- 192 (294)
Q Consensus 128 ~~l~~Lh~~~i~h~di~p~nili~--~~~--~~~l~dfg~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~---- 192 (294)
+++.|||++|+.|+|+|.+||++. +|+ .+.++|||.+-.-.. ........|...-+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999994 333 478899997643221 11222334677889999875322
Q ss_pred -cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHh
Q 022617 193 -YAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP 263 (294)
Q Consensus 193 -~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 263 (294)
.+-.++|.|+.|.+.||+++...||....... ...-.....+.+|+.+++.+++++...|+.||++|++..
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 22357999999999999999999997733211 111123445678889999999999999999999999944
No 425
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.84 E-value=1.8e-19 Score=144.31 Aligned_cols=138 Identities=24% Similarity=0.333 Sum_probs=114.9
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 96 (294)
++.||+|++|.||+|.+ .+..+++|+......... .....+.+|+.++..+.++++..+..++...+..+++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 36789999999999987 667899998654332221 12346778999999999999887777776777889999
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
||++|++|.+++..... ....++.+++.++.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865432 7889999999999999999999999999999999 77899999998864
No 426
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.82 E-value=9.6e-20 Score=157.99 Aligned_cols=197 Identities=27% Similarity=0.466 Sum_probs=157.2
Q ss_pred HHhCCCCceeEEEEEEEcCCeEEEEEeccCCCChHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCe
Q 022617 71 LRLFMHPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVE-KGRLQEDEARNFFQQIISGVEYCHRNMV-VHRDLKPENL 148 (294)
Q Consensus 71 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~l~~~~~~~~~~ql~~~l~~Lh~~~i-~h~di~p~ni 148 (294)
|+.+.|.|+.++++.+......+.+++||.-|+|.+.+.. .-.++......++++++.++.|||+..| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999976 3468888899999999999999998875 9999999999
Q ss_pred EecCCCcEEEeeecccccccC---CCccccccCCCcccCCccccCCcc------CCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617 149 LLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYALLCGTLPFDD 219 (294)
Q Consensus 149 li~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~ll~~l~~g~~p~~~ 219 (294)
+++....+|++|||+...... ............|.|||.+..... .+.+.|+||+|++++++++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876642 111122234557999999865311 25679999999999999999999965
Q ss_pred C----CHHHHHHHHhC-CCccCCC------CCChhHHHHHHHhcccCCCCCCCHhHHhc
Q 022617 220 E----NIPNLFKKIKG-GIYTLPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQ 267 (294)
Q Consensus 220 ~----~~~~~~~~~~~-~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~il~ 267 (294)
. ...+....+.+ +...+.+ ..++++..++..||..+|.+||++.++-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 2 22345555555 2221111 34557999999999999999999998754
No 427
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.81 E-value=4.7e-19 Score=140.57 Aligned_cols=133 Identities=23% Similarity=0.301 Sum_probs=107.5
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccc-----hHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEec
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-----MEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
.||+|++|.||++.+ ++..+++|+........ ......+.+|+++++.+.++++..+..++......+++||+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 56789999865432221 11236678899999999988765555555566677899999
Q ss_pred cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
++|++|.+++..... .++.+++.++.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998754321 8889999999999999999999999999999 78999999998865
No 428
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.80 E-value=2.4e-20 Score=159.23 Aligned_cols=174 Identities=27% Similarity=0.457 Sum_probs=138.7
Q ss_pred CeEEEEEeccCCCChHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKG---RLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~---~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
.++++.|++|...+|.+|+.++. ..+......++.|+..++.| +|.+|+|++|.||+...+..++|+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35889999999999999997543 36677888999999999999 9999999999999999999999999999876
Q ss_pred ccCCC-------ccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhCCCcc--C
Q 022617 167 MRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT--L 236 (294)
Q Consensus 167 ~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~~~~~~~~~~--~ 236 (294)
..... .+....++..|++||.+.+..+ +.++|||+||+++++++. -...+ ........+..+.++ +
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCChHH
Confidence 65444 4556779999999999999988 899999999999999996 22222 222333344555544 3
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 237 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..+++.+ ..|+.+||...|.+||++.+.--|+|.
T Consensus 482 ~~d~p~e-~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDYPEE-YTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCcHH-HHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 3445544 589999999999999977776667664
No 429
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.80 E-value=7.7e-19 Score=139.12 Aligned_cols=141 Identities=21% Similarity=0.297 Sum_probs=109.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccch-------------------HHHHHHHHHHHHHHhCCCC-
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-------------------EMEEKVRREIKILRLFMHP- 77 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-------------------~~~~~~~~e~~~l~~l~~~- 77 (294)
.|.+.+.||.|++|.||++.+. +++.+++|++........ ........|+.++..+.++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888999999999999999875 799999999764321100 0112356788888888776
Q ss_pred -ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcE
Q 022617 78 -HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNV 156 (294)
Q Consensus 78 -~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~ 156 (294)
.++.+++. ...+++|||++|++|..+... .....++.+++.++.++|+.|++|+||+|+||++++++.+
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44444432 345899999999988776421 3456788999999999999999999999999999999999
Q ss_pred EEeeecccccccC
Q 022617 157 KIADFGLSNIMRD 169 (294)
Q Consensus 157 ~l~dfg~~~~~~~ 169 (294)
+|+|||.+.....
T Consensus 165 ~liDfg~~~~~~~ 177 (198)
T cd05144 165 YIIDWPQMVSTDH 177 (198)
T ss_pred EEEECCccccCCC
Confidence 9999999865433
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.79 E-value=1.2e-17 Score=151.38 Aligned_cols=139 Identities=20% Similarity=0.237 Sum_probs=112.4
Q ss_pred cCCcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----chHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCe
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----NMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSD 91 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 91 (294)
..|...+.||+|++|+||++.+.. ..+++|+....... .......+.+|+++++.++|++++.+..++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345678999999999999998743 34455543222111 11234568899999999999999888777777778
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
.+++|||++|++|.+++. ....++.+++.++.+||+.|++|+||+|+||++ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 356789999999999999999999999999999 577999999999865
No 431
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.77 E-value=3.6e-20 Score=167.50 Aligned_cols=258 Identities=34% Similarity=0.570 Sum_probs=209.0
Q ss_pred cccCCcccccccccCceEEEEEEEccCC-ceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTG-HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDI 92 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 92 (294)
-...|.+.+.||.|.++.|-.+....+. ..++.|.+.... ........+..|..+-..+. |+|++..++....++..
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 4678999999999999999888764333 345666654443 23344566667888878887 99999999999999999
Q ss_pred EEEEeccCCCChHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCC-cEEEeeeccccccc
Q 022617 93 YVVMEYVKSGELFDYI-VEKG-RLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKW-NVKIADFGLSNIMR 168 (294)
Q Consensus 93 ~lv~e~~~~~sL~~~l-~~~~-~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~-~~~l~dfg~~~~~~ 168 (294)
++..++..|+++.+-+ .... ..+.......+.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999988 5444 5677788899999999999999 99999999999999999999 99999999998765
Q ss_pred C-C---CccccccC-CCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhCC----CccCCC
Q 022617 169 D-G---HFLKTSCG-SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGG----IYTLPS 238 (294)
Q Consensus 169 ~-~---~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~----~~~~~~ 238 (294)
. . .......+ ++.|.|||...+..+..+..|+||.|+++.-+++|..||......... ...... ....+.
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 5 2 22334456 899999999988767688999999999999999999999764433311 111111 244556
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 239 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
..+....+++.+++..+|..|.+.+++-.+||+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 78888999999999999999999999999999988
No 432
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.76 E-value=9.2e-18 Score=131.79 Aligned_cols=139 Identities=21% Similarity=0.312 Sum_probs=99.9
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHH---------------------HHHHHHHHHhCCCCc-
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEK---------------------VRREIKILRLFMHPH- 78 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~~~~- 78 (294)
+.+.||+|++|+||+|.+. +++.|++|++............. ...|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 78999999986543221111111 135566666665433
Q ss_pred -eeEEEEEEEcCCeEEEEEeccCCCChHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCc
Q 022617 79 -IIRLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWN 155 (294)
Q Consensus 79 -i~~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~ 155 (294)
++++++. ...++++||++++++.. .+.... . ......++.+++.++.++|. .|++|+||+|+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 4555543 23589999999843321 121111 1 16688999999999999999 9999999999999999 889
Q ss_pred EEEeeecccccc
Q 022617 156 VKIADFGLSNIM 167 (294)
Q Consensus 156 ~~l~dfg~~~~~ 167 (294)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998654
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.74 E-value=7e-17 Score=131.04 Aligned_cols=138 Identities=19% Similarity=0.273 Sum_probs=105.6
Q ss_pred ccccc-ccCceEEEEEEEccCCceEEEEEeecccc-----c-----chHHHHHHHHHHHHHHhCCCCce--eEEEEEEEc
Q 022617 22 GKTLG-IGSFGKVKIAEHALTGHKVAIKILNRRKI-----K-----NMEMEEKVRREIKILRLFMHPHI--IRLYEVIET 88 (294)
Q Consensus 22 ~~~lg-~g~~~~vy~~~~~~~~~~~~~K~~~~~~~-----~-----~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~ 88 (294)
...|| .||.|+||.+... +..++||.+..... . .......+.+|+.++.++.|+++ +.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34576 7888899988763 67899998854321 0 11234567889999999998775 677766433
Q ss_pred CC----eEEEEEeccCC-CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 89 PS----DIYVVMEYVKS-GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 89 ~~----~~~lv~e~~~~-~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
.. ..++++|+++| .+|.+++.. .++++.. +.+++.++.+||+.||+|+||+|.||+++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 22 23599999987 689888754 4555543 56899999999999999999999999999988999999998
Q ss_pred ccc
Q 022617 164 SNI 166 (294)
Q Consensus 164 ~~~ 166 (294)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
No 434
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.72 E-value=3.3e-16 Score=137.80 Aligned_cols=231 Identities=19% Similarity=0.274 Sum_probs=160.8
Q ss_pred CcccccccccCceEEE-EEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 19 YKLGKTLGIGSFGKVK-IAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy-~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
|++ +...-++.+ +| .|..+.++.++.+.++....- .....+.+.++.++.++||||+++++.++..+.+|+|+|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 444 444444444 44 566777889999998865432 445678889999999999999999999999999999999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCCcEEEeeecccccccCCCc-ccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKT 175 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 175 (294)
.+. .|...+++.+ ...+...+.||+.||.+|| +.+++|++|+-..|+++..|.++|++|..+........ ...
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~ 164 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKS 164 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccccc
Confidence 984 7888887643 7778888999999999998 66799999999999999999999999998765543321 112
Q ss_pred ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHHHHHhcccC
Q 022617 176 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 255 (294)
Q Consensus 176 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 255 (294)
...-..|..|+...... ...|.|.||+++++++.|..+ .... .......+.....+..+-+--.
T Consensus 165 ~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~~~-----------~~~~~~ipk~~~~~~~k~~~~~ 228 (690)
T KOG1243|consen 165 LYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TKTD-----------LSNTGKIPKALIELYCKKLGAT 228 (690)
T ss_pred chhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cchh-----------hhccCccchhHHHHHHHHhccc
Confidence 22233456666543332 357999999999999998222 1110 1111233444444444444445
Q ss_pred CCCCCCHhH-----HhcCCcccccC
Q 022617 256 PMKRITIPE-----IRQHPWFQAHL 275 (294)
Q Consensus 256 p~~Rps~~~-----il~h~~~~~~~ 275 (294)
+..||.... .+-|+||++.+
T Consensus 229 ~~~r~n~~~~~~~~~~~~gff~n~f 253 (690)
T KOG1243|consen 229 ELKRPNKLRFILECRLLGGFFRNDF 253 (690)
T ss_pred cccccchhhHHHHHHhccccccchH
Confidence 556665222 23388887754
No 435
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.70 E-value=2e-16 Score=119.59 Aligned_cols=132 Identities=23% Similarity=0.293 Sum_probs=111.2
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC--CceeEEEEEEEcCCeEEEEEec
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH--PHIIRLYEVIETPSDIYVVMEY 98 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~ 98 (294)
+++.|+.|.++.||++.+.. ..+++|....... ...+.+|+..++.+.+ .++++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 56789999999999999743 6799999754432 4578889999999976 5899999888877889999999
Q ss_pred cCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 99 VKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN---MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 99 ~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~---~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
++|.++..+ +......++.+++.+++.||.. +++|+|++|.||++++++.++++||+.+..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 988777654 5566778889999999999985 699999999999999988999999998753
No 436
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.68 E-value=1.2e-17 Score=135.12 Aligned_cols=236 Identities=19% Similarity=0.259 Sum_probs=160.5
Q ss_pred EEEEEEEccCCceEEEEEeecccccch-HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCC-----eEEEEEeccCCCChH
Q 022617 32 KVKIAEHALTGHKVAIKILNRRKIKNM-EMEEKVRREIKILRLFMHPHIIRLYEVIETPS-----DIYVVMEYVKSGELF 105 (294)
Q Consensus 32 ~vy~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~sL~ 105 (294)
.||++-++..|..++-..+......+. ........-+..+-.+-|.|+++++.||.+.+ ...+++||+..+++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 346666666665554433332222211 12233344455566677999999999986543 478899999999999
Q ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeEecCCCcEEEeeecccccccC-----CCccc
Q 022617 106 DYIVEK----GRLQEDEARNFFQQIISGVEYCHRNM--VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLK 174 (294)
Q Consensus 106 ~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~~--i~h~di~p~nili~~~~~~~l~dfg~~~~~~~-----~~~~~ 174 (294)
.+|++. ..+......+|+-||+.||.|||+.. |+|+++..+.|+++.+|-+|++--........ .....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 999753 45788888899999999999999875 99999999999999998888764332221110 11122
Q ss_pred cccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhCCCccCCCCCChhHHHHHHHhcc
Q 022617 175 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 253 (294)
Q Consensus 175 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 253 (294)
...+.++|.+||.=..... .-++|||++|+...+|.-+..--.... .....+.+....+.+..+. -+.++..|++
T Consensus 241 ~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~len~l---qr~~i~kcl~ 316 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLENGL---QRGSITKCLE 316 (458)
T ss_pred ccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeeccCcc---ccCcCccccc
Confidence 3345778999997554444 467999999999999987765533222 2222223333333322222 2467889999
Q ss_pred cCCCCCCCHhHHhcCCcc
Q 022617 254 VDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 254 ~~p~~Rps~~~il~h~~~ 271 (294)
..|..||++++++.||.+
T Consensus 317 ~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 317 GEPNGRPDARLLLFHPLL 334 (458)
T ss_pred CCCCCCcchhhhhcCcee
Confidence 999999999999999986
No 437
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.67 E-value=8e-17 Score=140.12 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=195.6
Q ss_pred cccccCCcccccccc--cCceEEEEEEE--ccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEE
Q 022617 13 DMFLPNYKLGKTLGI--GSFGKVKIAEH--ALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIE 87 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~--g~~~~vy~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 87 (294)
.-+...+.+.+.+|. |.+|.+|.+.. ..++..+++|.-........ ....-.+|+.-.++++ |++.++.+..++
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~-~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPL-DSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcc-ccccccchhhcccccCccccccccCcccc
Confidence 345567888899999 99999999988 88889999998433322111 1222334555555554 889999888999
Q ss_pred cCCeEEEEEeccCCCChHHHHHHhC-CCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCeEecCC-CcEEEeee
Q 022617 88 TPSDIYVVMEYVKSGELFDYIVEKG-RLQEDEARNFFQQIIS----GVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADF 161 (294)
Q Consensus 88 ~~~~~~lv~e~~~~~sL~~~l~~~~-~l~~~~~~~~~~ql~~----~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~df 161 (294)
..+..++-+|.++ .+|..+...-. .+++..++..+.+..+ |+.++|..+++|.|++|.||+...+ ..++++||
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCc
Confidence 9999999999995 58887776543 4889999999999999 9999999999999999999999999 88999999
Q ss_pred cccccccCCCccc-----c-ccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhC-CCc
Q 022617 162 GLSNIMRDGHFLK-----T-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG-GIY 234 (294)
Q Consensus 162 g~~~~~~~~~~~~-----~-~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-~~~ 234 (294)
++...+....... . ..+...|++||...+.. +..+|+|+||.++.+..++..+........+.+.-.. ...
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 9987776554221 1 15678999999987664 6889999999999998887666543311111111000 111
Q ss_pred cCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcccccC
Q 022617 235 TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 275 (294)
Q Consensus 235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~~ 275 (294)
++-...+.++...+..|++.+|..|++++.+++++++..-+
T Consensus 346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchh
Confidence 22345567788899999999999999999999999998543
No 438
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.60 E-value=3.7e-14 Score=110.32 Aligned_cols=143 Identities=17% Similarity=0.203 Sum_probs=103.3
Q ss_pred cccccccCceEEEEEEEcc------CCceEEEEEeeccccc--c-----------------hHHHHH----HHHHHHHHH
Q 022617 22 GKTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIK--N-----------------MEMEEK----VRREIKILR 72 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~--~-----------------~~~~~~----~~~e~~~l~ 72 (294)
...||.|..+.||.|.... .+..+|+|++...... . ...... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 3478999998633211 0 011223 337999999
Q ss_pred hCCC--CceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCeE
Q 022617 73 LFMH--PHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYC-HRNMVVHRDLKPENLL 149 (294)
Q Consensus 73 ~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L-h~~~i~h~di~p~nil 149 (294)
++.. -+++.++++ ..-+++||++++..+....-++..++.+....+..+++.++..| |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8875 456677764 45678999997643322222233456667778889999999988 8999999999999999
Q ss_pred ecCCCcEEEeeecccccccC
Q 022617 150 LDSKWNVKIADFGLSNIMRD 169 (294)
Q Consensus 150 i~~~~~~~l~dfg~~~~~~~ 169 (294)
+++ +.+.|+|||.+.....
T Consensus 158 ~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 158 WHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEC-CcEEEEECCCceeCCC
Confidence 974 5899999998876543
No 439
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.59 E-value=3.1e-14 Score=125.23 Aligned_cols=148 Identities=21% Similarity=0.295 Sum_probs=98.9
Q ss_pred ccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchH-------------------------------HH---
Q 022617 16 LPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME-------------------------------ME--- 61 (294)
Q Consensus 16 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~-------------------------------~~--- 61 (294)
...|. .+.||+|++|.||+|..+ +|+.|+||+..+.-..... ..
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 33444 367999999999999975 7899999998543111000 00
Q ss_pred ---HHHHHHHHHHHhC----C-CCceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHh-CCCCHHHHHHHHHHHHH-HHH
Q 022617 62 ---EKVRREIKILRLF----M-HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEK-GRLQEDEARNFFQQIIS-GVE 131 (294)
Q Consensus 62 ---~~~~~e~~~l~~l----~-~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~l~~~~~~~~~~ql~~-~l~ 131 (294)
-++.+|...+.++ + ++++.-..-+.......+++|||++|.+|.++.... ...+ ...++.+++. .+.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence 0133344444443 2 233322222223344568999999999998876432 1222 3345556555 467
Q ss_pred HHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 132 YCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 132 ~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
.+|..|++|+|++|.||+++.+++++++|||++....
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999999987654
No 440
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.56 E-value=1.9e-15 Score=138.71 Aligned_cols=259 Identities=28% Similarity=0.432 Sum_probs=200.1
Q ss_pred cccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEE
Q 022617 15 FLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 94 (294)
-.+.+.+.+-+.++.++.+..+.-..++..+..|+......-.....+.+..+-.++-...+|.++.....+......++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34567777788999999999998777776666666533322111122333333333333334555554444555677899
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc------
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------ 168 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~------ 168 (294)
++++.++++|...+.+.+..+.+-....+..+.+++.+||...+.|+|++|.|.++..+++..+.+|+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99999999999999887878888888899999999999999999999999999999999999999997321110
Q ss_pred --------------------------CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Q 022617 169 --------------------------DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI 222 (294)
Q Consensus 169 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~ 222 (294)
+........+++.|.+||...+... ...+|+|+.|.++++.++|..||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0011122347889999999988877 7889999999999999999999999999
Q ss_pred HHHHHHHhCCCccCC---CCCChhHHHHHHHhcccCCCCCCCHh---HHhcCCccccc
Q 022617 223 PNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAH 274 (294)
Q Consensus 223 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~---~il~h~~~~~~ 274 (294)
+...+++.....+.+ ...+.+.++++...+..+|.+|..+. +.-.|+||+..
T Consensus 1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 999998888776554 35788999999999999999999988 88999999764
No 441
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.55 E-value=8.4e-15 Score=130.43 Aligned_cols=149 Identities=23% Similarity=0.340 Sum_probs=96.7
Q ss_pred ccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccc---------------------------h----HH
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---------------------------M----EM 60 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---------------------------~----~~ 60 (294)
++.+...|.. +.||+|++|+||+|..+.+|+.||||+..+.-... . +.
T Consensus 115 ~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~ 193 (537)
T PRK04750 115 VEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEF 193 (537)
T ss_pred HHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHH
Confidence 4456677887 89999999999999998779999999986441100 0 11
Q ss_pred HHHHH------HHHHHHHhCC----CCceeEEEEE-EEcCCeEEEEEeccCCCChHHHH--HHhCC----CCHHHHHHHH
Q 022617 61 EEKVR------REIKILRLFM----HPHIIRLYEV-IETPSDIYVVMEYVKSGELFDYI--VEKGR----LQEDEARNFF 123 (294)
Q Consensus 61 ~~~~~------~e~~~l~~l~----~~~i~~~~~~-~~~~~~~~lv~e~~~~~sL~~~l--~~~~~----l~~~~~~~~~ 123 (294)
.+.+. +|...+.++. +...+.+=.+ .......+++|||+.|+++.+.- ...+. +.+..+..++
T Consensus 194 ~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 194 EKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH
Confidence 12222 3333333332 3322222222 22345678999999999998742 22221 2222222333
Q ss_pred HHHHHHHHHHHhCCceecCCCCCCeEecCCC----cEEEeeeccccccc
Q 022617 124 QQIISGVEYCHRNMVVHRDLKPENLLLDSKW----NVKIADFGLSNIMR 168 (294)
Q Consensus 124 ~ql~~~l~~Lh~~~i~h~di~p~nili~~~~----~~~l~dfg~~~~~~ 168 (294)
. .+...|++|+|++|.||+++.++ +++++|||++....
T Consensus 274 ~-------Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 T-------QVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------HHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3 34569999999999999999888 99999999987653
No 442
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.54 E-value=2.2e-13 Score=102.62 Aligned_cols=135 Identities=22% Similarity=0.326 Sum_probs=106.9
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHH-----HHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEEEe
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME-----EKVRREIKILRLFMHPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~-----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 97 (294)
..+.+|+-+.+|.+.. -+.++++|.-.+..+...+.. ..-.+|..+++++..-++..+.-+..++....++||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 344588888665555544433 445578999999887777777777777888889999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
|.+|..|.+.+... ...++..+-..+.-||..||+|||+.++||++..++ +.++|||++...
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998999888655 255666777778889999999999999999998874 999999998743
No 443
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.50 E-value=1.8e-14 Score=125.61 Aligned_cols=255 Identities=18% Similarity=0.156 Sum_probs=184.6
Q ss_pred ccccccCCcccccccccCceEEEEEEEc-cCCceEEEEEeecccccchHHHHHHHHHHHHHHhC-CCCceeEEEEEEEcC
Q 022617 12 VDMFLPNYKLGKTLGIGSFGKVKIAEHA-LTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLF-MHPHIIRLYEVIETP 89 (294)
Q Consensus 12 ~~~~~~~y~~~~~lg~g~~~~vy~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 89 (294)
.-....+|..+..||.+.++.|+.+.-+ .++..|++|............+. -..|..+...+ .|.+++.....|...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccc
Confidence 4456778999999999999999987644 56667888876544333322222 23344444444 478888877777777
Q ss_pred CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCC-CcEEEeeeccccccc
Q 022617 90 SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSK-WNVKIADFGLSNIMR 168 (294)
Q Consensus 90 ~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~-~~~~l~dfg~~~~~~ 168 (294)
...++--|||.++++...+.....+.+..++++..|++.++.++|+..++|.|++|+||++..+ +..+++||+......
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 8888999999998888777555668899999999999999999999999999999999999886 778899998876421
Q ss_pred CCCccccccCCCccc-CCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617 169 DGHFLKTSCGSPNYA-APEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
- .........++. ..|++........+.|+++||..+.+..++...-.. ......+..+..+...+....+..+
T Consensus 419 ~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~~ 493 (524)
T KOG0601|consen 419 F--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQVL 493 (524)
T ss_pred e--ecccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhhh
Confidence 1 111111222344 255555444447899999999999999987543222 1222334555555556666888999
Q ss_pred HHHhcccCCCCCCCHhHHhcCCccc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQ 272 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~ 272 (294)
.+.+...++..||.+.++..|.=|.
T Consensus 494 ~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999988876543
No 444
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.48 E-value=1.7e-12 Score=97.57 Aligned_cols=145 Identities=19% Similarity=0.248 Sum_probs=112.3
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccch-----HHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEEEE
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM-----EMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 95 (294)
....+-+|+.+.|+++.+ .|+.++||.-....+... -..+...+|+..+.++.--+|.-+--++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 678889999999999986 678888887654443332 2456677899999998876776666666677777899
Q ss_pred EeccCC-CChHHHHHHh-CC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC---cEEEeeecccccc
Q 022617 96 MEYVKS-GELFDYIVEK-GR-LQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNIM 167 (294)
Q Consensus 96 ~e~~~~-~sL~~~l~~~-~~-l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~---~~~l~dfg~~~~~ 167 (294)
|||++| .++.+++... .. ...+....++.++-+.+.-||..+++|||+.++||++..++ .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 4788887653 22 23333478999999999999999999999999999997654 3589999998654
No 445
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.48 E-value=2.4e-13 Score=104.90 Aligned_cols=127 Identities=20% Similarity=0.210 Sum_probs=94.2
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEeccC
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~ 100 (294)
.+.|+.|..+.||++... +..+++|+...... .......|+..++.+.+.++ ++++.+.. ...+++||+++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 456889999999999864 77899998754321 12345678888888765443 45555433 34579999999
Q ss_pred CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCeEecCCCcEEEeeecccc
Q 022617 101 SGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV-----VHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 101 ~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i-----~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
|.++... . ......+.+++.+++.||..++ +|+|++|.||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887653 0 1123456789999999999885 9999999999999 6689999999875
No 446
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=99.36 E-value=4e-11 Score=101.04 Aligned_cols=238 Identities=16% Similarity=0.170 Sum_probs=159.2
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEE------EE-cCCe
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEV------IE-TPSD 91 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~------~~-~~~~ 91 (294)
.....-||+|+.+.+|..-.- ...+-|+++....-. ......++...-.||-+-.-+.+ .. ....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred cCCCccccCCccceeeecchh---hchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 345677899999999976432 224678886554221 11111122233345433321111 11 2233
Q ss_pred EEEEEeccCCCC-hHHHHH------HhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 92 IYVVMEYVKSGE-LFDYIV------EKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 92 ~~lv~e~~~~~s-L~~~l~------~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
+.++|..+.|.. ...+.. +.....+....+.++.++.+.+.||+.|.+-||+.++|+|+++++.+.|+|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778888877642 222221 1233678899999999999999999999999999999999999999999987766
Q ss_pred ccccCCCccccccCCCcccCCcccc-----CCccCCCchhHHHHHHHHHHHHh-CCCCCCCCC--------HHHHHH---
Q 022617 165 NIMRDGHFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLC-GTLPFDDEN--------IPNLFK--- 227 (294)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~ll~~l~~-g~~p~~~~~--------~~~~~~--- 227 (294)
....++....+.++...|.+||... +... +...|-|.||+++++++. |++||.+.. .+..+.
T Consensus 165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred eeccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 6656777788889999999999764 2223 567899999999999998 499996642 111110
Q ss_pred -----HHhCCCccCC-----CCCChhHHHHHHHhccc--CCCCCCCHhHH
Q 022617 228 -----KIKGGIYTLP-----SHLSPGARDLIPRMLIV--DPMKRITIPEI 265 (294)
Q Consensus 228 -----~~~~~~~~~~-----~~~~~~l~~li~~~l~~--~p~~Rps~~~i 265 (294)
+...+..+.| .-+++++..++.+|+.. ++.-|||++..
T Consensus 244 f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 244 FAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred eeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 0111111111 35788999999999875 46789997753
No 447
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.36 E-value=4.3e-11 Score=103.13 Aligned_cols=212 Identities=16% Similarity=0.263 Sum_probs=156.1
Q ss_pred CceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEc----CCeEEEEEeccCC-CC
Q 022617 29 SFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIET----PSDIYVVMEYVKS-GE 103 (294)
Q Consensus 29 ~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~s 103 (294)
...+.|++..+.+|..|++|.++-..... ......-++.++++.|+|++++.+++.. ...+++|++|+++ .+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34688999999999999999984333222 2344566888999999999999888763 4568999999875 36
Q ss_pred hHHHHHH---------------hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 104 LFDYIVE---------------KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 104 L~~~l~~---------------~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
|.+.--. +...+++.+|.++.|+..||.++|+.|+..+-+.|.+|+++.+-+++|+.+|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6664421 2247889999999999999999999999999999999999998899999999877654
Q ss_pred CCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHhCCCccCCCCCChhHHH
Q 022617 169 DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP-FDDENIPNL-FKKIKGGIYTLPSHLSPGARD 246 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p-~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~ 246 (294)
... . +-+.. -.+.|.=.||.+++.|.+|..- +........ .+ .+...++.++++
T Consensus 445 ~d~-----------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~-------~I~~~yS~D~rn 500 (655)
T KOG3741|consen 445 EDP-----------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT-------RITTTYSTDLRN 500 (655)
T ss_pred CCC-----------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHH-------HhhhhhhHHHHH
Confidence 322 0 11111 2356888999999999998533 111111111 11 123467889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcC
Q 022617 247 LIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 247 li~~~l~~~p~~Rps~~~il~h 268 (294)
++.-....++++ -++.+++.+
T Consensus 501 ~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 501 VVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHhcCccc-ccHHHHHHH
Confidence 999998888887 778877653
No 448
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.31 E-value=9.7e-11 Score=96.25 Aligned_cols=138 Identities=14% Similarity=0.100 Sum_probs=98.4
Q ss_pred cccCceEEEEEEEccCCceEEEEEeecccccch--------HHHHHHHHHHHHHHhCCCCce--eEEEEEEEc-----CC
Q 022617 26 GIGSFGKVKIAEHALTGHKVAIKILNRRKIKNM--------EMEEKVRREIKILRLFMHPHI--IRLYEVIET-----PS 90 (294)
Q Consensus 26 g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~ 90 (294)
.......|+.+.. .|+.|.||.......... .....+.+|...+.+|...+| +.++++++. ..
T Consensus 31 ~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 31 RELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred ecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 3333334556554 567899997643321100 001137789998888865444 444666543 23
Q ss_pred eEEEEEeccCCC-ChHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecC-------CCcEEEee
Q 022617 91 DIYVVMEYVKSG-ELFDYIVE--KGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDS-------KWNVKIAD 160 (294)
Q Consensus 91 ~~~lv~e~~~~~-sL~~~l~~--~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~-------~~~~~l~d 160 (294)
..++|+|++++. +|.+++.. ..+.+......++.+++..+.-||+.|++|+|++++||+++. +..+.++|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 578999999875 79998854 344567778899999999999999999999999999999975 46799999
Q ss_pred ecccc
Q 022617 161 FGLSN 165 (294)
Q Consensus 161 fg~~~ 165 (294)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99875
No 449
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.30 E-value=2.1e-11 Score=98.23 Aligned_cols=140 Identities=20% Similarity=0.313 Sum_probs=102.0
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcC---CeEEEEEe
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETP---SDIYVVME 97 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~---~~~~lv~e 97 (294)
+.|+.|..+.+|++... +|..+++|........ .....+..|.++++.+.+. .+++++.+.... +..++++|
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999874 3678999997544321 1345778899999998764 457777776543 25689999
Q ss_pred ccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 022617 98 YVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHR------------------------------------------ 135 (294)
Q Consensus 98 ~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~------------------------------------------ 135 (294)
+++|.++.+.+.. ..++.+....++.+++.++..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765421 345555566666666666666652
Q ss_pred --------------CCceecCCCCCCeEecC--CCcEEEeeeccccc
Q 022617 136 --------------NMVVHRDLKPENLLLDS--KWNVKIADFGLSNI 166 (294)
Q Consensus 136 --------------~~i~h~di~p~nili~~--~~~~~l~dfg~~~~ 166 (294)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34799999999999998 56689999998753
No 450
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=99.28 E-value=4e-11 Score=95.88 Aligned_cols=140 Identities=22% Similarity=0.335 Sum_probs=106.7
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeeccccc-----------------c--hHHHHHHHHHHHHHHhCCCC--
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-----------------N--MEMEEKVRREIKILRLFMHP-- 77 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-----------------~--~~~~~~~~~e~~~l~~l~~~-- 77 (294)
+.+...||-|.-|.||.|.+. .+.++++|.-..-... + ........+|++.|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 356788999999999999987 7889999985321100 0 11235577899999999866
Q ss_pred ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (294)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~ 157 (294)
.+++++++ +.-.++||+++|..|...- ++.+....++..|+..+..+...|++|||+++-||+++++|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 67887765 5667999999997666542 23445566667777777777799999999999999999999999
Q ss_pred Eeeeccccccc
Q 022617 158 IADFGLSNIMR 168 (294)
Q Consensus 158 l~dfg~~~~~~ 168 (294)
++||-.+....
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99998776543
No 451
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.26 E-value=1e-10 Score=90.82 Aligned_cols=129 Identities=25% Similarity=0.357 Sum_probs=85.2
Q ss_pred EEEEEEEccCCceEEEEEeeccccc-----------------------chHHHHHHHHHHHHHHhCCCC--ceeEEEEEE
Q 022617 32 KVKIAEHALTGHKVAIKILNRRKIK-----------------------NMEMEEKVRREIKILRLFMHP--HIIRLYEVI 86 (294)
Q Consensus 32 ~vy~~~~~~~~~~~~~K~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~ 86 (294)
.||.|... ++..+|+|+....... .........+|+..|.++... ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888875 6779999997532111 111335677899999999876 467776552
Q ss_pred EcCCeEEEEEeccC--CCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeEecCCCcEEEeeecc
Q 022617 87 ETPSDIYVVMEYVK--SGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLDSKWNVKIADFGL 163 (294)
Q Consensus 87 ~~~~~~~lv~e~~~--~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~-Lh~~~i~h~di~p~nili~~~~~~~l~dfg~ 163 (294)
.-+++|||++ |..+..+.... ++.+....++.+++..+.. +|..|++|||+++.||+++++ .+.++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3369999998 76666544322 2244566777788775444 689999999999999999988 999999998
Q ss_pred ccccc
Q 022617 164 SNIMR 168 (294)
Q Consensus 164 ~~~~~ 168 (294)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87553
No 452
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.26 E-value=2.1e-12 Score=114.55 Aligned_cols=149 Identities=22% Similarity=0.386 Sum_probs=113.5
Q ss_pred HHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEEeeecccccccCCCccc----------cccCCCcccCCccccCCcc
Q 022617 125 QIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----------TSCGSPNYAAPEVISGKLY 193 (294)
Q Consensus 125 ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~----------~~~~~~~~~aPE~~~~~~~ 193 (294)
++..|+.++|. .+++|++|.|++|.++.++.+||+.|+++.....+.... .......|.+||.+.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 44499999995 579999999999999999999999999876554322111 1124568999999988544
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCCHHHHH----HHHhCCCccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcC
Q 022617 194 AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLF----KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH 268 (294)
Q Consensus 194 ~~~~~Di~slG~ll~~l~~-g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h 268 (294)
+.++|+||+|+++|.+.. |+..+......... .............+++++++-+.+++..++.-||++.+++..
T Consensus 187 -~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 187 -TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred -cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 899999999999999994 66665543221111 111222234457899999999999999999999999999999
Q ss_pred Cccccc
Q 022617 269 PWFQAH 274 (294)
Q Consensus 269 ~~~~~~ 274 (294)
|||++.
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999875
No 453
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=99.11 E-value=2.2e-09 Score=85.40 Aligned_cols=106 Identities=18% Similarity=0.265 Sum_probs=86.4
Q ss_pred HHHHHHHHHHHHhCCCCc--eeEEEEEEEcC----CeEEEEEeccCCC-ChHHHHHHhCCCCHHHHHHHHHHHHHHHHHH
Q 022617 61 EEKVRREIKILRLFMHPH--IIRLYEVIETP----SDIYVVMEYVKSG-ELFDYIVEKGRLQEDEARNFFQQIISGVEYC 133 (294)
Q Consensus 61 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~L 133 (294)
.....+|...+..|...+ +++++++.+.. ...++|+|++++. +|.+++......+......++.++...++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 356778888887776443 56667776553 2458999999874 7999997755577788899999999999999
Q ss_pred HhCCceecCCCCCCeEecCCC---cEEEeeeccccc
Q 022617 134 HRNMVVHRDLKPENLLLDSKW---NVKIADFGLSNI 166 (294)
Q Consensus 134 h~~~i~h~di~p~nili~~~~---~~~l~dfg~~~~ 166 (294)
|+.|++|+|+++.|||++.++ .+.++||+.+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999997764
No 454
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=99.08 E-value=1.3e-09 Score=85.49 Aligned_cols=142 Identities=20% Similarity=0.245 Sum_probs=93.6
Q ss_pred cccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHH------HHHHHHHHHHHhCCC---CceeEEE
Q 022617 13 DMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEME------EKVRREIKILRLFMH---PHIIRLY 83 (294)
Q Consensus 13 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~------~~~~~e~~~l~~l~~---~~i~~~~ 83 (294)
+.+.++|.+.+.+-.....-|.+..- ++..+++|............. ....+++....++.. .....++
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 34667888888888888776766654 678999999765432221111 112334444444432 3333333
Q ss_pred EEE-----EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEE
Q 022617 84 EVI-----ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 84 ~~~-----~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l 158 (294)
... ......++++||++|..|.+... +++ .+...+.+++..||+.|++|||.+|.|++++++ .+++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~i 175 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRI 175 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEE
Confidence 222 22345678999999988876532 222 244567788899999999999999999999866 5999
Q ss_pred eeecccc
Q 022617 159 ADFGLSN 165 (294)
Q Consensus 159 ~dfg~~~ 165 (294)
+||+...
T Consensus 176 ID~~~k~ 182 (229)
T PF06176_consen 176 IDTQGKR 182 (229)
T ss_pred EECcccc
Confidence 9998654
No 455
>PRK09902 hypothetical protein; Provisional
Probab=99.02 E-value=8.1e-09 Score=80.77 Aligned_cols=139 Identities=10% Similarity=0.117 Sum_probs=101.0
Q ss_pred cccCceEEEEEEEccCCceEEEEEeecccccc---hHHHHHHHHHHHHHHhCCCCc--eeEEEEEEEc----CCeEEEEE
Q 022617 26 GIGSFGKVKIAEHALTGHKVAIKILNRRKIKN---MEMEEKVRREIKILRLFMHPH--IIRLYEVIET----PSDIYVVM 96 (294)
Q Consensus 26 g~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~----~~~~~lv~ 96 (294)
|.||-|.|+.... .|+.+-+|.-....... ......+.+|+..+.+|...+ ++++...... ...-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6688889998775 34468888754111111 224578899999998886433 5555522211 12467899
Q ss_pred eccCC-CChHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCc--EEEeeeccccc
Q 022617 97 EYVKS-GELFDYIVEK--GRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWN--VKIADFGLSNI 166 (294)
Q Consensus 97 e~~~~-~sL~~~l~~~--~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~--~~l~dfg~~~~ 166 (294)
|-++| .+|.+++.+. .+.+......++.+++.++.-||+.|+.|+|+-+.||+++.++. +.++||.-+..
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 5899988653 34577788899999999999999999999999999999987677 99999986653
No 456
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.94 E-value=2.2e-08 Score=94.33 Aligned_cols=244 Identities=17% Similarity=0.149 Sum_probs=165.8
Q ss_pred cccccccCceEEEEEEEccC----CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCceeEEEEEEEcCCeEE----
Q 022617 22 GKTLGIGSFGKVKIAEHALT----GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHIIRLYEVIETPSDIY---- 93 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~---- 93 (294)
...+..-.+|+++...+... ..++-++.-................|++.+.+..|+|+..++.|........
T Consensus 183 y~~ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~ 262 (1351)
T KOG1035|consen 183 YPILSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLD 262 (1351)
T ss_pred eeeeccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHH
Confidence 33366667777776665321 1122222111111112233455667788888999999999998876544332
Q ss_pred EEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC---CeEecCCCcEEEe--eeccccccc
Q 022617 94 VVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPE---NLLLDSKWNVKIA--DFGLSNIMR 168 (294)
Q Consensus 94 lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~---nili~~~~~~~l~--dfg~~~~~~ 168 (294)
+..+++...++.+.+++-+..+.+..+.+..+...++.++|+....|.-+..+ +.-++..+.+..+ ||+.+....
T Consensus 263 v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~ 342 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP 342 (1351)
T ss_pred HHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCC
Confidence 44678989999999998899999999999999999999999986666555444 3444555666666 888887776
Q ss_pred CCCccccccCCCcccCCccccCCccC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCccCCCCCChhHHHH
Q 022617 169 DGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 247 (294)
Q Consensus 169 ~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
..........+..+.++|........ +...|+|++|.+...+..+..+-.. ......+. +.....+..++
T Consensus 343 d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~---~~~~~~~l------~~~~~~~~~d~ 413 (1351)
T KOG1035|consen 343 DNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEK---SAVPVSLL------DVLSTSELLDA 413 (1351)
T ss_pred CcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccc---ccchhhhh------ccccchhhhhh
Confidence 66665566667778888877654431 2346999999999999887544211 11111111 11222267889
Q ss_pred HHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 248 IPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 248 i~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
..+|+.-++++|+++.+++.|+|.+..
T Consensus 414 ~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 414 LPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhhcchhhhhccchhhhhhchhcccc
Confidence 999999999999999999999998653
No 457
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.92 E-value=7.1e-08 Score=85.99 Aligned_cols=141 Identities=21% Similarity=0.295 Sum_probs=94.2
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccc-------------------------------hHHHHH------HH
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN-------------------------------MEMEEK------VR 65 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~-------------------------------~~~~~~------~~ 65 (294)
+-|+.++-|+||+|..+ +|+.||||+.++.-... .+..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67889999999999987 59999999975321110 001112 22
Q ss_pred HHHHHHHhCC-----CCceeEEEEEEEcCCeEEEEEeccCCCChHHHH--HHhCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 022617 66 REIKILRLFM-----HPHIIRLYEVIETPSDIYVVMEYVKSGELFDYI--VEKGRLQEDEARNFFQQIISGVEYCHRNMV 138 (294)
Q Consensus 66 ~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l--~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i 138 (294)
+|...+.+++ .+++.-+.-+++..+.-.++|||++|..+.+.. +. ...+...+...+.++. +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 3333333332 355444444455556778999999999988874 33 3455444443333332 334446899
Q ss_pred eecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 139 VHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 139 ~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
+|+|.+|.||++..+|++.+.|||+....
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999988654
No 458
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.85 E-value=6.2e-08 Score=78.06 Aligned_cols=133 Identities=16% Similarity=0.175 Sum_probs=84.8
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEEEEcCCeEEEEEeccC
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEVIETPSDIYVVMEYVK 100 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~ 100 (294)
..|+.|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +++++++....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 24468899875422 2345788999999887544 5778888888888899999999
Q ss_pred CCC-hHHHH--------------HH------h---CCCCHHHHH-HHHHH----------HHHH-HHHHH----hCCcee
Q 022617 101 SGE-LFDYI--------------VE------K---GRLQEDEAR-NFFQQ----------IISG-VEYCH----RNMVVH 140 (294)
Q Consensus 101 ~~s-L~~~l--------------~~------~---~~l~~~~~~-~~~~q----------l~~~-l~~Lh----~~~i~h 140 (294)
|.+ +...+ .+ . ...+..... .+..+ +... ..+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 21111 00 0 001111111 11000 1111 11222 124789
Q ss_pred cCCCCCCeEecCCCcEEEeeecccc
Q 022617 141 RDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 141 ~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
+|++|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999887 9999999775
No 459
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.84 E-value=3.4e-08 Score=78.45 Aligned_cols=140 Identities=19% Similarity=0.235 Sum_probs=96.3
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccchH---------------------HHHHHHHHHHHHHhCCCC--cee
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNME---------------------MEEKVRREIKILRLFMHP--HII 80 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~---------------------~~~~~~~e~~~l~~l~~~--~i~ 80 (294)
.|++|..+.||.|.. .++..+++|++......-.. .......|+.-|+++... .++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566788889999986 36788999998644322111 112234677777777543 456
Q ss_pred EEEEEEEcCCeEEEEEeccCCCChHH-HHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeEecCCCcEEE
Q 022617 81 RLYEVIETPSDIYVVMEYVKSGELFD-YIVEKGRLQEDEARNFFQQIISGVEYCHR-NMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~sL~~-~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~-~~i~h~di~p~nili~~~~~~~l 158 (294)
+++++. .-.++||+++....-. .| +.-++..++...+..++++.+.-|.. .+++|+|++.=|||+. ++.+.+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 666654 3368999996531111 11 12233444677788888888888877 8999999999999999 779999
Q ss_pred eeecccccccCC
Q 022617 159 ADFGLSNIMRDG 170 (294)
Q Consensus 159 ~dfg~~~~~~~~ 170 (294)
+|++.+....++
T Consensus 208 ID~~QaV~~~hp 219 (268)
T COG1718 208 IDVSQAVTIDHP 219 (268)
T ss_pred EECccccccCCC
Confidence 999998766543
No 460
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.66 E-value=3.7e-07 Score=74.00 Aligned_cols=138 Identities=21% Similarity=0.282 Sum_probs=81.5
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEE---cCCeEEEEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIE---TPSDIYVVM 96 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~---~~~~~~lv~ 96 (294)
++.|+.|..+.||.+.... ..+++|..... .....+.+|..+++.+... .+++++.... .....++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4678999999999999754 58999986433 3456777888888877643 3566776442 234578999
Q ss_pred eccCCCChHH----------------HHHH--hC--C---CCHH------HHHHH---------------HHHHHH-HHH
Q 022617 97 EYVKSGELFD----------------YIVE--KG--R---LQED------EARNF---------------FQQIIS-GVE 131 (294)
Q Consensus 97 e~~~~~sL~~----------------~l~~--~~--~---l~~~------~~~~~---------------~~ql~~-~l~ 131 (294)
++++|.++.. .+.. +. + .... ..... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 1110 00 0 0000 00000 111111 223
Q ss_pred HHH-------hCCceecCCCCCCeEec-CCCcEEEeeeccccc
Q 022617 132 YCH-------RNMVVHRDLKPENLLLD-SKWNVKIADFGLSNI 166 (294)
Q Consensus 132 ~Lh-------~~~i~h~di~p~nili~-~~~~~~l~dfg~~~~ 166 (294)
.++ ...++|+|++|.||+++ +++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24599999999999999 666678999997753
No 461
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.60 E-value=7.6e-07 Score=67.15 Aligned_cols=132 Identities=22% Similarity=0.313 Sum_probs=94.4
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEE
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVM 96 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~ 96 (294)
.-++.+.|+.|..|.||++.+ .|..+++|+-..+ +....+..|.++|..+...++ ++++.|... ++.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 345678999999999999998 4568999985433 335788899999999987665 445555432 3559
Q ss_pred eccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC-CCeEecCCCcEEEeeecccccc
Q 022617 97 EYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKP-ENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 97 e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p-~nili~~~~~~~l~dfg~~~~~ 167 (294)
||..|.+|.++-... + .+-+..+++...-|...||-|+.|+- ...++..++.+.|+||..|+..
T Consensus 92 e~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 92 EYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 999998887764311 2 23344555666668899999999874 4444445558999999998744
No 462
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.57 E-value=1.3e-06 Score=71.46 Aligned_cols=133 Identities=12% Similarity=0.033 Sum_probs=81.9
Q ss_pred ccccCc-eEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCceeEEEEEEEcCCeEEEEEeccCCC
Q 022617 25 LGIGSF-GKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHIIRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 25 lg~g~~-~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
|..|.. +.||++... +..+++|...... ...+.+|+.+++.+. +--+++++++....+..+++|++++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444444 789999753 3678899864332 235667888887774 344677888877666788999999998
Q ss_pred ChHHHHH----------------H--hC-----CCCHH--HHHHHHH--------------------HHHHHHHHHH---
Q 022617 103 ELFDYIV----------------E--KG-----RLQED--EARNFFQ--------------------QIISGVEYCH--- 134 (294)
Q Consensus 103 sL~~~l~----------------~--~~-----~l~~~--~~~~~~~--------------------ql~~~l~~Lh--- 134 (294)
++..... + .- +.... ....... .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7764320 0 00 01000 0000000 0111122221
Q ss_pred ----hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 135 ----RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 135 ----~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
No 463
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.49 E-value=1.3e-06 Score=77.80 Aligned_cols=142 Identities=18% Similarity=0.288 Sum_probs=90.3
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeecccccc----------------------------hHHHHHHHHHHHH---
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN----------------------------MEMEEKVRREIKI--- 70 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----------------------------~~~~~~~~~e~~~--- 70 (294)
.+.|+..+.|.|++|+.+. |+.|+||+-++.-... .+..+.+..|+..
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4678999999999999874 9999999964331110 0111222222222
Q ss_pred -------HHhCCCCc------eeEEEEEEEcCCeEEEEEeccCCCChHHHHH-HhCCCCHHHHHHHHHHHHHHHH-HHHh
Q 022617 71 -------LRLFMHPH------IIRLYEVIETPSDIYVVMEYVKSGELFDYIV-EKGRLQEDEARNFFQQIISGVE-YCHR 135 (294)
Q Consensus 71 -------l~~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~-~~~~l~~~~~~~~~~ql~~~l~-~Lh~ 135 (294)
.+.+.|-+ |++++..+ .....++|||++|..+.+.-. +...++...+ +..+.++.. .+=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHh
Confidence 22333444 55555433 356689999999987766532 1233555543 334444322 2446
Q ss_pred CCceecCCCCCCeEecC----CCcEEEeeecccccccC
Q 022617 136 NMVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRD 169 (294)
Q Consensus 136 ~~i~h~di~p~nili~~----~~~~~l~dfg~~~~~~~ 169 (294)
.|++|+|-+|.||+++. ++.+.+.|||+......
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 78999999999999984 66899999999876543
No 464
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.49 E-value=7.4e-06 Score=64.25 Aligned_cols=134 Identities=24% Similarity=0.367 Sum_probs=91.8
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeeccccc-------------chHHHHHHHHHHHHHHhCC------CCceeEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-------------NMEMEEKVRREIKILRLFM------HPHIIRL 82 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-------------~~~~~~~~~~e~~~l~~l~------~~~i~~~ 82 (294)
...||.|+.-.||.- . .....+||+....... .........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457899999999954 3 2344689998766500 0112345555655555444 7889999
Q ss_pred EEEEEcCCeEEEEEeccCC------CChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCC--
Q 022617 83 YEVIETPSDIYVVMEYVKS------GELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKW-- 154 (294)
Q Consensus 83 ~~~~~~~~~~~lv~e~~~~------~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~-- 154 (294)
+|+.+++....+|+|.+.. .||.+++.+ +.+++ ...+. +-+...+|-+.+|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999986532 378888844 44555 44443 44445678899999999999999996432
Q ss_pred --cEEEee-ecc
Q 022617 155 --NVKIAD-FGL 163 (294)
Q Consensus 155 --~~~l~d-fg~ 163 (294)
.+.|+| ||.
T Consensus 158 ~~~lvlIDG~G~ 169 (199)
T PF10707_consen 158 EFRLVLIDGLGE 169 (199)
T ss_pred ceEEEEEeCCCC
Confidence 467776 443
No 465
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.39 E-value=7.5e-08 Score=85.59 Aligned_cols=250 Identities=18% Similarity=0.103 Sum_probs=168.5
Q ss_pred CCCCCCCccccccCCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEE
Q 022617 5 SNRSSSGVDMFLPNYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLY 83 (294)
Q Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~ 83 (294)
|+......+.-..-|......++++++.+++.+...+.... .+++... ....-++++|.+++||| .+..+
T Consensus 230 S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~ 300 (829)
T KOG0576|consen 230 SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYL 300 (829)
T ss_pred cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCccccc
Confidence 44445555666677788888899999999999876554333 5554322 45567899999999999 55656
Q ss_pred EEEEcCCeEEEEEeccCCC-ChHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEEEeee
Q 022617 84 EVIETPSDIYVVMEYVKSG-ELFDYI-VEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVKIADF 161 (294)
Q Consensus 84 ~~~~~~~~~~lv~e~~~~~-sL~~~l-~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~l~df 161 (294)
+-++.+...++.++++.++ +....+ ...-.+-..+.....+.-+..++++|+..-+|+| ||+-++ +..+..+|
T Consensus 301 ~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~ 375 (829)
T KOG0576|consen 301 EDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDF 375 (829)
T ss_pred ccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccc
Confidence 6666678899999999876 221111 1111233344556667778889999988777887 777665 57899999
Q ss_pred cccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhCCCcc-CCCCC
Q 022617 162 GLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL 240 (294)
Q Consensus 162 g~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~ 240 (294)
+...............+++.++|||+.....+ ...-|.|++|.-..++--|.+|-.... .. ....+..+ .+...
T Consensus 376 ~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~--~~~~g~~p~s~~L~ 450 (829)
T KOG0576|consen 376 AVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRSSPP--AV--LPMIGNGPNSPMLT 450 (829)
T ss_pred cCCcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCCCCc--cc--cCCCCCCCCccccc
Confidence 98877766555667778999999998877766 578899999987777777766653310 00 00000000 00000
Q ss_pred C------hhHHHHHHHhcccCCCCCCCHhHHhcCCcccc
Q 022617 241 S------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 273 (294)
Q Consensus 241 ~------~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~ 273 (294)
+ ..-.++...|+...|..|+....++.|.+|..
T Consensus 451 ~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 451 DKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred hhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 1 01114667788899999999999998888865
No 466
>PLN02876 acyl-CoA dehydrogenase
Probab=98.31 E-value=1.3e-05 Score=76.79 Aligned_cols=81 Identities=19% Similarity=0.323 Sum_probs=57.4
Q ss_pred cccccccCceEEEEEEEccCC--ceEEEEEeecccccchHHHHHHHHHHHHHHhCC-CCce--eEEEEEEEcC---CeEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTG--HKVAIKILNRRKIKNMEMEEKVRREIKILRLFM-HPHI--IRLYEVIETP---SDIY 93 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~ 93 (294)
++.++.|.++.+|+......+ ..+++|........ .....+.+|+.+++.+. |.++ ++++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 567788999999998765332 46788876433211 12357889999999986 5654 7788877654 4678
Q ss_pred EEEeccCCCCh
Q 022617 94 VVMEYVKSGEL 104 (294)
Q Consensus 94 lv~e~~~~~sL 104 (294)
+|||+++|..+
T Consensus 121 lVME~v~G~~~ 131 (822)
T PLN02876 121 YIMEYLEGRIF 131 (822)
T ss_pred EEEEecCCccc
Confidence 99999988653
No 467
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=98.30 E-value=6.4e-06 Score=66.96 Aligned_cols=73 Identities=10% Similarity=0.074 Sum_probs=46.6
Q ss_pred ccccccCce-EEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC---ceeEEEEEEEcCC---eEEEE
Q 022617 23 KTLGIGSFG-KVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP---HIIRLYEVIETPS---DIYVV 95 (294)
Q Consensus 23 ~~lg~g~~~-~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~---~~~lv 95 (294)
+.|+.|+.. .||... ..+++|..... .....+.+|.++++.+... .++++++.....+ ..+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456666665 588762 34788875432 1245788899999887642 3555555443322 34789
Q ss_pred EeccCCCChH
Q 022617 96 MEYVKSGELF 105 (294)
Q Consensus 96 ~e~~~~~sL~ 105 (294)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997764
No 468
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=98.26 E-value=8.9e-07 Score=73.19 Aligned_cols=136 Identities=13% Similarity=0.213 Sum_probs=97.4
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccc------h---------H----HHHHHHHHHHHHHhCCCC--
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKN------M---------E----MEEKVRREIKILRLFMHP-- 77 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~------~---------~----~~~~~~~e~~~l~~l~~~-- 77 (294)
+.+++.||-|.-+.||.+-+. .|.++++|.-......- + . ..-...+|+..++.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567889999999999999885 68888998753221110 0 0 112345688888888643
Q ss_pred ceeEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeEecCCCcEE
Q 022617 78 HIIRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKWNVK 157 (294)
Q Consensus 78 ~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~h~di~p~nili~~~~~~~ 157 (294)
-+++.+++ +.-++|||.+.|-+|...-.- .+ +..+...+...+.-|.+.|++|||+.-=||+++++++++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 35666654 566899999999888765321 12 233444556666778899999999999999999999999
Q ss_pred Eeeecccc
Q 022617 158 IADFGLSN 165 (294)
Q Consensus 158 l~dfg~~~ 165 (294)
++||-...
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997643
No 469
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.22 E-value=5.6e-05 Score=58.98 Aligned_cols=130 Identities=21% Similarity=0.264 Sum_probs=88.6
Q ss_pred cccCCcccccccccCc-eEEEEEEEccCCceEEEEEeec---ccc-------c--ch------HHHHHHHHHHHHHHhCC
Q 022617 15 FLPNYKLGKTLGIGSF-GKVKIAEHALTGHKVAIKILNR---RKI-------K--NM------EMEEKVRREIKILRLFM 75 (294)
Q Consensus 15 ~~~~y~~~~~lg~g~~-~~vy~~~~~~~~~~~~~K~~~~---~~~-------~--~~------~~~~~~~~e~~~l~~l~ 75 (294)
....++.++.||.|.- |.||++.. .|+.||+|++.. ... . .. .....+..|.....+|+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 4478999999999999 99999986 677999999321 110 0 00 12335666766666665
Q ss_pred ---CCce--eEEEEEEEcC------------------CeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 022617 76 ---HPHI--IRLYEVIETP------------------SDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY 132 (294)
Q Consensus 76 ---~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~ 132 (294)
+.++ ++.+|+..-. -...||.|+..... .++... +.+|..-+..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHH
Confidence 4566 8888887211 11356677665432 223333 4566666778
Q ss_pred HHhCCceecCCCCCCeEecCCCcEEEeeeccc
Q 022617 133 CHRNMVVHRDLKPENLLLDSKWNVKIADFGLS 164 (294)
Q Consensus 133 Lh~~~i~h~di~p~nili~~~~~~~l~dfg~~ 164 (294)
+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999988 5688999864
No 470
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=98.07 E-value=5.7e-05 Score=63.62 Aligned_cols=136 Identities=13% Similarity=0.091 Sum_probs=81.1
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc--eeEEEEE------EEcCCeEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH--IIRLYEV------IETPSDIY 93 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~~ 93 (294)
.+.+..|....+|++.. ++..+++|++... . ...+..|+.++..+...+ +++++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 55667787789998864 3457899987531 1 345667777777765332 4454432 23345678
Q ss_pred EEEeccCCCChHH----HHH----------H-hCCCC--------HHHHH------------HHHHHHHHHHHHHHh---
Q 022617 94 VVMEYVKSGELFD----YIV----------E-KGRLQ--------EDEAR------------NFFQQIISGVEYCHR--- 135 (294)
Q Consensus 94 lv~e~~~~~sL~~----~l~----------~-~~~l~--------~~~~~------------~~~~ql~~~l~~Lh~--- 135 (294)
+++++++|.++.. ... . ...+. ..-.. .....+..++..+.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876522 110 0 00000 00000 011112233344442
Q ss_pred ----CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 136 ----NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 136 ----~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
.+++|+|++|.||++++++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999998777899999774
No 471
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=98.06 E-value=4.4e-05 Score=64.73 Aligned_cols=158 Identities=15% Similarity=0.158 Sum_probs=90.8
Q ss_pred CCCCCCCCCCCccccccCCcc-----cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC
Q 022617 1 MDGASNRSSSGVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM 75 (294)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (294)
|+-.|+-+...+..+..+|.+ .+.++.|....+|++.. ++..+++|+..... ....+..+.+++..|.
T Consensus 1 ~~~~~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~ 73 (307)
T TIGR00938 1 MAVYTSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRV-----KAEELPFFLALTTHLA 73 (307)
T ss_pred CCccccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCC-----CHHHHHHHHHHHHHHH
Confidence 444455555666666667765 34566777789998864 23468899864421 1234556667666664
Q ss_pred CCc--eeEEEEE------EEcCCeEEEEEeccCCCChH----HHHH----------H-hCCC--C-----HHHHHH----
Q 022617 76 HPH--IIRLYEV------IETPSDIYVVMEYVKSGELF----DYIV----------E-KGRL--Q-----EDEARN---- 121 (294)
Q Consensus 76 ~~~--i~~~~~~------~~~~~~~~lv~e~~~~~sL~----~~l~----------~-~~~l--~-----~~~~~~---- 121 (294)
..+ +++++.. ....+..++++++++|.++. .... . ...+ + ....|.
T Consensus 74 ~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~ 153 (307)
T TIGR00938 74 ARGLPVPKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAE 153 (307)
T ss_pred HCCCCCCccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHH
Confidence 322 4444432 12245678999999885432 1110 0 0000 0 001100
Q ss_pred ------------HHHHHHHHHHHHH-------hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 122 ------------FFQQIISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 122 ------------~~~ql~~~l~~Lh-------~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
....+...+.++. ..+++|+|+++.||++++++...++||+.+.
T Consensus 154 ~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 154 KCFEAAPQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcccccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 0111223444443 2679999999999999988777899999774
No 472
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=98.06 E-value=2.3e-05 Score=61.18 Aligned_cols=99 Identities=17% Similarity=0.242 Sum_probs=77.6
Q ss_pred HHHHHHHHhCCC-CceeEEEEEEEcCCeEEEEEeccCCCChHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 022617 65 RREIKILRLFMH-PHIIRLYEVIETPSDIYVVMEYVKSGELFDY---IVEKGRLQEDEARNFFQQIISGVEYCHR---NM 137 (294)
Q Consensus 65 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~sL~~~---l~~~~~l~~~~~~~~~~ql~~~l~~Lh~---~~ 137 (294)
..|.-+++.+++ +++++++|+|- . +++.|+.+.+++... +..-...++..+.+++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357788888876 69999999982 2 568899876655421 1111235889999999999999999997 34
Q ss_pred ceecCCCCCCeEecCCCcEEEeeecccccc
Q 022617 138 VVHRDLKPENLLLDSKWNVKIADFGLSNIM 167 (294)
Q Consensus 138 i~h~di~p~nili~~~~~~~l~dfg~~~~~ 167 (294)
+...|++++|+-++++++++++|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999876544
No 473
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=98.04 E-value=0.00026 Score=61.62 Aligned_cols=80 Identities=16% Similarity=0.135 Sum_probs=54.0
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeeccccc--c--hHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--N--MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYV 94 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~l 94 (294)
.+.||.|....||++.+...++.++||.-...... . .-.......|.+.|+.+. ..++++++.+. +...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 45789999999999998644358999985322110 1 123456677777777653 24677888774 455779
Q ss_pred EEeccCCCC
Q 022617 95 VMEYVKSGE 103 (294)
Q Consensus 95 v~e~~~~~s 103 (294)
+||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999987643
No 474
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=98.02 E-value=3.4e-05 Score=63.58 Aligned_cols=133 Identities=16% Similarity=0.145 Sum_probs=76.8
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEeccCCC
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVMEYVKSG 102 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~ 102 (294)
.+..|-.+.+|+.. .++..+++|....... ...-...+|..+++.+...++ ++++.... -++++||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 45667778999887 3567888997543211 100134678888887765433 44454432 36899999987
Q ss_pred ChHHH-------H-------HH--h-----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceecCC
Q 022617 103 ELFDY-------I-------VE--K-----GRLQE-DEARNFFQQI---------ISGVEYCHR--------NMVVHRDL 143 (294)
Q Consensus 103 sL~~~-------l-------~~--~-----~~l~~-~~~~~~~~ql---------~~~l~~Lh~--------~~i~h~di 143 (294)
++... + .+ + .+++. ..+..+..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 65321 1 10 0 11121 1112221111 111222211 24899999
Q ss_pred CCCCeEecCCCcEEEeeeccccc
Q 022617 144 KPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 144 ~p~nili~~~~~~~l~dfg~~~~ 166 (294)
.|.||++++++ +.++||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999876 78999998754
No 475
>PRK05231 homoserine kinase; Provisional
Probab=97.98 E-value=0.00025 Score=60.39 Aligned_cols=153 Identities=12% Similarity=0.172 Sum_probs=82.0
Q ss_pred CCCCCCCccccccCCcc-----cccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-
Q 022617 5 SNRSSSGVDMFLPNYKL-----GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH- 78 (294)
Q Consensus 5 ~~~~~~~~~~~~~~y~~-----~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~- 78 (294)
|+=+...+..+...|.+ .+.|+.|....+|.+... + ..+++|++. .. . ...+..++.+++.|...+
T Consensus 5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~-~-g~~vLK~~~--~~-~---~~~l~~~~~~l~~L~~~gl 76 (319)
T PRK05231 5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTT-Q-GEYVLTLFE--RL-T---AEDLPFFLGLMQHLAARGV 76 (319)
T ss_pred ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeC-C-CcEEEEEec--cC-C---hHHhHHHHHHHHHHHHCCC
Confidence 33334444445556655 345667777889998753 3 368999875 11 1 233344555555543222
Q ss_pred -eeEEEE------EEEcCCeEEEEEeccCCCChH-----HH------HHH----hCCC--------CH---HHHH-----
Q 022617 79 -IIRLYE------VIETPSDIYVVMEYVKSGELF-----DY------IVE----KGRL--------QE---DEAR----- 120 (294)
Q Consensus 79 -i~~~~~------~~~~~~~~~lv~e~~~~~sL~-----~~------l~~----~~~l--------~~---~~~~----- 120 (294)
+++++. +....+..++++++++|..+. .. +.+ ...+ .. ....
T Consensus 77 pvP~~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~ 156 (319)
T PRK05231 77 PVPAPVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLP 156 (319)
T ss_pred CCCcceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhh
Confidence 344442 122345678999999886431 11 110 0000 00 0000
Q ss_pred -------HHHHH-HHHHHHHHH-------hCCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 121 -------NFFQQ-IISGVEYCH-------RNMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 121 -------~~~~q-l~~~l~~Lh-------~~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
..+.+ +...+..+. ..+++|+|++|.||+++.+....++||+.+.
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 157 FLADEQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccChhHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 01111 111122222 2479999999999999977556899999775
No 476
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.98 E-value=8.7e-05 Score=60.27 Aligned_cols=76 Identities=16% Similarity=0.228 Sum_probs=47.9
Q ss_pred cccccccCceEEEEEEEcc-CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCc-eeEEEEEEEcCCeEEEEEecc
Q 022617 22 GKTLGIGSFGKVKIAEHAL-TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH-IIRLYEVIETPSDIYVVMEYV 99 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 99 (294)
++.|..|-...+|++.... .+..|++|+...... ..-...+|..+++.+...+ .+++++... + .+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788888999997543 356889997653211 1123346888888775444 344544332 2 3799999
Q ss_pred CCCChH
Q 022617 100 KSGELF 105 (294)
Q Consensus 100 ~~~sL~ 105 (294)
+|.++.
T Consensus 75 ~G~~l~ 80 (235)
T cd05157 75 PGRTLE 80 (235)
T ss_pred CCCcCC
Confidence 987763
No 477
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.93 E-value=9.9e-05 Score=62.01 Aligned_cols=141 Identities=16% Similarity=0.264 Sum_probs=86.5
Q ss_pred CcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCC--ceeEEEEEEEcCC--eEEE
Q 022617 19 YKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHP--HIIRLYEVIETPS--DIYV 94 (294)
Q Consensus 19 y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~~~--~~~l 94 (294)
-.+++.+..|....+|...+. ++.+++. . +.............+|+.+++.+..- -+...++++.... ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~-P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-K-PPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEecC--CceEEEe-c-CCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 344555555555667777654 7788888 3 22233345567888999999888653 3444555555444 5699
Q ss_pred EEeccCCCChHHHHHHhCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------
Q 022617 95 VMEYVKSGELFDYIVEKGRLQEDEARNFF-QQIISGVEYCHR-------------------------------------- 135 (294)
Q Consensus 95 v~e~~~~~sL~~~l~~~~~l~~~~~~~~~-~ql~~~l~~Lh~-------------------------------------- 135 (294)
+|++++|..+.+.+.. .+. ..+.+ ..+...|+.||+
T Consensus 103 v~~~veGe~~~~~~~~---~~~--~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 103 VMEWVEGEVVWSALPP---ESL--GRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred EEEEecceeccCcCCc---ccc--hHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9999998433221100 000 00111 123333333332
Q ss_pred --------------------CCceecCCCCCCeEecCCCcEEEeeeccccccc
Q 022617 136 --------------------NMVVHRDLKPENLLLDSKWNVKIADFGLSNIMR 168 (294)
Q Consensus 136 --------------------~~i~h~di~p~nili~~~~~~~l~dfg~~~~~~ 168 (294)
-.++|||+++.|+++++++-+-+.||+.+....
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 248999999999999998889999999987654
No 478
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.84 E-value=0.001 Score=56.46 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=96.0
Q ss_pred ccccccCceEEEEEEEccCCceEEEEEeeccccc--c--------------------hH-HHHHHHHHHHHHHhCCCCce
Q 022617 23 KTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK--N--------------------ME-MEEKVRREIKILRLFMHPHI 79 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~--~--------------------~~-~~~~~~~e~~~l~~l~~~~i 79 (294)
..|+.|.-+.||-|... +|..+|||++..+-.. + +. ..-....|+.-|.++...+|
T Consensus 150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34678888999999864 7888999998533211 0 00 11223456677777776665
Q ss_pred eEEEEEEEcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeEecCCCcEEE
Q 022617 80 IRLYEVIETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCH-RNMVVHRDLKPENLLLDSKWNVKI 158 (294)
Q Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh-~~~i~h~di~p~nili~~~~~~~l 158 (294)
+-+--+.. ..-.|||++++...--.-.-++-.++...+..+-.+++.-+.-|. ..+++|.||+--|+|+..+ .+.+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG-~lyi 305 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG-KLYI 305 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC-EEEE
Confidence 54433332 334689999964222111123456788888888888888887766 5689999999999999765 8999
Q ss_pred eeeccccccc
Q 022617 159 ADFGLSNIMR 168 (294)
Q Consensus 159 ~dfg~~~~~~ 168 (294)
+|.+.+....
T Consensus 306 IDVSQSVE~D 315 (520)
T KOG2270|consen 306 IDVSQSVEHD 315 (520)
T ss_pred EEccccccCC
Confidence 9998876543
No 479
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=97.77 E-value=0.00013 Score=64.20 Aligned_cols=162 Identities=18% Similarity=0.224 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHHhCCCCceeEEEEEEEc-CCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 022617 61 EEKVRREIKILRLFMHPHIIRLYEVIET-PSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMVV 139 (294)
Q Consensus 61 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~~i~ 139 (294)
...+.-.+++++.+.|++....+++-.. .....+|+|++ +.||++.+..+. +-..... .
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~ 85 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------A 85 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------c
Confidence 3567778899999999999999887642 34578899999 559999987654 2222111 2
Q ss_pred ecCCCCCCeEecCCCcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhCCCCCCC
Q 022617 140 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 219 (294)
Q Consensus 140 h~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p~~~ 219 (294)
|+ +-+-|++... | .+++.. |- ...+++|||++|.++.++.-|...+..
T Consensus 86 ~~-~~~~~~~~~t-------d-~~~t~~-----------------~~------~~~pKsdVwsl~~i~~el~L~~~l~~~ 133 (725)
T KOG1093|consen 86 HG-VLHLNIIYIT-------D-HFLTKY-----------------PS------PIGPKSDVWSLGFIILELYLGISLEAE 133 (725)
T ss_pred cc-cceehhhhcc-------c-cccccC-----------------CC------CCCcchhhhhHHHHHHHHHHhhHHHHH
Confidence 22 2222222222 2 111100 11 113589999999999999999877766
Q ss_pred CCHHHHHHHHhCCCccC------------CCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCccccc
Q 022617 220 ENIPNLFKKIKGGIYTL------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 274 (294)
Q Consensus 220 ~~~~~~~~~~~~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~~~~ 274 (294)
....+..+.+.+-.... .-.++..+..+...|+-..|..||...++.+++-|...
T Consensus 134 ~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 134 LTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 65555555443322111 12356667788999999999999999999999999775
No 480
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.75 E-value=0.00022 Score=60.31 Aligned_cols=75 Identities=16% Similarity=0.209 Sum_probs=47.4
Q ss_pred ccccccCceEEEEEEEcc------CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEE
Q 022617 23 KTLGIGSFGKVKIAEHAL------TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVV 95 (294)
Q Consensus 23 ~~lg~g~~~~vy~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv 95 (294)
+.+..|-...+|++.... .++.+++|+..... .......+|..+++.+...++ +++++++. + ..+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 456667777999887543 25789999965432 112355677777777764333 45555543 2 357
Q ss_pred EeccCCCChH
Q 022617 96 MEYVKSGELF 105 (294)
Q Consensus 96 ~e~~~~~sL~ 105 (294)
+++++|.++.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 8998887664
No 481
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=97.73 E-value=4e-06 Score=81.77 Aligned_cols=205 Identities=19% Similarity=0.106 Sum_probs=138.6
Q ss_pred HHHHHHHhCCCCceeEEEEEEE--cCCeEEEEEeccCCCChHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---
Q 022617 66 REIKILRLFMHPHIIRLYEVIE--TPSDIYVVMEYVKSGELFDYIVEK----GRLQEDEARNFFQQIISGVEYCHRN--- 136 (294)
Q Consensus 66 ~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~----~~l~~~~~~~~~~ql~~~l~~Lh~~--- 136 (294)
.|..-++...|+++.....-.. +....+..++++.+|.+.+.|-+. .++....+.....+.+.+....|..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 3444455567877766554432 234467788999999999988543 2344444444444446666665533
Q ss_pred C--ceecCCCCCCeEecCCCcEEEeeecccccc-cCCCccccccCCCcccCCccccCCccCCCchhHHHHHHHHHHHHhC
Q 022617 137 M--VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG 213 (294)
Q Consensus 137 ~--i~h~di~p~nili~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 213 (294)
| .+|.++++.|.+|..+-+++++++|+.+.. +.........+++.|+.|+..+.-++ +.++|+|..|+.+|....|
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcc
Confidence 2 678999999999999999999999999833 33334455567888999999887777 5669999999999999888
Q ss_pred CCCCCCCCHHHHHHHHhCCC-ccCCCCCChhHHHHHHHhcccCCCCCCCHhHHhcCCcc
Q 022617 214 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 271 (294)
Q Consensus 214 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~h~~~ 271 (294)
..+|..-....+...+.... ...+...|.+.......+|.+...+||.-...+.-+.|
T Consensus 1437 n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1437 NAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred cHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence 77763322222222222222 23344455666667777777888899998888887766
No 482
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.43 E-value=0.0027 Score=55.35 Aligned_cols=77 Identities=19% Similarity=0.132 Sum_probs=51.4
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeeccccc-c---hHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEE
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK-N---MEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIY 93 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~-~---~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 93 (294)
..+.||.|....||++.+. +..++||.-...... . .........|...|+.+. ...+++++.++. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4667899999999999873 456999986522211 1 013444455566666554 247888998876 4456
Q ss_pred EEEeccCC
Q 022617 94 VVMEYVKS 101 (294)
Q Consensus 94 lv~e~~~~ 101 (294)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999976
No 483
>PLN02236 choline kinase
Probab=97.37 E-value=0.0021 Score=55.35 Aligned_cols=142 Identities=18% Similarity=0.166 Sum_probs=81.7
Q ss_pred cCCcccccccccCceEEEEEEEcc----CCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCe
Q 022617 17 PNYKLGKTLGIGSFGKVKIAEHAL----TGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSD 91 (294)
Q Consensus 17 ~~y~~~~~lg~g~~~~vy~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~ 91 (294)
....-.+.+..|-...+|++.... .++.+++|+..... ..... -.+|..+++.+...++ +++++.+.. .
T Consensus 36 ~~~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g- 109 (344)
T PLN02236 36 DEALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G- 109 (344)
T ss_pred cCcEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c-
Confidence 334445566678888999987532 24679999875432 11122 2567888877765444 355565532 2
Q ss_pred EEEEEeccCCCChHHH-------H----H---H--hC-------CCCHHHHHHHHHHH-----------------HHHHH
Q 022617 92 IYVVMEYVKSGELFDY-------I----V---E--KG-------RLQEDEARNFFQQI-----------------ISGVE 131 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~-------l----~---~--~~-------~l~~~~~~~~~~ql-----------------~~~l~ 131 (294)
.+.+|+++.++... + + + +. +...+.+..++.++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 57888887776421 1 0 0 00 01122222322111 11121
Q ss_pred HHH--------hCCceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617 132 YCH--------RNMVVHRDLKPENLLLDS-KWNVKIADFGLSNI 166 (294)
Q Consensus 132 ~Lh--------~~~i~h~di~p~nili~~-~~~~~l~dfg~~~~ 166 (294)
.|. ...++|+|+++.||++++ ++.+.++||..+..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 221 235899999999999986 46799999998753
No 484
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=97.33 E-value=0.0023 Score=53.26 Aligned_cols=30 Identities=27% Similarity=0.568 Sum_probs=25.2
Q ss_pred CceecCCCCCCeEecCCCc-EEEeeeccccc
Q 022617 137 MVVHRDLKPENLLLDSKWN-VKIADFGLSNI 166 (294)
Q Consensus 137 ~i~h~di~p~nili~~~~~-~~l~dfg~~~~ 166 (294)
.++|+|++|.||+++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 56999998764
No 485
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=97.30 E-value=0.0018 Score=55.51 Aligned_cols=137 Identities=12% Similarity=0.177 Sum_probs=77.0
Q ss_pred cccccccCceEEEEEEEccC---CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeEEEEEe
Q 022617 22 GKTLGIGSFGKVKIAEHALT---GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDIYVVME 97 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e 97 (294)
.+.|..|-...+|++..... +..|++|+..... . . .-.-.+|..+++.+...++ +++++++. +. ++.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~--~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-D--Y-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-C--e-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--Eeeh
Confidence 44555577778998875432 2378999874321 1 1 1122567777777765555 45565552 22 4889
Q ss_pred ccCCCChHH-------HHH-------H--hCC------C-CHHHHHHHHHHH----------------------HHHHHH
Q 022617 98 YVKSGELFD-------YIV-------E--KGR------L-QEDEARNFFQQI----------------------ISGVEY 132 (294)
Q Consensus 98 ~~~~~sL~~-------~l~-------~--~~~------l-~~~~~~~~~~ql----------------------~~~l~~ 132 (294)
|++|.+|.. .+. + ..+ . ....+..+..++ ...+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 988776532 111 0 101 1 112222222221 111222
Q ss_pred HH----hC----CceecCCCCCCeEecC-CCcEEEeeeccccc
Q 022617 133 CH----RN----MVVHRDLKPENLLLDS-KWNVKIADFGLSNI 166 (294)
Q Consensus 133 Lh----~~----~i~h~di~p~nili~~-~~~~~l~dfg~~~~ 166 (294)
+. .. -++|+|+.+.||++++ ++.++++||+.+..
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 21 11 2899999999999975 56899999998753
No 486
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=97.27 E-value=0.0063 Score=52.16 Aligned_cols=76 Identities=16% Similarity=0.029 Sum_probs=49.0
Q ss_pred cccccCceEEEEEEEccCCceEEEEEeecccc----cchHHHHHHHHHHHHHHhCC--CC-ceeEEEEEEEcCCeEEEEE
Q 022617 24 TLGIGSFGKVKIAEHALTGHKVAIKILNRRKI----KNMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 24 ~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~----~~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv~ 96 (294)
.||.|....||++.+...++.++||.-...-. ...-...+..-|...|+... .| .+++++.+- +....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cccceehH
Confidence 57999999999999864346899998542211 11234456667777777654 24 456666543 44556889
Q ss_pred eccCC
Q 022617 97 EYVKS 101 (294)
Q Consensus 97 e~~~~ 101 (294)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 88854
No 487
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=97.14 E-value=0.024 Score=48.06 Aligned_cols=30 Identities=20% Similarity=0.328 Sum_probs=27.5
Q ss_pred CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 137 ~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
+++|+|+.++||++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999998999999998753
No 488
>PRK10593 hypothetical protein; Provisional
Probab=97.09 E-value=0.0076 Score=50.79 Aligned_cols=107 Identities=11% Similarity=0.117 Sum_probs=74.9
Q ss_pred CCcccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCC---CceeEEEEEEEc---CCe
Q 022617 18 NYKLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMH---PHIIRLYEVIET---PSD 91 (294)
Q Consensus 18 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~ 91 (294)
.-.-.+.||.|..+.||..... ++ .+++|.... . .....+..|...++.+.. -.++++++++.. .+.
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~ 87 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDS-QG-NPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP 87 (297)
T ss_pred hhheeeecCCccceeEEEEEcC-CC-CEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence 3344667999999999998753 23 477787432 1 113578889999988864 368888887754 366
Q ss_pred EEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC
Q 022617 92 IYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN 136 (294)
Q Consensus 92 ~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~ 136 (294)
.+++||+++|.++.+. ..+......+..+++++++-||+.
T Consensus 88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 8999999999877651 123444556667788888888874
No 489
>PRK12396 5-methylribose kinase; Reviewed
Probab=97.04 E-value=0.0065 Score=52.74 Aligned_cols=78 Identities=19% Similarity=0.132 Sum_probs=51.5
Q ss_pred cccccccCceEEEEEEEccCCceEEEEEeeccccc---chHHHHHHHHHHHHHHhCC--CC-ceeEEEEEEEcCCeEEEE
Q 022617 22 GKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIK---NMEMEEKVRREIKILRLFM--HP-HIIRLYEVIETPSDIYVV 95 (294)
Q Consensus 22 ~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~lv 95 (294)
.+.||.|....||++.+...++.++||.-...-.. ..-...+..-|.+.|+... .| .+++++.+- +....++
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 56789999999999998544567999975422111 1234567777888887664 34 566666553 3455577
Q ss_pred EeccCC
Q 022617 96 MEYVKS 101 (294)
Q Consensus 96 ~e~~~~ 101 (294)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 887743
No 490
>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=96.92 E-value=0.015 Score=46.44 Aligned_cols=77 Identities=17% Similarity=0.161 Sum_probs=56.0
Q ss_pred ccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEEEEe
Q 022617 21 LGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVME 97 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e 97 (294)
..+.+..|.--..|...+ ...++.+|+= .......+..|+.-|+.+. .-.+++++....+..+.|+|+|
T Consensus 20 er~~v~gG~inea~~v~d--g~~~~FvK~n------~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle 91 (286)
T COG3001 20 EREEVSGGDINEAWRLRD--GTDPFFVKCN------QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLE 91 (286)
T ss_pred cccccCCccccceeEeec--CCcceEEEec------chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEe
Confidence 345566677777787765 4567889973 2233566777777666554 4568889999999999999999
Q ss_pred ccCCCChH
Q 022617 98 YVKSGELF 105 (294)
Q Consensus 98 ~~~~~sL~ 105 (294)
|++.+.+.
T Consensus 92 ~L~~~~~d 99 (286)
T COG3001 92 YLPTGPLD 99 (286)
T ss_pred eccCCCCC
Confidence 99887665
No 491
>PTZ00384 choline kinase; Provisional
Probab=96.78 E-value=0.031 Score=48.77 Aligned_cols=78 Identities=15% Similarity=0.106 Sum_probs=45.4
Q ss_pred cccccccccCceEEEEEEEccC-Cce-----EEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCeE
Q 022617 20 KLGKTLGIGSFGKVKIAEHALT-GHK-----VAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSDI 92 (294)
Q Consensus 20 ~~~~~lg~g~~~~vy~~~~~~~-~~~-----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 92 (294)
...+.|..|-...+|++..... +.. |++++... .. ...-.-.+|+.+++.+...++ +++++.+. -
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~ 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----D 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC---CC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----C
Confidence 3455666688889999975432 122 44443211 11 111122568888888876554 55666653 2
Q ss_pred EEEEeccCCCChH
Q 022617 93 YVVMEYVKSGELF 105 (294)
Q Consensus 93 ~lv~e~~~~~sL~ 105 (294)
+++.||++|.+|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5889999987664
No 492
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=96.77 E-value=0.014 Score=49.83 Aligned_cols=119 Identities=19% Similarity=0.261 Sum_probs=75.3
Q ss_pred CCceeEEEEEE-EcCCeEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeEecCC
Q 022617 76 HPHIIRLYEVI-ETPSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRN-MVVHRDLKPENLLLDSK 153 (294)
Q Consensus 76 ~~~i~~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~Lh~~-~i~h~di~p~nili~~~ 153 (294)
.++..+.+-+- .+..+.|+++++. |+++.. + +.-..+++..++.+.+..++-+... .+-|+++...||+|+ +
T Consensus 284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred chhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34444433332 3345677888887 445542 2 2235678888888888888877754 589999999999999 8
Q ss_pred CcEEEeeecccccccCCCccccccCCCcccCCccccCCccCCCchhHHHHHHH
Q 022617 154 WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI 206 (294)
Q Consensus 154 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~l 206 (294)
|++.|+||-+++........... ..--|-.+.|.. +..-+||-+-..
T Consensus 358 GnvtLIDfklsRl~~~q~~isy~----rldhp~lF~G~d--d~QFeIYrlMr~ 404 (488)
T COG5072 358 GNVTLIDFKLSRLSYSQGIISYN----RLDHPDLFNGVD--DYQFEIYRLMRR 404 (488)
T ss_pred CceEEEEeeeeecccCCceeecc----ccCchhhhcCcc--ceeeeHHHHHHH
Confidence 89999999999843332222111 222333344333 567788775443
No 493
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=96.76 E-value=0.0083 Score=50.13 Aligned_cols=75 Identities=12% Similarity=0.178 Sum_probs=47.7
Q ss_pred cccccccccCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCC---CCceeEEEEEEEcCCeEEEEE
Q 022617 20 KLGKTLGIGSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFM---HPHIIRLYEVIETPSDIYVVM 96 (294)
Q Consensus 20 ~~~~~lg~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~ 96 (294)
+-.+.++.|..+.+|... .+++.+.+|+-.. .....+..|.+-|+.|. .-.+++++++....+.-++++
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 335667888889999887 5778899998642 22346677777777774 456889999998887889999
Q ss_pred eccCCC
Q 022617 97 EYVKSG 102 (294)
Q Consensus 97 e~~~~~ 102 (294)
|+++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 998765
No 494
>PRK11768 serine/threonine protein kinase; Provisional
Probab=96.61 E-value=0.07 Score=45.64 Aligned_cols=71 Identities=10% Similarity=0.079 Sum_probs=41.3
Q ss_pred cCceEEEEEEEccCCceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce--eEEE---E--EEEcCCeEEEEEeccC
Q 022617 28 GSFGKVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI--IRLY---E--VIETPSDIYVVMEYVK 100 (294)
Q Consensus 28 g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--~~~~---~--~~~~~~~~~lv~e~~~ 100 (294)
+....||.+... ++..+++|+...... ....+..|.+.+..|....+ +... + ....++..+.++++.+
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 344578988753 566799998753322 23556667777665542221 2211 1 1223466788999988
Q ss_pred CCC
Q 022617 101 SGE 103 (294)
Q Consensus 101 ~~s 103 (294)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 764
No 495
>PTZ00296 choline kinase; Provisional
Probab=96.18 E-value=0.2 Score=44.73 Aligned_cols=76 Identities=12% Similarity=0.077 Sum_probs=44.5
Q ss_pred ccccccccCceEEEEEEEccC--------CceEEEEEeecccccchHHHHHHHHHHHHHHhCCCCce-eEEEEEEEcCCe
Q 022617 21 LGKTLGIGSFGKVKIAEHALT--------GHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPHI-IRLYEVIETPSD 91 (294)
Q Consensus 21 ~~~~lg~g~~~~vy~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~ 91 (294)
-++.|..|-...+|++..... ++.|++++.-... .... .-.+|..+++.+...++ +++++.+.
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~---- 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS---- 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC----
Confidence 456666777778888875421 4678999874321 1111 23456666666654444 34555442
Q ss_pred EEEEEeccCCCCh
Q 022617 92 IYVVMEYVKSGEL 104 (294)
Q Consensus 92 ~~lv~e~~~~~sL 104 (294)
-+.+.+|++|.+|
T Consensus 181 gg~I~efi~g~~l 193 (442)
T PTZ00296 181 GGRIEEWLYGDPL 193 (442)
T ss_pred CCEEEEeeCCccC
Confidence 2357888887644
No 496
>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]
Probab=95.96 E-value=0.029 Score=46.49 Aligned_cols=45 Identities=24% Similarity=0.443 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHhC--CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 122 FFQQIISGVEYCHRN--MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 122 ~~~ql~~~l~~Lh~~--~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
.+..+-.++.-++.. -++|+|+.|.|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 344444444444444 599999999999999988999999997753
No 497
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=95.81 E-value=0.045 Score=47.53 Aligned_cols=60 Identities=20% Similarity=0.287 Sum_probs=44.9
Q ss_pred eEEEEEeccCCCChHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeEec
Q 022617 91 DIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEY-CHRNMVVHRDLKPENLLLD 151 (294)
Q Consensus 91 ~~~lv~e~~~~~sL~~~l~~~~~l~~~~~~~~~~ql~~~l~~-Lh~~~i~h~di~p~nili~ 151 (294)
...++-+|..|.++..+++.. ..+++....++.-...|+-. |--.+++|.|++|.||++.
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred cceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 345677788899999998643 34566677777777777655 4456799999999999994
No 498
>PRK06148 hypothetical protein; Provisional
Probab=95.61 E-value=0.59 Score=46.43 Aligned_cols=31 Identities=29% Similarity=0.457 Sum_probs=25.9
Q ss_pred CCceecCCCCCCeEecCCC--cEE-Eeeeccccc
Q 022617 136 NMVVHRDLKPENLLLDSKW--NVK-IADFGLSNI 166 (294)
Q Consensus 136 ~~i~h~di~p~nili~~~~--~~~-l~dfg~~~~ 166 (294)
.+++|+|+.+.||+++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4699999999999999875 454 999998754
No 499
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=95.37 E-value=0.043 Score=46.48 Aligned_cols=29 Identities=28% Similarity=0.402 Sum_probs=25.4
Q ss_pred CCceecCCCCCCeEecCCCcEEEeeecccc
Q 022617 136 NMVVHRDLKPENLLLDSKWNVKIADFGLSN 165 (294)
Q Consensus 136 ~~i~h~di~p~nili~~~~~~~l~dfg~~~ 165 (294)
.+++|||+++.||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999988 578999999664
No 500
>PRK10271 thiK thiamine kinase; Provisional
Probab=95.18 E-value=0.018 Score=44.72 Aligned_cols=29 Identities=17% Similarity=0.315 Sum_probs=25.5
Q ss_pred CceecCCCCCCeEecCCCcEEEeeeccccc
Q 022617 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNI 166 (294)
Q Consensus 137 ~i~h~di~p~nili~~~~~~~l~dfg~~~~ 166 (294)
..+|+|+.|.|+++++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 479999999999998876 99999998754
Done!